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  In Memoriam: Tatyana Borisovna Dmitrieva 
 
 
 After graduating from the Ivanovo State Medical Institute, Tatyana Borisovna 
Dmitrieva worked as a psychiatrist in the Ivanovo Regional Psychiatric Hospital. 
After she received a PhD in psychiatry at the V.P. Serbsky State Research Centre for 
Social and Forensic Psychiatry in Moscow, she continued to be associated with the 
Centre, becoming its Director in 1990. She became a Professor of Medicine in 1993.  
 In addition to her teaching activities, Ms. Dmitrieva was very active in 
research in public health medicine, forensic psychiatry and social psychiatry, 
publishing numerous research papers and books, including manuals on the subject 
of forensic psychiatric expertise. She also wrote two books for a more general 
readership: Character: Russian, in which she analysed the Russian mentality and its 
historical roots; and Alliance of Human Rights and Mercy. 
 Her academic achievements were formally recognized in 1997, when she 
became a member of the Russian Academy of Medical Sciences. She later became a 
member of its Presidium. 
 Ms. Dmitrieva also made major contributions to policymaking at the highest 
level of government. In 1996, she became Chairman of the Russian Security 
Council Commission on Health Protection. From 1996 to 1998, she was Minister of 
Health of the Russian Federation; she was also Deputy Chairperson of the State 
Commission for Counteracting Drug Abuse and Illegal Traffic. In 2005, she became 
the Chairperson of the Russian Federation Public Council of Carers and Users of 
Psychiatric Services. She played a key role in the creation of a new organizational 
and legislative basis for forensic psychiatric services in the Russian Federation.  
 Ms. Dmitrieva received numerous national awards, including the Order of 
Honour, the highest decoration in the Russian Federation. She became a member of 
the International Narcotics Control Board in 2005, serving as its Rapporteur in 
2006, as Chairperson of the Standing Committee on Estimates and Second  
Vice-President of the Board in 2007 and as First Vice-President of the Board in 
2009. She was to start her second term as a member of the Board in May 2010. 
 In recognition of her contribution to international drug control, the Board 
wishes to dedicate this report to the memory of Tatyana Borisovna Dmitrieva. She 
will be remembered as a talented researcher, an able policymaker and a remarkably 
warm and kind person. 
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  Foreword 
 
 
 The international drug control conventions enjoy almost universal adherence 
and the International Narcotics Control Board monitors their implementation by 
Governments to ensure that there is a sufficient supply of narcotic drugs and 
psychotropic substances used for scientific and medical purposes. As a result of the 
implementation of the conventions, the diversion of controlled substances at the 
international level has been virtually eliminated. Furthermore, Governments have 
intensified their efforts to prevent the diversion of precursor chemicals used in the 
illicit manufacture of drugs. Unfortunately, corruption is undermining international 
efforts to eliminate problems related to controlled drugs. Thus, chapter I of the 
present report is devoted to the issue of drugs and corruption.  
 By systematically using violence and corruption, intimidating and 
blackmailing public officials, wealthy and powerful organized criminal groups have 
been able to weaken law enforcement and judicial systems. Violence is often used to 
threaten or punish “whistle-blowers”. Witnesses who provide evidence of drug-
related corruption often risk their lives and the lives of their family members. 
Unless the vicious cycle of corruption and drug trafficking is broken, international 
drug control efforts cannot be fully successful.  
 Developing countries and societies in post-conflict situations are particularly 
vulnerable to drug-related corruption. Corruption facilitates the illicit drug trade, 
which, if left unchecked, can destabilize economies, political systems and civil 
society and eventually threaten peace and security. In severe cases, organized 
criminal groups exert their considerable political influence to gain control over large 
population groups or geographical areas.  
 Law enforcement and customs authorities throughout the world are highly 
vulnerable to drug-related corruption. Drug control units are at risk of being 
infiltrated by criminal groups, which often have at their disposal enormous 
resources and sophisticated technology. Regulatory agencies are also exposed to 
drug-related corruption, as drug traffickers must engage in money-laundering to 
hide their huge profits. If military units are used in illicit crop eradication and 
border control, they may also be exposed to drug-related corruption. The judicial 
system may also be affected by drug-related corruption and intimidation.  
 In spite of the power of organized criminal groups, the overwhelming majority 
of law enforcement and judicial officials worldwide manage to resist corruption and 
intimidation. Regrettably, some law enforcement and judicial officials lose their 
lives fighting drug-related corruption. 
 Another challenge is to ensure the availability of medication containing 
substances under international control. In many countries, access to such controlled 
substances for use in the treatment of severe pain is limited or non-existent. In view 
of the seriousness of the problem, the Board has decided to issue a supplement to 
the present report: a report on the availability of internationally controlled drugs. 
 Global consumption of opioid analgesics used for pain management has 
increased significantly. For example, global consumption of morphine increased by 
a factor of almost 7 in the period 1989-2009. However, the increase in morphine 
consumption has been considerably higher in some regions and there are disparities 
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among countries in each region. The highest levels of consumption of opioid 
analgesics are reported in countries in North America and Europe. Governments 
must identify problems encountered in ensuring the availability of controlled 
substances used for medical purposes and, if necessary, take appropriate measures to 
remedy the situation. In addition, Governments must have monitoring and control 
systems in place to ensure that narcotic drugs and psychotropic substances are used 
only for legitimate medical purposes.  
 The use of substances, including pharmaceutical preparations, to facilitate the 
commission of crime continues to be a cause for concern. Much media attention has 
been given to the use of so-called “date-rape drugs”, such as flunitrazepam, to 
facilitate sexual assault. “Designer drugs”, substances that have been developed 
especially to avoid existing drug control measures, are a major concern. “Designer 
drugs” are manufactured by making a minor modification to the molecular structure 
of controlled substances, resulting in new substances with pharmacological effects 
similar to those of the controlled substances. Instructions for manufacturing 
“designer drugs” can often be easily found on the Internet. One widely publicized 
“designer drug”, mephedrone, has been reported in an increasing number of 
countries and regions, and many countries have placed it under national control. As 
synthetic cannabinoid receptor agonists, marketed under brand names such as Spice, 
are becoming more and more available, there has been increasing concern about the 
health risks of such products. In some countries, certain synthetic cannabinoid 
receptor agonists have been added to the list of substances controlled under national 
legislation. Governments and relevant international organizations must develop 
comprehensive measures to counter the problem of “designer drugs”. There is a 
need for similar action to be taken with regard to precursor chemicals, as 
Governments are increasingly being confronted with substances not under 
international control and substitutes for controlled precursors, including substances 
that are specifically designed to circumvent existing controls and that can be 
reconverted into controlled precursors using readily available means. 
 In Africa, the lack of regulatory controls and the availability of controlled 
substances on the unregulated market pose a significant health risk. In South 
America, while the total area under illicit coca bush cultivation decreased in 2009, 
there was an increase in the abuse of cocaine in the Southern Cone. In Afghanistan, 
there continues to be a high level of illicit opium poppy cultivation; efforts to 
reduce such cultivation have been hindered by corruption, lack of security and 
limited law enforcement capacity. In South-East Asia, there was an increase in illicit 
opium poppy cultivation in the so-called Golden Triangle, which accounted for  
5 per cent of global opium poppy cultivation. Increased trafficking in amphetamine-
type stimulants remains a major problem in East and South-East Asia. South Asia is 
now one of the main regions used as a source of precursor chemicals required for 
the illicit manufacture of methamphetamine.  
 The present report highlights the many challenges faced in drug control. It 
presents a realistic snapshot of the current drug control situation throughout the 
world. The news is not all bad. Governments have gained experience in preventing 
and treating drug abuse. There is broad recognition of the fact that the drug-related 
problems must be tackled by using a delicate balance of both supply and demand 
reduction measures. There are regional and international mechanisms for promoting 
cooperation in drug control. Non-governmental organizations are playing an 
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increasingly important role in highlighting the need for equitable access to 
medicines used for the treatment of pain. The need to ensure respect for human 
rights in supply and demand reduction measures is emphasized repeatedly by 
international organizations and non-governmental organizations. Organized criminal 
groups are dynamic — always seeking the path of least resistance. It is only 
together — through cooperation — that the international community can make real 
progress in its efforts to prevent drug-related problems and continue to ensure the 
availability of controlled drugs for medical and scientific purposes.  
 
Hamid Ghodse 
President 
International Narcotics Control Board 
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 I. Drugs and corruption 
 
 
1. Nothing has a more debilitating effect on efforts 
to curtail the illicit drug trade than the successful 
attempts of criminal organizations to intimidate  
and corrupt public officials. Nothing undermines 
international drug control efforts as much as the 
numerous cases of corrupt officials who facilitate or 
participate in drug trafficking. Yet violence and 
corruption are integral parts of illicit drug markets.  
2. Intimidation and corruption are the most effective 
tools used by organized criminal groups to counter the 
drug control efforts of law enforcement agencies. They 
are two sides of the same coin. An organized criminal 
group can purchase the complicity of a public official 
just as easily as it can pay for his or her assassination. 
The intimidation or corruption of public officials is 
ultimately what empowers criminal organizations, 
often placing the organizations beyond the reach of the 
law. Corruption is a pernicious phenomenon that has a 
deep and detrimental effect on people, societies and 
social institutions. It is frequently responsible for the 
disappointing results (or outright failure) of drug 
control efforts. 
3. When it comes to fighting organized crime and 
stopping the illicit drug trade, the police, together with 
other criminal justice officials, have a difficult and 
often dangerous task. They work tirelessly and 
courageously, but the odds are often stacked against 
them when they confront some of the wealthy and 
powerful criminal organizations involved in drug 
trafficking. In some cases, the police face incredible 
pressure from organized crime: when they are not 
fending off attacks or immediate threats of violence 
and retaliation, they are thwarting attempts to corrupt 
officials, including officials from their own ranks. In 
spite of the power of organized crime, an 
overwhelming number of law enforcement and judicial 
officials worldwide resist corruption and intimidation. 
Regrettably, some law enforcement and judicial 
officials even lose their lives in the fight against drug-
related corruption.  
4. Without adequate support and protection, many 
law enforcement and judicial officials find themselves 
confronted with a difficult choice: to become victims 
of violence and possibly even lose their lives; or to 
sacrifice their integrity and become the accomplices of 
ruthless criminals. If they choose to accept a bribe, for 
example, they (and many of the drug control efforts of 
the law enforcement and criminal justice institutions 
for which they work) are compromised forever.  
5. Vast drug trafficking networks have emerged in 
most parts of the world, extending across borders. The 
huge profits generated by illicit drug markets fuel the 
growth of powerful criminal organizations, whose 
financial resources sometimes exceed those of state 
institutions. That the intimidation and corruption of 
public officials facilitate the exploitation of those illicit 
drug markets by criminal organizations is a fact that 
cannot be neglected. All of the factors described above 
contribute to the weakening of law enforcement and 
criminal justice institutions. They constitute a threat to 
national and international security and stability. 
6. Over the years, the International Narcotics 
Control Board has expressed its deep concern about the 
many ways in which the illicit drug trade is facilitated 
by violence and corruption. The Board is responsible 
for examining the functioning of the international drug 
control mechanisms at the national and international 
levels. Thus, the Board is well aware of how the huge 
profits generated by illicit drug markets have fuelled 
corruption. It is also quite aware of the fact that 
corruption and the illicit drug trade are interlocked 
with each other in mutually reinforcing cycles. The 
Board is very concerned about the broader social 
consequences of drug-related corruption, including the 
fact that in some cases the illicit drug trade and the 
accompanying violence and corruption have weakened 
governments and debilitated social institutions.  
7. It is important to recognize that drug-related 
corruption, or “narco-corruption” as it is often called, 
allows some criminal organizations to perpetuate their 
illicit activities, to operate with minimal interference 
from the authorities and to derive maximum profit 
from illicit drug markets. For international drug control 
to be more effective, the violence and corruption 
associated with drug trafficking must be addressed 
more resolutely and more systematically. Drug control 
strategies must be informed by a better understanding 
of how criminal organizations conspire to buy the 
complicity of key officials, particularly law 
enforcement and criminal justice officials, and often 
succeed in weakening drug control initiatives and 
operating with relative impunity. The stakes are high. 
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The widespread corruption and recurring violence 
associated with illicit drug markets can easily get out 
of control and disrupt or completely paralyse existing 
drug control mechanisms.  
8. Combating corruption is an essential element of 
any comprehensive strategy to curb drug trafficking. 
Putting in place effective measures to counter 
corruption is one way to reduce the illicit drug trade 
and the proliferation of powerful organized criminal 
groups. The present chapter focuses on the issue of 
corruption and the complex linkages between it and 
illicit drug markets, as well as on strategies to fight 
drug-related corruption. The Board’s main interest lies 
in identifying practical measures and strategies that can 
be used to help counter drug-related corruption at the 
national and international levels. Some of those 
measures are not very different from those designed to 
combat corruption in general. Others will need to be 
carefully integrated into existing drug control 
strategies.  
9. International cooperation in repressing drug 
trafficking and the related violence and corruption is a 
necessity. It was precisely the need to foster such 
cooperation that led to the establishment of the 
International Narcotics Control Board in 1961 and the 
adoption of the United Nations Convention against 
Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 1988.1 Since then, other international 
instruments have been adopted to remove obstacles to 
international cooperation in fighting organized crime 
and corruption. Over the past 10 years or so, the 
implementation of the United Nations Convention 
against Transnational Organized Crime2 and the United 
Nations Convention against Corruption3 has led to the 
development of some effective tools for the prevention 
and control of organized crime and corruption. Those 
tools can be used to fight drug-related corruption and 
can help States cooperate more effectively in efforts to 
disrupt drug trafficking operations. 
10. In this chapter, there is a brief section on 
corruption and illicit drug markets and on the impact of 
drug-related corruption. That is followed by a section 
on the corrupting influence of organized crime and 
how it can undermine international drug control 
__________________ 
 1  United Nations, Treaty Series, vol. 1582, No. 27627. 
 2  Ibid., vol. 2225, No. 39574. 
 3  Ibid., vol. 2349, No. 42146. 
efforts; that section includes a discussion on some of 
the main manifestations of drug-related corruption 
among the police, the military and the judiciary, as 
well as among policymakers and politicians. The third 
section outlines some strategies for controlling  
drug-related corruption and emphasizes the particular 
importance of international cooperation in addressing 
that problem. The final section contains a list of 
recommendations made by the Board to prompt 
Governments and drug control authorities to reconsider 
what they can do to prevent and control drug-related 
corruption.  
 
 
 A. Drug-related corruption and its impact 
 
 
 1. What is corruption 
 
11. Corruption is not a new phenomenon, nor is it a 
simple one. There may not be universal agreement on a 
definition of corruption, but corruption in one form or 
another is condemned everywhere. It takes on many 
forms, reflecting the many ways in which people use 
and exchange wealth and power and the relative 
strength of the norms and institutions that govern and 
control those exchanges. In the final analysis, it is  
the responsibility of governments to protect their 
populations against intimidation and corruption. 
12. There is no reason to believe that drug-related 
corruption is fundamentally different from other forms 
of corruption. Bribery, bribe-seeking and extortion are 
often associated with drug trafficking or organized 
crime in general, but they are also prevalent in many 
other social and economic areas. In some instances, 
other types of corruption may also be significant and 
damaging; examples of such corruption include 
electoral fraud; procurement fraud; or corruption 
related to the smuggling of migrants, trafficking in 
persons, trafficking in firearms or the illicit trade in 
diamonds. Bribery in international business 
transactions, for example, has been and continues to be 
a major concern.4 That type of corruption can have a 
__________________ 
 4 See, for example, the Organization for Economic 
Cooperation and Development (OECD) Convention on 
Combating Bribery of Foreign Public Officials in 
International Business Transactions; the United Nations 
Convention against Corruption; and the United Nations 
Declaration against Corruption and Bribery in 
International Commercial Transactions (General 
Assembly resolution 51/191, annex). 
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devastating effect on good governance and economic 
development. 
13. In the absence of a universal definition of 
corruption, legal definitions have been limited to the 
definition of certain acts of corruption. For example, 
States parties to the United Nations Convention against 
Corruption are required to criminalize a number of 
specific acts such as bribery, illicit enrichment, abuse 
of function, trading in influence, embezzlement and 
misappropriation or other diversion of property by a 
public official. Corruption tends to involve the abuse 
of entrusted power. For a public official, it involves 
giving or obtaining an advantage through illegitimate 
means or through means inconsistent with his or her 
duty.  
14. Beyond legal definitions, there are some cultural 
and historical differences in how corruption is defined 
and perceived in various parts of the world. Cultural 
differences are very relevant, especially as they relate 
to social status, gift-giving, family ties, reciprocity and 
community, and they must be acknowledged. Paying 
attention to those cultural variations may lead to a 
better understanding of how people in different cultural 
contexts recognize and respond to corrupt behaviour. 
However, such cultural differences should not be used 
to justify corruption. In virtually all cultures, corrupt 
conduct seems to be regarded as unacceptable.  
15. Corruption needs to be understood in the 
political, economic and social context within which it 
occurs. For example, the level of tolerance towards 
corruption, irrespective of existing legislation, may 
vary from one context to another. Understanding why 
corruption is tolerated or even accepted in some 
contexts is equally relevant. Corruption, in some 
circumstances, may be a natural social reaction to 
institutional failure. Individuals may feel that the cost 
of fighting corruption is greater than the benefits that 
could be accrued by eradicating it. Some groups may 
perceive corruption as instrumental and expedient in 
achieving some legitimate collective or political goals. 
Ultimately, however, corruption can only lead to a 
weakening of social and political institutions. A vicious 
cycle is created whereby corruption undermines 
effective governance and ineffective governance breeds 
corruption. 
 
 2. Corruption and illicit drug markets 
 
16. Illicit drug markets are complex and constantly 
changing; they also tend to be quite resilient. Drug 
traffickers adapt quickly in order to counter 
governments’ efforts. Drug trafficking activities are 
frequently displaced when law enforcement initiatives 
threaten to disrupt them. A minimum level of 
sophistication and organization is required in order for 
any group to effectively exploit the illicit drug markets. 
That is why criminal organizations tend to dominate 
such markets. The most successful criminal 
organizations are usually those that are able to make 
strategic use of violence and systematic use of 
corruption and intimidation to weaken official controls 
and law enforcement. What criminal organizations 
cannot achieve through corruption, they achieve 
through violence and intimidation. That is why cities, 
countries or other geographical areas exposed to 
intensified drug trafficking activities often have a high 
incidence of violence and corruption.  
17. Some criminal organizations focus their activities 
entirely on the illicit drug markets. Others have added 
illicit drug production and drug trafficking to their 
criminal activities. For them, illicit drug production 
and drug trafficking and related criminal activities 
represent sources of enormous revenue. Since criminal 
organizations must mitigate the risk of detection and 
prosecution, they use the proceeds of their illegal 
activities to corrupt law enforcement, justice and other 
officials, to obstruct justice and to enable them to 
operate as much as possible without interference. In 
many instances, criminal organizations manage to buy 
the protection of public officials so that they can 
undermine the activities of competing criminal 
organizations and establish a near-monopoly over 
illicit drug markets.  
18. There is evidence suggesting that criminal 
groups, including youth gangs, involved in the illicit 
drug trade are more violent than other criminal groups. 
Competition among such criminal groups leads to 
violent confrontation and puts ordinary citizens at risk. 
There are also frequent violent confrontations between 
criminal organizations and law enforcement agencies. 
Intimidation and violence are routine aspects of the 
illicit drug trade. The inherently risky and violently 
competitive nature of the illicit drug trade drives those 
involved to seek the collusion, protection and 
assistance of certain public officials, whether through 
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bribes or through intimidation and violence. When a 
criminal group has secured such protection and 
threatens to use it to eliminate its rivals, the struggle to 
control the illicit market for a particular drug can 
become quite violent.  
19. Having a share of the proceeds of drug trafficking 
is a strong incentive to engage in corruption. In fact, 
some senior law enforcement officials have argued that 
it is the most powerful driving force behind the 
corruption faced by their agencies. The huge profits 
generated by the illicit drug trade enable criminal 
organizations to engage in corruption on a very large 
scale. Corruption is essential to maintaining the flow of 
illicit drug shipments. In order to ensure that they 
receive the highest returns on their investment in illicit 
drug production and trade, most criminal organizations 
are constantly looking for and finding ways to obtain 
the complicity of key public officials. 
20. Officials involved in drug law enforcement are at 
great risk of corruption, blackmail and intimidation. In 
exchange for a share of the profits obtained from drug 
trafficking, some officials may refrain from enforcing 
the law or may not enforce it thoroughly, thereby 
allowing criminals to operate relatively freely; and 
some officials may be paid to enforce the law 
selectively or to use it to harass the rivals of a 
particular criminal group.  
21. In some cases, criminal organizations with 
thriving drug trafficking operations have become 
political forces of their own and have succeeded in 
usurping the power and authority of legitimate political 
institutions. Some of those criminal organizations, in 
collusion with corrupt political elites striving to gain 
some political advantage or to establish a political 
monopoly, have succeeded in obtaining control over 
large illicit markets. Such mutually reinforcing spheres 
of political and criminal influence eventually 
undermine the legitimacy of public institutions.  
22. Thus, the very mechanisms and authorities 
established to reduce the illicit drug trade are often 
hindered or neutralized by corruption. In some Central 
American countries, for example, drug-related 
corruption has been detected among high-level 
officials, including heads of drug law enforcement 
agencies. In 2008, the Government of Mexico launched 
Operation Clean-up, aimed at purging the top ranks of 
the police of the influence of drug cartels. As a result, 
both the interim commissioner of the federal police and 
the acting head of the division of drug control 
operations were arrested and convicted. That is an 
example of how Governments are capable of fighting 
pervasive drug-related corruption at the highest level. 
 
 3. How widespread is corruption 
 
23. Corruption is secretive; the persons affected by 
corruption may be unaware that they have been 
victimized. For that reason, the problem is extremely 
hard to quantify. It has been argued that it is not 
possible to accurately measure the prevalence of 
corruption, as most methods used to measure it are 
inherently flawed. 
24. Data based on reported cases of bribery or 
corruption usually do not reflect the true extent of the 
problem. Official data on corruption are usually drawn 
from national crime statistics; such “objective” 
measures of corruption are more indicative of the 
relative success of anti-corruption initiatives than of 
the prevailing level of corruption. Official data on 
corruption are also affected by public confidence in the 
police and by the willingness to report the crime to the 
authorities. Finally, since official definitions of 
corruption tend to vary from country to country, 
international comparisons based on official criminal 
justice data are difficult to make and potentially 
misleading. 
25. Surveys are often used to measure or estimate the 
prevalence of corruption based on the experiences 
and/or perceptions of respondents. Indicators based on 
the perceptions of citizens, public officials or business 
people are widely used and are popular with the media. 
Those indicators are often aggregated into composite 
indices, such as the annual Corruption Perceptions 
Index, published by Transparency International, the 
World Bank’s governance indicators, which also 
measure the ability of countries to control corruption, 
and the indices prepared by the World Economic 
Forum to identify obstacles to business. Such indices 
can be useful, but their findings are typically affected 
by methodological limitations and by the varying 
cultural and social environments from which they are 
drawn. Victimization studies, such as the International 
Crime Victim Survey conducted by the United Nations 
Office on Drugs and Crime (UNODC) and the United 
Nations Interregional Crime and Justice Research 
Institute, focus on how respondents have experienced 
corruption. In recent years, the results of the 
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International Crime Victim Survey have led to the 
development of the International Crime Business 
Survey, focusing on respondents who have experienced 
corruption, fraud and extortion.  
 
 4. The impact of drug-related corruption 
 
26. The huge proceeds of the illicit drug trade are a 
powerful corrupting force. The consequences of 
corruption can be pervasive and profound. Corruption 
is a threat to democracy and development, working to 
the detriment of good governance and weakening 
social institutions. Drug-related corruption can have an 
extremely detrimental effect on the credibility and 
efficiency of the criminal justice system and weaken 
the rule of law. It can also have an adverse effect on 
the credibility and legitimacy of other social 
institutions. It fuels public distrust in both public and 
private sector initiatives. It can have a devastating 
impact on a country’s economic and social 
development.  
27. If left unchecked, low-level corruption can spread 
throughout social institutions. Once corruption has 
become systemic and institutionalized, officials find it 
easier to engage in various forms of extortion and 
protection rackets. To speak of such forms of 
corruption as a major crisis requiring immediate 
attention is hardly an exaggeration. Experience has 
shown how serious that danger is. There are numerous 
examples of the catastrophic effect of drug-related 
corruption on the state and its institutions. In some 
instances, drug-related corruption has had a damaging 
effect on the country’s entire political system.  
28. Corruption can be both a product and a cause of 
the failure of governance mechanisms. Corruption 
thrives where policies and the regulatory regime 
provide scope for it and where institutions for 
providing control are weak. Corruption can thus be 
seen as a direct consequence of inadequate, illegitimate 
or ineffective governance mechanisms and institutions 
at various levels. The converse is also true: corruption 
can sabotage those institutions and the essential 
governance functions they perform.  
29. Countries with serious drug trafficking problems 
are particularly vulnerable to the machinations of 
organized criminal groups. The illicit drug trade can 
have a destabilizing effect on the national economy, the 
political process and civil society.5 Political corruption, 
patronage and clientelism create opportunities for 
criminal groups to establish their control over certain 
population groups, as well as over the political process. 
Drug traffickers can find ways to enter into the process 
by ensuring that votes are exchanged for favours. The 
clientelism practised by certain criminal organizations, 
with or without the involvement of politicians, can 
have a profound impact on the political life of a 
community. The above-mentioned challenges, which 
are very complex, demonstrate the need for broad 
initiatives to prevent drug-related corruption through 
community empowerment, education and institutional 
reform. When fighting drug-related corruption and 
addressing its detrimental social effects, denial and 
abdication cannot be tolerated. Governments clearly 
need to adopt strong measures to prevent and control 
corruption. Ironically, those Governments which have 
already been infiltrated and weakened by drug-related 
or other types of corruption are the least likely to adopt 
effective anti-corruption measures.  
 
 
 B. Corruption and drug control 
 
 
30. Just as corruption is a major impediment to social 
and economic development, it is also an impediment to 
a well-functioning justice and security sector. People 
are more likely to commit a criminal act if the 
likelihood of being caught is low and if a bribe is the 
best way to avoid being held accountable for a  
criminal act. As time goes on, corruption becomes 
institutionalized and systemic and can affect the entire 
justice system. The credibility and legitimacy of the 
justice system are soon affected. The effectiveness of 
the justice system suffers because it is no longer able 
to count on the public support it requires in order to 
perform its function effectively. From that point, 
corruption can eventually reach the highest levels of a 
government and affect its credibility, legitimacy, 
stability and, ultimately, its viability.  
 
 1. Organized crime and the corruption and 
intimidation of public officials  
 
31. A fundamental characteristic of organized crime 
is its ability to take advantage of weak institutions and 
__________________ 
 5  See Report of the International Narcotics Control  
Board for 2002 (United Nations publication,  
Sales No. E.03.XI.1), chap. I. 
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its reliance on corruption and intimidation to enable it 
to conduct its business with as little interference as 
possible. Organized crime is more likely to flourish in 
cities, countries and other geographical areas where 
government control and local institutions are weak and 
public officials are corrupt. The extent to which 
criminal organizations succeed in infiltrating the public 
sector depends on their characteristics and activities, 
and on the relative strength and resilience of the public 
institutions. The activities of drug traffickers and  
other organized criminal groups are not necessarily  
the main cause of corruption; weak law enforcement 
and criminal justice institutions represent an open 
invitation to corruption. In extreme cases, organized 
criminal groups may even use corruption to control 
dysfunctional state agencies. 
32. There is abundant evidence of the systematic use 
of corruption and intimidation by organized criminal 
groups and of the frequent collusion between criminals 
and corrupt officials at various levels of government. 
The most common type of corruption is bribery to 
influence the functions of government. Corrupt public 
officials become the puppets of criminals, who are then 
able to rely on their complicity.  
 
 2. Corruption of police, customs and other law 
enforcement officials 
 
33. There is a growing realization that police 
corruption is not always just an aberration. The 
corrupting effect of organized crime is systemic and 
lasting. Criminal groups have been known to enter into 
relatively stable arrangements with the police or other 
law enforcement and regulatory agencies. Those 
arrangements may involve non-enforcement or 
selective enforcement of the law by an official who, in 
exchange for a share of the proceeds derived from 
illicit activities, allows a criminal group to obtain or 
consolidate control over an illicit market. Law 
enforcement authorities may carry out raids against 
insignificant illegal operations or against a competing 
criminal group. In some instances, violence erupts 
between criminal groups wishing to have access to or 
influence over corrupt officials who control certain 
areas (such as a landing strip or a border control 
station). Criminal groups may, out of fear of being 
betrayed, target the officials they have bribed.  
34. Police, customs and other agencies involved in 
drug law enforcement are particularly exposed to 
corruption. Several official reports, for example, in 
Australia, the Bahamas and the United States of 
America,6 have acknowledged the fact that the illicit 
drug trade has left law enforcement and customs 
agencies highly vulnerable to drug-related corruption. 
Drug control units are particularly vulnerable to 
corruption because of both the large sums of money 
and quantities of drugs involved in their work and the 
willingness of criminals to pay bribes to avoid trouble. 
The frequent contact that members of specialized drug 
law enforcement units have with drug abusers and 
illicit drug suppliers multiply the opportunities for 
corruption and heighten the risk of misconduct. 
Officers working in drug control units are more 
exposed to corruption than others; they are also 
aggressively recruited by criminal groups. Drug control 
units are often at risk of being infiltrated by organized 
criminal groups involved in drug trafficking. Law 
enforcement officers working on drug trafficking cases 
are particularly prone to corruption because their work 
entails the use of informants, undercover investigations 
and investigative techniques such as controlled 
delivery. Furthermore, police and police recruits may 
believe that corruption is justifiable and acceptable in 
certain circumstances, a misperception that is 
sometimes reinforced by the local police subculture.  
35. There have been frequent reports of drug-related 
corruption involving police officers who were engaged 
in serious criminal activities such as stealing money 
and/or drugs from drug dealers, conducting illegal 
searches to appropriate drugs or drug money, selling 
stolen drugs, protecting drug trafficking operations, 
providing false testimony or submitting false crime 
reports.7 There have been reports in many countries of 
__________________ 
 6  Bahamas, Report of the Commission of Inquiry, 
Appointed to Inquire into the Illegal Use of the Bahamas 
for the Transshipment of Dangerous Drugs Destined  
for the United States of America, November 1983-
December 1984 (Nassau, Commission of Inquiry, 1984); 
United States of America, General Accounting Office, 
Law Enforcement: Information on Drug-Related Police 
Corruption, GAO report GAO/GGD-98-111 
(Washington, D.C., May 1998); The Knapp  
Commission Report on Police Corruption (New York, 
George Braziller, 1973); and Australia, New South 
Wales, Project Odin: Identifying and Managing High 
Risk Officers in the NSW Police Force (Sydney, Police 
Integrity Commission, September 2009). 
 7  Law Enforcement: Information on Drug-Related Police 
Corruption … (see footnote 6). 
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rogue police officers being actively engaged in 
trafficking in drugs in some cases drugs that had been 
confiscated, or guarding illicit crop cultivation sites for 
a criminal organization.  
36. There have also been reports of drugs being 
diverted in large quantities from licit distribution 
channels to be sold on illicit markets as a result of 
officials abusing their authority, thereby defeating the 
purposes of regulatory agencies and drug control 
mechanisms.  
37. As it relates to the illicit drug trade, police 
corruption frequently takes the form of a bribe: a “tax” 
or “rent” secretly levied on illicit profits. As drug law 
enforcement efforts intensify, so does the capacity of 
the police (and other criminal justice officials) to levy 
a “tax” on the profits of the illicit drug trade. In some 
instances, that practice has led to open competition and 
even violent conflict between corrupt police officers to 
determine who collects the bribes. Well-established 
drug trafficking organizations may find that such a 
system works in their favour, as they are able to pay 
the bribes and redirect the attention of the police and 
prosecutors towards more poorly “connected” criminal 
groups. Corruption can help a criminal group establish 
tight control over a particular licit or illicit market by 
enlisting the authorities’ help to drive out or weaken 
the competition.  
38. Police corruption hinders international 
cooperation in criminal matters and in drug control. 
There are many obstacles to effective law enforcement 
cooperation at the international level. Sovereignty 
issues, absence of enabling legislation, poor channels 
of communication and diversity of law enforcement 
structures have been identified as some of the 
challenges that must be faced in that area. International 
cooperation in fighting organized crime and drug 
trafficking is facilitated by various legal instruments 
and institutional arrangements. Ultimately, however, 
international cooperation is based on relationships of 
trust and reciprocity among law enforcement agencies 
and officials. Those relationships can be seriously 
compromised by corruption or even the mere suspicion 
of corruption. Corruption undermines international 
coordination efforts and condemns some of the best 
international drug control initiatives to failure.  
39. The success of strategic approaches to fighting 
drug trafficking, whether at the local, regional or 
international levels, always depends on the capacity 
and willingness of the officials in the various agencies 
involved to cooperate with each other. That capacity 
can be seriously reduced by corruption and the level of 
distrust it generates among those involved. When 
corrupt police officers or prosecutors have access to 
critical information or evidence received from another 
jurisdiction about an ongoing investigation, that 
investigation is compromised. As a result, some of the 
witnesses, informants and agents involved in that 
investigation may also be compromised, threatened or 
even killed. Some of the police and criminal justice 
officials involved may face betrayal, intimidation and 
retaliation. Thus, corruption may render joint police 
operations or cross-border investigations useless. 
International cooperation in the areas of intelligence-
sharing and witness protection may also be precluded 
by police corruption. 
40. Police corruption is difficult to control, but it 
should be clear to all those concerned that no amount 
of corruption should ever be tolerated within a police, 
customs or drug control unit. Temporary repressive 
measures are usually insufficient to address the 
problem. Their impact tends to be limited and short-
lived. Broader anti-corruption strategies are necessary, 
including measures focusing on the prevention of 
corruption and periodic checks. Independent police 
oversight mechanisms, proactive internal investigations 
and the creation of special anti-corruption units must 
be part of any comprehensive strategy to identify and 
eradicate corruption as soon as it emerges.  
41. In addition to front-line police, customs and other 
law enforcement officers, other security officers may 
be targeted by criminal organizations. For example, 
security and other personnel working at international 
airports and other border control points are also 
vulnerable to attempts to infiltrate or corrupt them. In 
Canada, a strategic assessment conducted by the Royal 
Canadian Mounted Police revealed that organized 
criminal groups had attempted to exploit airports by 
corrupting employees or by placing criminal associates 
in the airport workforce.8  
42. Regulatory agencies are also exposed to drug-
related corruption. For instance, because criminal 
__________________ 
 8  Royal Canadian Mounted Police, Project SPAWN:  
A Strategic Assessment of Criminal Activity and 
Organized Crime Infiltration at Canada’s Class 1 
Airports (Ottawa, 2008). 
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organizations must hide the proceeds of their illicit 
activities, they often need to collaborate with 
regulators, people in financial institutions and other 
professionals to launder those proceeds. That 
collaboration, obtained through intimidation or 
corruption, is used to defeat the efforts of police and 
other law enforcement agencies to trace, freeze, seize 
and/or confiscate those assets. 
 
 3. Military corruption 
 
43. In several countries, police corruption has 
resulted in pressure being generated to involve the 
military in drug control, illicit crop eradication and 
border control efforts. That, in turn, has sometimes 
resulted in the problem of drug-related corruption 
spreading to the military and, in some cases, has 
affected the integrity, credibility and legitimacy of the 
military institutions involved. In some cases, in order 
to limit the devastating effects of corruption, a decision 
has had to be made to withdraw the military personnel 
that had been stationed in illicit drug production areas 
or assigned to pursue drug traffickers. In other cases, 
the population saw the police and the military accuse 
each other of corruption (or even attacking each other) 
and the credibility of both institutions suffered greatly.  
 
 4. Judicial corruption 
 
44. The judiciary is equally at risk of drug-related 
corruption and intimidation. Because of the influence 
they have over the entire criminal justice process, 
judges and prosecutors are often targeted by criminal 
groups. The authority that judges and prosecutors have 
to initiate and terminate criminal investigations makes 
them extremely vulnerable to corruption and 
intimidation. Many members of the judiciary fall 
victim to intimidation, retaliation and violence. Others 
become corrupt. Once compromised, those officials are 
outside of the normal protection of the law and are 
unable to resist the pressure exerted by criminal 
organizations.  
45. Once members of the judiciary or the 
prosecutorial services are compromised, they are 
unable to effectively perform their function of 
overseeing the rest of the criminal justice system. 
Unfortunately, existing judicial oversight and control 
mechanisms are not always sufficient to prevent or 
repress corruption. Protecting the independence of the 
judiciary is an important means of protecting it against 
corruption, but it must also be supported by other 
effective action against judicial corruption. Preventive 
measures should include the elaboration of codes of 
professional conduct for members of the judiciary, as 
well as educational and training activities. Mechanisms 
should be put in place for ensuring that judges report 
and seek support in cases of intimidation. In some 
countries, it is difficult to enforce sanctions against 
judges convicted of corruption. Therefore, 
Governments should ensure that legislation enables 
sanctions to be enforced where appropriate.  
46. Judges obviously have an important role to play 
in the fight against corruption. In some legal systems, 
they often play a direct role in the investigation and 
prosecution of corruption. Lack of resources, the 
complexity of the cases involved, the failing support of 
the police, the destruction of evidence, violence, 
intimidation, insufficient protection and political 
interference can all hinder effective action against 
corruption.  
 
 5. Drug-related corruption in countries with 
weakened controls or in post-conflict situations 
 
47. Drug-related organized crime is becoming a 
major threat to peace and security. Countries in post-
conflict situations and countries with economies in 
transition are particularly vulnerable to that threat. 
War, civil conflict, insurgency and natural disaster can 
all put tremendous pressure on justice and public safety 
institutions. The social control vacuum resulting from 
such situations often leads to violence, instability and 
corruption. The rapid social change and the weakened 
and disoriented law enforcement and justice 
institutions that tend to characterize those situations 
provide an environment in which organized criminal 
groups thrive and the illicit drug trade and corruption 
flourish. Drug-related corruption and organized crime 
can cause immeasurable harm to the social, political 
and economic development of countries in which such 
conditions prevail. Drug trafficking and the violence 
and corruption associated with it usually have a 
destabilizing effect on post-conflict societies and a 
devastating impact on their peacebuilding and 
reconstruction efforts. The proceeds of drug trafficking 
are all too frequently used in such situations to  
support insurgencies, supply weapons, destabilize 
Governments, undermine the democratic process or 
neutralize law enforcement and criminal justice 
institutions. 
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48. In Afghanistan, for instance, drug trafficking 
accelerated the development of organized crime and 
has been a massive source of corruption. Drug 
trafficking and corruption are major obstacles to 
peacekeeping, peacebuilding and reconstruction 
efforts. A recent UNODC report entitled Corruption in 
Afghanistan: Bribery as Reported by the Victims has 
revealed that drug trafficking and corruption are the 
two largest income generators in Afghanistan. Together 
they account for half of the gross domestic product of 
Afghanistan. The report highlights how corruption has 
eroded the trust in public officials and the Government 
as a whole and how it is one of the most significant 
factors undermining peacebuilding in that country.  
49. Many countries with economies in transition have 
experienced a rapid proliferation of organized crime 
and drug trafficking. In the Balkans, for example, 
organized criminal groups have become firmly 
established. In Senegal, the police have reported that 
trafficking in cannabis in the Casamance region has 
benefited from low-intensity conflict.9 In Sierra Leone, 
the police reported that members of the Armed Forces 
Revolutionary Council, which had controlled the 
country in the period 1997-1998, were responsible for 
establishing Sierra Leone as a transit area for illicit 
drug shipments. In South-Eastern Europe where, 
according to a recent UNODC report, drug trafficking 
is the criminal activity with the highest value, drug-
related corruption is a significant problem that has a 
direct effect on criminal justice institutions.10  
50. Since the late 1980s, coups and wars in West 
Africa have resulted in a blurring of the relationship 
between politics and crime in that subregion, not to 
mention general uncertainty surrounding wealth and 
the manner of its acquisition. That has provided fertile 
ground for corruption and has exacerbated the problem 
of organized crime in that subregion.11 According to a 
UNODC report,12 cocaine and other drugs illicitly 
__________________ 
 9  Transnational Organized Crime in the West African 
Region (United Nations publication, Sales  
No. E.05.XI.1), p. 8. 
 10  Crime and Its Impact on the Balkans and Affected 
Countries, published by the United Nations Office on 
Drugs and Crime in March 2008, pp. 12-13.  
 11  Transnational Organized Crime in the West African 
Region, p. 7. 
 12  Drug Trafficking as a Security Threat in West Africa, 
published by the United Nations Office on Drugs and 
Crime in November 2008. 
manufactured in South America are increasingly being 
smuggled through West Africa on their way to the 
growing illicit markets in Europe. West Africa, a 
subregion recovering from several violent civil 
conflicts, is affected to such a great extent by drug 
trafficking mainly because of the ability of traffickers 
to operate with impunity. One of the greatest 
vulnerabilities of West Africa is its under-resourced 
criminal justice agencies, which are extremely 
susceptible to corruption. According to the UNODC 
report, international drug traffickers operating in West 
Africa, when arrested, are seldom convicted and 
sentenced. 
 
 
 C. Combating drug-related corruption 
 
 
 1. Tackling organized crime 
 
51. Dismantling the criminal organizations involved 
in drug trafficking or, at the very least, disrupting their 
activities is a prerequisite for successful drug control 
strategies. Organized crime presents many unique and 
pressing challenges to criminal justice systems 
throughout the world. The rapid globalization of 
criminal networks adds to those challenges by testing 
the will and capacity of national agencies and 
institutions to work with each other to curtail the 
international activities of powerful criminal groups. 
Criminal organizations are good at exploiting the 
weaknesses of drug control agencies and other law 
enforcement agencies. They are also able to quickly 
adjust to new drug control and law enforcement tactics 
and approaches. Often the most that can be achieved is 
the short-term disruption of the activities of criminal 
organizations, leaving more or less intact their capacity 
to further engage in drug trafficking.  
52. There are some obvious difficulties involved in 
fighting organized crime. Organized criminal groups 
usually have enormous resources at their disposal and 
have access to sophisticated technologies to support 
their activities. Organized criminal groups are difficult 
to infiltrate and they go to great lengths to protect 
themselves against defectors, informants and police 
agents. They do not hesitate to use violence. Because 
of the dynamic nature of the criminal activities 
involved, particularly drug trafficking activities, law 
enforcement and criminal justice institutions must 
constantly refine, redefine and perfect their own 
strategies. When possible, modern techniques of 
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investigation, such as controlled delivery, electronic 
surveillance or infiltration must be utilized. Law 
enforcement and criminal justice institutions must 
develop a capacity for international cooperation and be 
able to work effectively with their counterparts in other 
countries. 
53. It is also important to emphasize the importance 
of efforts to address money-laundering and to trace and 
seize the proceeds of the illicit drug trade, corruption 
and other types of crime. The regime for countering 
money-laundering is based on a number of standards 
and international instruments that are intended to 
ensure that there are no safe havens for criminals. 
Some of those key instruments are the United Nations 
Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances of 1988, the United Nations 
Convention against Transnational Organized Crime, 
the United Nations Convention against Corruption and 
the recommendations of the Financial Action Task 
Force on Money Laundering. The regime for 
countering money-laundering makes it possible to 
disrupt criminal organizations and seize the proceeds 
of their illegal activities. 
 
 2. Implementing necessary preventive measures 
 
54. There are several measures that can be taken to 
prevent drug-related corruption. Many are the same as 
those that can be taken to fight corruption in general. 
They include measures to prevent, detect and 
investigate incidents of corruption. In the law 
enforcement and justice sectors, they include measures 
to develop and strengthen multiple accountability 
structures, internal investigation mechanisms and 
disciplinary processes. The most important measures to 
prevent drug-related corruption are found in the United 
Nations Convention against Corruption.  
55. Deterring drug-related corruption through 
investigations, prosecutions and serious sanctions is a 
fundamental element of any comprehensive strategy to 
address the problem. It is, however, only one part of 
such a strategy. Emphasis must also be placed on 
education and prevention because, in the long run, they 
have more far-reaching benefits in terms of promoting 
the integrity of public institutions and managing the 
conduct of public officials. The Convention against 
Corruption allows for the establishment of independent 
bodies, with formal legislative authority, that can 
promote good practices in preventing corruption.  
The Convention also suggests that there should  
be periodic evaluations of relevant legal instruments 
and administrative measures to determine their 
effectiveness in preventing corruption. 
56. The prevention of corruption requires all public 
agencies to have in place some efficient, transparent 
and objective systems for the recruitment, hiring, 
retention, promotion and retirement of public officials. 
Those systems must also recognize that certain persons 
or agencies, such as those involved in drug law 
enforcement and drug control activities, may be more 
susceptible to corruption than others. The specific 
vulnerabilities of those persons and agencies must be 
indentified and analysed. The specific risks in those 
areas of work need to be identified and addressed by 
concrete measures, and those measures need to be 
evaluated and revised periodically. Some of the risks 
may be addressed by measures such as the following: 
pre-appointment screening of successful candidates for 
the post or for special assignments involving drug 
control activities; rotation of staff; and benchmarking 
the performance of individuals and teams.  
57. All agencies involved in drug control activities 
should ensure that they have in place specific support 
and oversight procedures for all their staff, in particular 
for those who are directly exposed to corruption. Those 
agencies, because of their vulnerability to corruption, 
should all have in place procedures such as: regular 
appraisals; disclosure of conflicts of interest, 
incompatibilities and associated activities; and the 
declaration and registration of assets, interests and 
gifts, as well as adequate procedures for monitoring the 
accuracy of those declarations. Procedures to allow for 
confidential reporting of suspicious transactions and 
incidents ought to be put in place, together with 
provisions for effective investigation of those reports 
by internal affairs departments or independent 
oversight mechanisms.  
58. Whenever the existing process and procedures 
provide a level of discretionary authority for certain 
officials, effective measures to monitor and review the 
use of that authority must be instituted. Depending on 
the level of risk of corruption, systems providing 
multiple levels of review and approval for certain 
decisions are always preferable to having a single 
individual with the sole authority to make  
those decisions. Encouraging transparency and 
accountability with respect to the decisions made at all 
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levels is one of the most effective ways of preventing 
corruption. The operational requirement for secrecy to 
protect the integrity of drug control investigations and 
protect the officials involved must not serve as a means 
to avoid operational and public accountability. 
59. Preventing the laundering of the proceeds of 
corruption is an important prevention method. 
Attempts to trace and seize the profits of drug dealers 
have led to the creation of sophisticated international 
mechanisms to prevent and counter money-laundering 
and deprive drug traffickers of the proceeds of their 
illegal activities. Those mechanisms can also be  
used to prevent corrupt officials from laundering  
their illegally obtained wealth. Measures to counter  
money-laundering rely in part on the vigilance and 
collaboration of financial institutions and their 
employees and other professionals (accountants, 
investors, lawyers). They, too, must be protected 
against corruption.  
60. Addressing corruption and intimidation of the 
judiciary is a priority of an effective anti-corruption 
strategy. When members of the judiciary are 
compromised, the legal and institutional mechanisms 
designed to curb corruption are neutralized. In order to 
prevent such corruption, codes of conduct for the 
judiciary, effective oversight mechanisms and strong 
disciplinary measures can be put into place without 
affecting the independence of the judiciary. The 
Bangalore Principles of Judicial Conduct13 reaffirm the 
notion that judges must be accountable for their 
conduct to appropriate institutions established to 
maintain judicial standards, which are themselves 
independent and impartial, and are intended to 
supplement and not to derogate from existing rules of 
law and conduct that bind judges. The Principles 
reaffirm the fact that integrity is essential to the proper 
discharge of the judicial office and that judges must 
ensure that their conduct is above reproach.  
61. The work for which judges and prosecutors are 
responsible must be protected against the risk of 
corruption and intimidation by ensuring that the 
judicial process is open and accessible. Judicial 
proceedings should be open to the public, judges must 
be required to provide reasons for their decisions and 
those decisions must be recorded and accessible to the 
__________________ 
 13  E/CN.4/2003/65, annex; see also Economic and Social 
Council resolution 2006/23, annex. 
public through the media. Judges and court 
administrators have a responsibility to prevent 
corruption by ensuring the effective and accountable 
administration of court proceedings, including systems 
to maintain and manage court records, procedures for 
reducing court delays, registries of decisions and 
procedures to respond to public complaints. Measures 
must be in place to prevent the destruction or theft of 
evidence and exhibits and the disappearance or 
destruction of court records. 
62. Prosecutors have a special role to play in 
preventing corruption. They must be able to perform 
their professional functions without intimidation, 
hindrance, harassment, political interference or 
unjustified personal exposure to liability. They must be 
held accountable for their decisions and should be able 
to explain them in a frank and transparent manner. 
Where disciplinary steps are necessary, they should 
only be taken after an expeditious and fair hearing has 
taken place. Prosecutors, like judges, must be well 
protected: their personal safety and that of their 
families should never be threatened as a result of them 
carrying out their professional responsibilities.  
63. There are several approaches to preventing 
corruption among the police and customs. In law 
enforcement, preventing corruption involves taking 
decisive action in a number of areas, including:  
(a) recruitment, training and promotion; (b) provision 
of adequate resources; (c) correcting faulty 
compensation, reward and incentive structures within 
the organization; (d) strengthening the existing 
governance and accountability structures within and 
outside the organization; (e) increasing transparency; 
(f) changing attitudes and traditions within the 
organization that inhibit the development of 
professional and ethical police standards; and  
(g) countering any internal subculture that may 
perpetuate the acceptance of corruption.  
64. Preventing and reducing corruption within the 
customs administration are also particularly relevant to 
the prevention of drug trafficking. Customs 
administrations are very vulnerable to corruption. A 
decision by a customs official to knowingly accept a 
fraudulent declaration can compromise the 
achievements representing months of work in a drug 
control operation. Considerable attention must be given 
to the recruitment, training and monitoring of customs 
staff and supervisory personnel. The development of 
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strategies to counter corruption among customs 
officers involves determining the specific risks of 
corrupt behaviour at the various stages of the customs 
clearance process and, if appropriate, the developments 
of a “risk map” outlining the extent to which various 
elements of the existing process facilitate potential 
violations and create opportunities for corruption. The 
World Customs Organization has identified a number 
of areas to be focused on in efforts to prevent 
corruption in customs operations: leadership and 
commitment; regulatory framework; transparency; 
automation; reform and modernization; audit and 
investigation; code of conduct; human resource 
management; and morale and organization culture.14 
65. Integrated approaches are therefore needed to 
effectively address the factors that facilitate corruption 
within law enforcement agencies. The main elements 
of a comprehensive corruption prevention plan include 
improved recruiting and training practices, adequate 
remuneration, adequate policies, procedures, 
supervision, and administrative control to detect and 
respond to the problems of drug abuse and corruption 
among law enforcement officers. Responsible and 
accountable management and supervision are essential 
to the success of those approaches. Police managers 
must be inculcated with a sense of responsibility and 
be held accountable for the integrity of their staff. 
Organizational reforms must be introduced to ensure 
internal accountability and effective supervision, and 
to change procedures and practices that are conducive 
to corruption. Finally, corruption cannot be completely 
rooted out without having in place effective measures 
to detect, investigate and punish corruption. For that, 
an independent internal investigative unit is required, 
functioning as it should under an independent civilian 
oversight mechanism.  
66. Detecting corruption within a law enforcement 
agency may present some challenges. The detection of 
corruption may rely in part on reports from citizens or 
from law enforcement officers, but reports alone are 
usually insufficient. The agency may also rely on 
integrity testing, an early warning system to detect 
officers who may be prone to corruption, and the 
__________________ 
 14  World Customs Organization, Revised Arusha 
Declaration: Declaration of the Customs Cooperation 
Council concerning Good Governance and Integrity in 
Customs, 2003; see also World Customs Organization, 
Integrity Development Guide (2007). 
proactive investigation of individual officers involved 
in squads or areas with a high number of corruption-
related complaints. The identification of officers at risk 
of corruption or misconduct is an important part of 
effective detection and investigation. Some areas of 
policing, in particular drug law enforcement, require 
special attention: they are at greater risk of corruption 
because they tend to be characterized by a large degree 
of secrecy and little managerial, administrative or 
civilian oversight. Corruption resistance and 
prevention plans can be developed once a proper risk 
assessment has been conducted and the risks of 
misconduct and the officers at risk have been 
identified.15  
67. Measures to protect against unjustified treatment 
those persons who report in good faith an alleged 
incident of corruption are essential to efforts to combat 
and prevent corruption at all levels. Such measures 
must strike a balance between the need to protect the 
rights of the person who is the object of the allegation 
and the need to protect the person making the 
allegation. Because false accusations of corruption may 
be used to discredit officials and neutralize their efforts 
to combat crime, such measures must also offer some 
protection against false accusation. There is also a need 
to protect witnesses, experts and victims who give 
information or testimony in cases involving corruption. 
Intimidation can take many forms and a variety of 
measures are usually necessary to protect those at risk. 
Measures should be designed to provide physical 
protection for witnesses who might be in danger and 
evidentiary rules should be adopted to allow them to 
provide testimony in a manner that ensures their safety. 
It is important to have in place comprehensive witness 
protection programmes to protect those who 
collaborate with the justice system in the investigation 
and prosecution of cases involving corruption.  
 
 
 D. Recommendations 
 
 
68. Efforts to curtail the illicit drug trade must be 
better coordinated and aligned with broader strategies 
to control organized crime and to limit the damaging 
effects of drug-related corruption. To ensure more 
effective implementation of the international drug 
__________________ 
 15  See, for example: Project Odin: Identifying and 
Managing High Risk Officers in the NSW Police Force 
(see footnote 6). 
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control conventions, the Board recommends the 
following: 
 (a) Governments must give greater attention to 
initiatives to prevent corruption, particularly those 
initiatives relating to public agencies and officials 
actively engaged, at all levels, in the enforcement of 
drug control laws. Those officials are particularly 
vulnerable to the threat of corruption and must be 
protected against it. Corruption resistance and 
prevention plans can be developed once a proper risk 
assessment has been conducted and the risks of 
misconduct and corruption have been identified; 
 (b) Governments must give priority to 
strategies aimed at preventing corruption and raising 
public awareness about corruption, building on the 
strengths and values that are unique to each cultural 
context; 
 (c) Governments must give priority to 
preventing corruption and intimidation, in particular 
among the judiciary. A corrupt judiciary is as serious 
an impediment to the success of anti-corruption 
measures as it is to the success of drug control 
strategies;  
 (d) All law enforcement and criminal justice 
agencies involved in drug control or in the fight against 
organized crime should formally adopt and enforce 
within their agencies a policy of absolute intolerance 
towards corruption; 
 (e) Law enforcement and criminal justice 
agencies involved in drug control should adopt, as a 
matter of priority, concrete measures to prevent drug-
related and other forms of corruption and misconduct 
within their ranks. Such measures may include: 
promoting incorruptible and transparent recruitment, 
training, deployment and supervision practices; 
integrity-testing; strengthened internal investigation 
mechanisms; independent civilian oversight; effective 
prosecution; and greater protection for informants 
(“whistle-blowers”) and witnesses;  
 (f) All agencies involved in drug control 
activities should prevent corruption by ensuring that 
they have in place specific support and oversight 
procedures for all their staff, in particular for those 
who are directly exposed to corruption. Those 
agencies, because they are particularly vulnerable to 
corruption, should all have in place prevention 
procedures such as: regular appraisals; disclosure of 
conflicts of interest, incompatibilities and associated 
activities; and declaration and registration of assets, 
interests and gifts, as well as adequate procedures for 
monitoring the accuracy of those declarations. 
Procedures should be in place to allow for confidential 
reporting of suspicious transactions and incidents, with 
provisions for effective investigation of those reports 
by internal affairs departments, inspectorates or 
independent civilian oversight mechanisms;  
 (g) There must be renewed efforts, at the 
national and international levels, to further strengthen 
measures to counter money-laundering and ensure that 
they focus on the identification and confiscation of the 
proceeds of drug-related corruption, as well as other 
types of drug-related crime;  
 (h) International and regional cooperation and 
the capacity of the relevant law enforcement and 
criminal justice agencies to cooperate with each other 
must continue to be strengthened, particularly as they 
relate to the prevention and eradication of drug-related 
corruption and intimidation; 
 (i) States that have not already done so are 
encouraged to ratify and implement the United Nations 
Convention against Transnational Organized Crime and 
the United Nations Convention against Corruption (see 
annex III), thereby enabling those conventions to 
realize their full potential in fighting drug-related 
crime, particularly at the international level; 
 (j) The international community should 
provide assistance to States that are struggling to cope 
with drug-related corruption and intimidation and 
require technical and other assistance in order to build 
their capacity to combat drug-related corruption.  
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 II. Functioning of the international drug control system 
 
 
 A. Promoting the consistent application of 
the international drug control treaties 
 
 
69. In discharging its mandate under the international 
drug control treaties, the Board maintains an ongoing 
dialogue with Governments through various means, 
such as regular consultations and country missions. 
That dialogue has been instrumental to the Board’s 
efforts to assist Governments in complying with the 
provisions of the treaties. 
 
 1. Status of adherence to the international drug 
control treaties 
 
70. Since the publication of the report of the Board 
for 2009, no additional countries have acceded to any 
of the international drug control treaties.  
71. Thus, as at 1 November 2010, the number of 
States parties to the Single Convention on Narcotic 
Drugs of 1961 as amended by the 1972 Protocol16 
remained at 184. Two States, namely Afghanistan and 
Chad, continued to be parties to the 1961 Convention 
in its unamended form.17 A total of eight States had yet 
to accede to the 1961 Convention: one State in Africa 
(Equatorial Guinea), one in Asia (Timor-Leste) and  
six in Oceania (Cook Islands, Kiribati, Nauru, Samoa, 
Tuvalu and Vanuatu). 
72. The number of States parties to the Convention 
on Psychotropic Substances of 197118 stood at 183. A 
total of 11 States had yet to become parties to that 
Convention: two States in Africa (Equatorial Guinea 
and Liberia), one in the Americas (Haiti), one in Asia 
(Timor-Leste) and seven in Oceania (Cook Islands, 
Kiribati, Nauru, Samoa, Solomon Islands, Tuvalu and 
Vanuatu). 
73. The number of States parties to the United 
Nations Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988 stood at 
184. A total of 10 States had yet to become parties to 
that Convention: two States in Africa (Equatorial 
Guinea and Somalia), one in Asia (Timor-Leste), one 
in Europe (Holy See) and six in Oceania (Kiribati, 
__________________ 
 16  United Nations, Treaty Series, vol. 976, No. 14152. 
 17  Ibid., vol. 520, No. 7515. 
 18  Ibid., vol. 1019, No. 14956. 
Nauru, Palau, Papua New Guinea, Solomon Islands and 
Tuvalu). 
74. The Board notes that, despite its continual efforts 
to promote universal application of the international 
drug control treaties, 16 States have not yet become 
parties to all the international drug control treaties. The 
Board is concerned that failure to accede to any of the 
international drug control treaties may weaken the 
collective efforts of the international community to 
fight against drug abuse and trafficking. The Board 
urges those States that have not done so to identify any 
impediments in that regard and to take the steps 
necessary to accede to all the international drug control 
treaties without further delay. 
 
 2. Evaluation of overall treaty compliance in 
selected countries 
 
75. The Board reviews on a regular basis the drug 
control situation in various countries and 
Governments’ overall compliance with the provisions 
of the international drug control treaties. The review 
covers various aspects of drug control, including the 
functioning of national drug control administrations, 
the adequacy of national drug control legislation and 
policy, measures taken by Governments to combat drug 
trafficking and abuse, and Governments’ fulfilment of 
their reporting obligations under the treaties. 
76. The findings of the review, as well as the Board’s 
recommendations for remedial action, are conveyed to 
the Governments concerned as part of the ongoing 
dialogue between the Board and Governments to 
ensure that the international drug control treaties are 
fully implemented. 
77. In 2010, the Board reviewed the drug control 
situation in Brazil, Mexico and Peru, as well as 
measures taken by the Governments of those countries 
to implement the international drug control treaties. In 
doing so, the Board took into account all information 
available to it, with particular attention paid to new 
developments in drug control in those countries. 
 
  Brazil 
 
78. Brazil continues to be used as a major transit 
country for illicit drug shipments destined for the 
United States of America and countries in Africa and 
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Europe. There is no evidence of cocaine-manufacturing 
laboratories on Brazilian territory, but the proximity of 
Brazil’s north-east coast to West Africa has made that 
area attractive to South American drug trafficking 
organizations. Brazil is used to smuggle by air and sea 
to West African countries a significant portion of 
cocaine from Bolivia (Plurinational State of), 
Colombia and Peru. The Board notes the determination 
of the Government of Brazil to continue to counter the 
smuggling of cocaine and other drugs through the 
country and calls upon the Government to further 
intensify its efforts in this regard. 
79. The Board notes with concern the increasing 
spread of the abuse of “crack” (a cocaine derivative 
converted from cocaine hydrochloride) cocaine in 
Brazil in recent years. It notes that the Government has 
taken action to curb the abuse of this substance, such 
as the launch of an integrated action plan against the 
abuse of “crack” and other drugs in May 2010. Under 
that plan, the Government has allocated significant 
resources to implement measures to fight drug 
trafficking, mainly in the municipalities located in 
border regions, and to expand and improve facilities 
for the treatment of drug abuse and the social 
reintegration of drug addicts. The Board urges the 
Government to continue its efforts in that area and to 
inform the Board of progress made in addressing the 
abuse of cocaine and other drugs. 
80. For many years, consumption levels of stimulants 
in Schedule IV of the 1971 Convention in countries of 
the Americas, including Brazil, have been among the 
highest in the world. The Board notes that measures 
have been taken by the Government of Brazil to curb 
the consumption of anorectics in recent years by 
amending national legislation to allow better 
monitoring of the domestic distribution of such 
substances and by strictly enforcing the prescription 
requirements. In this connection, the Board welcomes 
the steps taken by the Government in August 2010 to 
adopt new regulations aimed at further strengthening 
controls over the manufacture, import, marketing and 
prescription of amphetamine-type stimulants in the 
country. The Board encourages the Government to 
continue taking all necessary measures to ensure that 
anorectics are used only for medical purposes and to 
prevent the misuse and overprescribing of those 
substances. 
81. Recent developments indicate that some progress 
has been made by the Government of Brazil in 
addressing the drug control problems of the country. 
Improvements have also been noted in the cooperation 
that the Government has extended to the Board. The 
Board trusts that the Government will take appropriate 
measures to further improve its cooperation with it, 
including the mandatory reporting of statistical 
information as required under the international drug 
control treaties.  
 
  Mexico 
 
82. Mexican territory is used for the production of 
illicit drugs to be smuggled into countries in North 
America, particularly the United States. Much of the 
cannabis smuggled into the United States is illicitly 
produced in Mexico. According to UNODC, the illicit 
production of and trafficking in cannabis constitute the 
most important source of income for Mexican drug 
cartels, accounting for an estimated $8.5 billion, or 
about 61 per cent, of their annual income. As much as 
90 per cent of the cocaine from South America is 
smuggled into the United States through Mexico. Illicit 
cultivation of opium poppy has increased every year 
since 2000, with a corresponding increase in the illicit 
manufacture of opiates, primarily heroin. Most opiates 
found in the United States originate in Mexico.  
83. The Board notes that tremendous efforts have 
been made by the Government of Mexico to combat 
drugs and to disrupt the operation of major drug 
trafficking organizations. The Government has 
reaffirmed its commitment to limiting the flow of 
drugs and combating drug trafficking organizations by 
dedicating more financial and human resources to the 
effort. A number of important leaders of drug 
trafficking organizations and their key associates have 
been captured, and the Government has continued to 
dismiss officials co-opted by the traffickers through 
various means, including intimidation and blackmail. 
In recent years, the Mexican authorities have detained 
several leaders of the main drug trafficking 
organizations and arrested or detained more than 
35,000 members of such organizations. According to 
the Government, since 2006, more than 28,000 people 
have died in Mexico’s campaign against drug 
trafficking organizations. 
84. Although Mexico has made concerted efforts to 
reduce corruption in recent years, including efforts at a 
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high level, corruption remains a serious problem. 
Strong ties continue to exist between drug cartels and 
some law enforcement authorities; some officials and 
police officers have been intimidated and bribed to 
protect the interests of organized crime. Corruption has 
severely hindered the effectiveness of law enforcement 
in Mexico, a fact confirmed by the Government when 
it announced that it needed to reduce the capacity of 
drug cartels to infiltrate the authorities and to corrupt 
officials.  
85. Drug abuse in Mexico has been rising. Cannabis, 
cocaine and inhalants, in that order, remain the most 
commonly abused substances in the country. The abuse 
of heroin and methamphetamine has been concentrated 
mainly in the north, close to the border with the  
United States. The Government reported a sharp 
increase in the abuse of cocaine, particularly “crack”, 
and methamphetamine in 2008. Rising levels of opioid 
abuse were also reported in Mexico in 2009, although 
no specific data were provided. 
86. The Board notes that, despite regulations banning 
ephedrine and pseudoephedrine in Mexico, precursor 
chemicals continue to be smuggled into the country, 
where the illicit manufacture of amphetamine-type 
stimulants continues. Furthermore, there continue to be 
shortcomings in the control of the licit movement of 
controlled substances, in particular with regard to the 
inspection of retail outlets for psychotropic substances. 
The Board urges the Government to take effective 
measures to ensure that those issues are adequately 
addressed.  
87. There appears to be a lack of progress in the 
implementation of the recommendations made by the 
Board following its last mission to Mexico, in 2005, on 
the use of opioid analgesics for medical purposes, 
which remains low. The Board encourages the 
Government to identify any impediments and take the 
necessary steps to ensure that adequate access to those 
narcotic drugs is provided for those in need of medical 
treatment, bearing in mind the aims of the international 
drug control treaties.  
 
  Peru 
 
88. In recent years, the area under illicit coca bush 
cultivation has started to increase in Peru, reaching 
almost 60,000 hectares (ha) in 2009. While Peru 
remained the world’s second largest coca bush grower 
(after Colombia), it became the world’s largest coca 
leaf producer in 2009, when its potential coca leaf 
production (119,000 tons) surpassed that of Colombia 
for the first time since 1997. The Board is concerned 
that if current trends in such cultivation continue 
unchecked, Peru could overtake Colombia in terms of 
the area under illicit coca bush cultivation and illicit 
coca leaf production in the coming years, regaining its 
position as the world’s largest supplier of cocaine, a 
position it held up to 1996.  
89. The Board notes the efforts of the Government to 
eradicate illicit coca bush cultivation (or at least to 
prevent further expansion of such cultivation), as part 
of its comprehensive and balanced national drug 
control policy for the period 2007-2011, aimed at 
combating drug abuse and drug trafficking. In recent 
years, through a national rapid-impact plan, additional 
resources have been allocated for investment projects 
and activities that reinforce means to reduce the illicit 
production and illicit use of drugs. However, efforts 
need to be further stepped up to effectively counter the 
increasing trend in illicit coca bush cultivation and 
illicit coca leaf production.  
90. The traditional habit of chewing coca leaf has  
not been abolished in Peru, as required under the  
1961 Convention. Although the Board has called upon 
the Government of Peru to abolish all uses of coca leaf, 
including coca leaf chewing, traditional uses of coca 
leaf still continue in the country. The Board calls upon 
the Government, as a party to the 1961 Convention as 
amended by the 1972 Protocol, to ensure full 
compliance with its obligations under the Convention, 
including the obligation to eliminate all uses of coca 
leaf for purposes other than those provided for in the 
Convention.  
91. The Board notes that the prevention of drug abuse 
is one of the priorities of the national drug control 
strategy. Peru has institutionalized policies on the 
prevention and treatment of drug abuse at different 
levels within the Government through the 
implementation of an educational plan for prevention, 
early detection and prompt referral relating to drug 
abuse.  
92. The Government has adopted adequate legislation 
for the control of precursor chemicals and put in place 
an effective monitoring mechanism with regard to the 
manufacture, distribution, import and export of 
controlled chemicals. The Board also notes that 
international cooperation by the Government, 
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including compliance with its reporting obligations 
under the international drug control treaties, has 
improved in recent years. The Board welcomes those 
developments and encourages the Government to step 
up efforts in areas where progress is lacking and to 
ensure that the progress already achieved is sustained.  
 
 3. Country missions 
 
93. In pursuing its mandate under the international 
drug control treaties and as part of its ongoing dialogue 
with Governments, the Board undertakes a number of 
country missions every year to discuss with competent 
national authorities measures taken and progress made 
in various areas of drug control. The missions provide 
the Board with an opportunity to obtain not only first-
hand information, but also a better understanding of 
the drug control situation in each country it visits, 
thereby enabling the Board to provide the Government 
with relevant recommendations and to promote treaty 
compliance. 
94. In 2010, the Board sent missions to the following 
countries: Armenia, Azerbaijan, Croatia, Gabon, 
Georgia, Guatemala, Israel, Lebanon, Morocco and 
Turkmenistan. The findings and recommendations of 
the 2009 missions of the Board to Hungary, Ireland, 
Jordan, Malta and Spain are also reflected in the 
present report.  
 
  Armenia  
 
95. A mission of the Board visited Armenia in 
October 2010. The Board’s previous mission to that 
country was in 1997. The Board notes the commitment 
of the competent national authorities of Armenia to 
comply with the provisions of the three international 
drug control conventions, to which Armenia is a party. 
The Board has identified shortcomings in mutual 
cooperation and information exchange among the drug 
control authorities in the country and encourages the 
Government to address that issue. 
96. Armenia has recently been targeted by criminal 
groups engaged in trafficking in precursors used in the 
illicit manufacture of heroin and amphetamine-type 
stimulants, as evidenced by the clandestine 
amphetamine laboratories uncovered and dismantled in 
the country in 2010. The Board has requested the 
Government to further strengthen the control of 
precursors. The Board recommends the Government to 
assess the requirements for narcotic drugs used for pain 
treatment in the country and to identify and address 
any impediments to making them available in 
sufficient quantities for medical use. 
 
  Azerbaijan  
 
97. A mission of the Board visited Azerbaijan in  
July 2010. The objective of the mission was to review 
the progress achieved in the country to implement the 
provisions of the international drug control treaties 
since the Board’s last mission to the country, in 1997. 
98. To address the problem of drugs being smuggled 
through Azerbaijan, certain measures, in particular the 
strengthening of border control, have been taken. In 
spite of those measures, Azerbaijan continues to be 
used as a transit country for illicit drug consignments. 
The Board encourages the Government to continue 
strengthening law enforcement, border protection, 
regional cooperation and information-sharing to 
prevent drug trafficking. In Azerbaijan, the availability 
of narcotic drugs used for pain treatment is relatively 
low. The Board therefore requests the Government to 
assess the requirements for narcotic drugs used for the 
treatment of pain, to identify impediments to efforts to 
ensure that such narcotic drugs are available in 
adequate quantities and to develop policies to 
overcome those impediments. In view of the growing 
problem in Azerbaijan with regard to the abuse of 
drugs, mainly opiates, the Board recommends the 
Government carry out a national survey of drug abuse 
and to use the survey findings to design and monitor 
appropriate drug control strategies. The Board also 
recommends the Government strengthen drug abuse 
prevention efforts and ensure the availability of 
facilities for the treatment of drug dependence. 
 
  Croatia 
 
99. A mission of the Board visited Croatia in  
May 2010. Croatia is a party to all three international 
drug control conventions, and the Government is 
committed to the implementation of the provisions of 
those treaties. The Board notes with satisfaction that 
the Government has developed a comprehensive 
national drug control strategy, as well as action plans, 
to ensure coordination among implementing agencies 
and institutions. However, data on the prevalence of 
drug abuse, which are important for guiding drug 
control policies and evaluating their effectiveness, are 
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lacking. The Board calls upon the Government to 
regularly assess the extent of drug abuse in Croatia. 
100. The strategic location of Croatia and its extensive 
borders make it vulnerable to drug trafficking by 
organized criminal groups that use the country for 
transit trafficking. The Government has undertaken a 
number of legal, judicial and institutional reforms in 
recent years to increase the country’s capacity to 
counter organized crime. Law enforcement agencies in 
Croatia also cooperate closely with their counterparts 
in other countries and with international organizations 
to strengthen border control. The Board encourages the 
Government to continue its efforts in preventing drug 
trafficking by organized criminal groups and to ensure 
that law enforcement agencies are provided with 
adequate training and equipment to be effective in this 
regard. 
 
  Gabon 
 
101. A mission of the Board visited Gabon in  
June 2010. It was the first time since 1998 that the 
Board had sent a mission to the country. The objective 
of the mission was to review the implementation of the 
three international drug control treaties, to which 
Gabon is a party. The discussions related primarily to 
recent developments in drug trafficking and abuse in 
Gabon and measures taken or planned by the 
Government to overcome the present difficulties. 
Although Gabon still appears relatively immune to 
problems related to drug abuse, the Board encourages 
the Gabonese authorities to take measures to ensure the 
collection and analysis of information on drug abuse in 
order to plan adequate treatment for drug addicts. 
102. The Board notes that the Government of Gabon 
has taken a series of steps to strengthen drug control as 
part of the implementation of the international drug 
control treaties and that the Gabonese authorities are 
very much involved in fighting drug-related problems. 
However, comprehensive legislation to control licit 
activities related to narcotic drugs, psychotropic 
substances and precursor chemicals and good 
coordination between the various control bodies are 
essential. Personnel should also be suitably trained and 
provided with the necessary resources. 
 
  Georgia  
 
103. The Board sent a mission to Georgia in  
July 2010. Georgia has the potential to become a major 
transit country used for consignments of narcotic drugs 
from Afghanistan destined for Western Europe. 
Georgia is a party to all three international drug control 
treaties and, in line with the provisions of the 
international drug control system, has in place legal 
and administrative mechanisms for the control of 
narcotic drugs, psychotropic substances and precursor 
chemicals. However, a balanced national drug control 
strategy has not yet been adopted. The drug law 
enforcement authorities in Georgia appear to be 
effective, cooperating with their counterparts in 
neighbouring countries. The abuse of drugs, including 
prescription drugs and home-made stimulants, is a 
problem in Georgia, although reliable data on the 
extent of drug abuse do not exist. HIV prevalence rates 
among persons who abuse drugs by injection are high. 
104. The Board recommends that the Government of 
Georgia adopt and implement a balanced national drug 
control strategy. In view of the fact that drug abuse is 
widespread, the Board urges the Government to 
regularly assess the extent of the abuse of specific 
drugs, including pharmaceutical preparations. The 
Board recommends that services for the prevention of 
drug abuse should be expanded to include all segments 
of the population that might need such services and 
programmes for the rehabilitation and social 
reintegration of drug-dependent persons should be 
strengthened. There is a need for stricter control over 
the domestic distribution of certain pharmaceutical 
preparations that are abused in the country. 
 
  Guatemala 
 
105. A mission of the Board visited Guatemala in  
May 2010. It was the first time since 1999 that a 
mission of the Board had visited the country. The 
Board notes the commitment of the competent national 
authorities of Guatemala to comply with the provisions 
of the international drug control conventions, to which 
Guatemala is a party. Guatemala, like several other 
countries in Central America, must cope with a high 
level of criminality, insecurity and impunity, which are 
considered to be the main concerns of its citizens.  
106. Guatemala continues to be used as a trans-
shipment area for consignments of drugs originating in 
South America. However, according to the latest 
household survey, conducted by the Government  
in 2005, the prevalence of the abuse of all drugs except 
cannabis in Guatemala was among the lowest in 
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Central America. The Board encourages the 
Government to carry out a new survey on drug abuse to 
enable a comparison of drug abuse data and to  
identify new trends in drug abuse in the country. In 
addition, large-scale trafficking in precursors of 
amphetamine-type stimulants has become one of the 
major problems faced by Guatemalan authorities. 
Despite imports of pseudoephedrine being banned  
in 2009, the country continues to be targeted by 
precursor traffickers. 
 
  Hungary 
 
107. A mission of the Board visited Hungary in 
October 2009. The Board notes with satisfaction that 
the Government of Hungary is fully committed to the 
goals of the international drug control treaties and has 
implemented a comprehensive strategy to combat drug-
related problems in that country. As a result, significant 
progress has been achieved in key areas such as drug 
abuse prevention and the treatment and rehabilitation 
of drug abusers. The Board encourages the 
Government to ensure that adequate resources are 
available for sustained progress in the implementation 
of drug control measures. 
108. The Board notes with appreciation that over the 
past few years, measures have been adopted in 
Hungary to facilitate the medical prescription of 
opioids for the treatment of pain. The Government 
should continue its efforts to address factors that 
impede the availability of opioid analgesics for 
medical purposes. There are signs that the illicit 
production of cannabis is on the increase in Hungary 
and that the country is being used as a transit area to 
smuggle cocaine into Western Europe. The Board urges 
the Government to strengthen law enforcement 
activities in order to address those challenges.  
 
  Ireland 
 
109. A mission of the Board visited Ireland in  
October 2009. Ireland is a party to all the international 
drug control treaties and has adopted comprehensive 
drug control legislation. In principle, legislative, 
administrative and regulative structures for 
implementation of the provisions of the international 
drug control treaties are in place. The Board reiterates, 
however, its request to the Irish authorities to extend 
the system of import and export authorizations to all 
substances in the schedules of the 1971 Convention. In 
September 2009, Ireland launched its second National 
Drug Control Strategy. The Strategy is implemented in 
close cooperation with all ministries and departments 
responsible for supply and demand reduction measures. 
The Strategy focuses on behavioural patterns leading to 
the abuse or misuse of drugs, including alcohol. 
110. Programmes for the prevention and treatment of 
drug abuse are carried out by governmental and non-
governmental agencies working in close cooperation 
with one another. The Board welcomes the 
involvement of local communities and civic society in 
those programmes. Close cooperation is established 
between various law enforcement offices and other 
governmental offices with regard to supply reduction 
measures, which has led to successes in the use of 
controlled deliveries and in the seizure of drugs and 
assets derived from criminal activities.  
 
  Israel  
 
111. A mission of the Board visited Israel in 
November 2009. Israel is party to all three 
international drug control conventions, and drug 
control activities are coordinated and guided by the 
Israel Anti-Drug Authority, a well-functioning 
coordination mechanism. Previously under the 
authority of the Prime Minister, the Anti-Drug 
Authority is now an independent entity under the 
Ministry of Public Security.  
112. The Board noted that the system established to 
ensure that narcotic drugs and psychotropic substances 
are used only for medical and scientific purposes 
functions well in Israel and that there are few cases in 
which narcotic drugs or psychotropic substances have 
been diverted into the illicit traffic. The Board 
welcomes the creation of the Pharmaceutical Crime 
Unit to prevent the diversion of drugs into illicit 
channels, as well as the steps taken by the Government 
to act against the sale and use of so-called kiosk drugs, 
which contain substances not under international 
control. The Board notes, however, that the 
Government of Israel has yet to enact precursor control 
legislation, as recommended by the Board following its 
2004 mission to that country.  
113. In conjunction with its mission to Israel, the 
Board also visited the Palestinian Authority and held 
meetings in Ramallah on 18 November 2009. The 
Palestinian areas were last visited by a mission of the 
Board in 1998. The Board urges the Palestinian 
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Authority to enact the draft law on drugs and to accord 
higher priority to the treatment and rehabilitation of 
drug abusers.  
114. The Board notes that, despite the difficult 
political situation, Israel and the Palestinian Authority 
have cooperated with each other on drug-related issues 
on a limited scale at the technical level. UNODC  
has played an important role in facilitating  
that cooperation. The Board emphasizes that such 
cooperation needs to be extended and strengthened. All 
relevant authorities should therefore explore avenues 
of potential cooperation to actively seek ways and 
means of reviving and strengthening cooperation and 
to establish and strengthen working relations in 
preventing drug trafficking along borders and drug 
abuse.  
 
  Jordan 
 
115. The Board sent a mission to Jordan in  
August 2009. The Government of Jordan is committed 
to drug control and applies a balanced approach to 
reduce the illicit supply of and demand for drugs. 
Monitoring of the movement of controlled substances 
in Jordan was found to be satisfactory. Law 
enforcement activities — both within the country and 
with other countries — are well coordinated. However, 
trade in precursor chemicals with other countries in 
West Asia has increased. The Board therefore requests 
all authorities involved in precursor control to improve 
their efforts to prevent Jordan from being used as a 
transit country for precursor chemicals destined for 
areas where illicit drug manufacture takes place.  
116. Drug abuse in Jordan appears to be limited when 
compared with the levels recorded elsewhere; however, 
there are indications that drug abuse in Jordan has been 
increasing in recent years. The Board calls upon the 
Government to assess regularly the extent of abuse of 
all types of substances. The Board further recommends 
that the programmes for the prevention and treatment 
of drug abuse be expanded to cover all sectors of the 
population that might need them and that the 
rehabilitation and social reintegration of drug-
dependent persons be facilitated. 
 
  Lebanon 
 
117. The Board sent a mission to Lebanon in  
March 2010. Lebanon is a party to all three 
international drug control conventions and has adopted 
comprehensive drug control legislation, as well as 
legislation to prevent money-laundering in line with 
the provisions of the 1988 Convention. The regulatory 
controls are reported to be strictly enforced. Law 
enforcement agencies have been making efforts to 
reduce the illicit cultivation of cannabis plant and 
opium poppy in Lebanon, and some measures have 
been implemented to prevent and treat drug abuse in 
the country.  
118. Nevertheless, important challenges remain. 
Trafficking in counterfeit Captagon through Lebanon 
continues. Reliable data on drug abuse in Lebanon are 
not available, but the problem appears to be growing. 
Drug abuse prevention and outreach and treatment 
activities targeting drug abusers are not sustainable and 
they do not cover all substances of abuse or the  
whole population. The Board recommends that the 
Government intensify efforts aimed at detecting and 
sanctioning illicit activities related to drugs, including 
trafficking in counterfeit Captagon. The Government 
should also regularly assess the abuse of all types of 
substances, establish a comprehensive national policy 
to prevent the abuse of all drug types and expand the 
services for the prevention and treatment of drug abuse 
to include all sectors of the population that might need 
such services, including the prison population, with a 
view to facilitating the rehabilitation and social 
reintegration of drug-dependent persons.  
 
  Malta 
 
119. The Board sent a mission to Malta in  
October 2009 for the first time to review the drug 
control situation and the Government’s compliance 
with the international drug control treaties. The Board 
notes that Malta adopted its first National Drugs Policy 
in February 2008 and encourages the Government to 
adopt and implement the legislation to establish as 
soon as possible the National Commission on the 
Abuse of Drugs, Alcohol and Other Dependencies as 
the main body responsible for the coordination of 
drug-related matters in the country.  
120. The Board notes the efforts of the law 
enforcement authorities of Malta in combating drug 
trafficking. The Board urges the Government to 
strengthen its capacity to identify, investigate and 
follow-up suspicious transactions involving substances 
under international control. The Board encourages the 
Government to allocate sufficient human and financial 
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resources in the area of law enforcement to develop its 
drug control capacity. Moreover, with regard to efforts 
to address the challenge of the smuggling of drugs 
through its territory, the Board encourages the 
Government to further strengthen customs and border 
control activities to prevent such smuggling, for 
example, through capacity-building and allocating 
additional resources for such activities. 
 
  Morocco  
 
121. The Board sent a mission to Morocco in 
December 2009. One of the main objectives of the 
mission was to review the situation with respect to the 
cultivation of cannabis plant in the country. The Board 
learned about the significant reduction of cannabis 
plant cultivation over the preceding five years and 
acknowledged the efforts of the Government of 
Morocco. It is important that the efforts to curb 
cannabis plant cultivation be sustained in the short, 
medium and long run. In addition, the Board 
encourages the Government to continue to monitor the 
situation by collecting and analysing pertinent 
statistical data on the extent of cannabis cultivation in 
the country and to share its experiences with the 
international community so that the efforts and 
achievements of Morocco in the reduction of cannabis 
plant cultivation can become more widely known.  
122. The controls applied to the licit movement of 
narcotic drugs and psychotropic substances were 
described as effective. Morocco regularly provides to 
the Board information required under the international 
drug control treaties. As some of the information is 
received late, the Board encourages the Government to 
review the mechanisms and procedures used for data 
collection so that reports can be submitted within the 
deadlines required by the treaties.  
 
  Spain  
 
123. The Board sent a mission to Spain in July 2009. 
The Board notes that Spain, a party to all three 
international drug control conventions, is firmly 
committed to the goals and objectives of those treaties. 
That commitment is reflected in the national drug 
control strategy and the national drug control action 
plan adopted by the Government, which are 
implemented within a well-designed administrative 
framework. The Government has established effective 
procedures for control over the licit manufacture of, 
trade in and use of narcotic drugs, psychotropic 
substances and precursors. A comprehensive and  
well-balanced system of prevention, treatment, 
rehabilitation and social reintegration programmes has 
been put in place to deal with drug abuse. The Board 
remains concerned, however, about the continued 
availability of “drug consumption rooms” in Spain.  
124. The Board notes the actions taken by the national 
law enforcement authorities in Spain to prevent the 
smuggling of narcotic drugs through Spanish territory. 
As Spain is used as a transit country for smuggling 
drugs from Latin America and Africa into other 
European countries, it is important to foster effective 
cooperation among the law enforcement authorities in 
Spain, as well as with the law enforcement agencies of 
the countries of origin and destination of drug 
shipments entering Spain, with a view to identifying 
and dismantling the drug trafficking rings involved.  
 
  Turkmenistan 
 
125. A mission of the Board visited Turkmenistan in 
June 2010. The Board notes that, since its last mission 
to Turkmenistan, in 2003, the Government has taken a 
series of measures to implement the international drug 
control treaties and has made some progress in certain 
areas of drug control. In particular, national drug 
control legislation and the Penal Code were amended 
in 2009 and the State Anti-Drug Control Service  
was established. The Government has also taken  
some steps to address the emerging problems of drug 
abuse and drug trafficking in the country, for example, 
by strengthening border control, enhancing law 
enforcement capacity and carrying out drug abuse 
prevention programmes targeting young persons. 
126. However, significant challenges remain. The 
Board notes that, although drug abuse does not appear 
to be significant in the country, no recent studies on the 
drug abuse situation have been carried out, and 
therefore precise information on the extent and nature 
of drug abuse in the country is not available. Regarding 
trafficking through Turkmenistan of drugs originating 
in Afghanistan, the Board urges the Government of 
Turkmenistan to take appropriate measures to make its 
drug control efforts effective. The Board also urges the 
Government to take measures to ensure the availability 
of narcotic drugs and psychotropic substances for 
medical purposes in compliance with the provisions of 
the international drug control treaties.  
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 4. Evaluation of the implementation by 
Governments of recommendations made by the 
Board following its country missions  
 
127. As part of its ongoing dialogue with 
Governments, the Board also conducts, on a yearly 
basis, an evaluation of Governments’ implementation 
of the Board’s recommendations pursuant to its country 
missions. In 2010, the Board invited the Governments 
of the following six countries, to which it had sent 
missions in 2007, to provide information on progress 
made in the implementation of its recommendations: 
Albania, Bhutan, Bolivia (Plurinational State of), 
Liberia, Nepal and Viet Nam. 
128. The Board wishes to express its appreciation to 
the Governments of Albania, Bhutan, Bolivia 
(Plurinational State of) and Nepal for submitting the 
information requested, which facilitated the Board’s 
assessment of the drug control situation in those 
countries and the Governments’ compliance with the 
international drug control treaties. The Board regrets 
that no information was received from the 
Governments of Liberia and Viet Nam, and it urges 
those Governments to provide the requested 
information without further delay. 
129. Information regarding the implementation of the 
Board’s recommendations by the Governments of 
Argentina, the Gambia and Myanmar following its 
missions to those countries in 2006, which was 
received too late to be included in the report for 2009, 
is also included in the present report. 
 
  Albania  
 
130. The Board notes that the Government of  
Albania has implemented some of the Board’s 
recommendations following its mission to that country 
in October 2007. In particular, some measures have 
been taken in the area of demand reduction. The 
Government has also improved its reporting to the 
Board, which is required under the international drug 
control treaties.  
131. The Board notes, however, that progress 
continues to be lacking in other areas. The Board 
remains concerned that the Inter-Ministerial Drug 
Control Committee, though established many years 
ago, has not been able to function adequately, owing to 
lack of resources, and that cooperation between 
Government agencies responsible for drug control 
continues to be seriously hampered by lack of 
coordination. Furthermore, the following problems 
have yet to be addressed: the absence of reliable 
information on the extent of drug abuse; the lack of 
legislation on precursor control and of a designated 
competent authority for the implementation of the 
provisions of article 12 of the 1988 Convention; and 
the lack of progress reported in the eradication of illicit 
cultivation of cannabis plant. 
132. The Board urges the Government of Albania to 
take effective measures to ensure that progress is made 
in the above-mentioned areas, particularly with regard 
to the strengthening of the Inter-Ministerial Drug 
Control Committee to ensure coordination among 
various Government agencies involved in drug control.  
 
  Argentina  
 
133. The Government of Argentina has acted upon the 
recommendations made by the Board following its 
mission to that country in May 2006, and progress has 
been made in a number of areas of drug control. Most 
notably, the Government has improved coordination 
between all agencies involved in implementing drug 
control and has strengthened coordination and 
cooperation on law enforcement issues between the 
competent national authority and other agencies 
involved in drug control at the national level and 
between the national authorities and the provincial 
authorities. Progress has also been made in integrating 
customs authorities in national drug control policy.  
134. The Board welcomes the measures taken by the 
Government of Argentina to prevent the diversion of 
narcotic drugs and psychotropic substances from licit 
distribution channels, to be sold on illicit markets. 
Those measures include, inter alia, the standardization 
of official prescriptions and monitoring of 
pharmaceutical preparations containing substances 
under international control, a nationwide programme 
aimed at detecting possible irregularities in the 
handling of controlled substances, and the creation of a 
unified model for official prescriptions to prevent 
adulterations and the falsification of prescriptions. 
135. Steps have also been taken by the competent 
national authorities to further curb the high rate of 
consumption of anorectics in Argentina, for example 
by reducing the country’s assessments for those 
substances and limiting their use in “magistral” 
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preparations, which are permitted in Argentina under 
current legislation. 
136. The Board, while acknowledging the progress 
made in drug control, encourages the Government of 
Argentina to continue its efforts in improving the 
collection and analysis of data, including data on drug-
related crime, and expanding drug abuse prevention 
programmes and facilities for the treatment and 
rehabilitation of drug abusers, as necessary, to ensure 
that all sectors of the population have access to those 
services, including at the provincial level.  
137. The Board notes that consumption of coca leaf 
(by chewing or in the form of tea) and its possession 
for such purposes are still permitted under the national 
legislation currently in force in Argentina. The  
Board calls upon the Government, as a party to the 
1961 Convention as amended by the 1972 Protocol, to 
ensure full compliance with its obligations under the 
Convention, including the obligation to eliminate all 
uses of coca leaf for purposes other than those 
provided for in the Convention.  
 
  Bhutan  
 
138. The Government of Bhutan has acted upon the 
Board’s recommendations following its mission to that 
country in 2007, and some progress has been made in a 
number of areas. The Board notes that the Government 
has developed an implementation framework for  
the Narcotic Drugs, Psychotropic Substances and 
Substance Abuse Act of 2005, as well as rules and 
regulations for the implementation of the provisions of 
the Act. The Government has also made the prevention 
of drug trafficking an operational priority. Concrete 
steps taken in that regard include increasing border 
control, law enforcement capacity-building and 
strengthening cooperation with neighbouring countries.  
139. The Board notes that increased efforts have been 
made in Bhutan to strengthen the mechanism for 
controlling the licit movement of narcotic drugs and 
psychotropic substances, as well as in the area of 
demand reduction. In particular, the Government has 
expanded facilities for the treatment and rehabilitation 
of drug addicts and carried out campaigns to raise 
awareness about drug abuse, with assistance from 
regional and international organizations.  
140. The Board, while welcoming the positive 
developments in drug control in Bhutan, notes that 
there appears to be a lack of progress in strengthening 
coordination among Government agencies involved in 
drug control. The Board requests the Government to 
step up its efforts in that area, particularly in view of 
the increased drug trafficking in South Asia. 
 
  Bolivia (Plurinational State of)  
 
141. The Board notes with regret that no progress has 
been made by the Government of the Plurinational 
State of Bolivia in implementing the recommendations 
made by the Board following its mission in 2007 
regarding coca bush cultivation and coca leaf 
production. The Government continues to implement 
its national Strategy for Fighting Drug Trafficking and 
Revaluing the Coca Leaf 2007-2010, which marks a 
significant shift in the political will and commitment of 
the Government to the objectives of the international 
drug control treaties. While the Strategy reaffirms the 
strong stand of the Government on dealing with the 
illicit manufacture of and trafficking in cocaine and 
with criminal organizations, the Strategy addresses the 
coca-chewing issue in a manner that is not in line with 
that country’s obligations under the international drug 
control treaties to which it is a party. 
142. The Board remains concerned about the 
continuous increase in both the reported total area 
under coca bush cultivation and the expected coca leaf 
production since 2005. Despite the social control 
measures currently being pursued by the Bolivian 
Government with the aim of reducing coca bush 
cultivation and coca leaf production, in 2009 the total 
area cultivated reached 30,900 ha and potential 
production of coca leaf rose to 40,200 tons, the largest 
amount of coca leaf produced in the country since 
1998. Those developments could increase the risk of 
coca leaf being diverted for use in the illicit 
manufacture of cocaine. 
143. The Board, while noting its agreement with the 
Bolivian Government’s position of zero tolerance for 
the illicit manufacture of and trafficking in cocaine, 
urges the Government to adopt effective policies and to 
take a proactive role to eliminate coca bush cultivation 
and coca leaf production in the country, as well as to 
address in a decisive manner the illicit manufacture of 
and trafficking in cocaine. 
144. The Bolivian Government has yet to implement 
other recommendations made pursuant to the 2007 
mission of the Board, notably the recommendations 
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concerning demand reduction and the monitoring of 
the licit movement of substances under international 
control. The Board is concerned about the rise of drug 
abuse among the general population and the student 
population in the country. In particular, the abuse of 
cocaine and cannabis continues to increase among  
the population aged 12-65 years, while drug abuse 
prevention programmes are largely absent from 
Government policy. Moreover, the existing mechanism 
for the control and monitoring of substances under 
international control does not function adequately. The 
Board urges the Government to take the necessary 
measures to ensure that progress is made in those 
areas.  
 
  Gambia  
 
145. The Board notes with concern that little progress 
has been made by the Government of the Gambia in 
implementing the recommendations made by the Board 
following its mission to the country in May 2006. In 
particular, the Board notes that the current national 
legislation concerning the import and export of 
narcotic drugs and psychotropic substances has not 
been updated to meet the requirements of the 
international drug control treaties; legal provisions for 
precursor control have yet to be adopted; and the 
administrative mechanism for licit drug control 
remains inadequate. The Gambia has failed to fulfil its 
reporting obligations for many years, including the 
furnishing of estimates and assessments of the 
country’s requirements for narcotic drugs and 
psychotropic substances. The Board urges the 
Government to take the necessary remedial action, as a 
matter of priority. 
146. The Board notes that the extent of drug abuse in 
the Gambia is largely unknown to the authorities. 
Reliable data on drug abuse continue to be scarce, and 
no epidemiological study on the prevalence of drug 
abuse has been undertaken. The Board urges the 
Government to take steps to address those issues, 
including the elaboration of drug abuse prevention and 
demand reduction programmes; the conduct of a rapid 
assessment of the extent of drug abuse in the country; 
the provision of adequate support to the existing 
medical structures to ensure proper treatment for 
drug-dependent patients; and the creation of suitable 
facilities for the rehabilitation of drug abusers. 
147. The capacity of the Gambia in drug law 
enforcement is limited. In view of the smuggling of 
cocaine through West Africa, the Board is concerned 
that the Gambia, like other countries in the region, is at 
risk of being used as a transit country for cocaine 
shipments. The recent large seizure of cocaine in the 
Gambia might be an indication that traffickers are 
taking advantage of the serious weaknesses in the drug 
control and law enforcement structures of the country. 
The Board urges the Government of the Gambia to take 
effective measures to intensify its drug law 
enforcement efforts and make further progress in 
complying with the international drug control treaties. 
In doing so, the Government may wish to consider 
requesting needed technical assistance from UNODC 
and other international organizations.  
 
  Myanmar  
 
148. The Board notes that some progress has been 
made in Myanmar since the Board’s last mission to that 
country, in 2006. A series of measures have been taken 
towards achieving the goals of the 15-year national 
drug control plan calling for the elimination of all drug 
trafficking and illicit drug production by 2014, 
including the prevention and eradication of illicit 
opium poppy cultivation and the improvement of living 
standards to reduce the financial incentive for such 
cultivation. Specific steps have also been taken in 
supply and demand reduction: law enforcement, 
awareness-raising programmes, the improvement of 
access and communication between people living in 
various lowland and highland areas and the 
improvement of living standards of those residing in 
border areas.  
149. The Board notes, however, that illicit opium 
poppy cultivation has increased in Myanmar in recent 
years. Although there have been increasing seizures of 
precursor chemicals and amphetamine-type stimulants 
by the Myanmar law enforcement agencies in recent 
years, the illicit manufacture of methamphetamine 
remains a significant challenge. Clandestine drug 
laboratories continue to be active in Myanmar along 
the borders with Thailand and China. The Board 
further notes that the availability of narcotic drugs and 
psychotropic substances used for medical purposes 
remains limited and that little progress seems to have 
been made in the collection of data on drug abuse in 
the country.  
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150. The Board urges the Government to step up its 
efforts in drug control and to ensure that continued 
progress is made in the elimination of illicit opium 
poppy cultivation in the country. Additional measures 
should be taken to address the illicit manufacture of, 
and trafficking in, amphetamine-type stimulants and, in 
particular, to identify the sources and routes of 
shipments of precursor chemicals that are seized,  
as well as new methods used for illicit drug 
manufacturing. To that end, the Government should 
strengthen its cooperation with neighbouring countries.  
 
  Nepal  
 
151. The Board notes that the Government of Nepal 
has been making efforts to strengthen drug control 
since the mission of the Board to that country in  
March 2007. In particular, the Board notes that the 
National Strategy for Drug Control was adopted  
in 2010, that the Narcotics Drug Control Act is under 
review to make it fully compliant with the provisions 
of the international drug control treaties and that 
considerable efforts have been made in the area of  
law enforcement. The Board also notes that the 
Government has continued its efforts in demand 
reduction, for example, through the development of 
facilities for the treatment of drug abusers and 
community-based programmes for drug abuse 
prevention. 
152. The Board notes, however, that coordination 
among Government agencies involved in drug control 
has not improved and that there continues to be a need 
for more resources to be allocated to law enforcement 
agencies to enable them to operate more effectively. In 
addition, there appears to be lack of progress in the 
adoption of legislation on precursor control and the 
designation of a competent authority for the 
implementation of the provisions of article 12 of the 
1988 Convention.  
153. In view of the worsening situation in Nepal with 
regard to drug abuse, including drug abuse by 
injection, the Board urges the Government to further 
strengthen its efforts in the area of demand reduction, 
particularly with regard to a nationwide assessment of 
the drug abuse situation, and to take all measures 
necessary to address the problem in accordance with 
the international drug control treaties. The Board trusts 
that the Government of Nepal will take the necessary 
measures to ensure that progress is made in all those 
areas as well. 
 
 5. Evaluation of the implementation of the 
recommendations made by the Board in its 
annual reports for 2005, 2006 and 2007  
 
154. Since 2005, the Board has devoted chapter IV  
of its annual report to highlighting major 
recommendations addressed to Governments and 
international organizations. At its session held in 
November 2008, the Board decided to evaluate the 
implementation of the recommendations published  
in chapter IV of its annual reports for 2005, 2006  
and 2007.  
 
  Recommendations addressed to Governments 
 
155. In March 2010, the Board sent a letter to all 
Governments, inviting them to complete a 
questionnaire on their implementation of the Board’s 
recommendations published in its annual reports for 
2005, 2006 and 2007. The questionnaire covers various 
aspects of drug control, including: (a) prevention of the 
diversion of controlled substances; (b) illicit crop 
cultivation and drug trafficking; (c) prevention of drug 
abuse; (d) availability and rational use of narcotic 
drugs and psychotropic substances for medical 
purposes; and (e) Internet pharmacies and misuse of 
courier services. 
156. As at 1 November 2010, the completed 
questionnaire had been received from a total of  
117 States and territories, as well as the European 
Union. Of the States and territories that had sent the 
completed questionnaire, 25 (45 per cent) were in 
Africa, 20 (45 per cent) were in the Americas,  
29 (59 per cent) were in Asia, 39 (83 per cent) were in 
Europe and 4 (18 per cent) were in Oceania. The Board 
wishes to thank those States and territories and the 
European Union for their cooperation in this matter 
and encourages those that have not done so to provide 
the requested information without further delay. 
Information received will be compiled and analysed for 
review by the Board.  
 
  Recommendations addressed to international 
organizations 
 
157. In May 2010, the Board reviewed the 
implementation by relevant international organizations 
of its recommendations published in its annual reports 
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for 2005, 2006 and 2007, on the basis of information 
received. The Board wishes to express its appreciation 
for the excellent cooperation of the Council of the 
European Union, the European Commission, the 
International Criminal Police Organization 
(INTERPOL), UNODC, the Universal Postal Union, 
the World Customs Organization and the World Health 
Organization (WHO) in providing the required 
information. The Board notes that a response has yet to 
be received from the United Nations Development 
Programme and looks forward to its cooperation in this 
matter.  
158. The Board notes that most of the 
recommendations have been addressed by the above-
mentioned organizations, with progress made in 
varying degrees. The information provided has made it 
possible for the Board to determine to what extent its 
recommendations have been implemented, as well as 
the impact of its recommendations on the drug control 
situation at the national and international levels.  
 
 
 B. Action taken by the Board to ensure 
the implementation of the international 
drug control treaties 
 
 
 1. Action taken by the Board pursuant to  
article 14 of the 1961 Convention and article 19 
of the 1971 Convention 
 
159. Article 14 of the 1961 Convention (and of that 
Convention as amended by the 1972 Protocol) and 
article 19 of the 1971 Convention set out measures that 
the Board may take to ensure the execution of the 
provisions of those conventions. Such measures, which 
consist of increasingly severe steps, are taken into 
consideration when the Board has reason to believe 
that the achievement of the aims of the conventions is 
being seriously endangered by the failure of a State to 
carry out the provisions of the conventions. 
160. The Board has invoked article 14 of the  
1961 Convention and/or article 19 of the  
1971 Convention with respect to a limited number of 
States. The Board’s objective in so doing has been to 
encourage compliance with those Conventions when 
other means failed. The States concerned are not 
named until the Board decides to bring the situation to 
the attention of the parties, the Economic and Social 
Council and the Commission on Narcotic Drugs (as in 
the case of Afghanistan). After dialogue with the Board 
pursuant to articles 14 and 19, most of the States 
concerned have taken remedial measures, resulting in 
the Board’s decision to terminate action taken under 
those articles vis-à-vis those States. 
161. Afghanistan is currently the only State for which 
action is being taken pursuant to article 14 of the  
1961 Convention. 
 
 2. Consultation with the Government of 
Afghanistan pursuant to article 14 of the  
1961 Convention 
 
162. At the International Conference on Afghanistan, 
held in London in January 2010, the Government of 
Afghanistan and the international community 
reaffirmed their commitment to achieving lasting 
peace, stability and prosperity in the country, with 
particular emphasis on the need for a reinvigorated and 
prioritized Afghanistan National Development 
Strategy. This commitment has led to an encouraging 
step forward, as evidenced by the Government-led plan 
for improved development, governance and stability in 
Afghanistan, endorsed at the Kabul Conference on  
20 July 2010, including a strategy for the transfer of 
lead responsibility for security on a province-by-
province basis. The Kabul Conference concluded with 
the adoption of a communiqué reflecting a renewed 
commitment of the Government of Afghanistan to 
addressing various key issues, including counter-
narcotics, as well as the commitment of the 
international community to the principles of aid 
effectiveness.  
163. The Board welcomes those important 
developments and the commitment of the Government 
of Afghanistan to attaining the goals of its National 
Development Strategy and of its National Drug Control 
Strategy. The Board reiterates that the achievement of 
peace, security and development in Afghanistan is 
closely linked to the solving of the drug control 
problem and expects that the Government of 
Afghanistan will continue its efforts towards 
eliminating illicit crop cultivation and related drug 
activities within the country, in compliance with the 
provisions of the international treaties, particularly the 
1961 Convention.  
164. The last decade has witnessed a continued high 
level of illicit opium poppy cultivation in Afghanistan, 
despite some reductions observed in 2008 and 2009. 
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Those reductions were, however, due largely to market 
factors, notably the high wheat and low opium prices at 
the time, which made licit crop cultivation more 
attractive. In 2010, the area under illicit opium poppy 
cultivation remained at 123,000 ha, the same as in 
2009. Although illicit opium production decreased 
significantly, by 48 per cent, in 2010, the decline was 
caused by a plant disease that affected the major 
poppy-growing regions. Clearly, no significant 
progress has been made over the past nine years in 
addressing illicit opium poppy cultivation in 
Afghanistan. 
165. As in previous years, in 2010 most of the illicit 
cultivation of opium poppy (98 per cent) continued to 
take place in the southern and western provinces which 
are the most insecure areas in Afghanistan. Helmand 
remained the main province in which opium poppy is 
illicitly cultivated, accounting for 53 per cent of the 
total area under illicit opium poppy cultivation in 
Afghanistan. It was followed by Kandahar, where the 
total area under illicit opium poppy cultivation reached 
26,000 ha in 2010; such cultivation has been on the 
rise in that province since 2004, when 4,959 ha were 
under cultivation. Unless tangible and continued 
progress is made in the reduction of illicit opium 
poppy cultivation in those two provinces, no 
significant decline in such cultivation in Afghanistan 
can be expected.  
166. The Board, while acknowledging increased 
efforts in drug control in Afghanistan, is concerned that 
activities to eliminate illicit opium poppy cultivation 
have been seriously hampered by widespread 
corruption at all levels of government, and that 
counter-narcotics programmes, despite some progress, 
remain challenged by a lack of security, political will 
and Government capacity. The Board underlines that 
long-term success depends on the sustainability of 
programmes for economic development in poppy-
growing provinces and, more importantly, good 
governance and the rule of law to be established and 
enhanced in those provinces.  
167. The Board points out that the prevention of illicit 
crop cultivation and the eventual elimination of such 
cultivation continue to be of the utmost importance to 
the efforts of Afghanistan to fulfil its treaty 
obligations, and those goals can be achieved only when 
the relevant laws are fully respected and strictly 
implemented and when sustainable alternative sources 
of income are made available to farmers. The Board 
urges the Government of Afghanistan to take effective 
measures to ensure that progress is made in the areas 
that are essential to the country’s long-term economic 
growth and sustainable progress in the elimination of 
illicit opium poppy cultivation, as reaffirmed at recent 
international conferences in support of Afghanistan.  
168. The Board notes that the Government of 
Afghanistan has pledged to take all measures necessary 
to increase transparency and accountability and tackle 
corruption. Efforts are being made to establish the 
statutory basis for the Major Crimes Task Force and 
the Anti-Corruption Tribunal (Special Courts) and to 
establish a committee to review Afghan laws for 
compliance with the United Nations Convention 
against Corruption. The Board welcomes the concrete 
steps taken by the Government of Afghanistan and 
calls upon UNODC to continue to provide assistance in 
that area, particularly with regard to the reforming of 
Afghanistan’s anti-corruption legislation to bring it in 
line with the Convention against Corruption, ratified 
by Afghanistan in 2008.  
169. The Board notes that increased efforts have been 
made to strengthen regional cooperation. The 
Government of Afghanistan has continued its dialogue 
and cooperation with neighbouring countries through 
bilateral talks and regional meetings on issues of 
security, economic cooperation and counter-narcotics. 
In particular, several other regional meetings were held 
on issues of crime, counter-narcotics and border 
management, with the participation of high-ranking 
officials from Afghanistan and the neighbouring 
countries. In addition, a new round of joint operations 
conducted in August 2010, by Afghan and Iranian 
forces and by Afghan and Pakistan forces, resulted in 
significant seizures of illicit drugs, including heroin, 
opium and cannabis, and the arrest of drug traffickers. 
170. Effective action to counter the threat of Afghan 
opium and to provide support to the Government of 
Afghanistan requires close regional cooperation and a 
concerted effort at the national, regional and 
international levels. The Board calls upon all relevant 
international and regional organizations to work 
closely together and to play an active role in 
addressing the challenges posed by opium originating 
in Afghanistan.  
171. The Board acknowledges the complexity of the 
drug-related problems in Afghanistan, which are 
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affected by insurgency, violence and the involvement 
of organized crime. Hence, addressing those problems 
requires the long-term commitment and support of the 
international community, including military forces, as 
well as their involvement in efforts in the areas of 
counter-insurgency, drug control and alternative 
development.  
172. The Board notes that the Government of 
Afghanistan is in the process of updating and 
improving its National Drug Control Strategy, as 
declared by the Government and reflected in the 
communiqué of the Kabul Conference. The Board 
trusts that the updated National Drug Control Strategy 
will be comprehensive and balanced, comprising all 
aspects of drug control, including measures against 
illicit cultivation of cannabis plant in the country, in 
compliance with the international drug control treaties. 
The Board urges the international community to 
support Government-led counter-narcotics efforts in 
Afghanistan, including in the areas of agricultural 
development, interdiction, demand reduction, 
eradication and public information, as well as the 
effective implementation of Security Council 
resolution 1817 (2008), on precursor control. The 
Board, pursuant to article 14 of the 1961 Convention, 
will maintain the consultation process with the 
Government of Afghanistan to ensure that progress is 
made in the drug control situation in that country.  
 
 
 C. Governments’ cooperation with the 
Board 
 
 
 1. Provision of information by Governments to the 
Board  
 
173. Parties to the international drug control treaties 
have an obligation to furnish to the Board information 
on narcotic drugs, psychotropic substances and 
precursors, in accordance with the provisions of those 
treaties. Governments are required to provide 
additional information to the Board pursuant to 
resolutions of the Economic and Social Council and 
the Commission on Narcotic Drugs. 
174. The Board uses the statistical data and other 
information received from Governments to monitor 
licit activities involving controlled substances 
throughout the world. The analysis of statistical data 
allows the Board to determine whether Governments 
have implemented treaty provisions requiring them to 
limit to medical and scientific purposes the licit 
manufacture of, trade in and use of narcotic drugs and 
psychotropic substances and, at the same time, have 
ensured the availability of narcotic drugs and 
psychotropic substances for legitimate purposes. The 
Board also identifies whether Governments have 
implemented measures to prevent diversion of 
precursors — substances listed in Tables I and II of the 
1988 Convention, which are frequently used in the 
illicit manufacture of narcotic drugs and psychotropic 
substances.  
175. Information received from Governments is also 
used by the Board to analyse various aspects of the 
functioning of the international drug control system. 
On the basis of its analysis, the Board makes 
recommendations to improve the system and the 
control of narcotic drugs, psychotropic substances and 
precursors at the international and national levels. 
176. Several achievements in international drug 
control are directly linked to the exchange of data 
between the Board and Governments. For example, 
universal implementation of the system of estimates 
and the system of statistical returns for narcotic drugs, 
in which the submission of data to the Board plays a 
pivotal role, made it possible to virtually stop the 
diversion of narcotic drugs from licit international 
trade into the illicit traffic. The implementation of 
similar systems for the control of psychotropic 
substances led to a significant reduction in the 
diversion of those substances from international trade. 
Those achievements would not have been possible if 
Governments had not submitted to the Board data on 
their legitimate requirements for narcotic drugs and 
psychotropic substances (estimates and assessments) 
and furnished the Board with detailed statistical reports 
on licit activities involving narcotic drugs and 
psychotropic substances, including their import and 
export. The Board trusts that the introduction of 
estimates for certain precursors will bring similar 
results.  
 
 2. Submission of statistical reports  
 
177. Governments have an obligation to furnish to the 
Board each year statistical reports containing 
information required by the international drug control 
conventions. As at 1 November 2010, reports on 
narcotic drugs for 2009 had been submitted by  
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166 States and territories, reports on psychotropic 
substances had been submitted by 159 States and 
territories and reports on precursors had been 
submitted by 127 States and territories. A report on 
precursors was also submitted by the European Union 
(on behalf of its member States). As in previous years, 
it is expected that several more Governments will 
submit reports for 2009. In recent years, the number of 
States and territories that submitted reports on narcotic 
drugs averaged about 180, or 85 per cent of the States 
and territories required to furnish those reports. For 
reports on psychotropic substances, the average 
number was about the same. For reports on precursors 
the average number was about 140, or 66 per cent of 
the States and territories required to furnish those 
reports.  
178. Governments are also required to submit to the 
Board quarterly statistical reports on trade in narcotic 
drugs and quarterly statistical reports on trade in 
psychotropic substances in Schedule II of the  
1971 Convention. A total of 188 States and territories 
provided for 2009 quarterly statistics on their imports 
and exports of narcotic drugs; that figure represents  
89 per cent of the States and territories requested to 
furnish such statistics. A total of 178 States and 
territories furnished quarterly statistics on their imports 
and exports of psychotropic substances in Schedule II 
of the 1971 Convention; that figure represents  
84 per cent of the States and territories requested to 
furnish such statistics. 
179. Pursuant to article 12 of the 1988 Convention, 
Governments are required to report information with 
respect to substances frequently used in the illicit 
manufacture of narcotic drugs and psychotropic 
substances. As at 1 November 2010, 57 Governments 
had reported seizures of such substances in 2009. All 
but one of those Governments had reported seizures of 
such substances, which are listed in Tables I and II of 
the 1988 Convention, and nearly half had reported 
seizures of substances not controlled under the  
1988 Convention.  
180. Details of the statistical data received by the 
Board, including the status of compliance of parties 
with their reporting obligations, are contained in the 
2010 technical reports of the Board on narcotic drugs 
and psychotropic substances and in the 2010 report of 
the Board on the implementation of article 12 of the 
1988 Convention.19  
181. While the majority of Governments regularly 
submit the mandatory and voluntary statistical reports, 
the cooperation of some has not been satisfactory. The 
number of Governments not submitting their statistics 
regularly has been high in Africa, the Caribbean and 
Oceania. In recent years, about one third of 
Governments in Africa and about 40 per cent of 
Governments in the Caribbean and Oceania have not 
furnished annual statistical reports. The rate of 
submission of statistical reports by Governments in 
those regions and subregions has not improved in spite 
of the repeated requests sent by the Board to the 
Governments concerned. 
182. The Governments of several low-income 
countries have encountered difficulties in submitting 
statistical reports to the Board. Those difficulties 
indicate major deficiencies in their national 
mechanisms for regulating controlled substances. The 
Board requests the Governments concerned to enhance 
their mechanisms for regulating licit activities 
involving controlled substances, including national 
systems for compiling data for the mandatory 
statistical reports on narcotic drugs, psychotropic 
substances and precursors. The Board will continue to 
provide assistance to those Governments in order to 
facilitate reporting. The Board requests UNODC and 
the relevant regional organizations to provide support 
to Governments in Africa, the Caribbean and Oceania 
with a view to increasing those Governments’ capacity 
for controlling licit activities involving narcotic drugs 
and psychotropic substances and taking measures to 
prevent the diversion of precursors. 
__________________ 
 19  Narcotic Drugs: Estimated World Requirements for 2011 
— Statistics for 2009 (United Nations publication, Sales 
No. T.11.XI.2); Psychotropic Substances: Statistics for 
2009 — Assessments of Annual Medical and Scientific 
Requirements for Substances in Schedules II, III and IV 
of the Convention on Psychotropic Substances of 1971 
(United Nations publication, Sales No. T.11.XI.3); 
Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2010 on the Implementation of  
Article 12 of the United Nations Convention against 
Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances of 1988 (United Nations publication,  
Sales No. E.11.XI.4). 
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183. Several Governments did not provide in 2010 the 
requested annual statistical reports in a timely manner, 
including the Governments of some countries that are 
major manufacturers, exporters, importers and users of 
narcotic drugs and/or psychotropic substances, such as 
Canada, India, Japan and the United States. Late 
submission of statistical reports makes it difficult for 
the Board to monitor licit activities involving 
controlled substances and delays the analysis by the 
Board of the worldwide availability of narcotic drugs 
and psychotropic substances for legitimate purposes, as 
well as its analysis of the global balance between the 
supply of opiate raw materials and the demand for 
opiates. Many Governments have submitted their 
annual reports on precursors after the deadline set by 
the Board for the submission of those reports  
(30 June), thereby delaying the analysis by the Board 
of action taken by Governments to implement  
article 12 of the 1988 Convention. The Board requests 
all the Governments concerned to identify the reasons 
for the late submission of statistical reports and to 
adopt measures to enable them to comply in a timely 
manner with their reporting obligations pursuant to the 
international drug control conventions.  
184. When examining the statistics received from 
Governments, the Board brings to the attention of the 
Governments any inconsistencies in their statistical 
reports and requests them to rectify the inconsistencies 
and resolve the problems that have led to those 
inconsistencies. In recent years, the Board has noted 
with concern the deterioration in the quality of 
statistical data furnished by the Governments of certain 
countries that are major manufacturers, exporters, 
importers and users of narcotic drugs and psychotropic 
substances. The Board has contacted the Governments 
concerned and requested them to correct the situation. 
The Board notes that some of those Governments, 
including the Governments of India and the United 
Kingdom of Great Britain and Northern Ireland, 
examined in 2009 and 2010 their systems for reporting 
on narcotic drugs and psychotropic substances to 
identify the reasons for inconsistencies in their 
statistical reports and, since then, have started 
improving their national reporting mechanisms. The 
Board will continue to support those Governments and 
other Governments concerned in their efforts to ensure 
timely and accurate reporting in accordance with their 
obligations under the international drug control 
treaties.  
 3. Submission of estimates and assessments 
 
185. Parties to the 1961 Convention have an obligation 
to submit to the Board each year estimates of their 
requirements for narcotic drugs for the following year. 
As at 1 November 2010, a total of 153 States  
and territories had submitted estimates of their 
requirements for narcotic drugs for 2011; that figure 
represents 73 per cent of the States and territories 
required to furnish such annual estimates for 
confirmation by the Board. For those States and 
territories that did not submit their estimates in time 
for the Board to examine and confirm them, the  
Board had to establish estimates in accordance with  
article 12, paragraph 3, of the 1961 Convention.  
186. Pursuant to Economic and Social Council 
resolutions 1981/7 and 1991/44, Governments are 
requested to provide to the Board assessments of their 
annual medical and scientific requirements for 
psychotropic substances in Schedules II, III and IV of 
the 1971 Convention. As at 1 November 2010, all 
Governments had submitted at least once assessments 
of their annual medical requirements for psychotropic 
substances. The Board recommends that Governments 
review and update the assessments of their annual 
medical and scientific requirements for psychotropic 
substances at least every three years. However,  
24 Governments have not submitted an update of their 
legitimate requirements for psychotropic substances in 
over three years. 
187. By adopting resolution 49/3, the Commission  
on Narcotic Drugs requested Member States to provide 
the Board with estimates of their legitimate 
requirements for four substances frequently used in the  
manufacture of amphetamine-type stimulants —  
3,4-methylenedioxyphenyl-2-propanone (3,4-MDP-2-P), 
pseudoephedrine, ephedrine and 1-phenyl-2-propanone 
(P-2-P) — and preparations containing those 
substances. As at 1 November 2010, 121 States and 
territories had submitted those estimates; that figure 
represents 57 per cent of the States and territories that 
were requested to submit that information. 
188. The estimates and assessments for all States and 
territories are published by the Board in its technical 
reports on narcotic drugs and psychotropic substances 
and the report of the Board on the implementation of 
article 12 of the 1988 Convention. Updates of  
those estimates and assessments, which reflect 
supplementary estimates furnished by Governments, 
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are made available on the website of the Board 
(www.incb.org). 
189. Failure to submit adequate estimates or 
assessments for narcotic drugs and psychotropic 
substances may have a negative impact on the 
effectiveness of control. When estimates or 
assessments are lower than the actual legitimate 
requirements, the importation or use of narcotic drugs 
or psychotropic substances needed for medical or 
scientific purposes may be delayed. If estimates or 
assessments are significantly higher than the legitimate 
requirements, the risk of narcotic drugs and 
psychotropic substances being diverted into illicit 
channels may increase. The Board calls upon all 
Governments to ensure adequacy of their estimates and 
assessments. When necessary, Governments should 
submit to the Board supplementary estimates for 
narcotic drugs or inform the Board of modifications to 
their assessments for psychotropic substances. 
190. The estimates for narcotic drugs established by 
the Board are based on estimates and statistics reported 
in the past by the Governments concerned. If a 
Government has not furnished estimates and statistics 
for several years, the Board may, as a precaution 
against diversion, establish estimates that are lower 
than the estimates submitted in the past by the 
Government. Therefore, the Governments for which 
estimates were established by the Board are urged to 
examine closely their requirements for narcotic drugs 
for 2011 and provide their own estimates to the Board 
for confirmation as soon as possible, in order to 
prevent any possible difficulties in importing the 
quantities of narcotic drugs required for legitimate 
purposes. 
191. The Board notes that approximately 40 per cent 
of Governments have not yet provided estimates of 
their annual requirements for certain precursors. 
Moreover, many Governments that provided estimates 
in the past have failed to ensure that the information on 
record is up to date, despite the fact that their 
legitimate requirements for certain precursors may 
have changed. The Board calls upon Governments to 
comply with the request contained in Commission on 
Narcotic Drugs resolution 49/3 and to ensure the 
timely submission and continued accuracy of the 
estimates for precursors. This is necessary to ensure 
that the estimates can continue to be used to identify 
suspicious transactions involving precursors. 
 4. Assistance to Governments in dealing with 
deficiencies in reporting statistics, estimates  
and assessments 
 
192. Information available to the Board shows that 
problems encountered by Governments in furnishing 
adequate statistics and/or estimates to the Board are 
often an indication of deficiencies in their national 
mechanisms for the control of substances. Such 
deficiencies frequently reflect problems in those 
countries in the implementation of provisions of the 
international drug control treaties, such as lacunae in 
national laws or administrative regulations regarding 
reporting by licensees to the national authorities, the 
failure of some licensees to comply in a timely manner 
with their reporting obligations under national law and 
the absence of an efficient inspection system. The 
Board invites the Governments concerned to find the 
causes of such deficiencies in reporting to the Board 
statistics, estimates and/or assessments, with a view to 
resolving those problems. 
193. In some countries, deficiencies in the quality of 
data are the result of the Government providing 
insufficient resources to the authorities responsible for 
the control of licit activities involving narcotic drugs, 
psychotropic substances or precursors. The Board calls 
upon the Governments concerned to provide adequate 
resources to ensure the compliance of those authorities 
with all reporting obligations under the international 
drug control treaties. 
194. The Board provides assistance to Governments to 
facilitate their compliance with reporting obligations 
under the international drug control treaties. In 2010, 
the Board provided to several Governments, at their 
request, explanations regarding reporting requirements 
for controlled substances. Training material on the 
control of narcotic drugs, psychotropic substances and 
precursors and guidelines for reporting on those 
controlled substances have been made available on the 
website of the Board (www.incb.org) for use by 
competent national authorities. Reporting requirements 
for narcotic drugs, psychotropic substances and 
precursors were discussed during an informal 
consultation organized by the Board for selected 
Governments during the fifty-third session of the 
Commission on Narcotic Drugs, in March 2010. All 
Governments are encouraged to request from the Board 
any information that they may consider useful 
regarding reporting requirements for narcotic drugs, 
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psychotropic substances and precursors pursuant to the 
international drug control treaties. 
195. The Board will continue to evaluate the 
cooperation of Governments in providing reports on 
narcotic drugs, psychotropic substances and precursors 
and take action, as necessary, to ensure timely and 
accurate reporting by Governments.  
 
 
 D. Ensuring the implementation of the 
provisions of the international drug 
control treaties 
 
 
196. To monitor compliance with the international 
drug control treaties, the Board examines action taken 
by Governments to implement the treaty provisions 
aimed at preventing the diversion of controlled 
substances into illicit channels, to be subsequently sold 
to drug abusers or, in the case of precursor chemicals, 
used in the illicit manufacture of narcotic drugs and 
psychotropic substances. Over the years, the treaty 
provisions have had to be supplemented with 
additional control requirements to close loopholes that 
were being exploited by traffickers to divert controlled 
substances. In the present section, the Board highlights 
action that needs to be taken to implement the 
international control regime, describes problems 
encountered in preventing the diversion of controlled 
substances and provides specific recommendations on 
how to deal with such problems. 
 
 1. Legislative and administrative basis  
 
197. Governments need to ensure that national 
legislation is in line with the provisions of the 
international drug control treaties. In addition, they 
need to amend the lists of substances controlled at the 
national level when a substance is included in a 
schedule of an international drug control treaty or 
transferred from one schedule to another. Inadequate 
legislation or implementation mechanisms at the 
national level or delays in bringing (or failure to bring) 
lists of substances controlled at the national level in 
line with the schedules of the international drug control 
treaties will result in inadequate national controls being 
applied to substances under international control. Such 
inadequacies could result in the competent national 
authorities experiencing problems in reporting on those 
substances to the Board. Failure to reflect in national 
legislation or mechanisms changes made in schedules 
of substances under international control may result in 
the diversion of substances into illicit channels. 
198. The Board welcomes the adoption of legislative 
measures to strengthen precursor control in China, the 
Czech Republic, El Salvador, Mexico, Myanmar, 
Samoa and South Africa, which will help to reduce the 
diversion of precursor chemicals used for the illicit 
manufacture of drugs. 
 
 2. Changes in the scope of control of the  
1988 Convention 
 
199. In 2006, the Board initiated a review of the status 
of phenylacetic acid, a substance in Table II of the 
1988 Convention, in view of the increased number of 
seizures of the substance, which is used in the illicit 
manufacture of amphetamine and methamphetamine. 
Using as a basis the substantial information provided 
by Governments, the Board submitted to the 
Commission on Narcotic Drugs in November 2009 a 
recommendation to reschedule phenylacetic acid. 
Taking into account the recommendation of the  
Board, the Commission at its fifty-third session, in 
March 2010, adopted decision 53/1, by which it 
decided to transfer phenylacetic acid from Table II to 
Table I of the 1988 Convention. Pursuant to article 12 
of the 1988 Convention, the decision will become fully 
effective on 17 January 2011. 
 
 3. Control measures for preparations containing 
psychotropic substances 
 
200. The Board has noted that some Governments 
need to take action with regard to the control of 
preparations containing psychotropic substances, 
ensuring that national control measures comply with 
the 1971 Convention. Unlike the 1961 Convention, the 
1971 Convention does not provide a list of 
preparations that are exempted in all countries from 
some of the control measures included in the 
Convention. Instead, the 1971 Convention allows 
Governments to exempt certain preparations from 
some mandatory control measures applicable under the 
Convention. However, if Governments decide to 
exempt certain preparations from some control 
measures, they must notify the Secretary-General of 
those exemptions, in accordance with article 3 of the 
1971 Convention. The Board requests all Governments 
that are exempting certain preparations at the  
national level from control measures foreseen in the 
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1971 Convention and that have not yet notified the 
Secretary-General of those exemptions to do so 
without delay. The Board wishes to remind 
Governments that all other preparations containing 
psychotropic substances should be subject to the 
provisions of the 1971 Convention. 
201. The Board stands ready to clarify the meaning of 
specific provisions of the international drug control 
treaties for Governments, when required. 
 
 4. Prevention of diversion from international 
trade 
 
  Import and export authorization requirement  
 
202. One of the main pillars of the international 
control system is the universal application of the 
requirement of import and export authorization. Import 
and export authorizations are required for a transaction 
involving any of the substances controlled under the 
1961 Convention or listed in Schedules I and II of the 
1971 Convention. The competent national authorities 
are required by those conventions to issue import 
authorizations for transactions involving the 
importation of such substances into their country. The 
exporting countries must verify the authenticity of the 
import authorizations before issuing the export 
authorizations required to allow the shipments 
containing the substances to leave the country.  
203. The 1971 Convention does not require import and 
export authorizations for trade in psychotropic 
substances listed in Schedules III and IV of the 
Convention. As the diversion of those substances from 
international trade was widespread in the 1970s and 
1980s, the Economic and Social Council, in its 
resolution 1996/30, requested Governments to extend 
the system of import and export authorizations to cover 
those substances. By 2010, most countries had made 
import and export authorizations a requirement for 
such substances. The Board appreciates that the 
Governments of Cuba, Gabon, Guatemala, the Libyan 
Arab Jamahiriya, the Russian Federation and the 
Syrian Arab Republic have, in the meantime, amended 
their national legislation to require an import 
authorization for any of the substances in Schedules III 
and IV of the 1971 Convention.  
204. Data on cases involving diversion indicate that 
traffickers are quick to target countries in which 
controls are less strict than in others. The Board 
therefore urges the Governments of the few States in 
which national legislation does not yet require import 
and export authorizations for all psychotropic 
substances, regardless of whether or not they are States 
parties to the 1971 Convention, to extend such controls 
to all substances in Schedules III and IV of the  
1971 Convention as soon as possible and to inform the 
Board accordingly. 
 
  Assistance to Governments in verifying the 
legitimacy of import authorizations 
 
205. Government authorities are encouraged to verify 
with the Board all import authorizations that  
they consider to be suspicious — for example, 
authorizations using new or unknown formats or 
bearing unknown stamps or signatures or 
authorizations with other aspects that differ from the 
norm. Import authorizations may need to be verified if 
they have not been issued by a recognized competent 
national authority or if the consignment consists of 
substances known to be frequently abused in the region 
of the importing country. The Board maintains a 
collection of samples of official certificates and 
authorizations used for importing narcotic drugs, 
psychotropic substances and precursor chemicals, 
which can be compared with questionable import 
documents, thus assisting Governments in verifying the 
authenticity of documents. The Board appreciates that 
the Governments of many exporting countries continue 
to request the assistance of the Board in verifying the 
legitimacy of import authorizations.  
206. When the sample in the Board’s collection of 
official authorizations differs from the newly submitted 
import authorization or when there is no corresponding 
sample in the collection, the Board, on behalf of the 
competent authorities of the exporting country, 
contacts the importing country to ascertain the 
legitimacy of the transaction. In such cases, the Board 
calls upon the Government of the importing country to 
respond in a timely manner. Failure to quickly confirm 
the legitimacy of import authorizations may hinder the 
investigation of diversion attempts and/or cause delays 
in legitimate trade in controlled substances, thus 
adversely affecting the availability of those substances 
for legitimate purposes. 
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  Online system of pre-export notification for 
precursor chemicals 
 
207. The rapid exchange of information between 
exporting and importing countries through the pre-
export notification system has proved to be an efficient 
way of identifying the legitimacy of individual 
consignments of precursor chemicals. The Pre-Export 
Notification Online (PEN Online) system, developed 
by the Board, is the main system used for the exchange 
of such information. The number of countries using the 
PEN Online system has continued to increase:  
115 countries and territories now use the system on a 
regular basis, issuing about 1,500 notifications per 
month (compared with 600 per month in 2007). 
Despite the widespread use of PEN Online by national 
authorities and its established position in international 
precursor control, the Board notes with concern that 
some countries still have not registered to use the 
system. African countries account for about half of the 
countries that have not yet registered.  
208. The Board notes that several countries that have 
registered for the PEN Online system do not use the 
system on a regular basis, thereby foregoing access to 
one of the most important tools available for precursor 
control. The Board urges all Governments that have not 
yet done so to register with and make use of the  
PEN Online system. The Board encourages those 
Governments already using the system to respond to 
enquiries as quickly as possible, in order to enable the 
legitimacy of shipments to be verified in a timely 
manner.  
 
  System of estimates and assessments of annual 
requirements for controlled substances 
 
209. Another important control measure used to 
prevent the diversion of controlled substances  
from international trade is the system of estimates  
of legitimate annual requirements. Estimates of 
requirements for narcotic drugs are used in the 
calculation of limits that must be observed by parties 
when authorizing imports and exports of narcotic 
drugs. The assessments of annual requirements for 
psychotropic substances and estimates of annual 
requirements for selected precursors help Governments 
to identify unusual transactions. In many cases, the 
diversion of a controlled substance was prevented 
when the exporting country did not authorize the 
export of the substance because the quantities of the 
substance to be exported would have exceeded the 
quantities required in the importing country.  
210. The Board regularly investigates cases involving 
possible non-compliance by Governments with the 
system of estimates or assessments, as such non-
compliance could facilitate the diversion of controlled 
substances from licit international trade into illicit 
channels. The Board notes that in 2009, almost all 
Governments complied with the system of estimates 
for narcotic drugs. The authorities of 17 countries 
issued authorizations in 2009 for the import of 
psychotropic substances for which they had not 
established any assessments or in quantities that 
significantly exceeded their assessments. With regard 
to precursors, the Board has noted that many States 
parties continue to authorize the import of precursors 
in quantities that greatly exceed the quantities provided 
in their estimates of legitimate annual requirements.  
211. The Board once again calls on Governments to 
respect the system of estimates and assessments, 
pursuant to the 1961 Convention, the relevant 
Economic and Social Council resolutions and 
Commission resolution 49/3, and to ensure increased 
vigilance in the monitoring of imported substances. 
Governments that have not yet done so should 
establish a mechanism to make certain that their 
estimates and assessments are in line with their actual 
legitimate requirements and that no imports in 
quantities exceeding those requirements are authorized. 
The Board also calls upon the Governments of 
exporting countries to regularly check the estimates 
and assessments of importing countries and not to 
authorize exports that are not in line with legitimate 
requirements.  
 
 5. Effectiveness of the control measures aimed at 
preventing the diversion of controlled 
substances from international trade 
 
212. The system of control measures laid down in the 
1961 Convention provides effective protection of 
international trade in narcotic drugs against attempts to 
divert such drugs into illicit channels. Similarly, as a 
result of the almost universal implementation of the 
control measures stipulated in Economic and Social 
Council resolutions, in recent years there have been no 
identified cases involving the diversion of psychotropic 
substances from international trade into illicit channels. 
However, cases involving attempts to divert narcotic 
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drugs and psychotropic substances continue to be 
detected by vigilant competent national authorities, 
which often work in close cooperation with the Board. 
The Board calls upon Governments to continue to 
monitor international trade in those substances by 
using the tools mentioned above. Competent national 
authorities are encouraged to request the Board to 
assist in verifying the legitimacy of suspicious 
individual transactions. 
213. With regard to the diversion of precursor 
chemicals from international trade, Project Prism and 
Project Cohesion, two international initiatives launched 
by the Board, have continued to be the driving force 
behind the increased monitoring of licit trade in 
precursor chemicals used in the illicit manufacturing of 
amphetamine-type stimulants, heroin and cocaine.  
214. The Board welcomes the success of Operation 
Pila, launched in 2009 under Project Prism to monitor 
global trade in ephedrine, pseudoephedrine, P-2-P and 
phenylacetic acid. One of the aims of Operation Pila, 
which lasted from 1 July 2009 to 31 March 2010, was 
to replicate the success of previous operations such as 
Crystal Flow and Ice Block, generating intelligence on 
the trafficking methods used and identifying 
weaknesses in national and regional mechanisms for 
precursor control. As a result of Operation Pila,  
40 suspicious shipments of ephedrine and 
pseudoephedrine, involving a total of 12.8 tons and 
199 million tablets, were suspended, stopped or  
seized, thus preventing the illicit manufacture of 
approximately 11.5 tons of methamphetamine. In 
addition, through Operation Pila, it was possible to 
identify a number of suspicious shipments of P-2-P. 
Intelligence collected in the course of Operation Pila 
corroborated information about the emergence of 
Central America as a major destination for shipments 
of precursor chemicals used in the illicit manufacture 
of methamphetamine. Information gathered through the 
Operation also indicated that traffickers were 
increasingly using substances not under international 
control, including esters of phenylacetic acid. 
215. The Board acknowledges the strong support from 
Governments in the implementation of Operation  
Dice-2, launched under Project Cohesion. Under 
Operation Dice-2, the Board reviewed nearly  
900 international shipments of acetic anhydride and 
issued notifications regarding suspicious transactions, 
which led to the seizure of over 26 tons of acetic 
anhydride. Like Operation Pila, Operation Dice-2 
prompted an increase in the exchange of intelligence 
with respect to trafficking patterns, which in turn made 
it possible to identify weaknesses in existing control 
measures and facilitated the development of remedial 
measures. 
216. The Board notes that because of the weak 
regulatory and enforcement frameworks in African 
countries traffickers continue to target those countries 
for the diversion of precursors. Problems related to the 
absence of effective controls over the availability of 
precursor chemicals in African countries have been 
exacerbated by the fact that a relatively small 
percentage of African countries have registered with 
the PEN Online system and that those African 
countries that have registered with the system do not 
use it regularly. The Board urges the Governments of 
African countries to adopt and enforce comprehensive 
legislative and regulatory frameworks governing 
precursors and to register with and make use of the 
PEN Online system. 
 
 6. Prevention of diversion from domestic 
distribution channels  
 
217. Since the diversion of narcotic drugs and 
psychotropic substances from international trade has 
almost stopped, the diversion of such substances from 
licit domestic distribution channels has become a major 
source used to supply illicit markets. Precursor 
chemicals are also increasingly being diverted from 
domestic distribution channels. 
218. In principle, the provisions of the international 
drug control conventions, if complied with, should 
prevent diversion from domestic distribution channels. 
Lack of national legislation in line with the 
conventions, inadequate implementation of national 
legislation and insufficient monitoring of the 
implementation have enabled traffickers to divert 
controlled substances from domestic distribution 
channels. That fact is illustrated by the following  
case involving the diversion of a psychotropic 
substance from domestic distribution channels for use 
as a precursor chemical in illicit drug manufacture. 
Cathine, a stimulant in Schedule III of the  
1971 Convention, is used mainly for industrial 
purposes, as direct medical use of the substance is 
limited. In the 10-year period 1999-2008, South Africa 
was the main importer of cathine, importing on  
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average 1.8 tons of the substance each year. When the 
Board enquired about the final use of the large amounts 
of cathine being imported into South Africa, it was 
revealed that the substance had been purchased by 
criminal associations for use in clandestine laboratories 
illicitly manufacturing amphetamine-type stimulants. 
At the time, cathine was not controlled in South Africa 
in line with the provisions of the 1971 Convention. The 
Government then amended its national legislation so 
that in South Africa cathine became subject to the 
provisions foreseen in the 1971 Convention. As a 
result, no imports of cathine into South Africa were 
reported in 2009. 
219. The Board calls on all Governments to monitor 
shipments of cathine, in particular when they are 
destined for Africa, in order to prevent the illicit use of 
that substance in countries in the region where national 
control measures may not be adequate. 
220. With regard to precursor chemicals, Operation 
Dice-2 (see para. 215 above) confirmed the diversion 
of acetic anhydride from domestic distribution 
channels, for use in the illicit drug manufacture in 
other countries. 
 
  Diversion of pharmaceutical preparations 
containing controlled substances 
 
221. While controlled substances are sometimes 
diverted from domestic distribution channels in bulk 
form, pharmaceutical preparations (prescription drugs) 
containing those substances are often diverted. In many 
cases, the diverted preparations are smuggled into 
other countries, particularly countries in which there is 
considerable illicit demand for a specific substance 
with a relatively high street price. Diverted 
pharmaceutical preparations are frequently marketed 
via illegal Internet sites.  
222. The narcotic drugs most often diverted  
and abused include fentanyl, hydrocodone, methadone, 
morphine and oxycodone. The psychotropic  
substances most often diverted and abused are 
stimulants, benzodiazepines (alprazolam and 
diazepam), gamma-hydrobutyric acid (GHB) and 
buprenorphine.  
223. In addition, attempts to divert pharmaceutical 
preparations containing precursor chemicals continue 
to occur. In response to the threat posed by the 
diversion of such pharmaceutical preparations, China, 
the Czech Republic, El Salvador and South Africa 
enacted in 2009 national legislation explicitly 
extending control measures to pharmaceutical 
preparations containing ephedrine or pseudoephedrine. 
Operation Pila focused on monitoring global trade in 
pharmaceutical preparations containing ephedrine or 
pseudoephedrine, thereby helping to raise awareness of 
that aspect of precursor control. 
224. While loopholes in national legislation regarding 
precursors are exploited to divert pharmaceutical 
preparations containing precursors from international 
trade, the modus operandi most frequently used for the 
diversion of narcotic drugs and psychotropic 
substances include falsified prescriptions, the 
supplying of substances by pharmacies without the 
required prescriptions, or theft from pharmacies, 
wholesalers or factories. In many cases, prescription 
drugs are obtained from the persons to whom they 
were prescribed by physicians. 
225. In addition, modern telecommunication and 
information technologies (such as the Internet and 
international call centres) are used for the illicit 
distribution of pharmaceutical preparations containing 
controlled substances. Mail and courier services  
are used for smuggling diverted or counterfeit 
pharmaceutical preparations containing controlled 
substances. Video-sharing websites promote 
pharmaceutical preparations containing substances 
under international control and direct the viewer  
to illegal websites selling without prescription 
pharmaceutical preparations containing controlled 
substances, including strictly controlled substances 
such as oxycodone, methadone, methylphenidate  
or dexamphetamine. Unsolicited electronic 
communication (spamming) continues to be one of the 
main means of advertising used by illegally operating 
Internet pharmacies. Criminal networks hire spammers 
to promote websites where drugs are sold illegally.  
226. As stated above, diversions from domestic 
distribution often indicate loopholes in national 
legislation or insufficient monitoring of compliance 
with existing legislation or regulations. The Board 
requests Governments that are faced with problems 
involving the diversion of trafficking in or abuse of 
prescription drugs to identify the source of the diverted 
preparations and take measures to prevent such activity 
in future. The main measures to be taken to counter 
such activity includes: ensuring implementation of the 
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prescription requirement; enhancing national 
monitoring and inspection mechanisms; educating 
doctors about the rational use of drugs; and using 
prescription monitoring programmes to identify 
unethical behaviour by doctors or patients.  
227. When such medications are being supplied by 
friends or family members, that shows that public 
awareness of the dangers involved in the abuse of 
prescription drugs is not adequate and that national 
authorities, in cooperation with professional 
associations, need to alert the general population about 
the negative effects of such abuse. The Board wishes to 
remind all Governments that they should ensure the 
implementation of the provisions of article 10 of the 
1971 Convention, by including warnings on packages 
of psychotropic substances and by prohibiting the 
advertising of such substances to the general public.  
228. An analysis of the extent of abuse of prescription 
drugs and a recommendation on action to be taken to 
prevent such abuse are contained in the report of the 
Board for 2009.20 To prevent the use of the Internet  
for illicit distribution of diverted pharmaceutical 
preparations containing controlled substances, the 
Board advises Governments to consider the Guidelines 
for Governments on Preventing the Illegal Sale of 
Internationally Controlled Substances through the 
Internet,21 developed by the Board, and to implement 
the recommendations contained in the report of the 
Board for 2009 on action to deal with illegal Internet 
pharmacies.22  
229. When distributing the Guidelines to 
Governments, the Board expressed its hope that the 
Guidelines would help Governments to effectively 
counter and prevent trafficking in internationally 
controlled substances through the Internet. In order to 
assess progress achieved in implementing the 
Guidelines, the Board in 2010 requested all 
Governments to complete a questionnaire. The 
responses to the questionnaire will allow the Board to 
evaluate the effectiveness of the Guidelines and  
to identify those recommendations for which 
Governments may need additional support to 
__________________ 
 20  Report of the International Narcotics Control Board for 
2009 (United Nations publication, Sales No. E.10.XI.1), 
paras. 229-241 and 787 (recommendation 31). 
 21  United Nations publication, Sales No. E.09.XI.6. 
 22  Report of the International Narcotics Control Board for 
2009 …, paras. 272 and 790. 
implement. The Board therefore requests all 
Governments that have not yet done so to submit their 
replies to the questionnaire as soon as possible.  
230. The Board notes with appreciation that, according 
to the responses to the questionnaire received so far, a 
number of Governments have implemented the 
Guidelines and had acquired expertise in dealing with 
illegal Internet pharmacies. Other Governments have 
expressed a need for international support, in particular 
in the area of training law enforcement and drug 
regulatory authorities, to enable them to implement the 
Guidelines. The Board notes with concern that the 
recommendations pertaining to sharing information, 
making expertise available to other States and 
providing training to the authorities of other countries 
have been implemented by only a small number of 
Governments. Sharing information and providing 
expertise and training to States in need of such support 
would, however, be in the interest of all States, given 
the transnational nature of the problem of illegal 
Internet pharmacies. 
231. The Board notes that some competent national 
authorities would like to learn from the experiences of 
their counterparts in countries that have already 
implemented the Guidelines, in order to identify good 
practices. To support those cooperative efforts, the 
Board plans to identify ways to facilitate the exchange 
of such experiences and to organize a meeting of 
interested parties. 
232. The Board notes with appreciation efforts by 
Austria and the United Kingdom to bring to the 
attention of the general public the dangers associated 
with the purchase of medications through illegal 
Internet pharmacies. Those efforts were carried out in 
cooperation with professional bodies representing 
pharmacies, patient groups and industry. The Board 
notes that Austria prohibited in 2010 the import of any 
medications ordered over the Internet. 
 
  Diversion and abuse of drugs used in substitution 
treatment 
 
233. One matter of particular concern is the continued 
diversion of substances used in substitution treatment, 
such as buprenorphine, methadone and morphine. The 
Board has examined this problem several times in the 
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past (including, for example, in its report for 2006).23 
In 2010, the Board contacted the Governments of the 
countries that had been most affected by the diversion, 
abuse of or trafficking in buprenorphine, requesting 
them to inform the Board of the current extent of the 
diversion of buprenorphine, including the diversion of 
buprenorphine from programmes in which it is used in 
substitution treatment for opioid addicts, and of the 
measures taken to prevent such diversion. The  
Board notes that the Governments concerned have 
investigated the diversions that were detected with a 
view to identifying the persons involved in those illicit 
activities and bringing them to justice and have taken 
action to prevent such diversion.  
234. The Board requests the Governments of all 
countries that have substitution treatment programmes 
and that are faced with problems involving the 
diversion and abuse of preparations used in such 
treatment to continue their efforts to prevent the 
diversion and abuse of those preparations while 
making them available for medical treatment. 
 
 7. Other issues related to the implementation of 
drug control treaties or related resolutions 
 
  Secure area for the use of Governments 
 
235. On 1 August 2010, the Board established on its 
website a secure area that is accessible to authorized 
Government officials only. The secure area, which is 
still in its initial stages and therefore available in 
English only, will be used by the Board to publish 
restricted information to assist competent national 
authorities in the international control of narcotic 
drugs, psychotropic substances and precursors.  
236. The only information currently available to 
Governments in the secure area is a summary of 
national requirements in place for authorizing the 
import and export of ketamine, in compliance with 
Commission on Narcotic Drugs resolution 49/6 entitled 
“Listing of ketamine as a controlled substance”. The 
Board calls upon Governments to review that 
information when considering authorizing imports or 
exports of ketamine and to inform themselves about 
any restrictions to international trade in ketamine that 
may be in place in countries that are trading partners.  
__________________ 
 23  Report of the International Narcotics Control Board  
for 2006 (United Nations publication, Sales  
No. E.07.XI.11), paras. 187-195. 
237. The Board is pleased to note that already in the 
first three months of its existence, officials from about 
80 Governments asked for access to the secure area, 
although the information available on the site is still 
limited. The Board encourages all Governments to 
continue to make use of that tool and to provide the 
Board with feedback on its usefulness and ideas about 
other types of information that might be useful to 
include in the secure area of the Board’s website.  
238. The Board wishes to remind Governments of the 
information package on the control of precursors, 
which details control measures adopted by 
Governments for substances in Tables I and II of the 
1988 Convention, based on information provided to the 
Board by Governments. The information package, 
which is updated annually, is available in the secure 
area for competent national authorities responsible for 
implementing article 12 of the 1988 Convention. In 
order for the information package to continue to be a 
reliable source of information, Governments should 
keep the Board informed of any changes in their 
national control regime for precursors. 
 
 8. Use of non-scheduled substances in the illicit 
manufacture of narcotic drugs and 
psychotropic substances 
 
239. As more and more States have implemented the 
provisions of the 1988 Convention, it has become more 
difficult for traffickers to obtain some of the substances 
listed in Tables I and II of that Convention. In 
response, traffickers are seeking non-scheduled 
substitutes for the more closely monitored precursors. 
The Board has noted this development over the past 
several years and has identified the following general 
trends: 
 (a) Shifts to different forms of, or products 
containing, the controlled precursor, for example, 
pharmaceutical preparations, natural products  
(e.g. ephedra extracts) or derivatives that can be 
converted into the controlled precursor through readily 
available means. These may include commercially 
available products that do not fall within the purview 
of precursor control or products and derivatives that 
are specifically designed to circumvent existing 
controls, including made-on-order preparations; 
 (b) The illicit manufacture of the controlled 
primary precursor from non-scheduled pre-precursors; 
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 (c) The use of new or altered methods of 
processing or manufacture that require substances not 
currently listed in Table I or II of the 1988 Convention;  
 (d) The illicit manufacture of related “designer 
drugs” that require as starting material substances not 
currently listed in Table I or II of the 1988 Convention. 
240. Forty-four Governments reported the seizure of a 
total of 170 non-scheduled substances in the five-year 
period 2005-2009. Because of the flexibility inherent 
to the manufacture of amphetamine-type stimulants 
and the variety of such substances, the range of 
reported non-scheduled substances has been greater for 
this group than for other drug groups. However, the 
Board has noted in its technical reports on precursors 
the seizure or actual use of non-scheduled substitute 
chemicals used in the illicit manufacture of cocaine 
and heroin.  
241. Specifically, the Board has drawn attention to 
several substitutes for ephedrine- and pseudoephedrine-
based methods for illicit methamphetamine 
manufacture, including l-phenylacetylcarbinol (l-PAC), 
an intermediate substance used in the industrial 
manufacture of ephedrine, and N-acetylpseudoephedrine 
acetate, which can be easily converted to 
pseudoephedrine using a hydrolysis reaction. Both 
substances enable illicit operators to continue to use 
familiar manufacturing techniques. The Board is also 
aware of attempts to produce ephedrine from  
N-methyl-DL-alanine. In connection with P-2-P-based 
methods for the illicit manufacture of 
methamphetamine, seizures of non-scheduled 
derivatives of phenylacetic acid, in particular its esters, 
are among the most significant developments. Seizures 
of tartaric acid, a chemical employed in the post-
manufacture purification of methamphetamine 
manufactured from P-2-P, provide further evidence  
of a resurgence of P-2-P-based methods in the  
wake of strengthened controls on ephedrine and 
pseudoephedrine and preparations containing them. 
Purpose-made P-2-P in the form of its bisulphite 
adduct has also been encountered in an attempt to 
disguise its physical characteristics and thus 
circumvent controls, as has been a purpose-made 
derivative of 3,4-MDP-2-P known as “3,4-MDP-2-P 
glycidate”. The latter two may also be classified as 
“hidden” precursors.  
242. With regard to the manufacture of cocaine, the 
use of non-scheduled substances brought to the 
attention of the Board extends from the use of a range 
of alternative solvents and a method employing  
ethanol to substitute for the traditional potassium 
permanganate process for the purification of the crude 
cocaine base, to the illicit manufacture of key 
precursors such as sulphuric acid, and potassium 
permanganate from potassium manganate or 
manganese dioxide. 
243. For heroin, the majority of the non-scheduled 
substances are chemicals that are employed, in addition 
to acetic anhydride, in various steps of the traditional 
manufacturing process, such as ammonium chloride, 
sodium carbonate and bicarbonate and ammonia. In 
addition, large-scale seizures of acetyl chloride and 
glacial acetic acid have led to claims of the illicit 
manufacture of acetic anhydride from non-scheduled 
pre-precursors or the direct use of substitute 
acetylating agents. However, while those processes are 
technically feasible, the claims remain to be 
corroborated.  
244. Concern over such developments led the Board  
in 1998, in response to Economic and Social Council 
resolution 1996/29, to establish the limited 
international special surveillance list of non-scheduled 
substances — substitute and “new” chemicals for 
which there was substantial information on actual use 
in illicit drug manufacture. A total of 26 substances 
aside from those listed in Tables I and II of the  
1988 Convention were originally included on the 
special surveillance list. The special surveillance list, 
which is available on the Board’s secure website, 
currently includes 45 chemicals. Distributed annually 
by the Board to competent national authorities, the 
special surveillance list is aimed at assisting 
Governments in devising, in cooperation with the 
industries concerned, a flexible system that is sensitive 
to the requirements of legitimate trade while 
preventing the use of non-scheduled substances in the 
illicit manufacture of drugs. The usefulness of the 
special surveillance list has been demonstrated by the 
numerous seizures of substances included on the list 
and by the establishment of similar surveillance lists at 
the regional level. 
245. With regard to the maintenance and use of the 
special surveillance list, the Board notes that there is a 
need to improve the gathering and sharing of 
intelligence and other information with regard to the 
chemicals found when dismantling illicit drug 
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manufacturing laboratories, both among other entities 
at the national level and among international 
organizations and bodies, such as the Board.  
246. Individual Governments have introduced 
additional regulations for substances not under 
international control. The Board is aware of 38 States 
that have established some form of control over a total 
of 132 substances not included in Tables I and II of the 
1988 Convention or on the special surveillance list. 
While the Board welcomes the increased alertness and 
the introduction of appropriate measures by individual 
Governments to prevent the use of non-scheduled 
substances by traffickers, it wishes to highlight the 
importance of coordinating those approaches at the 
regional level to avoid situations whereby sources, 
points of diversion or trans-shipment routes are 
displaced from one country to another. The Board also 
wishes to remind all competent national authorities to 
keep themselves up to date on, and comply with, the 
existing regulations of their trade partners and to 
cooperate with each other in verifying the legitimacy 
of orders and investigating suspicious shipments of all 
substances that could be used in illicit drug 
manufacture.  
247. There is a need to counter the use of numerous 
substitute chemicals not controlled under the  
1988 Convention of which a negligible proportion of 
the amounts required for legitimate purposes is being 
used in illicit drug manufacture. The Board considers 
comprehensive voluntary cooperation between the 
industries concerned and the competent national 
authorities to be one of the main means of countering 
continual shifts between such substitute chemicals used 
as precursors. Key elements of such cooperation 
include: good trade practices, such as the sharing of 
knowledge and the continuous monitoring of patterns 
of legitimate manufacture and trade involving such 
substances, in order to identify irregularities and 
suspicious transactions; the know-your-client principle 
and reliable estimates of annual legitimate 
requirements for the substances in question and the 
products containing them, such as pharmaceutical 
preparations. In addition, Governments are reminded  
to consider, pursuant to General Assembly 
resolution S-20/4 B, punishing, as a criminal offence in 
the sense of article 3 of the 1988 Convention, unlawful 
conduct of persons or companies in connection with 
the diversion of non-scheduled substances with the 
knowledge that they are intended for use in the illicit 
manufacture of narcotic drugs or psychotropic 
substances and introducing related penal, civil and 
administrative sanctions. 
248. The Board is aware that the above-mentioned 
recommendations can be only a subset of the measures 
required to address an issue as complex as that of 
preventing the use of non-scheduled substances in the 
illicit manufacture of drugs. It therefore calls on 
Governments to examine all available options to 
establish appropriate mechanisms to monitor the 
movement of non-scheduled substances and identify 
suspicious transactions involving them and to 
cooperate with each other and the Board to that end.  
 
 
 E. Special topics 
 
 
 1. Use of cannabis seeds for illicit purposes 
 
249. The Commission on Narcotic Drugs, in its 
resolution 52/5, entitled “Exploration of all aspects 
related to the use of cannabis seeds for illicit 
purposes”, addressed the use of cannabis seeds for the 
illicit cultivation of the cannabis plant. In that 
resolution, the Commission requested the Board, 
within its mandate under the international drug control 
treaties and, as appropriate, in cooperation with other 
competent international bodies, to gather from Member 
States regulatory information on cannabis seeds, 
including on the sale of cannabis seeds through the 
Internet, and to share that information with Member 
States. 
250. The Board sent to all Governments a 
questionnaire on regulations pertaining to cannabis 
seeds in order to identify provisions in national laws 
and administrative regulations aimed at preventing the 
use of cannabis seeds for the illicit cultivation of the 
cannabis plant and to obtain descriptions of the various 
regulations on cannabis seeds applied in countries 
worldwide. International organizations were requested 
to provide information on any regulations pertaining to 
cannabis seeds that were obtained in the course of 
carrying out their mandates and programmes.  
251. The European Commission provided an overview 
of European Union legislation on hemp seeds. 
European Union legislation provides that only cannabis 
varieties listed in the Commission’s Common 
Catalogue of Varieties of Agricultural Plant Species 
and having a tetrahydrocannabinol (THC) content not 
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exceeding 0.2 per cent are eligible for direct 
agricultural support payments. Accordingly, import of 
cannabis seeds into the European Union for sowing is 
authorized only when the THC content of the cannabis 
variety in question does not exceed 0.2 per cent. 
Cannabis seeds not for sowing may be imported only if 
they are non-viable (having been rendered unsuitable 
for sowing), mixed with other grains for animal 
nutrition or destined for re-export to a country outside 
the European Union.  
252. The Board received responses to the 
questionnaire on regulations pertaining to cannabis 
seeds from 104 (49 per cent) of the 211 Governments 
requested. In general, the responses showed that a wide 
range of regulatory approaches are applied in different 
countries.  
253. A majority of the responding Governments  
(59 per cent) stated that national laws or administrative 
regulations on the production of cannabis seeds were in 
place. One regulatory approach is to include cannabis 
seeds in the legal definition of cannabis (reported by 
Anguilla, Australia, El Salvador, Guyana, Hong Kong 
(China), Lithuania, Malaysia, Malta, Mauritius, 
Mexico, New Zealand and Zimbabwe), hence placing 
cannabis seeds under the relevant narcotic drug laws 
and regulating production of cannabis seeds as 
production of a narcotic drug. Other approaches are: 
placing only viable cannabis seeds under national drug 
control (in Canada, Malta and the United States); 
permitting the production of seeds of cannabis whose 
THC content is below an established threshold 
(reported by a number of States members of the 
European Union); or permitting the import of cannabis 
seeds only with special authorization (reported by 
Colombia and India).  
254. With respect to international trade in cannabis 
seeds, about half of the responding Governments  
(53 per cent) indicated having provisions to control the 
import of cannabis seeds and about half (47 per cent) 
reported having provisions to control the export of 
cannabis seeds. In most of those countries, 
authorization is required for the import or export of 
cannabis seeds. In countries where cannabis seeds are 
controlled drugs, international trade is regulated in 
accordance with the provisions on trade in narcotic 
drugs. In some countries, imports or exports are limited 
to certain types of cannabis seeds, such as cannabis 
seeds having undergone anti-germination treatment 
(reported by Japan), seeds of cannabis varieties with a 
THC content below a specified level or seeds listed in 
a catalogue of approved species (as reported by a 
number of States members of the European Union). 
The import or export of cannabis seeds is prohibited in 
some countries (Argentina, Brazil, China, Guatemala, 
Iceland, Lebanon, Panama and Zambia). 
255. About half of the responding Governments  
(51 per cent) regulate the domestic sale, purchase, 
advertisement or possession of cannabis seeds. In 
countries where cannabis seeds are subject to national 
drug control, the unlawful sale, purchase and 
possession of cannabis seeds are drug-related offences. 
In some countries (such as Cyprus, Estonia, Finland, 
Hungary and Japan), it is illegal to possess, purchase 
and/or sell cannabis seeds if the seeds are to be used 
for the illicit cultivation of cannabis plants. In such 
cases, the possession of and trade in cannabis seeds are 
regarded as preparatory acts of such illicit cultivation 
and are dealt with under provisions against such illicit 
cultivation. A few States (Brazil, Dominican Republic, 
Israel, Japan, Mexico, United States and Zimbabwe) 
have prohibited the advertisement of cannabis seeds or 
have made it illegal to advertise illicit drugs. The vast 
majority of the responding Governments (87 per cent) 
reported not having specific regulations on the sale of 
cannabis seeds through the Internet. Many, however, 
emphasized that the sale of cannabis seeds through the 
Internet was covered by general provisions on the sale 
of cannabis seeds, which were applicable irrespective 
of the mode of sale. One third of the responding 
Governments (33 per cent) reported having noted 
suspicious transactions involving cannabis seeds to be 
used for illicit purposes or having effected seizures of 
cannabis seeds, mostly in small quantities.  
256. A number of Governments felt that 
comprehensive measures were required, including in 
the areas of law enforcement, cooperation among 
government agencies, the sharing of information at the 
international level and awareness-raising, to prevent 
the use of cannabis seeds for the illicit cultivation of 
the cannabis plant. With respect to possible measures 
for the control of cannabis seeds, it was suggested that 
a distinction should be made between cannabis seeds 
capable of germination and non-viable seeds. The view 
was also expressed that the international community, 
when considering control measures, should seek to 
avoid having an adverse impact on legitimate use of 
cannabis seeds. 
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257. The Board notes that the wide availability of 
cannabis seeds, which are not controlled under the 
international drug control treaties, contributes to the 
illicit cultivation of the cannabis plant. Given the 
various regulatory approaches with respect to cannabis 
seeds that were described in the responses to the 
questionnaire, the Board encourages all Governments 
to continue identifying best practices in addressing the 
use of cannabis seeds for illicit purposes. The Board 
invites Governments to consider appropriate measures 
at the national level to effectively prevent such use. 
Those measures may include, for instance, trade 
restrictions on cannabis seeds capable of germination 
or on seeds of cannabis varieties with a THC content 
exceeding a certain threshold. 
258. The Board is concerned about the widespread 
sale, particularly over the Internet, of cannabis seeds to 
be used for illicit purposes. Those who use websites 
and electronic advertisements to sell cannabis seeds 
obviously incite individuals to engage in the illicit 
cultivation of cannabis plants. The Board therefore 
requested selected Governments to provide information 
on the sale of cannabis seeds over the Internet, 
including on detected transactions, the website 
operators involved and the sources and destinations of 
shipments of cannabis seeds, and on measures taken by 
Governments to address this issue. From the responses 
received, it appears that information on Internet 
transactions involving the sale of cannabis seeds to be 
used for illicit purposes is often not available  
to Governments. The Board therefore invites 
Governments to increasingly monitor cases involving 
the use of the Internet to sell cannabis seeds to be used 
for illicit purposes and to strengthen efforts to stop 
such activity. In that connection, the Board calls upon 
Governments to apply article 3, paragraph 1 (c) (iii), of 
the 1988 Convention, which requires States parties to 
establish as a criminal offence public incitement or 
inducement of others to engage in, inter alia, the illicit 
cultivation of cannabis plant and the illicit use of 
cannabis. 
 
 2. Synthetic cannabinoid receptor agonists 
 
259. During the past several years, synthetic 
cannabinoid receptor agonists have emerged as a new 
class of substances of abuse requiring the attention of 
drug regulators. These substances are added to herbal 
mixtures, marketed under brand names such as Spice, 
which are sold through the Internet and in specialized 
shops. The synthetic cannabinoid receptor agonists that 
have been detected in these herbal mixtures are not 
under international control. However, in 2009, concern 
about the potential health risks posed by their abuse 
prompted authorities in several countries to adopt 
national measures to prevent such abuse. Some 
countries have added specific synthetic cannabinoid 
receptor agonists, notably ones such as JWH-018 and 
CP 47497 and homologues most commonly identified 
in seized samples of herbal mixtures, to the list of 
substances controlled under national legislation. 
However, a large number of synthetic cannabinoid 
receptor agonists have been synthesized such that 
non-controlled ones could appear on the market. To  
pre-empt this problem, some States, such as the United 
Kingdom, have adopted measures for the control of 
groups of structurally related synthetic cannabinoid 
receptor agonists. 
260. Concerned that herbal mixtures containing 
cannabinoid receptor agonists were increasingly being 
sold through various channels, the Commission on 
Narcotic Drugs, adopted resolution 53/11, entitled 
“Promoting the sharing of information on the potential 
abuse of and trafficking in synthetic cannabinoid 
receptor agonists”. In that resolution, the Commission 
welcomed the work of the Board in bringing to the 
attention of Member States the abuse of herbal 
mixtures containing synthetic cannabinoid receptor 
agonists through the inclusion of information on that 
matter in the report of the Board for 200924 and 
requested the Board to continue to play a role in 
gathering from Member States information on 
synthetic cannabinoid receptor agonists, including new 
types of those substances not under international 
control, and in sharing that information with other 
Member States and WHO.  
261. Pursuant to that request, the Board has sent a 
letter to the Governments of selected countries in all 
regions requesting information regarding recent trends 
in the abuse of synthetic cannabinoid receptor agonists 
and the presence on the market of new types of such 
substances. The Board has reviewed the information 
provided by Governments, as well as other official 
reports about measures implemented to deal with the 
problem of the abuse of synthetic cannabinoid receptor 
agonists in various parts of the world. 
__________________ 
 24  Report of the International Narcotics Control Board for 
2009 …, paras. 242-248. 
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262. The availability on the market of products 
containing synthetic cannabinoid receptor agonists 
continues to be a matter of concern for Governments. 
In 2010, a number of Governments have introduced or 
intend to introduce measures to prevent trafficking in 
such products. In countries such as Belarus and 
Ukraine, a number of synthetic cannabinoid receptor 
agonists have been added to the list of substances 
controlled under national legislation, whereas Ireland 
has placed groups of structurally related synthetic 
cannabinoid receptor agonists under national control. 
In the United States, only the synthetic cannabinoid 
HU-210 is under control due to its being a structural 
analogy to THC. However, concerned that herbal 
mixtures containing synthetic cannabinoid receptor 
agonists have recently become available in specialized 
shops throughout the United States, lawmakers in 
several states have adopted legislation to control the 
use of and trade in specific synthetic cannabinoid 
receptor agonists, including JWH-018 and CP 47497 
and some of its homologues. 
263. Governments of some countries that had already 
adopted national legislation to control specific 
synthetic cannabinoid receptor agonists reported to the 
Board that law enforcement authorities had, since the 
adoption of that legislation, detected non-controlled 
agonists in samples taken from herbal mixtures that 
had been seized in their countries. For example,  
JWH-250 was recently detected in herbal mixtures 
seized in France, Japan and the Russian Federation. 
Another synthetic cannabinoid receptor agonist,  
JWH-081, was detected in samples taken from herbal 
mixtures seized in Finland, France and Sweden. 
264. The Board encourages Governments to continue 
monitoring the abuse of synthetic cannabinoid receptor 
agonists and adopt measures to prevent their trafficking 
and abuse. In that regard, all Governments concerned 
are encouraged to implement Commission on  
Narcotic Drugs resolution 53/11. The Board invites 
Governments to continue to provide it with information 
regarding the extent of abuse of and trafficking in 
products containing synthetic cannabinoid receptor 
agonists and measures that have been adopted to 
counter such abuse.  
 
 3. Recently identified “designer drugs” 
 
265. The term “designer drugs” is used to describe 
substances of abuse that have been developed to avoid 
existing control measures, including those foreseen 
under the international drug control conventions. 
Frequently, they are manufactured by means of a minor 
modification of the molecular structure of controlled 
substances, resulting in a new substance with  
similar pharmacological effects. They can be easily 
manufactured, as instructions on their manufacture and 
a description of their pharmacological effects are often 
found on the Internet.  
266. The abuse of 4-methyl-methcathinone, a 
“designer drug” also known as “mephedrone” or  
“4-MMC”, has been reported in a growing number of 
countries and regions. Mephedrone is a derivative of 
methcathinone, which itself is chemically related to 
cathinone, one of the psychoactive ingredients found in 
khat (Catha edulis). Its chemical structure is also 
related to amphetamines. The effects of the substance 
are reported to be similar to other stimulant drugs, such 
as cocaine, amphetamine and MDMA (“ecstasy”), 
although there is little existing research into its 
pharmacology and toxicity.  
267. The abuse of mephedrone was first noted in 2007, 
in the United Kingdom. By 2008, its abuse had become 
so widespread in Europe that notification was given to 
the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA) so that the substance could be 
monitored through the European Union early warning 
system. In a few cases, the abuse of mephedrone, 
especially in combination with other substances, has 
resulted in death. In 2010, there was an increasing 
number of reports of the seizure or abuse of 
mephedrone in regions other than Europe — in 
countries in North America, South-East Asia and 
Oceania, in particular Australia and New Zealand. 
268. Mephedrone is easily obtained through the 
Internet and has been marketed through retail outlets 
(“smart shops”) in some countries. Organized criminal 
groups are involved in its trafficking and distribution. 
Mephedrone has been advertised as bath salt, plant 
food and a research chemical, presumably to escape 
detection by drug control authorities and to avoid legal 
proceedings against the marketing of the substance. 
The substance appears to have no legitimate use.  
269. In many countries where mephedrone was not 
already controlled as an analogue of methcathinone, 
the substance has been placed under national control 
fairly rapidly. Other Governments are planning to place 
the substance under national legislation or have already 
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taken steps to do so. In addition, in Europe, the region 
where the abuse of mephedrone started and has spread 
the most so far, the Council of Europe took a decision 
to undertake a formal risk assessment of the substance. 
The Board appreciates those actions, which show that 
Governments can respond quickly to emerging trends 
in drug abuse.  
270. However, mephedrone is not the only recent 
designer stimulant that is abused. For example, in 
Europe alone, some 15 other “designer cathinones” are 
currently being monitored by EMCDDA. Among those, 
methedrone and methylone, which are also analogues 
of methcathinone, are abused in the United Kingdom. 
In addition, naphyrone, another synthetic compound 
with stimulating effects that is not related to cathinone, 
is abused in Europe.  
271. In countries where the national legislation does 
not support generic scheduling, the list of substances 
that are subject to national controls has to be amended 
for each newly identified “designer drug” or other 
substance that has been identified as problematic. For 
example, in Japan, 51 drugs (including mephedrone 
and salvinorin A, a substance obtained from the plant 
Salvia divinorum) have recently been placed under 
national control. Belarus, Brazil and Finland also 
found it necessary to amend their national drug control 
legislation and place several “designer drugs” on the 
list of controlled substances. 
272. Governments are well aware that the abuse of 
new substances can spread quickly within and among 
regions. The Board recommends that all Governments 
closely monitor trends in drug abuse on their territory, 
with a view to identifying new substances of  
abuse, such as designer stimulants. In that regard, 
Governments should monitor Internet forums to 
identify the substances that might replace mephedrone 
as a result of that substance being placed under 
national control in a growing number of countries. 
Governments are urged to share with the Board and 
WHO any new trends in substance abuse. If necessary, 
Governments that have not yet done so should take 
immediate action to place mephedrone and other 
“designer drugs” under national control, in order to be 
able to prosecute the persons responsible for their 
distribution. To that end, Governments might consider 
generic scheduling, where national legislation allows 
it.  
273. Furthermore, in view of the fact that mephedrone 
is abused in several regions and appears to be 
smuggled from region to region, Governments might 
consider notifying the Secretary-General of problems 
experienced with the abuse of mephedrone on their 
territory, with a view to adding the substance to any of 
the Schedules of the 1971 Convention. In that regard, 
the Board notes that WHO has, for some time, not been 
able to convene its Expert Committee on Drug 
Dependence to assess substances for possible 
scheduling under the 1961 Convention and the  
1971 Convention, a situation that has serious 
repercussions for the international drug control system.  
274. The Board therefore urges Governments and 
international entities such as UNODC, through its 
Laboratory and Scientific Section, and WHO to 
develop effective measures to address the problem of 
“designer drugs”. In view of the responsibility given  
to WHO under the 1961 Convention and the  
1971 Convention, the Board calls on WHO, as a first 
step, to resume its activities to assess new substances 
as soon as possible.  
 
 4. Abuse of volatile organic compounds referred 
to as “poppers”  
 
275. The Board notes that the Governments of some 
countries, in particular in South America, have 
experienced problems with regard to the abuse by 
inhalation of volatile organic compounds containing 
various alkyl nitrites, such as amyl nitrite. Those 
mixtures, which are commonly referred to as 
“poppers”, are currently not under international 
control. They are not “designer drugs”; however, their 
abuse raises concerns about adverse health effects. In 
response to those developments, in its resolution 53/13, 
entitled “Use of ‘poppers’ as an emerging trend in drug 
abuse in some regions”, the Commission invited 
Member States to address the potential problem of the 
use of “poppers” and to share information on best 
practices and lessons learned to counter that emerging 
trend. In that resolution, the Commission also invited 
Member States to share available information on abuse 
of “poppers” with the Board and other interested 
parties. In view of the concerns regarding the adverse 
health effects of the abuse of “poppers”, the Board 
recommends that Member States share with WHO 
information on health issues related to such abuse. 
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 5. International cooperation in countering the 
covert administration of psychoactive 
substances to facilitate the commission of sexual 
assault and other criminal acts 
 
276. Substances under international control, as well as 
some substances that are not controlled, have been 
known to be used to facilitate the commission of sexual 
assault or other criminal acts. The substances are 
concealed in food or, more frequently, drinks in doses 
that are higher than those used for therapeutic 
purposes, in order to weaken the resistance of 
individuals and ensure that victims have no 
recollection afterwards of what happened. Most 
notable has been the widespread use of flunitrazepam 
as a so-called “date-rape drug”. The Board has referred 
repeatedly to such use and the actions taken by 
Governments and industry to counter such problems.25  
277. In its resolution 52/8, the Commission on 
Narcotic Drugs addressed the use of pharmaceutical 
products to facilitate sexual assault (“date rape”). In its 
report for 2009, the Board welcomed the adoption of 
Commission resolution 52/8 and urged all 
Governments to implement the resolution as soon as 
possible. The Board also referred to cases in which 
those pharmaceutical products had been used to rob 
victims, for example, to obtain their credit card 
information or use of their motor vehicles, and invited 
the international community to consider the 
implementation of Commission resolution 52/8 with 
regard to such drug-facilitated crime, including sexual 
assault.26 The Board notes that, as a result, the risk of 
use of pharmaceutical products to weaken the 
resistance of potential victims with criminal intent has 
come to the attention of the general public and the 
media. In particular, the fact that sexual assault is often 
facilitated by “date-rape drugs”, and the lack of 
effective countermeasures taken so far was highlighted 
in media reports appearing in many countries and 
regions in 2010.  
278. In the light of those developments and in order to 
obtain more information on the extent of the problem 
and the countermeasures taken so far, the Commission 
on Narcotic Drugs adopted resolution 53/7, as  
__________________ 
 25  Report of the International Narcotics Control Board for 
2005 (United Nations publication, Sales No. E.06.XI.1), 
paras. 37-39. 
 26  Report of the International Narcotics Control Board for 
2009 …, paras. 260-268. 
follow-up to its resolution 52/8. In its resolution 53/7, 
the Commission urged States to combat the 
phenomenon, inter alia, by raising public awareness of 
the modi operandi of the assailants and of the means of 
recourse available to the victims, and encouraged 
States to forward any relevant experiences and research 
findings to the Board and UNODC. In addition, the 
Commission invited States to promote research in that 
area, with a view to measuring the extent of the 
problem, ascertaining the modi operandi and 
identifying the substances used, whether the substances 
were under international control or not. Moreover, the 
Commission urged relevant international organizations, 
including the Board, UNODC and WHO, to gather 
information and further analyse the phenomenon, with 
a view to developing common definitions and 
standards, such as guidelines for forensic analyses to 
identify the presence of psychoactive substances used 
to commit sexual assault or other criminal acts. 
279. Pursuant to Commission on Narcotic Drugs 
resolution 53/7, the Board contacted all Governments 
in July 2010, drawing their attention to that resolution 
and requesting that the information required under the 
resolution be communicated to the Board. By  
1 November 2010, 47 Governments had replied to the 
Board.  
280. The replies received by the above date indicate 
that drug-facilitated criminal acts have occurred in 
many countries and regions. The information available 
suggests that psychoactive substances have been used 
predominantly on young women, for the purpose of 
committing sexual assault. However, in several 
countries, there is also information on drug-facilitated 
robbery and ownership fraud, in which cases the 
victims tend to be men. Most Governments indicated 
that they have difficulties in providing accurate data on 
this issue, owing to the lack of forensic or other 
evidence in such cases. The actual extent of the 
problem is therefore hard to ascertain, and it is 
believed to be significantly underreported in most 
countries.  
281. The reason for the difficulties in collecting such 
data is that victims themselves may not be aware that a 
crime has been committed, or may not be willing or 
able to make a public accusation. First, they may not 
remember what happened as a consequence of having 
taken such substances. Second, since the preparations 
used by the assailants are tasteless, colourless and 
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odourless, victims may not suspect that they have been 
drugged and thus may not consider undertaking a 
forensic examination of their blood or urine. Third, 
substances such as gamma-butyrolactone (GBL) and 
GHB are metabolized very quickly and may not, after a 
few hours, leave any traces in blood or urine. In 
addition, in the case of sexual assault, in some cultures 
the nature of the crime makes it difficult for the victim 
to seek professional help, especially when the assailant 
had been acquainted with the victim before the crime. 
Victims may not report such incidents out of shame or 
fear of being blamed or because of the stigma that, in 
some societies, is associated with being a victim of 
such crime. Therefore, law enforcement authorities 
dealing with cases involving drug-facilitated crime 
should undergo special training on interrogating the 
victims of such crime. The Board therefore trusts that 
Governments will not limit their search for such data to 
official criminal records but will also continue looking 
for empirical data, for example, by contacting social 
workers, including special services and crisis centres 
for women, and the medical profession, to obtain 
realistic estimates of the extent of the problem.  
282. The Board is pleased to note that many countries 
have introduced countermeasures to tackle this 
problem, as recommended in Commission on Narcotic 
Drugs resolution 53/7. In that connection, the Board 
welcomes initiatives started by some Governments, in 
cooperation with industry, to prevent the diversion and 
use of medicines for the commission of drug-facilitated 
crime, similar to what was done with flunitrazepam in 
the 1990s, without having a negative impact on the 
bioavailability and medical use of the preparations in 
question. The Board calls on all Governments that have 
not yet done so and that are affected by such problems, 
to consider taking appropriate measures to prevent the 
covert administration of psychoactive substances to 
commit sexual assault or other crime.  
283. The Board notes the actions taken and planned by 
UNODC and interested Governments to develop 
common definitions and guidelines for forensic 
analyses, with a view to identifying the presence of 
psychoactive substances used to commit sexual assault 
or other criminal acts. The Board welcomes those 
initiatives and will support them in accordance with its 
mandate. Furthermore, the Board will continue to 
monitor problems experienced with drug-facilitated 
crime, share the information collected with UNODC 
and other international bodies, such as WHO, take 
further action as necessary to develop appropriate 
countermeasures, and include in future annual reports 
newly received information on the subject, as 
applicable. 
 
 6. Plant material containing psychoactive 
substances  
 
284. Many plants that contain psychoactive substances 
with stimulating or hallucinogenic properties, as well 
as preparations made from those plants, have 
traditional uses in some countries or regions; for 
example, some are used in religious rites. Under the 
1961 Convention and that Convention as amended by 
the 1972 Protocol, plants that are the sources of 
narcotic drugs, such as cannabis plant, opium poppy 
and coca bush, are subject to specific control measures. 
In contrast, although some active stimulant or 
hallucinogenic ingredients contained in certain plants 
are controlled under the 1971 Convention, no plants 
are currently controlled under that Convention or under 
the 1988 Convention. Preparations (e.g. decoctions for 
oral use) made from plants containing those active 
ingredients are also not under international control. 
285. Examples of such plants or plant material include 
khat (Catha edulis), whose active ingredients cathinone 
and cathine are listed in Schedules I and III of the  
1971 Convention; ayahuasca, a preparation made from 
plants indigenous to the Amazon basin of South 
America, mainly a jungle vine (Banisteriopsis caapi) 
and another tryptamine-rich plant (Psychotria viridis) 
containing a number of psychoactive alkaloids, 
including DMT; the peyote cactus (Lophophora 
williamsii), containing mescaline; magic mushrooms 
(Psilocybe), which contain psilocybine and psilocine; 
Ephedra, containing ephedrine; “kratom” (Mitragyna 
speciosa), a plant indigenous to South-East Asia that 
contains mitragynine; iboga (Tabernanthe iboga), a 
plant that contains the hallucinogen ibogaine and is 
native to the western part of Central Africa; varieties of 
Datura containing hyoscyamine (atropine) and 
scopolamine; and Salvia divinorum, a plant originating 
in Mexico that contains the hallucinogen salvinorin A. 
286. The Board notes increased interest in the 
recreational use of such plant materials. In addition, 
such plants are often used outside of their original 
socio-economic context to exploit substance abusers. 
As they can be transported quickly by air to any 
country in the world, the use of such plants or of 
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preparations made from such plants, is no longer 
limited to the regions where the plants grow, or to the 
communities that have traditionally used the plants. 
Potential abusers have been using the Internet to 
inform themselves about the stimulating or 
hallucinogenic properties of such plant material, about 
the fact that the plant material is not under 
international control and about Internet sites through 
which the plant material can be purchased. As a result, 
increased trade, use and abuse of such plant material 
have been noted in many countries. The use of such 
plant material may have adverse effects on the abuser, 
including nausea, vomiting, drowsiness, poisoning and 
flashbacks. In addition, any impairment resulting from 
a person’s use of such plant material might have 
serious consequences for the well-being of other 
persons — consequences similar to those of driving 
under the influence of psychoactive substances. 
287. The Board notes that, in view of the health risks 
associated with the abuse of such plant material, some 
Governments have placed certain types of plant 
material and preparations under national control. The 
Board recommends that Governments that have not yet 
done so and have experienced problems with regard to 
persons engaging in the recreational use of or 
trafficking in such plant material, to remain vigilant 
(since the risks associated with such use may increase) 
and to notify the Board and the WHO of those 
problems. The Board recommends that Governments 
should consider controlling such plant material at the 
national level where necessary. 
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III. Analysis of the world situation 
 
 A. Africa 
 
 
 1. Major developments 
 
288. The threats posed by drug trafficking through 
Africa have remained high on the agenda of the 
international community. The political commitment to 
the issue was illustrated at a debate held by  
the Security Council in December 2009 on the 
transnational threats posed by drug trafficking to peace 
and security, during which specific reference was made 
to West Africa as one of the areas most affected by 
drug trafficking. The Council returned to the issue on 
subsequent occasions and called upon local authorities 
to take action. In January 2010, a United Nations 
integrated office was established in Guinea-Bissau, to 
be headed by a personal representative of the 
Secretary-General. 
289. The Board notes the steps taken by the African 
Union to implement its Plan of Action on Drug  
Control and Crime Prevention (2007-2012). At the 
fourth session of the African Union Conference of 
Ministers for Drug Control and Crime Prevention, held 
in Addis Ababa from 28 September to 2 October 2010, 
African ministers and experts responsible for drug 
control and crime prevention in the member States of 
the African Union agreed to fight the illicit cultivation 
and abuse of cannabis, to actively address the control 
of precursor chemicals and to develop adequate 
monitoring and regulatory systems for ensuring the 
availability of drugs for medical purposes while, at the 
same time, curbing the availability of drugs on 
unregulated markets.  
290. For the past several years, West African countries 
have been used by drug traffickers as trans-shipment 
areas for large quantities of cocaine from South 
America destined for Europe and North America. The 
large-scale smuggling of cocaine through West Africa 
by criminal organizations appeared to peak in 2007;  
in 2008 and 2009, the number of seizures reported  
in the subregion fell, possibly because heightened 
international awareness of the threat posed by  
drug trafficking had made such trafficking via that 
subregion more difficult. Recently, however, the large-
scale smuggling of cocaine via the subregion appears 
to have resumed, as indicated by several large seizures 
of cocaine effected in or linked to the subregion  
in 2010.  
291. East Africa is the major conduit for smuggling 
heroin from South-West Asia into Africa, mainly 
through the major airports of Addis Ababa and Nairobi. 
From East Africa, heroin is smuggled into Europe and 
North America, either directly or indirectly through 
countries in West Africa (especially Côte d’Ivoire, 
Ghana and Nigeria) and, to a lesser extent, through 
countries in North Africa. The abuse of heroin has 
become a matter of concern in some East and Southern 
African countries, in particular Kenya, Mauritius, 
South Africa and Zambia.  
292. The Board is concerned about the fact that in 
Africa there has been an increase in the abuse of 
almost all types of drugs over the past few years. Illicit 
cannabis production, trafficking and abuse continue to 
represent major challenges in Africa. Cannabis is the 
main drug of abuse in Africa. Cannabis that is illicitly 
produced in Africa is sold on the illicit markets in that 
region or smuggled into other regions, mainly Europe 
and North America. While cannabis herb is illicitly 
produced in many countries throughout Africa, the 
illicit production of cannabis resin is concentrated in 
North Africa, with Morocco being one of the world’s 
largest producers of that drug. 
293. The use of Africa as a transit area for the traffic 
in precursor chemicals appears to have decreased in the 
past few years. While some years ago a number of 
large shipments of ephedrine and pseudoephedrine 
destined for African countries and ultimately Central 
and North America were identified and stopped, no 
further cases involving the attempted diversion of 
ephedrine and pseudoephedrine on a large scale 
through Africa were reported in 2009 or 2010. This 
may be attributable to the improved controls applied by 
some African countries over imports of those precursor 
chemicals and to the intensified screening by the 
authorities of exporting countries of shipments of 
precursor chemicals destined for Africa. However, 
Africa continues to be used by traffickers as an area for 
the diversion of precursor chemicals, as indicated by 
the continued diversion and smuggling of small 
shipments of ephedrine, pseudoephedrine and other 
precursor chemicals used in the illicit manufacture of 
drugs. 
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 2. Regional cooperation 
 
294. Within the framework of the African Union Plan 
of Action, the African subregional economic 
communities are playing a key role in the 
implementation of the Plan of Action at the subregional 
and national levels. A five-year programme to improve 
drug and crime control in North Africa and the  
Middle East was adopted by the Council of the League 
of Arab States in the second half of 2010. The 
programme addresses the main challenges faced by the 
subregion, including trafficking, organized crime and 
drug abuse. The programme, together with a political 
declaration and the terms of reference for a steering 
committee, was elaborated at a regional expert meeting 
held in Cairo in April 2010.  
295. In West Africa, member States of the Economic 
Community of West African States (ECOWAS) 
continue to demonstrate their support for the ECOWAS 
Political Declaration on the Prevention of Drug Abuse, 
Illicit Drug Trafficking and Organized Crime in  
West Africa, and many of them have taken action to 
implement the ECOWAS Regional Action Plan to 
Address the Growing Problem of Illicit Drug 
Trafficking, Organized Crime and Drug Abuse in  
West Africa (2008-2011), which was adopted at the 
ECOWAS Ministerial Conference on Drug Trafficking 
as a Security Threat to West Africa, held in Praia in 
October 2008. Progress has been made by the 
ECOWAS Commission in putting into effect its 
operational plan, adopted in Abuja in June 2009, for 
implementation of the Regional Action Plan, and  
in setting up a monitoring and evaluation mechanism.  
In December 2009, support and funds for 
implementation of the ECOWAS Regional Action Plan 
were pledged at a donor round table in Vienna 
organized by the ECOWAS Commission and UNODC 
including 15 million euros pledged by the European 
Commission. 
296. In February 2010, the Dakar Initiative, an 
alliance of West African States, was established at a 
ministerial conference held in Dakar. The aim of the 
Dakar Initiative is to create a trans-Saharan network to 
counter the growing threat posed by cocaine trafficking 
through West African countries. The States currently 
participating in the Dakar Initiative are Cape Verde, the 
Gambia, Guinea, Guinea-Bissau, Mali, Mauritania and 
Senegal. 
297. At a ministerial meeting of the West Africa Coast 
Initiative held in Freetown in February 2010, the 
Freetown Commitment was adopted by the four States 
currently participating in the Initiative (Côte d’Ivoire, 
Guinea-Bissau, Liberia and Sierra Leone). The 
Freetown Commitment supports implementation of the 
ECOWAS Regional Action Plan and is designed to 
strengthen the capacity of specialized drug law 
enforcement agencies and of national criminal justice 
systems. The West Africa Coast Initiative was launched 
in 2009 as a joint technical assistance programme for 
capacity-building at the national and subregional 
levels. It is expected that the Initiative will eventually 
be expanded to include all 15 ECOWAS member States 
and Mauritania. 
298. In East Africa, a programme to promote the rule 
of law, health and human security in that subregion, 
covering Burundi, Comoros, Djibouti, Eritrea, 
Ethiopia, Kenya, Madagascar, Mauritius, Rwanda, 
Seychelles, Somalia, Uganda and the United Republic 
of Tanzania, was endorsed by a regional ministerial 
conference held in Nairobi in November 2009. 
299. At the Twentieth Meeting of Heads of National 
Drug Law Enforcement Agencies, Africa, held in 
Nairobi in September 2010, participants examined 
current illicit drug trends in Africa and ways in which 
to strengthen the investigation of drug trafficking and 
related offences. The Meeting focused in particular on 
issues relating to drug trafficking and its corrupting 
influence on law enforcement agencies.  
300. The Board notes that Governments of African 
countries have continued to establish legislative and 
administrative mechanisms to identify, trace, freeze, 
seize and confiscate the proceeds of drug trafficking 
with technical support by UNODC and the relevant 
subregional groups, notably the Eastern and Southern 
Africa Anti-Money Laundering Group and the 
Intergovernmental Action Group against Money 
Laundering in West Africa (GIABA). In January 2010, 
a GIABA workshop on the theme “Laundering the 
proceeds of illicit trafficking in narcotic drugs and 
psychotropic substances in West Africa” was held in 
Bissau to examine the techniques and methods used to 
launder the proceeds of drug-related crime in the 
subregion and to identify gaps in the national 
regulatory and institutional frameworks for countering 
money-laundering.  
Report of the International Narcotics Control Board  
 
50  
 
301. A high-level meeting of heads of drug law 
enforcement agencies of six West African countries 
(Cape Verde, the Gambia, Ghana, Guinea-Bissau, 
Sierra Leone and Togo), as well as Colombia, the 
Dominican Republic, Jamaica and Peru, was organized 
by UNODC in Bogota in January 2010 as part of its 
transatlantic intelligence exchange project. At the 
meeting, a total of 24 bilateral agreements were signed 
in order to facilitate joint investigations and the rapid 
exchange of operational information between law 
enforcement agencies with the aim of promoting 
intelligence-led investigations resulting in the 
interception of illicit drug shipments in South America, 
Central America and the Caribbean, West Africa and 
Europe. 
302. Relevant international organizations have 
continued to provide joint technical assistance to West 
African States in support of the efforts of those States 
to combat drug trafficking through their territory. The 
Board notes the various initiatives implemented by 
UNODC in 2009 and 2010 to provide technical 
assistance to West Africa in the areas of drug control 
and fighting organized crime, notably the development 
of the UNODC programme for West Africa for the 
period 2010-2014. The Container Control Programme, 
which is implemented jointly by UNODC and the 
World Customs Organization in Africa, Central 
America, South America and Central Asia, is assisting 
Governments in establishing effective container 
controls to prevent the smuggling of drugs and 
contraband while facilitating legal trade. The 
programme is fully operational in Senegal (the port of 
Dakar) and in Ghana (the port of Tema) and will be 
extended to Benin, Cape Verde, Côte d’Ivoire,  
Mali and Togo in the near future. The Airport 
Communication Project, developed by UNODC in 
cooperation with INTERPOL and the World Customs 
Organization and with funding from the European 
Commission, enhances border controls and border 
management systems in international airports on drug 
trafficking routes in Brazil and countries in Africa and 
links them with the communication systems of 
INTERPOL and the World Customs Organization. Joint 
units to counter drug trafficking are to be set up under 
the project in Cape Verde, Côte d’Ivoire, Ghana, 
Guinea, Mali, Morocco, Nigeria, Senegal and Togo.  
 
 3. National legislation, policy and action 
 
303. In 2009, the Government of Benin established 
three new bodies to monitor implementation of and 
enforce the drug control legislation adopted by that 
State in 1997: the inter-ministerial committee to 
combat the abuse of narcotic drugs and psychotropic 
substances (CILAS), the central office against drug 
trafficking (OCERTID) and the unit for combating 
money-laundering (attached to the economic and 
financial brigade). It also adopted a plan for combating 
drugs.  
304. An inter-ministerial coordination committee on 
drug control was established in Ethiopia, comprising 
all ministries and key Government agencies 
responsible for the prevention of drug trafficking and 
drug abuse. The committee’s role is to oversee 
implementation of the national drug control master 
plan, provide policy advice on the updating of national 
drug control legislation, monitor compliance by 
Ethiopia with its obligations under the international 
drug control treaties and provide guidance on drug 
abuse prevention strategies for the general public and 
specific target groups. 
305. Ghana has undertaken major restructuring of its 
national drug law enforcement agency, the Narcotics 
Control Board, and has also improved national  
inter-agency cooperation and collaboration with 
international partners. The number of interceptions and 
seizures of drug shipments has increased markedly as a 
result of Operation Westbridge, a passenger and  
cargo profiling operation carried out jointly with 
United Kingdom customs officials to improve drug 
interdiction at airports. The operation is to be extended 
to three airports in Nigeria. 
306. In November 2009, the Government of the 
Libyan Arab Jamahiriya signed an agreement with 
UNODC to open a UNODC subregional office in 
Tripoli for the Maghreb countries. The new  
office, which is to be opened in December 2010, will 
focus on promoting cooperation between Algeria, the 
Libyan Arab Jamahiriya, Morocco and Tunisia in 
strengthening drug and crime control at their national 
borders.  
307. The Government of Namibia is currently 
reviewing its national drug control master plan for the 
period 2003-2008. The Board encourages the 
Government to pass, as soon as possible, the 
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Combating of the Abuse of Drugs Bill, which  
would ban trafficking in and the sale, possession and 
use of addictive substances and bring Namibia into  
full compliance with the requirements of the  
1988 Convention, and the Drug Control Bill, which 
provides for up-to-date tools for the prosecution of 
drug related crime. 
308. In March 2010, the South African Police Service 
held its second national chemical monitoring and 
precursor control conference. The objectives of the 
conference were to bring together representatives of 
the chemical industry, pharmaceutical companies and 
the South African Police Service to develop strategies 
for countering the diversion of precursor chemicals  
for use in the illicit manufacture of drugs and to 
acquire international expertise on current international 
trends and best practices in the dismantling of 
clandestine drug laboratories. In October 2010, the 
Government of South Africa held a national conference 
to review its national drug control master plan for the  
period 2006-2011 and adopt a master plan for the 
period to follow. 
309. In the State of Zanzibar, United Republic of 
Tanzania, a draft law on illicit drugs was passed by the 
Zanzibar House of Representatives in 2009. The new 
law enhances the powers of police officers to conduct 
searches and seize narcotic drugs and provides for 
controlled delivery. It also establishes a commission to 
coordinate drug control efforts.  
310. In 2009, the Government of Tunisia adopted new 
drug control legislation focusing on the storage, 
transportation, prescription and dispensation of 
psychotropic substances. In addition, buprenorphine, 
methylphenidate and oripavine were added to the list 
of narcotic drugs subject to State control.  
311. The Parliament of Uganda is currently 
considering comprehensive draft national legislation on 
drug control that would introduce stiffer penalties for 
traffickers and provide for the establishment of a 
national body for coordinating drug control, the 
treatment and rehabilitation of drug abusers, regional 
and international cooperation, and the confiscation and 
forfeiture of assets. 
312. At the end of November 2009, a comprehensive 
national plan for combating drugs and crime for the 
period 2009-2013 was drawn up and approved by the 
Government of Togo under the auspices of UNODC. 
The Government of Togo has established a financial 
intelligence unit, managed by the Ministry of Security, 
to fight money-laundering.  
313. With regard to efforts to counter money-
laundering, the Government of Ethiopia passed 
legislation to combat that phenomenon in  
November 2009, while in Kenya, the Proceeds of 
Crime and Anti-Money-Laundering Act entered into 
force in December 2009. Despite the efforts undertaken 
by Ethiopia, the Financial Action Task Force on Money 
Laundering has identified Ethiopia as having 
significant anti-money-laundering deficiencies that 
pose a risk to the international financial system. The 
Government of Ethiopia may wish to seek technical 
assistance through UNODC in order to address those 
shortcomings. 
 
 4. Cultivation, production, manufacture and 
trafficking 
 
  Narcotic drugs 
 
314. Cannabis continues to be the drug most widely 
trafficked and abused, and cannabis plant the illicit 
crop most widely cultivated, throughout Africa. The 
African region remains among the world’s largest 
producers of cannabis. Cannabis plants continue to be 
illicitly cultivated chiefly by small farmers and 
cannabis distributed by small groups or individuals. 
315. Significant illicit production of cannabis resin 
continues to take place in countries of North Africa, 
notably Morocco. From 2003 to 2005 there was a 
marked decline in illicit cannabis plant cultivation in 
Morocco; that downward trend continued in 
subsequent years. The land used for cannabis plant 
cultivation was reported to have decreased from 
134,000 ha in 2003 to 56,000 ha in 2009, while 
cannabis resin production decreased from 3,070 tons to 
820 tons over the same period. The Board notes that 
while Moroccan authorities are actively engaged in 
efforts to interdict illicit drug shipments, data from 
European countries show that large quantities of 
Moroccan cannabis resin continue to be smuggled into 
Europe, the world’s largest market for cannabis resin. 
The Board commends the Government of Morocco for 
its endeavours and calls upon it to continue its efforts 
to achieve the total eradication of cannabis plant 
cultivation on its territory. At the same time, the Board 
calls upon Governments of European countries, which 
are among the main countries of destination of 
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shipments of African cannabis to take all necessary 
measures to curb cannabis abuse in their countries. The 
Board encourages the Government of Morocco to 
continue to monitor the situation in its country by 
collecting and analysing pertinent statistical data on the 
extent of cannabis plant cultivation in Morocco and to 
share its experience with the international community. 
In that connection, the Board notes with regret that the 
survey on cannabis plant cultivation and cannabis 
production that was to be conducted by the 
Government of Morocco in cooperation with UNODC 
in 2010 was not carried out. The Board encourages the 
Government of Morocco and UNODC to take all steps 
necessary to ensure that the survey is conducted as 
soon as possible. 
316. Cannabis herb production and trafficking are 
reported in practically all African countries. Cannabis 
herb is abused locally or smuggled within the region. 
Africa is also one of the main sources of the cannabis 
herb seized in Europe. The largest producers of 
cannabis herb in Africa are countries in West Africa 
(Ghana, Nigeria, Senegal and Togo), Central Africa 
(the Democratic Republic of the Congo and Equatorial 
Guinea), Southern Africa (Malawi, South Africa, 
Swaziland and Zambia) and East Africa (Comoros, 
Ethiopia, Kenya, Madagascar, Uganda and the United 
Republic of Tanzania).  
317. In Nigeria, more than 900 ha of cannabis plants 
were destroyed by the National Drug Law Enforcement 
Agency during 2009. As a result, the farm-gate price of 
cannabis quadrupled in that country during the same 
year. The quantity of cannabis seized in Nigeria 
decreased sharply, from 334 tons in 2008 to 115 tons  
in 2009. In Ghana, irrigation farming has been 
introduced on sites where cannabis plants are illicitly 
cultivated, making it possible for the illicit crops to be 
grown throughout the year. Cannabis from Ghana is 
shipped primarily to Europe, in particular to the United 
Kingdom. A Government pilot scheme launched in 
Ghana in 2003 to provide cannabis farmers with the 
means to cultivate alternative cash crops was 
discontinued in 2008, as the scheme was not 
sustainable and some farmers continued to grow 
cannabis plants despite receiving incentives to 
cultivate alternative crops. South Africa ranks among 
the world’s largest producers of cannabis. While most 
of the cannabis illicitly produced in that country is 
abused locally, some is smuggled into countries in 
Europe, primarily the United Kingdom. In Egypt, 
cannabis plants continue to be illicitly cultivated in the 
north of the Sinai peninsula and in Upper Egypt, and 
about 75 ha of illicit crops were eradicated on the Sinai 
peninsula and 30 tons of cannabis seized during 2009. 
318. While there is no evidence of the illicit 
cultivation of coca bush or the illicit manufacture of 
cocaine in Africa, for the past several years,  
West African countries have been used as trans-
shipment areas for smuggling large quantities of 
cocaine from South America into Europe. As a result, 
two key trans-shipment areas have emerged in West 
Africa: one in Guinea and Guinea-Bissau in the north 
of the subregion; and the other in the Bight of Benin in 
the south. The preferred modus operandi of traffickers 
has been to transport the cocaine shipments using 
mother ships that offload the shipments onto smaller 
sea vessels near the West African coast, which then 
transport the shipments to Portugal and Spain. Large 
cocaine shipments are also sent in modified small 
aircraft from Brazil or Venezuela (Bolivarian Republic 
of) to various destinations in West Africa. West African 
traffickers then traffic the cocaine onward to Europe, 
usually using commercial air courier services and often 
receiving a portion of the drug in payment for their 
services.  
319. In 2008, a decrease in the number of reported 
seizures suggested that cocaine trafficking through 
West Africa was beginning to subside, possibly 
because drug trafficking as a whole had become more 
difficult as a result of heightened international 
awareness of the threat posed by such trafficking.  
By 2009, there were almost no seizures of cocaine 
trafficked by sea or on flights originating in  
West Africa. However, there were indications that 
cocaine continued to be smuggled through West Africa, 
such as the discovery in the Mali desert of the 
wreckage of a large cargo plane suspected of having 
carried a multi-ton cocaine shipment from the 
Bolivarian Republic of Venezuela. By mid-2010, large-
scale cocaine trafficking via West Africa appeared to 
have resumed. In May 2010, members of a trafficking 
network were arrested in Liberia on charges of having 
attempted to smuggle at least 4 tons of cocaine  
from South America into European countries and the 
United States via Liberia. In June 2010, a record 
seizure of 2.1 tons of cocaine was effected in the 
Gambia and 12 suspects were arrested as a result of a 
joint investigation by Gambian and British law 
enforcement services. In July 2010, a shipment of  
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450 kilograms (kg) of cocaine from Chile was 
intercepted in Nigeria. Those seizures indicate that 
multi-ton shipments of cocaine are arriving in West 
Africa and will continue to do so in the future, 
particularly since the factors that previously facilitated 
such flows of illicit drugs continue to prevail.  
320. It appears that traffickers are adapting their 
modus operandi, for instance by using light aircraft to 
transport shipments of less than one ton of cocaine to 
coastal countries, notably Guinea-Bissau and Sierra 
Leone, and inland desert countries, such as Mali, which 
are closer to Europe and whose territory is more 
difficult to control. Drug traffickers constantly  
change their routes in response to successful law 
enforcement efforts; for instance, cocaine shipments 
are increasingly being routed from Argentina and 
Uruguay to Central and Southern Africa, while small-
scale cocaine trafficking by air between North Africa 
and Europe — for example, from Morocco to Spain, 
from Algeria to France and from Tunisia to Italy — is 
increasing. In contrast, no major maritime seizures 
have been reported off the West African coast or by the 
Lisbon-based Maritime Analysis and Operations Centre 
– Narcotics (MAOC–N) since late 2009. There was 
also a significant decrease, between 2006 and 2009, in 
the number of arrests of cocaine couriers arriving at 
European airports on flights originating in West Africa.  
321. A serious danger posed by cocaine is its 
enormous value relative to the size of local economies, 
a factor that allows traffickers to use bribery to protect 
their operations. For instance, in March 2010, 11 top-
level officials of Gambian law enforcement agencies 
were arrested in connection with drug trafficking.  
322. Some cocaine is also smuggled into South Africa, 
both via West Africa and directly out of South America 
using courier, air freight or express mail services. 
South Africa is becoming an important hub for cocaine 
shipments destined for illicit markets in Southern 
Africa and Europe. As regards East Africa, a series of 
cocaine seizures at the international airport of Nairobi 
in 2009 highlighted the continuing drug trafficking 
problem in Kenya. A growing number of cocaine 
seizures have been reported in North Africa, notably in 
Egypt and the Libyan Arab Jamahiriya. 
323. The illicit cultivation of opium poppy continues 
to take place on the Sinai peninsula and in Upper 
Egypt. Such cultivation has also been reported in 
Algeria. The opium produced in Algeria and Egypt is 
abused locally. There is no illicit manufacture of heroin 
in Africa. Heroin from South-East and South-West Asia 
enters Africa through East African countries, from 
where it is trafficked first to West Africa and then to 
the United States and, to a lesser extent, countries in 
Europe. According to UNODC estimates, about 35 tons 
of heroin are smuggled into Africa each year, of which 
some 25 tons are used to supply Africa’s population  
of drug addicts, which is tentatively estimated at  
1.2 million. 
324. Within Africa, heroin flows to South Africa and 
countries in North Africa. In recent years, Ethiopia has 
become a significant transit area for heroin. Heroin is 
trafficked through Ethiopia and Kenya primarily 
because those countries have good air transport 
connections. From Kenya, heroin is transported to the 
Indian Ocean islands of Comoros, Madagascar, 
Mauritius and Seychelles. South Africa is used as a 
transit country for heroin shipments destined for illicit 
markets in Southern Africa and Europe and is also a 
country of destination. Heroin seizures have increased 
in North African countries, notably Egypt and the 
Libyan Arab Jamahiriya. Countries in West Africa have 
also emerged as important trans-shipment areas for 
heroin trafficking, as corroborated by a series of 
significant seizures of heroin (each of quantities 
greater than 5 kg) linked to Côte d’Ivoire, Nigeria and 
Ghana in 2009 and 2010. West African trafficking 
organizations are playing a key role in heroin 
trafficking throughout the world.  
 
  Psychotropic substances 
 
325. In Africa, the illicit manufacture of psychotropic 
substances for local abuse takes place mainly in South 
Africa, but also in other Southern African countries 
and in East Africa. The illicitly manufactured drugs are 
predominantly methamphetamine, methcathinone and 
methaqualone (Mandrax). The precursor chemicals 
needed for the manufacture of methamphetamine, 
namely ephedrine and pseudoephedrine, are usually 
imported into South Africa legally but then diverted 
from domestic distribution channels. Legally imported 
cathine is also being used for the illicit manufacture of 
methamphetamine. Methaqualone originating in South 
Asia enters Africa through ports in East Africa and is 
smuggled via Mozambique into Southern Africa. 
Amphetamines appear to continue to be illicitly 
manufactured in Egypt (albeit to a lesser extent than 
previously) as evidenced by the discovery in Egypt in 
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April 2010 of a laboratory suspected to have been used 
for the illicit manufacture of methamphetamine. 
326. Amphetamines and other amphetamine-type 
stimulants continue to be smuggled into countries  
in West and Central Africa, to be sold on the  
illicit markets or smuggled into other countries. 
According to the World Drug Report 2010,27 prepared 
by UNODC, West and Central Africa accounted for 
almost 90 per cent of global seizures of unspecified 
amphetamines in 2008. In 2009, more than 700 kg of 
psychotropic substances were seized in Nigeria, a 
considerable increase compared with the 530 kg  
seized in 2008. Nigeria may be at risk of becoming a 
transit country for methamphetamine trafficking,  
as indicated by two seizures effected in Lagos,  
Nigeria, in April 2010: one of 36 kg of crystalline 
methamphetamine destined for Tokyo and the other of 
26.5 kg of amphetamine destined for the United States 
via South Africa. In both cases, the substances were 
detected by the National Drug Law Enforcement 
Agency of Nigeria in air cargo shipments.  
327. African countries continue to be vulnerable to the 
problems posed by illicitly manufactured or counterfeit 
pharmaceutical preparations containing narcotic drugs 
or psychotropic substances. In many African countries, 
it is possible to purchase pharmaceutical preparations 
without presenting a valid prescription. Many 
pharmaceutical preparations, some of them smuggled 
or imported without authorization, are sold on street 
markets. There is a need to increase the capacity of 
African countries to address the counterfeiting of 
medicines and the problems related to such medicines; 
lack of resources hampers the detection and 
investigation of such counterfeiting. The fact that 
counterfeit medicines can be easily obtained on African 
markets represents a serious risk to public health. 
 
  Precursor chemicals 
 
328. In 2008 and 2009, there was a decrease in the 
number of reported cases involving suspicious or 
stopped shipments of precursor chemicals being 
smuggled through Africa. During the period 2006-
2007, a large number of suspicious shipments of 
ephedrine, pseudoephedrine and preparations 
containing those substances were identified and 
__________________ 
 27  World Drug Report 2010 (United Nations publication, 
Sales No. E.10.XI.13), p. 207. 
stopped and a total of more than 75 tons of ephedrine 
and pseudoephedrine were prevented from being 
diverted to or through the region. In 2008, however, 
the smuggling of those substances through Africa 
began to decrease markedly, although the diversion and 
smuggling of small shipments have continued. In 
April 2010, the Egyptian authorities dismantled an 
illicit drug manufacturing laboratory in Alexandria and 
seized various precursor chemicals (pseudoephedrine, 
hydrochloric acid, toluene and sulphuric acid), as  
well as tools and equipment, used in the illicit 
manufacture of methamphetamine. In April 2010, two 
businesswomen were arrested in Lusaka for smuggling 
4 kg of ephedrine and 1 kg of cocaine. In South Africa, 
large quantities of ephedrine and pseudoephedrine 
continue to be diverted for use in the illicit 
manufacture of methamphetamine, which is abused 
mainly in the Western Cape province.  
329. West Africa is at risk of being used by traffickers 
as a source of precursor chemicals that are used to 
illicitly manufacture drugs in the subregion or 
smuggled to other subregions, as indicated by the 
interception by the customs authorities of  
Côte d’Ivoire, in June 2010, of a shipment of 960 kg of 
acetone and 2,145 kg of methyl ethyl ketone, precursor 
chemicals used in the illicit manufacture of cocaine 
and other drugs. The traffickers had intended to 
transport acetone to Benin and the methyl ethyl ketone 
to Guinea without the required authorizations. 
Subsequent investigations carried out jointly with those 
two States confirmed that the addresses to which the 
shipments were to be sent were false. The Board urges 
the Governments of the African countries that have not 
yet done so to put in place, as a matter of priority, the 
legislative and institutional framework necessary to 
combat effectively the smuggling of precursors into or 
through their territories.  
 
  Substances not under international control 
 
330. Khat continues to be cultivated in countries in 
East Africa, mainly Ethiopia and Kenya, and is used as 
a stimulant locally and in parts of the Arabian 
Peninsula. Despite the fact that the use of khat is 
associated with health risks, khat is prohibited only in 
some countries in the subregion, such as Eritrea, 
Madagascar, Rwanda and the United Republic of 
Tanzania, and in Canada, the United States and some 
European countries.  
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331. The abuse of tramadol, an opioid analgesic that is 
not under international control, is of increasing 
concern in North African countries. In 2009, the 
Egyptian authorities seized 1.2 million tablets 
containing that substance which had been placed under 
national control in Egypt in 2008.  
 
 5. Abuse and treatment 
 
332. Cannabis has remained the primary drug of  
abuse throughout Africa. The annual prevalence rate in  
Africa for cannabis abuse among the population  
aged 15-64 years fluctuates between 5 and 9.6 per cent, 
which is among the highest rates in the world and 
approximately double the global annual average. One 
matter of concern is that cannabis abuse in Africa 
appears to be increasing, the highest annual prevalence 
rates for such abuse being recorded in West and 
Central Africa (between 7.8 and 12.3 per cent), 
followed by Southern Africa, North Africa and East 
Africa. Zambia and Nigeria remain the African 
countries with highest prevalence of cannabis abuse 
(17.7 per cent and 13.8 per cent, respectively). 
According to the South African Community 
Epidemiology Network on Drug Use (SACENDU), in 
South Africa, the only country in Africa that 
systematically monitors drug abuse, 9 per cent of the 
population abuses cannabis and 26-58 per cent of 
patients attending specialist treatment centres reported 
cannabis as their primary or secondary drug of abuse.  
333. Cocaine abuse appears to be rising in Africa, 
albeit from low levels. In Africa, the annual prevalence 
rate for cocaine abuse among the population  
aged 15-64 years is estimated at 0.2-0.5 per cent, 
which corresponds to the global average rate for such 
abuse. Within Africa, the rate of cocaine abuse is 
highest in countries in West and Central Africa — 
where the transit traffic in cocaine has fuelled an 
increase in local abuse — followed by countries in 
Southern Africa. SACENDU has noted an increase in 
the number of persons admitted for the treatment of 
cocaine abuse in South Africa. 
334. There are estimated to be about 1.2 million heroin 
abusers in Africa. Within Africa, the subregion with the 
highest prevalence rate for opiate abuse is East Africa, 
followed by North Africa, Southern Africa, and  
West and Central Africa. The African countries with 
the highest annual prevalence rate for opiate abuse are 
Mauritius (1.9 per cent), Kenya (0.7 per cent) and 
Egypt (0.4 per cent). According to the World Drug 
Report 2010, in South Africa, the prevalence rate for 
heroin abuse has reportedly remained stable over the 
past few years.28 The abuse of buprenorphine, 
including by injection, has been reported in Mauritius 
and Tunisia.  
335. South Africa is possibly the world’s largest 
consumer of methaqualone. In that country, 
methaqualone is the preferred drug of abuse, and it is 
often abused in combination with cannabis.  
Another matter of serious concern is the abuse of 
methamphetamine (locally known as “tik”) and 
methcathinone in South Africa. Methamphetamine is 
illicitly manufactured in South Africa, to be sold on the 
illicit market. It is abused mainly in the Western Cape 
province, especially in Cape Town and, more recently, 
in Pretoria. According to police estimates, at  
least 30,000 addicts use more than a gram of 
methamphetamine every day. In Cape Town, 
methamphetamine is reported to be a primary or 
secondary substance of abuse among two thirds of drug 
abusers. Abuse of methamphetamine is believed to be 
spreading to other provinces of South Africa. In order 
to address the seriousness of the drug abuse problem, 
the provincial government of the Western Cape has 
adopted new substance abuse policies and in 2010 
appointed a substance abuse coordinator at the Office 
of the Premier of the Western Cape. 
336. In many African countries, national health-care 
systems, owing to lack of resources, are unable to meet 
medical needs adequately, particularly as regards 
facilities for the treatment and rehabilitation of  
drug-dependent persons. As a result of limited 
treatment options and in many cases no treatment 
programmes or facilities specifically for drug abusers, 
persons seeking assistance are often referred to the 
psychiatric wards of general hospitals, where only a 
small number of drug-dependent persons can be 
accommodated. The Board therefore welcomes the 
launch by UNODC and WHO of the project “Treating 
drug dependence and its health consequences” in 
Africa in 2009. The objective of the project is to 
improve the treatment available to drug-dependent 
persons and to facilitate their access to quality and 
affordable treatment services by providing support for 
the development and strengthening of such services 
and capacity-building for the entities that provide such 
__________________ 
 28  Ibid., p. 157. 
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services. To date, a total of 70 national trainers from  
13 sub-Saharan countries have been trained under the 
project. The training programme is to be implemented 
at the national level between September 2010 and 
October 2011, and participating countries will be 
provided with technical support for policy 
development and service provision.  
337. Capacity-building initiatives have been launched 
in Algeria, Egypt, the Libyan Arab Jamahiriya and 
Morocco to provide a comprehensive response to drug 
abuse and HIV/AIDS, including community outreach 
services for drug abusers, drug abuse prevention 
services and treatment services for drug abusers, 
including prison inmates. 
338. In Morocco, the programme for opioid 
substitution therapy launched by the Government  
in 2009 became operational in June 2010 as part of a 
comprehensive package of services for the treatment of 
heroin dependence. Morocco is the first country in 
North Africa (and in the Arab world) to adopt 
legislation allowing the use of methadone in the 
treatment of drug dependence.  
 
 
 B. Americas 
 
 
  Central America and the Caribbean 
 
 
 1. Major developments 
 
339. Because of its geographical location, at the 
crossroads of the main producing countries and  
the consumer markets, the Central American and 
Caribbean region continues to be used as a transit area 
for the large-scale smuggling of illicit drugs. The 
region’s long coastlines, porous borders and limited 
law enforcement and institutional capacity have 
facilitated trafficking activities, further compounding 
the impact of drug-related crime.  
340. Despite the considerable efforts made by 
Governments in the region, the drug problem facing 
Central America and the Caribbean has been 
exacerbated by endemic corruption, widespread 
poverty and high unemployment. It is estimated that 
the street value of all drugs transiting through the 
Caribbean alone exceeds that of the legal economy. 
Proceeds of drug trafficking have been used to bribe 
public officials, increasing corruption within 
government, law enforcement agencies and the 
judiciary and further undermining already weak 
institutions.  
341. In some instances, the resources amassed by drug 
trafficking syndicates through illicit activities have 
enabled them to challenge the Government for 
effective control of parts of the national territory, 
jeopardizing the State’s security and political stability. 
The Board notes with concern the negative effect that 
corruption has had on drug control efforts in Central 
America and the Caribbean and urges the Governments 
of all countries in the region to take urgent measures to 
combat corruption in all its manifestations. 
342. In Central America, drug-related violence has 
continued to plague El Salvador, Guatemala and 
Honduras, the countries of the so-called “Northern 
Triangle”, as national gangs are forming alliances with 
international criminal syndicates. According to the 
World Drug Report 2010,29 the “Northern Triangle” 
currently has the world’s highest murder rate and high 
rates of other forms of crime. It is reported that in 
Honduras alone about 60 per cent of all crimes are 
drug-related. In Panama, the murder rate more than 
doubled between 2006 and 2009, and the authorities 
attributed the increase to drug-related violence. In an 
effort to destabilize the Governments of countries in 
the area, drug syndicates have also targeted senior 
governmental officials; in Honduras, for example, the 
chief of the counter-narcotics police was murdered in 
December 2009. 
343. In the Caribbean, Jamaica has also been affected 
by significant drug-related violence. In the summer of 
2010, a police operation aimed at arresting the alleged 
head of a drug trafficking ring led to a stand-off 
between heavily armed gang members and police.  
The gravity of the ensuing violence, which caused over 
70 deaths, prompted the Government of Jamaica to 
declare a state of emergency in Kingston and mobilize 
the largest contingent of armed forces in the history of 
the country. The suspect was eventually arrested by 
police and extradited to the United States to face drug 
trafficking charges.  
344. The Board notes that natural disasters have also 
posed new challenges to the drug prevention efforts in 
Central America and the Caribbean. In January 2010, 
an earthquake of a magnitude of 7.0 struck Haiti, 
killing upwards of 200,000 people and causing 
__________________ 
 29  Ibid., p. 239. 
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widespread devastation to the country’s fledgling 
infrastructure. Before the quake, Haiti was already 
known to be used as a major transit area for illicit drug 
shipments bound for North America owing to its long 
and poorly patrolled coastline, as well as the presence 
of several clandestine airstrips on its territory. The 
magnitude of the destruction that occurred and the 
resulting loss of capacity of the Haitian State have 
given rise to fears that the country may be increasingly 
used as a trans-shipment area for illicit drugs.  
345. The adoption of strengthened drug law 
enforcement measures in many countries has had a 
displacement effect on trafficking routes, with drug 
traffickers seeking out the path of least resistance. The 
displacement effect, as manifested by the adoption of 
new trafficking routes, has led to a rise in demand for 
illicit drugs throughout the region and an increase in 
drug-related crime owing in particular to the  
growing prevalence of “payments in kind”, that is, the 
commission of crime in exchange for drugs or the 
exchange of drugs for different drugs.  
346. Although the total amount of cocaine smuggled 
into North America has declined due to decreased 
demand, the proportion of that amount that is smuggled 
through Central America, particularly Guatemala and 
Honduras, has increased. Illicit drug shipments from 
South America are also reportedly passing through the 
Caribbean to West Africa on their way to Europe.  
347. The primary means of drug trafficking remain 
maritime vessels, including go-fast boats, land 
transport and light aircraft landing on clandestine 
landing strips. Drug law enforcement agencies in 
Central America have also reported the renewed use by 
traffickers of submersible and semi-submersible 
vessels, which are rapidly increasing in capacity and 
technological sophistication. There have also been 
reports suggesting a resurgence in the use of drug 
couriers (sometimes referred to as “mules”). In 
addition, the exploitation of commercial aviation for 
smuggling is being facilitated by corrupt airport staff, 
including baggage handlers and customs and security 
agents. 
 
 2. Regional cooperation 
 
348. As mentioned in the report of the Board for 
2009,30 two ministerial conferences on drug 
__________________ 
 30  Report of the International Narcotics Control Board 
trafficking, transnational organized crime and terrorism 
as challenges for security and development were held 
in Central America and the Caribbean in 2009: one in 
Santo Domingo in February and the other in Managua 
in June. The political declarations and action plans 
adopted by the States participating in those conferences 
was evidence of the strong consensus that concerted 
action was required to address shared security threats 
and laid the groundwork for further cooperation at the 
regional and interregional levels.  
349. In March 2010, UNODC launched phase I of the 
Santo Domingo Pact and Managua Mechanism, an 
interregional programme scheduled to run until 
February 2013. The project is aimed at promoting the 
establishment of information-gathering and policy-
sharing initiatives and providing an integrated regional 
framework for the coordination of technical assistance 
activities aimed at combating drug trafficking and 
associated forms of transnational organized crime. The 
Santo Domingo Pact and Managua Mechanism also 
provide for the establishment of expertise and training 
focal points throughout the entire region. In its 
resolution 53/14, the Commission on Narcotic Drugs 
requested UNODC to assist the States of Central 
America and the Caribbean in obtaining the resources 
necessary for the effective implementation of the Santo 
Domingo Pact and Managua Mechanism. In order to 
facilitate the implementation of its related activities, 
UNODC has strengthened cooperation with States in 
the region through the establishment of the Regional 
Programme Office in Panama in 2009. The Board 
acknowledges the continuing role played by UNODC 
in assisting States in Central America and the 
Caribbean in the development and effective 
implementation of national and regional drug control 
strategies.  
350. At the Nineteenth Meeting of Heads of National 
Drug Law Enforcement Agencies, Latin America  
and the Caribbean, held on Isla Margarita,  
Bolivarian Republic of Venezuela, from 28 September 
to 2 October 2009, participants discussed new and 
emerging challenges and effective means of addressing 
them, including the need for sustainable alternative 
development initiatives as an incentive for crop 
growers to abandon the cultivation of illicit crops, as 
well as various issues concerning drug trafficking 
trends and techniques. In particular, participants noted 
__________________ 
 for 2009 ..., paras. 349 and 354. 
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a resurgence in the use of drug couriers, particularly 
couriers who concealed controlled drugs by ingesting 
them, and the increased use of light aircraft to smuggle 
drugs into the United States and countries in Europe. 
Participants also identified measures to enhance 
concerted action against drug trafficking and other 
forms of transnational crime, including the 
development of more efficient methods of data 
collection and structures for sharing information, an 
increase in capacity-building activities and cross-
border cooperation and the wider and more effective 
use of civil asset forfeiture actions. 
351. The Board welcomes the adoption of the 
Hemispheric Drug Strategy by the Inter-American 
Drug Abuse Control Commission (CICAD) at its  
forty-seventh regular session, in May 2010. The 
strategy is aimed at the grave threats posed by 
trafficking in and abuse of drugs to sustainable 
development, political and economic stability, good 
governance and the rule of law. It involves a 
multifaceted approach with five components: 
institutional strengthening; demand reduction; supply 
reduction; control measures, and international 
cooperation. 
352. The Central American Integration System (SICA) 
continues to be one of the primary multilateral engines 
for regional integration, including for the development 
of coordinated responses to shared security threats 
posed by drug trafficking. In April 2010, SICA 
announced the investment of $953 million in a joint 
project with Mexico aimed at combating drug 
trafficking, organized crime and gangs in the region. 
The project is intended to assist States in counteracting 
the smuggling of drugs through Central America as 
well as the growing influence of drug gangs in the 
“Northern Triangle”. 
353. The Thirty-fifth Regular Meeting of Heads of 
State and Government of SICA member States was 
held in Panama City on 29 and 30 June 2010. The 
meeting culminated in the adoption of the Panama 
Declaration, in which participants reiterated their 
commitment to taking meaningful steps to deal 
effectively with drug trafficking, gangs, illicit firearms, 
the smuggling of migrants and trafficking in human 
beings. Participants also pledged to make use of all 
resources at their disposal to prevent trafficking in and 
abuse of drugs in the region. 
354. An extraordinary summit of Heads of State and 
Government of SICA member States was held in  
San Salvador on 20 July 2010. The meeting led to the 
adoption of an action plan calling for the continued 
implementation of the security strategy for Central 
America and Mexico adopted in 2007. In addition, the 
action plan calls for a review of the role of national 
police chiefs as set forth in the regional plan against 
organized crime of SICA member States, Mexico  
and States of the Caribbean. The Board welcomes  
this initiative and recognizes the importance of 
interregional cooperation in dealing decisively with the 
shared threats posed by illicit crop cultivation and 
illicit drug production and trafficking. 
355. Under the auspices of the Caribbean Community 
(CARICOM), a four-day workshop was held in  
March 2010 to assist some CARICOM member  
States (Bahamas, Belize and Saint Vincent and the 
Grenadines) in the elaboration of their respective 
national drug control strategies. The subregional 
workshop was part of a technical assistance 
programme launched by the CARICOM Secretariat 
with the financial support of the European Union with 
the goal of building a critical mass of trained persons 
and developing good practices in addressing drug-
related problems.  
356. Building upon a pilot project previously 
implemented in South America, CICAD announced the 
expansion of the Seized and Forfeited Asset 
Management project (BIDAL) to Central America in 
2010. The project aims to establish and strengthen 
national systems for the investigation, seizure, 
forfeiture, administration and disposal of assets derived 
from drug trafficking. The project further aims to 
provide a framework to fund national drug control 
programmes using confiscated assets derived from 
drug trafficking. 
357. At a meeting held in Lima from 10 to 12 August 
2009, the CICAD Group of Experts on Chemical 
Substances issued a series of recommendations to 
CICAD which included the following: to confer a 
mandate on the Group of Experts to review and 
improve the CICAD Model Regulations to Control 
Chemical Precursors and Chemical Substances, 
Machines and Materials; to enhance the use of 
electronic means of gathering and exchanging 
information; and to expand the array of CICAD 
training activities relative to the illicit manufacture of 
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synthetic drugs through the elaboration of specific 
activities for prosecutors and judges. Several 
Governments expressed the need for simple and 
reliable methods of testing for ephedrine and 
pseudoephedrine. Others, including the Government of 
Costa Rica, reported having already made use of such 
tests in efforts to curb the diversion of precursor 
chemicals.  
358. El Salvador and Guatemala have continued to 
pursue integrated bilateral responses to shared security 
threats, acting primarily through the binational 
commission established in 2000. In April 2010, the 
Minister of the Interior of Guatemala and the Minister 
of Justice and Public Security of El Salvador held a 
meeting with a view to establishing joint mechanisms 
for the exchange of operational information and the 
elaboration of shared strategies to address common 
threats. Building upon the consensus reached at that 
meeting, the ministers of foreign affairs of the  
two countries signed an agreement for the 
establishment of a binational police force, which would 
undertake joint border patrols to combat drug 
trafficking and organized crime. 
 
 3. National legislation, policy and action 
 
359. In 2009, Belize adopted legislation prohibiting 
the importation of pseudoephedrine and restricting the 
importation of ephedrine. In 2010, El Salvador adopted 
two regulations for the control of ephedrine and 
pseudoephedrine: the first regulation prohibits 
pseudoephedrine and pseudoephedrine preparations, 
while the second prohibits ephedrine and ephedrine 
preparations, with the notable exception of ephedrine 
in its injectable pharmaceutical form. 
360. In 2008, Honduras reported a sharp increase in 
the amount of precursor chemicals seized, which was 
attributed to the displacement effect, as stricter 
precursor controls had been adopted in other countries 
in Central America and the Caribbean. In response  
to that growing problem, early in 2009, the 
Government of Honduras adopted a ministerial 
regulation prohibiting the importation, exportation, use 
and distribution of ephedrine, pseudoephedrine and 
their salts. Since then, seizures of those precursor 
chemicals have declined sharply.  
361. In El Salvador, the National Anti-drug 
Commission, composed of representatives of the 
ministries of public security, health, education and 
defence, announced the elaboration, in consultation 
with CICAD, of the national drug control strategy for 
the period 2010-2014. The strategy is aimed at 
reducing the supply of and demand for illicit drugs in 
the country by means of five central components: 
legislation; capacity-building; improved management; 
investigations; and the more efficient flow of 
information. In April 2010, the Government of  
El Salvador unveiled its National Drug and Crime 
Integrated Programme, developed with UNODC, 
envisaging investments of up to $15 million. 
362. In 2009, Costa Rica adopted several new laws 
strengthening the national legal regime against 
organized crime and money-laundering. In 2009, over 
64,000 drug-related arrests were made, an increase of 
more than 40 per cent over 2008. The Government  
also signed an agreement with UNODC on the 
establishment of a container intelligence programme. 
In September 2009, a Costa Rican delegation headed 
by the president of the Supreme Court signed at 
UNODC headquarters a plan of action addressing the 
needs of the country in the areas of drug control, 
fighting transnational organized crime and preventing 
terrorism. In July 2010, the Congress of Costa Rica 
authorized the entry of several United States warships 
and submarines into the territorial waters of Costa Rica 
between 1 July and 31 December 2010, in order to 
assist in drug control operations and humanitarian 
missions.  
363. In March 2010, the President of Guatemala 
launched a three-year national integrated programme at 
a cost of $16 million, to strengthen Guatemala’s 
capacity in the areas of drug control, justice, police 
reform, firearms control, prison reform and countering 
trafficking in human beings. The programme is also 
aimed at combating corruption, which is recognized as 
being one of the greatest problems facing Guatemala.  
364. The widespread corruption, impunity and 
recurring violence associated with drug trafficking in 
Central America have continued to adversely affect 
efforts in Guatemala to combat drug-related problems. 
According to the International Commission against 
Impunity in Guatemala (CICIG), established in 
cooperation with the United Nations in 2006 to support 
the Guatemalan justice system, about 97 per cent of the 
cases involving serious crime in the country, the 
perpetrators remain unpunished. In June 2010, CICIG 
expressed dissatisfaction with the measures taken by 
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Guatemala to reform its justice system and to curb 
corruption.  
365. In order to bolster its ability to deal effectively 
with the threats posed by large-scale drug trafficking, 
the Government of the Bahamas has adopted a 
capacity-building strategy focused on maximizing the 
participation of its law enforcement officials in 
national, regional and international training activities. 
366. The Government of Panama announced the 
creation of a joint task force with the goal of 
implementing measures to increase the country’s 
control over its territorial waters in order to deter drug 
trafficking in its territory. The main component of the 
strategy is the establishment of monitoring stations on 
both coasts. Building upon its participation in the 
Container Control Programme, the Government of 
Panama and the UNODC Regional Programme  
Office in Panama have created an investigative and 
intelligence unit to monitor container shipping. 
367. In April 2010, the Government of Honduras 
inaugurated a new naval base, built with the financial 
and logistic support of the United States Government, 
in the remote La Mosquitia region to facilitate the 
interception of light aircraft (“narcoavionetas”) 
smuggling cocaine from the Bolivarian Republic of 
Venezuela through Honduras.  
368. The Government of the Dominican Republic, in 
response to a marked increase in trafficking in the 
country, has taken decisive steps to increase its 
operational capacity to fight drug trafficking through 
the acquisition of new equipment such as aircraft, 
boats and radar systems. In June 2010, the Government 
of the Dominican Republic and UNODC finalized an 
agreement for the establishment of a regional centre of 
excellence on drug demand reduction and prison 
management. The centre is expected to become 
operational in early 2011. 
369. The Board notes with concern that many States in 
Central America and the Caribbean have not yet 
enacted effective legislation to prevent the diversion of 
precursor chemicals subject to international control. In 
countries in which such legislation has been adopted, 
poor enforcement of the legislation owing to limited 
resources and/or a lack of political will has hindered its 
effectiveness. The Board urges all States to adopt 
comprehensive legislation on precursor chemicals as 
expeditiously as possible and to provide their 
respective law enforcement authorities with the 
resources needed to ensure its systematic 
implementation. The Board also encourages 
Governments to disseminate and work towards 
implementing its Guidelines for a Voluntary Code of 
Practice for the Chemical Industry.31  
 
 4. Cultivation, production, manufacture and 
trafficking 
 
  Narcotic drugs 
 
370. Jamaica remains the largest illicit producer and 
exporter of cannabis in Central America and the 
Caribbean, accounting for approximately one third of 
cannabis produced in the Caribbean. An increased 
production of the drug has been noted in other 
countries, in particular Saint Vincent and the 
Grenadines and Dominica. Jamaica has also become a 
hub for the trafficking of cocaine, as trafficking routes 
have been displaced as a result of the strengthening of 
drug trafficking countermeasures in Latin America. 
Compounding the problem is the fact that Jamaican 
criminal groups are exploiting the elaborate networks 
originally established for trafficking cannabis to 
facilitate their attempts to traffic cocaine.  
371. The Government of the Bahamas has reported 
that cannabis herb smuggled out of Jamaica and Haiti 
using go-fast boats and light aircraft continues to pose 
challenges to the country’s drug control efforts. Further 
compounding the problem is the fact that drug 
trafficking groups in the Bahamas have formed 
strategic alliances with established drug syndicates in 
producer and consumer countries. 
372. The amount of cannabis seized in the Dominican 
Republic increased from 885 kg in 2008 to 1,400 kg  
in 2009, with almost 30 per cent of the seized cannabis 
originating in Haiti. The Dominican authorities also 
reported that in 2009 the amount of cocaine seized 
increased sharply to 3,400 kg, 64 per cent of which 
was accounted for by five large seizures. Although  
no official seizure data were provided for 2008, 
cannabis seizures in the Dominican Republic also rose 
significantly in 2009, to over 1,400 kg (compared with 
884 kg in 2007). The Dominican authorities also 
__________________ 
 31  United Nations publication, Sales No. E.09.XI.17; 
accessible to competent national authorities through the 
secure portal of the Board 
(www.incb.org/incb/cna.html). 
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reported having seized about 24,000 cannabis plants, 
covering an estimated area of 3 ha.  
373. In Costa Rica, law enforcement agencies have 
pursued a systematic cannabis crop eradication 
programme that has yielded significant results. In 
2009, the Government reported the eradication of 
nearly 1.7 million cannabis plants. The total area used 
for illicit cannabis plant cultivation, which had nearly 
tripled from 2005 to 2007, when it reached 9.21 ha, 
decreased to 5.25 ha in 2008 as a result of increased 
land and aerial reconnaissance efforts. Cannabis 
seizures in Costa Rica also sharply declined, with 
seizures of 2,064 kg reported in 2009, compared with 
4,809 kg in 2008. After a significant decline from 2007 
to 2008, cocaine seizures in Costa Rica once again 
increased, totalling 18,590 kg in 2009. Costa Rica also 
reported seizures of “crack” cocaine totalling over 
200,000 “doses” (“piedras”). 
374. The quantity of cocaine seized in El Salvador 
sharply declined for the second consecutive year, from 
4,074 kg in 2007 to 394 kg in 2009. According to 
official figures provided by the Salvadoran authorities, 
approximately 85 per cent of the cocaine seized was 
being smuggled by sea. Most of the seized drug had 
been bound for the United States, and a small 
proportion had been intended for illicit markets in  
El Salvador and countries in Europe. At approximately 
440 kg, cannabis seizures in El Salvador remained 
stable in 2009 compared with the amount reported for 
2008. The proportion of cannabis seized in the region 
that had originated in Guatemala was reported to be 
increasing significantly.  
375. After having reported a marked decrease in 
cannabis seizures from 2007 to 2008, Cuba reported a 
significant increase in such seizures in 2009. The total 
amount of cannabis seized in 2009 was 3,139 kg, an 
increase of 83 per cent over 2008.  
376. Large fluctuations in the quantity of cannabis 
seized were recorded in some Caribbean countries. 
Saint Lucia reported cannabis seizures in 2009 
totalling 94,841 kg, a quantity approximately 145 times 
greater than the 655 kg seized in 2008. In contrast, 
cannabis seizures in Saint Vincent and the Grenadines 
dropped sharply from 47,596 kg in 2008 to 9,882 kg  
in 2009 despite reports suggesting that the illicit 
production of cannabis in the country was increasing.  
  Psychotropic substances 
 
377. The spread of clandestine drug laboratories to 
Central America is thought to be linked to the 
increased control over precursor chemicals in Mexico 
and the United States, which has led to increased  
illicit manufacture of amphetamine-type stimulants in 
countries in Central America and the Caribbean.  
In 2008, for the first time, a clandestine laboratory 
manufacturing amphetamine-type stimulants was 
discovered in Guatemala. 
378. In 2009, over 10,000 units of methamphetamine 
were seized in the Dominican Republic, while 
Guatemala reported seizures totalling more than  
10,600 kg. Fewer than 500 tablets of 
methylenedioxymethamphetamine (MDMA, commonly 
known as “ecstasy”) were reported to have been seized 
in each of the following countries; Bahamas, Costa 
Rica and Trinidad and Tobago.  
 
  Precursors 
 
379. The Dominican Republic reported having seized 
over 1,332,000 tablets of pseudoephedrine in 2009. In 
the same year, Guatemala reported having seized more 
than 10,600 tablets of pseudoephedrine.  
380. Costa Rica reported the seizure of 30 kg of 
norephedrine that had entered the country through 
Panama. The Costa Rican authorities were unable to 
ascertain the country of origin of the seized drug.  
381. Following the adoption of legislation regulating 
ephedrine and pseudoephedrine in particular in Central 
America, the number of reported attempts to divert 
chemicals subject to international control has declined. 
At the same time, there is evidence suggesting that 
attempts to divert such chemicals have continued. The 
Central American subregion has also reportedly 
witnessed an increase in imports of chemicals that are 
not yet subject to international control but are 
suspected of being used in the illicit manufacture of 
drugs. 
 
 5. Abuse and treatment 
 
382. The development and successful implementation 
of initiatives for the prevention and treatment of drug 
abuse in Central America and the Caribbean are largely 
restricted by the limited resources and institutional 
capacity of countries in the region. Given those 
constraints, Governments have had to strike a balance 
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between competing developmental priorities and the 
need to adopt drug abuse prevention and treatment 
measures.  
383. The Board recognizes that a central problem in 
the design of effective prevention and treatment 
programmes is that throughout Central America and 
the Caribbean there is a lack of capacity for the 
collection of drug-related data and a lack of centralized 
agencies mandated to assess that information. Although 
the amount and the quality of information regarding 
drug abuse patterns in the region have greatly 
improved, more research on consumption patterns and 
trends is needed to tailor treatment initiatives to meet 
local needs. The Board reiterates the importance  
of States in the region taking tangible steps to  
improve frameworks for the collection and analysis of 
drug-related data and encourages greater international 
cooperation to that end. 
384. Several States in the region have adopted policies 
to develop and streamline national efforts to prevent 
and treat drug abuse. The Government of Saint Lucia 
has established the Substance Abuse Advisory Council 
Secretariat, a central authority coordinating national 
drug control policy. The Government of Saint Vincent 
and the Grenadines has established an advisory  
council on drug abuse prevention and is working with 
the Organization of American States to design and 
implement a demand reduction programme. 
385. While drug abuse by injection has not accounted 
for a high proportion of new HIV infections in most 
countries in Central America and the Caribbean,  
Puerto Rico remains a notable exception. According to 
research data released in 2009, in Puerto Rico, drug 
injection accounted for 40 per cent of HIV infection 
cases among men and 27 per cent of cases among 
women. 
386. Guatemala and Trinidad and Tobago noted a 
decrease in the age of first-time cannabis users. 
Guatemala also noted an increase in the overall 
availability of cocaine, including “crack” cocaine.  
387. The Board welcomes the expansion of the global 
project “Partnership for action on comprehensive 
treatment: treating drug dependence and its health 
consequences” into Latin America and the Caribbean 
in 2009. The programme, funded by the Fund for 
International Development of the Organization of the 
Petroleum Exporting Countries, in cooperation with the 
Governments of Spain, Sweden and the United States, 
is aimed at fostering the development of policies for 
the effective treatment of drug addiction and for the 
minimization of associated social and health-care 
costs. Components of the strategy include advancing 
scientific understanding of drug addiction, increasing 
the effectiveness of treatment services by providing 
greater access and increasing staff training and 
developing strategies for countering discrimination 
against persons with drug addiction.  
388. In cooperation with UNODC, CARICOM 
finalized its draft action plan for social development 
and crime prevention. The plan includes several 
measures aimed at preventing substance abuse among 
the general population and in schools, increasing the 
accessibility and quality of treatment, including in 
prison settings, addressing drug-related risk factors and 
facilitating the exchange of experiences and good 
practices in the Caribbean. 
 
 
  North America 
 
 
 1. Major developments 
 
389. North America continues to play a major role in 
illicit drug supply and demand. Large-scale drug 
trafficking within the region is carried out by organized 
criminal groups, meeting the continuing high illicit 
demand for drugs. The Governments of the countries in 
North America are addressing the situation by 
combining policies to reduce illicit drug supply with 
policies to reduce illicit drug demand. Since 2009,  
law enforcement components, as well as drug abuse 
prevention and treatment components, in national 
strategies and programmes have been strengthened in 
order to address drug-related problems in an effective 
and comprehensive manner. Regional and bilateral 
cooperation targeting cross-border drug trafficking has 
intensified. The Board recognizes the efforts of the 
Governments of the countries in North America to 
develop more effective policies against drug trafficking 
and abuse. 
390. The United States continues to be the main 
country of destination for illicit drug shipments. In the 
United States, in the case of all controlled drugs except 
cannabis and methamphetamine, most of the drugs 
have been illicitly manufactured outside of the country 
and then smuggled into the country. Drug trafficking 
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organizations based in Mexico dominate the illicit 
supply of cocaine, heroin and methamphetamine at the 
wholesale level in the United States, in addition to 
playing a significant role in the illicit supply of 
cannabis. The number of drug-related deaths increased 
sharply in the United States. The Board is deeply 
concerned about the fact that the United States 
recorded for 2009 an increase in the abuse of all drugs 
except cocaine. From 2006 to 2009, the abuse of 
cocaine declined in the United States. One matter of 
particular concern to the Board is the increasing  
abuse of cannabis and prescription drugs containing 
controlled substances among that country’s youth. The 
Board welcomes the steps that have been taken by the 
Government of the United States to address the abuse 
of prescription drugs. 
391. Mexico continues to be faced with significant 
challenges from drug trafficking organizations, which 
use it as a major transit and source country for illicit 
drugs. Vigorous law enforcement measures taken  
by the Government in 2009 and 2010 led to  
further disruptions of drug trafficking operations, the 
relocation of criminal activities and increased 
competition for shares in the illicit market. Once again, 
drug trafficking organizations responded by unleashing 
unprecedented violence, murdering a large number of 
persons, including law enforcement officials. Since 
2006, more than 28,000 people have been killed in 
drug-related incidents in Mexico. The Government 
intends to strengthen capabilities to combat drug 
trafficking by introducing comprehensive institutional 
reforms and anti-corruption measures. The abuse of 
certain illicit drugs in Mexico has increased sharply.  
392. Canada remains one of the world’s primary 
source countries for illicitly manufactured synthetic 
drugs, particularly MDMA (“ecstasy”) and 
methamphetamine, and a significant supplier of  
high-potency cannabis. The Board notes the decline in 
drug abuse in Canada, in particular among youth, 
reported by the Canadian Alcohol and Drug Use 
Monitoring Survey.  
393. The involvement of organized criminal groups in 
drug trafficking in North America expanded further. 
Mexico-based drug trafficking organizations 
strengthened their position as the main wholesale 
suppliers of illicit drugs in the United States, in 
particular in the eastern part of the country, where  
the influence of Colombia-based drug trafficking 
organizations was diminishing. The Mexico-based 
organizations also increased their cooperation with 
criminal gangs based in the United States. In 2009, the 
mid-level and retail-level distribution of illicit drugs in 
the United States was largely controlled by about 
20,000 street gangs. Alliances with the Mexico-based 
organizations enabled the street gangs to expand their 
illicit drug distribution operations at the expense of 
local independent drug dealers and small local criminal 
groups and to extend those operations into more rural 
and suburban areas. In Canada, some street gangs also 
started becoming involved in drug-related crime such 
as drug smuggling or illicit drug manufacturing, 
thereby enabling their activities to cover a larger 
geographical area. 
394. The Board notes the result of the referendum in 
California, which rejected the “legalization” of 
cannabis use in that state. That result represents a 
recognition of the danger of cannabis abuse and an 
affirmation of the international drug control 
conventions. The Board also notes the statement of the 
Government of the United States, confirming the 
Board’s position that federal law supersedes state law 
with regard to the obligations contained in the 
international drug control conventions. The Board 
notes that the Government of the United States will 
continue to enforce federal law in that regard. The 
cultivation of cannabis plants and the use of cannabis 
for purposes other than scientific purposes are illegal 
according to the federal law in the United States. The 
Board welcomes the statement of the Government of 
the United States that it firmly opposes the legalization 
of cannabis. 
395. The Board is deeply concerned about “medical” 
cannabis schemes, which so far have been introduced 
in 14 states in the United States. The control measures 
applied in those states to the cultivation of cannabis 
plants and the production, distribution and use of 
cannabis fall short of the control requirements of the 
1961 Convention.  
 
 2. Regional cooperation  
 
396. The Merida Initiative, a multi-year law 
enforcement and security cooperation programme 
involving Mexico, the United States and countries in 
Central America that was initiated in 2007, continues 
to be the focal point of cooperation at the regional 
level to counter drug trafficking and related forms of 
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organized crime. The Government of the United States 
provided about US$ 1.3 billion in funding for 2008  
and 2009 and proposed to allocate an additional  
US$ 450 million for Mexico (and US$ 100 million for 
Central America) for 2010. Notwithstanding the fact 
that only a small part of the initiative has been 
implemented so far, cooperation between Mexico and 
the United States has intensified within this 
framework. The emphasis of cooperation is shifting 
from the provision of equipment to improve law 
enforcement operations towards longer-term capacity-
building and institutional development in support of 
the systemic reforms that are under way in Mexico. 
Activities carried out under the Merida Initiative have 
included the provision of helicopters and inspection 
equipment, the expansion of police and customs canine 
teams, and the participation of over 5,500 federal  
and state officials from Mexican law enforcement  
and judicial agencies in training programmes. In 
addition, the Royal Canadian Mounted Police  
provided instructors for training Mexican investigators. 
The goals and commitments of the initiative  
were reaffirmed by the Governments of Mexico and  
the United States at the meeting of the Merida 
Initiative High-level Consultative Group on Bilateral 
Cooperation against Transnational Organized Crime 
held in Mexico City in March 2010. 
397. At its forty-seventh regular session, held in 
Washington D.C., in May 2010, CICAD adopted a new 
Hemispheric Drug Strategy, in which CICAD member 
States agreed to strengthen national drug control 
institutions and to apply comprehensive and evidence-
based national drug control policies. According to the 
new strategy, CICAD member States will endeavour to 
reduce illicit drug demand through prevention, early 
intervention, treatment, rehabilitation and recovery 
services. In order to reduce the supply of illicit drugs, 
CICAD member States intend to improve the gathering 
and analysis of information on illicit drug supply, 
adopt law enforcement and alternative development 
measures and identify and monitor emerging trends. 
The new strategy also involves the provision of 
guidance on precursor control, the prevention of 
diversion of pharmaceutical preparations and the 
dismantling of drug trafficking organizations. In the 
new strategy, CICAD member States recognize  
the need for international cooperation, including 
compliance with the international drug control 
conventions. In addition to adopting the new strategy, 
CICAD member States discussed their progress in the 
implementation of drug control policies within the 
Multilateral Evaluation Mechanism, strategies in the 
areas of treatment, prevention and recovery, trends 
with respect to selected illicit drugs and issues related 
to interdiction, forensic analysis and alternative 
development. 
398. At the eighth Binational Drug Demand  
Reduction Policy Meeting, held in Washington D.C., in  
February 2010, Government officials and experts from 
Mexico and the United States discussed measures to 
reduce illicit drug demand and to intensify the 
prevention and treatment of drug abuse. The 
participants adopted the Declaration of Drug Demand 
Reduction Cooperation, expressing their Governments’ 
commitment to strengthening both national and 
bilateral efforts to enhance the prevention and 
treatment of drug abuse, to advance effective 
reintegration practices and community development 
and to continue sharing information and good 
practices.  
399. In 2009, the law enforcement agencies of Mexico 
and the United States implemented new operating  
and communication procedures, which streamlined 
maritime patrol operations and the boarding and 
searching of vessels suspected of being involved  
in trafficking. Those procedures improved the 
coordination and effectiveness of such operations, 
contributed to a number of seizures of drugs and 
vessels and, in some cases, resulted in land routes 
being used instead of sea routes for drug trafficking 
operations. 
400. In 2009, cooperation between Canada and the 
United States continued to take place in different 
forms, including joint law enforcement operations, 
information-sharing and bilateral collaboration using 
the Cross-Border Crime Forum, which brings together 
senior law enforcement and justice officials from 
Canada and the United States, and similar forums. 
Joint law enforcement activities resulted in significant 
seizures of drugs, including cannabis, cocaine, heroin, 
methamphetamine and MDMA (“ecstasy”). In 2009, 
the Governments of Canada and the United States 
signed the Framework Agreement on Integrated  
Cross-Border Maritime Law Enforcement Operations, 
which, after the passing of legislation for its 
implementation, will enable joint law enforcement 
teams to operate along the Canada-United States 
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maritime border, thus facilitating maritime law 
enforcement operations. 
 
 3. National legislation, policy and action 
 
401. Mexico continued to devote considerable effort to 
combating drug trafficking and organized crime. The 
main approaches followed were law enforcement and 
longer-term institutional reforms. Law enforcement 
action resulted in the arrest of a number of leaders of 
cartels in 2009 and 2010. Drug-related arrests, as well 
as extraditions to the United States, reached a 
record-high number in 2009 and continued at a similar 
pace in 2010. At the institutional level, Mexico made 
progress in implementing comprehensive judicial and 
public security reforms. A major goal of the judicial 
reform in Mexico is to make the transition from a 
system of written trials to an adversarial system with 
oral trials by 2016, making trials more expeditious and 
transparent. Although the process has slowed down in 
the country as a whole, several Mexican states have 
made progress towards the implementation of the 
adversarial system. In 2009, a number of leading 
universities incorporated those concepts into their 
curricula. Training programmes in trial advocacy were 
started for judges and prosecutors. Another element is 
the introduction of methods for alternative case 
resolution, such as mediation. Judicial reforms have 
been supported by the development of a national 
prosecutorial case management system. As part of the 
reform of the security sector, the new federal police 
was established, its investigative powers were 
strengthened and vetting and hiring standards 
increased. In 2009, the Government of Mexico 
enhanced the capacity of the customs service by 
recruiting additional staff and providing specialized 
training. Forensic laboratories have been modernized 
to make better use of scientific evidence in the 
prosecution of crimes. Advances have been made in 
intelligence-gathering, such as through the ongoing 
implementation of the information exchange platform 
Plataforma Mexico, which links law enforcement 
agencies, states and municipalities.  
402. Corruption continues to impede efforts to counter 
drug trafficking in Mexico. Police and other law 
enforcement units at the state and municipal levels are 
exposed to threats and offered bribes from  
drug trafficking organizations. The Government of 
Mexico continued to combat corruption among law 
enforcement and government officials, including by 
screening and performing background checks on such 
officials and, when necessary, arranging for their 
dismissal or arrest. 
403. The Government of the United States adopted the 
2010 National Drug Control Strategy. The strategy, 
released in May 2010, was prepared after a  
broad consultation process involving stakeholders; it 
emphasizes a comprehensive evidence-based approach 
to addressing drug-related problems. The main 
elements of the strategy are community-based drug 
abuse prevention, early intervention, the integration of 
treatment for drug abuse into the mainstream health-
care system, innovations in criminal justice, the 
strengthening of law enforcement, international 
cooperation and improving information systems. With 
regard to drug abuse prevention, the strategy focuses 
on developing a community-based prevention system 
mainly for young people, information campaigns  
and increased collaboration involving different 
government levels and agencies. The strategy also 
establishes five-year goals to reduce drug abuse. Those 
goals include: reducing by 15 per cent, drug abuse  
among youth, the number of chronic drug users and 
drug-induced deaths; and reducing by 10 per cent the 
number of cases involving driving under the influence 
of drugs. The Board appreciates the efforts made by the 
Government aimed at ensuring that evidence-based 
measures are taken to address drug-related problems 
and at strengthening treatment and early intervention 
initiatives. 
404. In the United States, disparities in the amounts of 
cocaine and “crack” required for the imposition of 
minimum sentences were reduced significantly by the 
Fair Sentencing Act, signed in August 2010. The Act 
also eliminated the minimum prison term for simple 
possession of “crack” and significantly increased 
monetary penalties for major drug trafficking. 
405. The Government of the United States continued 
to implement the National Southwest Border 
Counternarcotics Strategy, adopted in 2009. The 
strategy requires law enforcement agencies of the 
United States to enhance operational capabilities and 
coordination to address cross-border drug trafficking. 
The United States intensified its law enforcement and 
intelligence operations in the areas near its border with 
Mexico, including by creating an inter-agency border 
law enforcement task force to identify, disrupt and 
dismantle criminal organizations engaged in drug 
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trafficking and related crime, such as arms trafficking 
and bulk cash smuggling. 
406. In the United States, a number of measures are 
being taken to deal with the problem of the abuse of 
prescription drugs containing controlled substances. 
The Government stated that reducing the abuse of 
prescription drugs was one of the areas of focus of the 
national drug control policy in 2010. Steps to address 
the problem include programmes for promoting the 
return and disposal of prescription drugs, informing the 
public of the risks of prescription drug abuse, 
educating physicians about prescribing opiate 
analgesics, addressing the practice of obtaining 
prescriptions for controlled substances from multiple 
physicians (“doctor shopping”), taking action against 
establishments for pain management that have 
inappropriate prescription practices and expanding 
prescription drug monitoring programmes. In 2010,  
40 states had in place programmes for monitoring 
prescription drugs or had passed legislation to 
implement such programmes. 
407. To tackle the problem of prescription drugs being 
sold through illegal Internet pharmacies the 
Government of the United States has introduced 
stronger control, law enforcement and legislative 
measures. One of those measures, the Ryan Haight 
Online Pharmacy Consumer Protection Act of 2008, 
prohibits Internet pharmacies from, inter alia, 
providing prescription drugs to individuals who have 
not had at least one face-to-face evaluation by a 
prescribing medical practitioner. The Food and Drug 
Administration issued in November 2009 warning 
letters to 22 operators of websites identified as having 
illegally sold unapproved or misbranded drugs to 
persons in the United States. These above-mentioned 
measures have contributed to reducing the number of 
illegal Internet pharmacies and will be further 
implemented by the Government.  
408. In addition to the existing federal regulations  
in the United States, restrictions on the retail sale  
of pseudoephedrine products had been adopted in  
45 states by the end of 2009, making pseudoephedrine 
a controlled drug at the state level, imposing point-of-
sale restrictions or introducing laws for tracking 
pseudoephedrine shipments. In Oregon, which in 2006 
became the first state to introduce a law that 
reclassified pseudoephedrine as a prescription drug, 
pseudoephedrine “smurfing”32 has been virtually 
eliminated and a sharp drop in the number of seized 
methamphetamine laboratories has been observed. In 
the light of that experience, Mississippi enacted a 
similar law in 2010 and other states are also 
considering such legislative measures.  
409. The Government of Canada continued to 
implement its National Anti-Drug Strategy, aimed at 
preventing and reducing drug abuse, enhancing the 
treatment of drug abusers and strengthening drug law 
enforcement. A 2010 report evaluating the strategy 
found that it had been implemented largely as intended, 
though some components related to the prevention and 
treatment of drug abuse had experienced delays. As 
Canada is a major source of illicitly manufactured 
synthetic drugs, the Government has decided to make 
countering the illicit manufacture of and trafficking in 
such drugs a national priority. In 2009, the Synthetic 
Drug Initiative, the first Canadian drug control strategy 
to focus on a single class of drugs, was launched as a 
component of the National Anti-Drug Strategy. The 
initiative utilizes a combination of law enforcement, 
deterrence and prevention measures targeting the illicit 
manufacture of synthetic drugs. The initiative is also 
aimed at preventing the diversion of precursor 
chemicals from licit distribution channels in Canada.  
410. In May 2010, the Government of Canada 
introduced in the Senate the Penalties for Organized 
Drug Crime Act. The bill provides a mandatory 
sentence of a minimum of one or two years in jail for a 
number of serious drug-related offences, including 
illicit drug production, trafficking, possession for the 
purposes of trafficking, importing and exporting, and 
possession for the purposes of exporting. The bill also 
provides for additional penalties when such offences 
are committed for the purposes of organized crime or 
when they involve selling drugs to young people.  
 
__________________ 
 32  “Smurfing” is a method used by some traffickers to 
acquire large quantities of a precursor chemical such as 
pseudoephedrine. Individuals purchase the chemical 
from multiple retail locations in quantities at or below 
the legal limit. Traffickers often use several associates in 
“smurfing” operations to increase the speed with which 
the chemical can be acquired. 
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 4. Cultivation, production, manufacture and 
trafficking 
 
  Narcotic drugs 
 
411. In the United States, cannabis continues to be 
illicitly produced on a large scale for the illicit market 
in that country. While there are no reliable estimates of 
the amount of illicitly produced cannabis, law 
enforcement data indicate a continuing high level of 
illicit cultivation of cannabis plants and illicit 
production of cannabis. In 2009, more than 2,000 tons 
of cannabis were seized in the United States, exceeding 
by more than one third the total amount seized in 2008. 
The number of eradicated cannabis plants increased by 
30 per cent to almost 10.4 million, largely as a result of 
the increased eradication of cannabis plants grown 
outdoors. Drug trafficking organizations from outside 
the United States continue to establish and expand sites 
for the illicit cultivation of cannabis plants within the 
United States borders, in order to reduce the risks and 
costs of smuggling cannabis. Criminal groups, in 
particular drug trafficking organizations based in 
Mexico, obtain significant quantities of cannabis from 
sites used for the illicit cultivation of cannabis plants 
on public land. Such growing sites on public land pose 
significant public safety and environmental hazards. 
The illicit cultivation of cannabis plants indoors by 
individuals and criminal groups is expanding partly in 
reaction to intensified efforts to eradicate cannabis 
plants illicitly cultivated outdoors. Those criminal 
groups include Canada-based drug trafficking 
organizations with indoor growing sites mainly in the 
north-western part of the United States. Indoor 
cultivation sites usually offer increased control over 
growing conditions and yield cannabis of a higher 
potency, which could be sold at a higher price. 
412. The Board is concerned that the “medical” 
cannabis programmes in some states of the United 
States and the insufficient control measures applied in 
those programmes have contributed to illicit cultivation 
of cannabis plants and trafficking in cannabis.  
413. The Government of Mexico estimates that the 
illicit production of cannabis declined slightly in 2009, 
to about 19,900 tons, most of which was destined for 
the United States. More than 2,100 tons of cannabis 
herb were seized in Mexico in 2009, an increase of 
about 27 per cent. North America continued to be  
the region in which the most cannabis herb is  
seized. The total area of illicitly cultivated cannabis 
plants eradicated continued to decline in 2009, to 
16,547 ha (a decrease of 11 per cent), partly owing to 
law enforcement units being increasingly involved 
with public security tasks. According to reports from 
the United States, the amount of cannabis seized along 
that country’s border with Mexico increased by 19 per 
cent in 2009, indicating a sustained high flow of 
cannabis from Mexico.  
414. Cannabis remains the main illicit drug produced 
in Canada. In 2009, Canadian law enforcement officers 
seized more than 34 tons of cannabis herb, a slight 
decrease over the figure for 2008. The majority of the 
illicitly produced cannabis in Canada has been 
cultivated indoors, which means that its potency is 
high. In 2008, the average THC level of cannabis 
seized in Canada was 11 per cent. Organized criminal 
groups continue to dominate illicit cannabis production 
in Canada. The Canadian market for cannabis is 
supplied almost entirely by cannabis illicitly-produced 
in Canada. A significant amount of the cannabis 
illicitly produced in Canada continues to be destined 
for the illicit market in the United States. Some 
organized criminal groups smuggle Canadian cannabis 
into the United States in exchange for cocaine and 
other contraband, such as firearms and tobacco. The 
amount of cannabis seized along the border between 
Canada and the United States increased slightly to 
about 3.4 tons in 2009.  
415. Cocaine trafficking in North America continued 
to decline as a result of various factors, including less 
cocaine abuse, decreased illicit cocaine manufacture in 
Colombia and sustained pressure on drug trafficking 
organizations in Mexico. Consequently, less cocaine 
was seized in Mexico (21.6 tons) and the United States 
(108.3 tons) (including at its border with Mexico  
(20.5 tons)) in 2009 than in previous years. Cocaine 
shortages persisted in many areas of the United States 
in 2009, as evidenced by higher prices and lower purity 
levels. Criminal groups are smuggling cocaine into 
Canada, mainly through Mexico and the United States, 
to be sold on the illicit market in Canada or shipped 
overseas. Thus, Canada is increasingly being used as a 
transit country for cocaine. Disruptions in cocaine 
trafficking in the region resulted in the decreased 
availability and increased prices of cocaine in major 
urban centres across Canada. 
416. Most of the heroin in the United States originates 
in Colombia or Mexico. Law enforcement reports 
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indicate that Mexican drug trafficking organizations 
have gained a more significant share of the heroin 
market in the United States at the expense of South 
American criminal groups. In addition to South 
American heroin being trafficked and distributed in 
greater quantities, there are some indications that 
“white heroin” (heroin with a higher purity level) is 
being illicitly manufactured in Mexico and that a 
mixture of both Mexican and South American heroin is 
being distributed. Mexico is the world’s third largest 
source of illicitly produced opium. The total area of 
illicitly cultivated opium poppy eradicated in Mexico 
increased from 13,095 ha in 2008 to 14,753 ha in 2009. 
The Government of Mexico also reported an increase 
in the illicit production of opium. Increased illicit 
heroin manufacture in Mexico and the increased 
involvement of Mexican criminal groups in trafficking 
in drugs from South America resulted in an increased 
amount of heroin being seized along the south-west 
border of the United States. Heroin continues to be 
widely available in the United States. In some areas of 
the United States, the availability of heroin is 
increasing, as evidenced by high purity levels and low 
prices.  
417. The heroin on the illicit market in Canada 
continues to be predominately from South-West Asia. 
Law enforcement agencies in Canada seized a total of 
213 kg of heroin in 2009. Most of the seized heroin 
had been smuggled into the country by post or by air or 
sea. 
418. In the United States, the illegal distribution  
of prescription drugs containing internationally 
controlled substances continues to increase. The 
prescription drugs involved are primarily opioid pain 
relievers containing codeine, fentanyl, hydromorphone, 
morphine, oxycodone, dextropropoxyphene, methadone 
or hydrocodone. From 2007 to 2009, the percentage of 
state and local law enforcement agencies reporting that 
problems related to prescription drugs posed the 
greatest drug-related threat to their areas more than 
doubled. Establishments involved in pain management 
have become a major source of the controlled 
prescription drugs used by drug abusers. According to 
the Government of the United States, so-called “pain 
clinics” are in some states operating outside the scope 
of acceptable medical practices and dispensing or 
prescribing large quantities of prescription opioids to 
persons with no legitimate need for such drugs. Those 
establishments have been identified as a significant 
source of the prescription opioids distributed in 
numerous states that have programmes for monitoring 
the distribution of prescription drugs. Obtaining 
prescription drugs by “doctor shopping” has decreased 
in states that have implemented such monitoring 
programmes but has continued in states without such 
programmes. 
 
  Psychotropic substances 
 
419. In spite of regulatory measures taken by 
Governments, the illicit manufacture of 
methamphetamine has increased in North American 
countries. In Mexico, the illicit manufacture of 
methamphetamine was disrupted in 2007 and 2008 as a 
result of the ban on precursors of methamphetamine 
that had been introduced by the Government. Then, 
however, drug trafficking organizations adapted to the 
new regulations. As a result, the illicit manufacture of 
methamphetamine in Mexico, the main supplier of the 
methamphetamine abused in the United States, 
resurged in 2009. That development was reflected in 
the sharp increase in the total amount of 
methamphetamine seized in Mexico (from about  
300 kg in 2008 to more than 6 tons in 2009) and in the 
number of clandestine methamphetamine laboratories 
uncovered in the country (21 laboratories in 2008 
compared with 191 in 2009).  
420. The increasing manufacture of methamphetamine 
in Mexico resulted in a greater flow of 
methamphetamine to the United States, as reflected in 
an increase in the total amount of methamphetamine 
seized along the south-west border of the United States 
(from 2.2 tons in 2008 to about 3.5 tons in 2009). In 
the United States sustained illicit manufacture of 
methamphetamine also contributed to the increased 
availability of the substance on the illicit market. In 
2009, the total amount of methamphetamine seized in 
the United States increased slightly to about 6.6 tons, 
while the number of clandestine laboratories uncovered 
increased to 4,571 (compared with 3,931 in 2008). The 
increase in the illicit manufacture of methamphetamine 
in the United States was primarily accounted for by 
laboratories manufacturing the substance on a small 
scale in several states. 
421. Methamphetamine illicitly manufactured in 
Canada accounts for a significant share of the 
methamphetamine found on illicit markets in other 
countries. The illicit manufacture of methamphetamine 
Chapter III. Analysis of the world situation
 
 69 
 
in Canada has risen to meet the illicit demand for the 
substance. In Canada, methamphetamine is illicitly 
manufactured mainly by organized criminal groups on 
a large scale in clandestine laboratories. The number of 
clandestine methamphetamine laboratories uncovered 
in Canada rose to 23 in 2009, more than doubling the 
figure for 2008. Almost all of the methamphetamine 
found on the illicit market in Canada has been illicitly 
manufactured in that country. While the smuggling of 
methamphetamine from Canada into the United States 
remained limited, a significant amount of 
methamphetamine was smuggled into countries in East 
and South-East Asia, especially Japan, and in Oceania, 
especially Australia. In recent years, methamphetamine 
has increasingly been found in tablets sold as MDMA 
(“ecstasy”) on the illicit market in Canada. 
422. Canada continues to be a major source of MDMA 
(“ecstasy”) found on the illicit markets of countries in 
North America and other regions. Organized criminal 
groups in Canada are illicitly manufacturing and 
distributing methamphetamine on a large scale. 
MDMA has continued to be widely available in 
Canada. Large quantities of MDMA illicitly 
manufactured in Canada were smuggled mainly into 
the United States and countries in East and South-East 
Asia and in Oceania. In the United States, as the illicit 
supply of MDMA increased, MDMA accounted for a 
larger share of the illicit drugs sold by street gangs. In 
“ecstasy” tablets originating in Canada the percentage 
of MDMA has decreased and the percentage of 
chemicals used as adulterants has increased. That 
development may have significant health implications 
for “ecstasy” abusers. 
 
  Precursors 
 
423. In Mexico, after a ban was placed on 
pseudoephedrine and ephedrine, prohibiting their 
import and use, drug trafficking organizations 
developed various ways to circumvent the ban. They 
used new smuggling routes such as through Central 
America and South America, they smuggled precursors 
in tablet form rather than in bulk, they shifted their 
illicit manufacturing operations to other countries and 
they used alternative manufacturing methods that 
required chemicals for which controls were less  
strict or non-existent. One of those methods for 
manufacturing methamphetamine without using 
ephedrine is the P-2-P method, which has become 
significantly more important. Phenylacetic acid, a 
chemical used to produce P-2-P, was found in 
clandestine methamphetamine laboratories in Mexico. 
Operation PILA, which was initiated in 2009, and 
coordinated by the Board, focused on monitoring  
trade in ephedrine and pseudoephedrine, including 
pharmaceutical preparations containing one of those 
chemicals. Analysis of the relevant data and seizures 
revealed that Mexico was the destination of many 
suspect ephedrine and pseudoephedrine shipments.33  
424. In the United States, the increase in illicit 
methamphetamine manufacture in 2008 and 2009 was 
fuelled primarily by individuals and criminal groups 
that organized “smurfing” operations to acquire large 
amounts of the precursor chemical pseudoephedrine.  
425. Canada continues to be used by traffickers as 
both a country of destination and a transit country for 
chemicals used in the illicit manufacture of synthetic 
drugs, particularly methamphetamine and MDMA 
(“ecstasy”).  
 
  Substances not under international control 
 
426. Khat continues to be smuggled into Canada, 
primarily by courier and air cargo. The abuse of khat is 
most common among East African communities in 
Canada. Most of the khat found in Canada comes from 
Ethiopia or Kenya. In 2009, the total amount of khat 
seized by law enforcement agencies throughout Canada 
decreased compared with the previous year, to about  
19 tons. 
427. According to Canadian law enforcement reports, 
there has been an increase in the demand for 
unregulated chemicals such as methylamine. 
 
 5. Abuse and treatment 
 
428. In the United States, an estimated 38 million 
persons (or 15.1 per cent of the population aged 12 or 
older) had used illicit drugs in 2009. That represents an 
increase of 2.5 million persons (or 0.9 per cent of the 
population aged 12 or older) over the figure for 2008 
and a reversal of the declining trend in illicit drug use 
in the preceding years. About 21.8 million persons (or 
8.7 per cent of the population aged 12 or older) were 
__________________ 
 33  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2010 …  
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“current users” (persons who reported having used 
illicit drugs in the past month). 
429. In the United States, one matter of concern is  
the increasing abuse among youth of cannabis and 
prescription drugs containing narcotic drugs. 
According to the 2009 survey “Monitoring the Future 
2009”, an annual survey on drug abuse among students 
aged 13-18 in the United States, annual prevalence 
of cannabis abuse increased for the first time  
after declining for seven consecutive years: from  
21.5 per cent in 2008 to 22.9 per cent in 2009. That 
turnaround was accompanied by a decline in students’ 
perceptions of the risks of cannabis abuse. The abuse 
of OxyContin (annual prevalence: 3.9 per cent), a 
product containing oxycodone, and Vicodin (annual 
prevalence: 6.5 per cent),34 a product containing 
hydrocodone, reached or remained at record-high 
levels in 2009. The abuse of other illicit drugs either 
declined (as in the case of cocaine, inhalants and 
hallucinogens) or remained fairly stable (as in the case 
of heroin, amphetamines and tranquillizers). 
430. In the United States, the number of drug-related 
deaths35 doubled from 1999 to 2007. According to  
the latest statistics available, there were a total of 
38,371 drug-related deaths in 2007. In a number of 
states, the number of drug-related deaths has surpassed 
the number of deaths resulting from motor vehicle 
accidents.  
431. In the United States, cannabis remains the most 
commonly abused drug. In 2009, 28.5 million persons 
(or 11.3 per cent of the population aged 12 or above) 
abused cannabis. That represents an increase of  
2.7 million persons (or 1 per cent of the population 
aged 12 or above) compared with the figure for 2008. 
432. In 2009, 4.8 million persons abused some form  
of cocaine in the United States (compared with  
5.3 million in 2008). Past-year prevalence of the abuse 
of cocaine (including “crack”) among the United States 
population aged 12 and older was 1.9 per cent.  
__________________ 
 34  The prevalence data for those preparations are queried in 
the “Monitoring the Future” questionnaire; therefore, 
trade names are used in this particular case. 
 35  Drug-related deaths include deaths resulting from drug-
induced diseases, accidental poisoning and intentional 
self-poisoning (suicide) but exclude accidents, 
homicides and other causes indirectly related to drug 
use. 
433. The increased availability of heroin in the  
United States has led to increased heroin abuse and, 
consequently, an increase in the number of heroin-
related overdoses and deaths resulting from overdose. 
In 2009, the number of heroin abusers increased by 
about one third, to over 600,000 (or 0.2 per cent of the 
population aged 12 and older). Abusers of prescription 
opioids reportedly switch to heroin because they build 
tolerance to prescription opioids and because heroin is 
cheaper and more easily available than prescription 
opioids. 
434. The abuse of methamphetamine increased in the 
United States: in 2009, 0.5 per cent of the population 
aged 12 and older were past-year abusers, compared 
with 0.3 per cent in 2008. 
435. According to the assessment of the Government 
of the United States, the abuse of prescription drugs is 
the fastest-growing drug problem in the country. In 
2009, the abuse of prescription drugs — measured as 
non-medical use of pain relievers, tranquillizers, 
stimulants or sedatives — was reported by 16 million 
persons (or 6.4 per cent of the population aged 12 and 
above), compared with 15.2 million (or 6.1 per cent of 
the population) in 2008. About 7 million persons were 
“current users”. Pain relievers were the most 
commonly abused prescription drugs: 12.4 million 
persons reported having abused pain relievers in 2009 
(compared with 11.9 million in 2008). More and more 
opiate-related overdoses are attributable to prescription 
analgesics. The number of unintentional deaths by 
overdose resulting from the abuse of prescription 
opioids has increased sharply. The number of drug-
related emergency room visits involving narcotic 
analgesics more than doubled from 2004 to 2008, 
mainly as a result of incidents involving the abuse of 
hydrocodone, methadone and oxycodone. Prescription 
drugs continued to be one of the most abused 
categories of drugs — second only to cannabis. 
436. According to the latest Canadian Alcohol and 
Drug Use Monitoring Survey, the abuse of most drugs 
among members of the population aged 15 and  
older declined in 2009, which is an encouraging 
development. The prevalence of past-year cannabis 
abuse continued to decrease, reaching 10.6 per cent  
in 2009. Annual prevalence of abuse of cocaine  
(1.2 per cent), methamphetamine (0.4 per cent) and 
MDMA (“ecstasy”) (0.9 per cent) also decreased 
compared with 2008. The rate of drug abuse among 
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males was almost double the rate among females. The 
abuse of prescription drugs (opioid pain relievers, 
stimulants, and sedatives and tranquillizers) in 2009 
remained at the level reported in 2008: 0.6 per cent of 
respondents indicated that they had used prescription 
drugs in the past year “to get high”. 
437. In Canada, drug abuse among youth (persons  
15-24 years old) declined in 2009. The Canadian 
Alcohol and Drug Use Monitoring Survey  
showed declining past-year abuse of cannabis (from 
32.7 per cent in 2008 to 26.3 per cent in 2009), cocaine 
(from 5.9 per cent in 2008 to 3 per cent in 2009), 
hallucinogens (from 10.2 per cent in 2008 to  
4.4 per cent in 2009), MDMA (“ecstasy”) (from  
6.5 per cent in 2008 to 3.6 per cent in 2009) and 
prescription drugs (from 2.1 per cent in 2008 to  
1.7 per cent in 2009). Cannabis abuse declined by 
almost 30 per cent during the five-year period 2004-
2009. The abuse of one type of prescription drugs, pain 
relievers, increased. Despite the overall positive 
development, the rate of drug abuse among youth 
remained 4-5 times higher than the rate among adults 
(persons aged 25 and older). 
438. In Mexico, a national survey showed that from 
2002 to 2008 there was a significant increase in the 
abuse of drugs, in particular cocaine. According  
to Government estimates, the abuse of cocaine, 
particularly “crack”, continued to increase sharply in 
2009. Most drug-related deaths were attributed to the 
abuse of cocaine (449 deaths in 2009, an increase of  
90 per cent over 2008). There was also a sharp increase 
in the abuse of heroin, methamphetamine, 
hallucinogens, solvents and inhalants. The most 
commonly abused drug continued to be cannabis, 
followed by cocaine. One reason for the increased 
abuse of drugs is that drug trafficking has resulted in 
drugs being more widely available in the country.  
439. In the United States, about 1.2 million persons 
were admitted for treatment of drug abuse in 2008,  
9 per cent more than in 2007. For most of those 
persons the primary drug of abuse was cannabis 
(346,000 persons in 2008, an increase of 20 per cent), 
followed by heroin (281,000), cocaine (230,000), 
amphetamines (127,000) and other opiates (121,000). 
The growing problem of abuse of prescription drugs is 
also reflected in data on persons admitted to treatment 
for drug abuse. Among the persons admitted for 
treatment and for whom medication-assisted opioid 
therapy was planned, the number of persons treated for 
the abuse of pain relievers more than tripled from 1998 
to 2008, reaching 26.5 per cent. According to the 
Government, 1,132 treatment facilities in the United 
States offered opioid treatment programmes in 2008, 
mostly maintenance programmes using methadone 
and/or buprenorphine. It is estimated that there is a 
significant treatment gap in the United States: in other 
words, the vast majority of drug addicts do not receive 
special treatment. According to the Government, that is 
partly attributable to the fact that there is no integration 
of treatment for drug addiction with the rest of the 
health-care system. As part of its drug control strategy, 
the Government therefore intends to better integrate 
treatment into health care, making treatment services 
more accessible and improving their quality. The 
Government also aims to support recovery from drug 
addiction through services involving, for example, 
transitional housing, mutual help groups, counselling 
and employment restoration.  
440. In the United States, the number of drug 
treatment courts has continued to increase. At the end 
of 2009, 2,459 drug treatment courts were operating 
throughout the country. More than half of them were 
for adults. In addition, there was a significant number 
of specialized drug treatment courts, including 
juvenile, family, tribal, campus or veterans’ drug 
treatment courts. Evaluations conducted by the 
Government, as well as by researchers, have shown 
that, compared with traditional courts that lead to 
traditional forms of punishment such as incarceration, 
drug treatment courts are more successful in reducing 
recidivism among drug-abusing offenders and more 
cost-effective in the long run. 
441. The Government of Canada is enhancing the 
national system for the treatment of drug abuse within 
the framework of the National Anti-Drug Strategy. The 
Drug Treatment Funding Program was launched to 
support provinces and territories in strengthening their 
systems for the treatment of drug abuse. Targeted 
treatment for imprisoned drug abusers is offered in the 
correctional system, significantly reducing recidivism.  
442. The action programme for the prevention and 
treatment of addictions was launched by the 
Government of Mexico to strengthen the infrastructure 
for providing treatment services for drug addicts. The 
community-based network of centres offering basic 
treatment and prevention services for drug abusers was 
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expanded further. In 2009, most persons received 
treatment for abuse of cannabis, followed by cocaine 
and inhalants. In 2009, about 39,000 persons began 
receiving treatment for drug abuse in specialized 
centres; that represented only a small proportion of the 
drug addicts in the country. A project to train and 
accredit providers of treatment for drug abuse was 
started in 2009, with a view to improving the 
functioning and running of treatment facilities.  
 
 
  South America 
 
 
 1. Major developments 
 
443. Trends related to the illicit manufacture of, 
trafficking in and abuse of drugs have changed in 
South America over the past decade. Criminal 
organizations that have traditionally been involved in 
drug trafficking at the international level have also 
started to engage in drug trafficking and other forms of 
drug-related crime at the national level. The 
availability of a greater variety of illicit drugs and the 
increase in the abuse of those drugs, in particular 
among youth, indicate that the illicit drug market 
continues to change. CICAD has warned of the 
growing influence of cartels in politics and of the 
threat that those cartels pose to security and 
development in the Americas.  
444. In 2009, the total area under illicit coca bush 
cultivation in South America decreased for a second 
consecutive year, as a result of a significant reduction 
of that area in such cultivation in Colombia. The total 
area under coca bush cultivation in the region in 2009 
was 158,800 ha, 8,800 ha less than in 2008 (a decrease 
of 5 per cent). The Board is pleased to note that in 
2009, the total area under illicit coca bush cultivation 
in Colombia decreased by 16 per cent, to 68,000 ha. In 
contrast with the situation in Colombia, the total area 
under illicit coca bush cultivation increased to 
30,900 ha in the Plurinational State of Bolivia (an 
increase of 1 per cent) and to 59,900 ha in Peru (an 
increase of 7 per cent), in 2009, the fourth consecutive 
year in which such cultivation increased in those two 
countries.  
445. In South America, over the years, there has been 
a tendency for illicit drug crop cultivation to move to 
new areas in response to local eradication campaigns. 
Thus, the decrease in illicit coca bush cultivation in 
Colombia in the past decade has been partly 
compensated for by an increase in such cultivation on 
Bolivian and Peruvian territory. The Board is 
concerned that if the current trend continues, in the 
period 2010-2011, Peru will replace Colombia as the 
world’s largest grower of illicit coca bush, a position 
last held by Peru in 1996.  
446. For a number of years, UNODC has estimated the 
potential manufacture of cocaine for the main coca leaf 
producing countries with a view to providing 
information on the global supply of cocaine. That 
estimation of potential manufacture takes into account 
several factors, including data on coca leaf production 
and efficiency in the transformation of coca leaf to 
cocaine. The Board notes that because of the ongoing 
review of conversion factors used for estimation in 
Bolivia (Plurinational State of) and Peru, no single 
estimated figure was provided for those two countries 
for 2009; instead, UNODC calculated an estimate of 
global potential manufacture of cocaine as a range 
(842-1,111 tons). In Colombia, potential illicit 
manufacture of cocaine in 2009 was estimated at  
410 tons, 40 tons less than in 2008. 
447. In some South American countries, financial 
resources in support of efforts to address drug-related 
problems continue to be insufficient. The Board calls 
upon the international community to enhance 
assistance, including expertise and financial resources, 
provided to countries in South America to overcome 
the problems of illicit drug crop cultivation and 
cocaine manufacture. The Board urges the 
Governments of Bolivia (Plurinational State of) and 
Peru to take the measures necessary to reduce the total 
area under illicit coca bush cultivation on their territory 
and to counter illicit cocaine manufacture and 
trafficking, in cooperation with the Governments of 
other countries and international organizations, 
including United Nations entities.  
448. The abuse of cocaine appears to be rising in 
several countries in the Southern Cone, including 
Argentina, Brazil, Chile and Uruguay. According to 
CICAD experts on demand reduction, although some 
progress has been made in the Americas in improving 
treatment for drug abuse over the past 20 years, the 
demand for such treatment is not being met. The  
Board encourages Governments of countries in  
South America to continue to give high priority to 
treatment for drug abuse when developing national 
Chapter III. Analysis of the world situation
 
 73 
 
drug control policies and to include such treatment in 
their national health-care systems. 
 
 2. Regional cooperation 
 
449. The Nineteenth Meeting of Heads of National 
Drug Law Enforcement Agencies, Latin America and 
the Caribbean, was held on Isla Margarita, Bolivarian 
Republic of Venezuela, from 28 September to  
2 October 2009. Pursuant to Commission on Narcotic 
Drugs resolution 52/10, representatives of 10 West 
African States also participated in the Meeting, and a 
round-table discussion was held on strengthening 
cooperation among bodies involved in tackling the 
smuggling of drugs from Latin America and the 
Caribbean into West Africa. The Meeting made 
recommendations on, inter alia, the need to pay 
attention to the collection and exchange of intelligence, 
training, joint operations, the placement of liaison 
officers, the provision of equipment, and technical 
support. It also recommended that bilateral or 
multilateral cooperation agreements be established and 
that confidence-building measures be developed. The 
participants agreed that the implementation of those 
recommendations should be supported by UNODC, 
ECOWAS and INTERPOL.  
450. In December 2009, the European Commission 
approved the Cooperation Programme between Latin 
America and the European Union on Anti-Drugs 
Policies. In the framework of the Cooperation 
Programme, efforts will be made to consolidate drug 
control coordination and cooperation mechanisms 
between the European Union and Latin America 
through policy support and dialogue, the consolidation 
of national observatories on drugs and capacity-
building in reducing illicit drug supply and demand. 
451. Under an interregional programme of the 
European Union and UNODC, a high-level meeting of 
heads of drug law enforcement agencies in West Africa 
and Latin America and the Caribbean was held in 
Bogota from 25 to 27 January 2010 to promote 
agreements on joint investigations. Twenty-four 
bilateral agreements were signed by six West African 
States (Cape Verde, Gambia, Ghana, Guinea-Bissau, 
Sierra Leone and Togo) and four Latin American and 
Caribbean States (Colombia, Dominican Republic, 
Jamaica and Peru). 
452. To exchange experiences with regard to the 
control of precursors and the negative environmental 
impact of disposing of residues from the illicit 
manufacture of synthetic drugs, experts from Bolivia 
(Plurinational State of), Colombia, Ecuador and Peru 
held a meeting in Lima on 16 February 2010 in the 
framework of a project funded by the European 
Commission entitled “Support for the Andean 
Community in the area of synthetic drugs” 
(DROSICAN). At the meeting, the experts stressed the 
importance of cooperating with the academic 
community, in particular universities, in efforts to 
address the problem.  
453. In 2009, the Union of South American Nations 
(UNASUR) established the Consejo Sudamericano de 
Lucha Contra el Narcotráfico (South American council 
for the fight against drug trafficking). In April 2010, 
ministers of the countries concerned ratified the 
council’s statute, which provides a legal framework for 
a concerted approach to fighting drug-related problems 
and for UNASUR drug control activities in that area.  
454. Participants in the Twelfth United Nations 
Congress on Crime Prevention and Criminal Justice, 
held in Salvador, Brazil, from 12 to 19 April 2010, 
adopted the Salvador Declaration on Comprehensive 
Strategies for Global Challenges: Crime Prevention 
and Criminal Justice Systems and Their Development 
in a Changing World,36 in which concern was 
expressed about the negative impact of organized 
crime on human rights, the rule of law, security and 
development. A workshop on the links between drug 
trafficking and other forms of organized crime was 
organized in the framework of the Congress with a 
view to strengthening the role of the United Nations, 
promoting good practices, training and capacity-
building and facilitating the efforts of Member States 
to prevent and control such trafficking.  
455. In April 2010, the Madrid Declaration was 
adopted at the twelfth high-level meeting of the 
Coordination and Cooperation Mechanism on Drugs 
between the European Union and Latin America and 
the Caribbean. The Declaration stresses, among other 
things, the importance of cooperation on alternative 
development in regions where crops are cultivated for 
use in the illicit manufacture of drugs.  
456. According to a CICAD study entitled 
Establishing Drug Treatment Courts: Strategies, 
Experiences and Preliminary Outcomes, published in 
__________________ 
 36  A/CONF.213/18, chap. I, resolution 1. 
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April 2010, drug treatment courts contribute 
significantly to reducing recidivism among drug-
dependent offenders and help to reduce crime at the 
local level. The study was developed in the framework 
of the EU-LAC Drug Treatment City Partnerships 
initiative and is based on a survey of drug treatment 
courts in 12 countries in Europe and the Americas, 
including Brazil, Chile and Suriname.  
457. On 19 and 20 May 2010, the Brazilian Federal 
Police, in partnership with UNODC, organized an 
international seminar on the interception of telephone 
and long-distance computerized communications. 
Experts from eight countries (Brazil, Canada, 
Colombia, France, New Zealand, Portugal, the  
United States and the United Kingdom) participated in 
the seminar, which was held in Brasilia, Brazil. The 
discussion focused on investigative techniques, 
legislative frameworks and changes to such 
frameworks, and cross-border cooperation to 
strengthen the capacity of law enforcement and the 
judiciary. 
458. In June 2010, the Government of Peru, in 
cooperation with the European Commission and 
UNODC, hosted in Lima an international precursor 
control symposium organized in the framework of a 
regional programme entitled “Prevention of the 
diversion of drug precursors in the Latin American and 
Caribbean region”. At the symposium, representatives 
from 15 countries in Europe and Latin America and the 
Caribbean agreed to strengthen controls over precursor 
chemicals in order to prevent them from being diverted 
and used in illicit drug manufacture. The topics 
discussed by national experts included cooperation 
with the private sector in the area of precursor control. 
459. Experts from 11 countries and several 
international organizations participated in the joint 
meeting of the task forces of Project Prism and Project 
Cohesion held in Bogota in June 2010. The meeting 
was organized to evaluate the projects’ earlier activities 
(Operation PILA and the second phase of Operation 
Dice), which had focused on monitoring the trade in 
and exchanging information on precursors used in the 
illicit manufacture of amphetamine-type stimulants and 
heroin, respectively. The experts proposed future 
operational activities under Project Prism and Project 
Cohesion and strategies to prevent the diversion of 
precursors.  
460. In July 2010, the Government of Colombia, in 
cooperation with UNODC, hosted a seminar on drugs 
and HIV in Colombia that was attended by national and 
international experts from Canada, Colombia, France, 
Spain, the United States and Uruguay. Attention was 
drawn to the relationship between drug abuse, 
especially the abuse of drugs by injection, and 
practices that increase the risk of HIV infection.  
461. Although cocaine continued to be smuggled by 
air out of a number of countries in South America, 
according to the World Customs Organization, airport 
authorities in South America, Africa and Europe  
had only recently begun to exchange operational 
information. The Airport Communication Project 
(AIRCOP), jointly developed by UNODC, the World 
Customs Organization and INTERPOL, will focus on 
strengthening border controls and management and on 
sharing intelligence among participating international 
airports in Africa and Latin America and the 
Caribbean. The Board encourages the Governments 
concerned to further strengthen such interregional 
cooperation within the framework of shared 
responsibility. 
462. UNODC, the Inter-American Observatory on 
Drugs of CICAD and the national drug control 
commissions of Argentina, Bolivia (Plurinational State 
of), Chile, Ecuador, Peru and Uruguay jointly 
published in 2010 the second comparative analysis 
of drug use among students in secondary schools. 
In addition, under project DROSICAN, Bolivia 
(Plurinational State of), Colombia, Ecuador and Peru 
conducted, from January to November 2009, an 
epidemiological study on the use of synthetic drugs 
among the university population in the Andean 
subregion.37  
463. Brazil, Colombia, Haiti, Nicaragua and Peru are 
participating in a global project entitled “Partnership 
for action on comprehensive treatment: treating drug 
dependence and its health consequences”. The project 
activities, which are supported by UNODC, include 
promoting a sound understanding of drug dependence 
and its treatment. 
464. Several countries in South America have signed 
bilateral agreements for enhancing cooperation in the 
area of drug control. In 2010, the National Anti-Drug 
__________________ 
 37  Available from 
www.comunidadandina.org/public/Estudio_drogas.pdf. 
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Secretariat (SENAD) of Paraguay and the National 
Commission for Development and a Drug-Free 
Lifestyle (DEVIDA) of Peru signed an agreement to 
enhance the cooperation of institutions in initiatives for 
preventing drug abuse and trafficking. Ecuador  
and Venezuela (Bolivarian Republic of) concluded a 
cooperation agreement to foster cooperation in the 
prevention and treatment of drug abuse, the 
rehabilitation and social reintegration of drug abusers 
and alternative development. Bolivia (Plurinational 
State of) and Brazil concluded a partnership agreement 
to enhance cooperation between police authorities 
involved in combating drug trafficking and 
transnational organized crime. 
 
 3. National legislation, policy and action 
 
465. In December 2009, the Argentine authorities 
published a national study on the use of psychoactive 
substances and the connection between the use of such 
substances and the commission of crime among the 
prison population. The study, the first of its kind in 
Argentina, concludes that alcohol and drug use and 
criminal behaviour are related to social, cultural and 
economic changes that have occurred in that country in 
recent decades. The study also found that illicit drug 
use was significantly higher among the prison 
population than among the general population.  
466. The Bolivian national council for the fight 
against drug trafficking (CONALTID), with the 
support of UNODC through its project on 
strengthening the fight against drug trafficking and 
related crimes in the Plurinational State of Bolivia, has 
assessed the country’s national strategy to fight drug 
trafficking and re-evaluate the coca leaf (covering the 
period 2007-2010). With the participation of public and 
private institutions, and international and civil society 
organizations, CONALTID is formulating a national 
plan for the prevention and treatment of drug abuse and 
the social reintegration of drug addicts, as well as a 
new national policy to fight drug trafficking (covering 
the period 2011-2015).  
467. In September 2010, the Supreme Court of Brazil 
ruled that failure to consider non-custodial sentences 
for individuals found guilty of small-scale drug-dealing 
offences would violate the Constitution. The 
Government of Brazil has made significant investments 
in technology to support the monitoring of illicit drug 
crops in the country and in activities of the Federal 
Police to counter drug trafficking.  
468. In December 2009, the Colombian Congress 
amended the Constitution to prohibit the possession 
and use of drugs for purposes other than medical 
purposes, thereby reversing the Constitutional  
Court ruling that the punishment for possession of  
illicit drugs for personal use was unconstitutional.38 In 
April 2010, the Government of Colombia launched a 
new campaign entitled “Colombia, a drug-free 
territory”, sponsored by the National Narcotics 
Directorate (DNE), the Ministry of the Interior and 
Justice and UNODC.  
469. In 2009, the Government of Chile approved  
the national drug control strategy for the period 2009-
2018. In the strategy, the role of the family in 
preventing drug abuse and alcohol consumption among 
children and youth is acknowledged. The Government 
also approved measures and activities, contained in its 
action plan for the period 2009-2013 and designed to 
achieve the goals of the strategy.  
470. In April 2010, DEVIDA published a catalogue of 
best practices in the prevention and treatment of drug 
abuse with the aim of sharing information among 
professionals on relevant programmes and projects 
carried out in Peru. In addition, DEVIDA has promoted 
an initiative aimed at preventing drug traffickers from 
gaining political influence in the country. As a result of 
the initiative, a number of political parties in Peru  
have committed themselves to transparency and the 
establishment of rigorous procedures for the selection 
of candidates for elections to be held in 2011.  
471. The Bolivarian Republic of Venezuela continued 
to implement its national drug control plan covering 
the period 2009-2013 and the national plan for drug 
abuse prevention entitled “Sowing values for life”. 
Measures to counter drug trafficking that have been 
implemented in the country include the installation of a 
radar network for defending the country’s airspace 
from drug traffickers, the installation of body scanners 
at the country’s international airports and the building 
of facilities for incinerating illicit drugs.  
 
__________________ 
 38  Article 49 of the Constitution states that the possession 
and consumption of narcotic drugs and psychotropic 
substances are prohibited, with the exception of medical 
prescriptions. 
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 4. Cultivation, production, manufacture and 
trafficking 
 
  Narcotic drugs 
 
472. Although cannabis plants are illicitly cultivated in 
most countries in South America, information on the 
areas under illicit crop cultivation is too scattered and 
scarce for a comprehensive analysis of trends in such 
cultivation to be carried out. Paraguay continues to be 
the main South American country used for illicit 
cannabis production. According to figures for 2008, 
illicitly cultivated cannabis plants covered about  
6,000 ha in Paraguay, in an area close to the Brazilian 
border (potential yield: 16,500 tons of cannabis herb). 
In 2009, the Paraguayan law enforcement authorities, 
in cooperation with their Brazilian counterparts, 
eradicated over 2,000 ha of cannabis plants. In the 
same year, the total amount of cannabis herb seized in 
Paraguay decreased by more than one half, to 85.4 tons 
(compared with 173.4 tons in 2008). UNODC 
estimates that about 80 per cent of the cannabis found 
in Brazil originates in Paraguay. 
473. In 2009, the Colombian drug observatory 
estimated that illicitly cultivated cannabis plants 
covered about 210 ha of the country’s territory. In 
2009, about 170 ha of illicitly cultivated cannabis 
plants were eradicated in the country. The Venezuelan 
authorities did not identify any illicit cultivation of 
cannabis plants in their country. In the Bolivarian 
Republic of Venezuela, the amount of seized 
Colombian cannabis increased from 20.7 tons in 2008 
to 32.6 tons in 2009. Cannabis is the only drug illicitly 
produced in Chile. The amount of cannabis herb seized 
in Chile increased gradually from 5 tons in 2005 to 
nearly 14 tons in 2009.  
474. The extent of the indoor cultivation of cannabis 
plants in South America is not known. According to 
UNODC, Argentina is the only country in the region 
that reported the illicit cultivation of cannabis plants 
indoors.  
475. In Colombia, the authorities seized 209 tons of 
cannabis herb in 2009; from 2006 to 2009, Colombian 
authorities seized on average 189 tons of cannabis  
herb per year. In the Plurinational State of Bolivia, 
seizures of cannabis plants and cannabis herb rose 
from 424 tons in 2007 to 1,964 tons in 2009. From 
2008 to 2009, the amount of cannabis plants seized in 
Peru increased from 61 to 137.5 tons, the largest 
amount seized since 2000.  
476. In 2009, the total area under illicit coca bush 
cultivation in South America decreased by 5 per cent, 
to 158,800 ha (compared with 167,600 ha in 2008). 
Colombia accounted for 43 per cent of that total 
(68,000 ha); it was followed by Peru (59,900 ha or  
38 per cent) and the Plurinational State of Bolivia 
(30,900 ha or 19 per cent). Illicit coca bush cultivation 
on sites covering less than 25 ha was reported in 
Ecuador.  
477. In South America, illicitly cultivated coca bush is 
eradicated manually or by aerial spraying.  
478. In Colombia, 60,500 ha of illicit coca bush 
cultivation were eradicated manually and an additional 
104,800 ha were subject to cumulative aerial spraying 
in 2009 (a total of 165,300 ha). In 2009, the Peruvian 
authorities eradicated 10,025 ha of illicit coca bush 
cultivation, the smallest area eradicated in the country 
since 2003. In 2009, Bolivian authorities eradicated 
6,300 ha of illicit coca bush cultivation (16 per cent 
more than in 2008), mostly in the Tropics of 
Cochabamba region.  
479. According to UNODC, between 2005 and 2008 
the global cocaine interception rate exceeded  
the annual benchmark of 40 per cent. In 2008,  
123 countries reported having seized a total of 360 tons 
of cocaine (amount adjusted for purity), thus 
contributing to a reduction in the potential availability 
of that drug (from 865 to about 500 tons).  
480. From 2008 to 2009, the total amount of seized 
cocaine increased in Paraguay (to 0.6 tons, an increase 
of 114 per cent) and Ecuador (from 15.7 to 53.4 tons, 
an increase of more than 300 per cent). The total 
amount of seized cocaine decreased in Bolivia 
(Plurinational State of) (to 4.9 tons, a decrease of  
32 per cent), Chile (to 2.7 tons, a decrease of  
10 per cent), Peru (to 10.7 tons, a decrease of  
36 per cent) and Venezuela (Bolivarian Republic of) 
(to 27.7 tons, a decrease of 17 per cent). In Brazil, a 
total of 20 tons of cocaine were seized in 2009, an 
amount not significantly different from the amount 
seized in 2008. In Colombia, seizures of cocaine 
hydrochloride remained stable in 2009, amounting to 
200 tons. 
481. The three main illicit markets for cocaine are in 
North America, Europe and the Southern Cone, which 
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in 2008, accounted for about 41, 29 and 10-20 per cent, 
respectively, of global cocaine consumption. While the 
market for cocaine has decreased in North America, it 
continues to increase in Europe.  
482. Despite the efforts of authorities in countries in 
Central America and the Caribbean to combat the drug 
trafficking, the region continues to be part of a major 
trafficking route for illicit shipments of controlled 
drugs originating in South America and destined for 
North America and Europe. Most of the cocaine abused 
in Canada and the United States is smuggled out of 
Colombia through Mexico or countries in Central 
America.  
483. Although Colombia remains the primary source 
of the cocaine found in Europe, Peru is becoming an 
increasingly important country of origin. The European 
Police Office (Europol) has identified the three main 
sea routes used to smuggle cocaine into Europe: the 
“northern route”, leading from the Caribbean via the 
Azores to the coasts of Portugal and Spain; the “central 
route”, leading from South America via Cape Verde or 
Madeira and the Canary Islands to Europe; and the 
“African route”, leading from South America to West 
Africa and then mainly to Spain and Portugal. The 
trans-shipment of cocaine has become a significant 
threat to the security and political stability of the 
countries in Central America and the Caribbean.  
484. The World Customs Organization has identified 
the Bolivarian Republic of Venezuela as one of the 
principal countries of origin of cocaine shipments 
seized in Western Europe and has warned of the 
increasing role played by Brazil, Ecuador and 
Suriname as countries of departure of cocaine 
shipments. In 2009, the Venezuelan authorities seized 
more than 30 aircraft that had been used to transport 
drugs and destroyed 48 unauthorized airstrips in the 
country. Some of the seized aircraft had been modified 
to increase their flying range. The Board is concerned 
about the continued smuggling of drugs through the 
Bolivarian Republic of Venezuela.  
485. Approximately five years ago, West Africa 
emerged as a hub for the smuggling of cocaine from 
Latin America into Europe. Most of the cocaine 
shipped to West Africa was being smuggled by boat  
or light aircraft. More recently, there have been 
indications that in order to smuggle drugs further 
inland, traffickers are taking advantage of the absence 
of a radar control network in the region by using 
aircraft designed to carry heavy cargo.  
486. In past years, the use of semi-submersibles for 
smuggling drugs has strongly increased. According to 
the Colombian authorities, 19 semi-submersibles were 
seized worldwide from 1993 to 2007. In 2008 and 2009 
alone, the law enforcement authorities seized 34 semi-
submersibles. The level of technological advancement 
and the transport capacity of such vessels have 
developed over the years, as evidenced by the seizure 
of a submarine capable of carrying 14 tons of drugs. 
The submarine was seized during a law enforcement 
operation carried out in Ecuador, near that country’s 
border with Colombia, in July 2010.  
487. Over the past four years, the size of coca-
processing laboratories in South America has 
decreased while their number has increased. Over  
99 per cent of the approximately 10,000 coca-
processing laboratories destroyed worldwide in 2008 
were located in Bolivia (Plurinational State of), 
Colombia or Peru. In 2008, cocaine laboratories were 
dismantled in Argentina (20), the Bolivarian Republic 
of Venezuela (10), Chile (4) and Ecuador (3).  
488. According to DNE of Colombia, about 90 per 
cent of the 2,959 clandestine drug laboratories 
destroyed in the country in 2009 had been illicitly 
processing coca paste or cocaine base; the remainder 
had been illicitly manufacturing cocaine hydrochloride. 
The number of clandestine drug laboratories 
dismantled in Colombia in 2009 decreased by  
14.3 per cent compared with the number of such 
laboratories dismantled in 2008 (3,451). In Colombia, 
clandestine drug laboratories are becoming smaller and 
easier to set up and disassemble, which makes them 
more difficult for law enforcement authorities to 
detect.  
489. The capacity of traffickers from Bolivia 
(Plurinational State of) and Peru to manufacture cocaine 
has grown in the past few years. In 2009, authorities in 
Peru dismantled approximately 1,200 laboratories for 
processing coca paste and 25 used for manufacturing 
cocaine hydrochloride. The Bolivian authorities 
destroyed about 6,700 maceration pits and about 4,900 
laboratories for processing coca paste and coca base.  
490. Ecuadorian law enforcement authorities 
destroyed several large-scale drug laboratories in 2009 
and 2010. In October 2009, they dismantled one of the 
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largest cocaine manufacturing laboratories in the 
country; it was estimated that the laboratory could 
manufacture 20 tons of cocaine per month. Another 
clandestine laboratory, capable of converting each 
month approximately 1 ton of coca paste into cocaine 
hydrochloride, was dismantled in April 2010. The 
Board is concerned about the increasing cocaine 
manufacturing capacity in Ecuador. Although the 
Venezuelan authorities did not detect any illicit 
cultivation of coca bush in their country, in 2009 they 
detected and destroyed 26 illicit drug manufacturing 
laboratories.  
491. The total area under illicit opium poppy 
cultivation in South America accounts for less than  
1 per cent of the total area under such cultivation 
worldwide. In Colombia, the country in which most of 
the illicit opium poppy cultivation in South America 
takes place, such cultivation is limited to mountainous 
areas and has gradually declined from 6,500 ha in 2000 
to 356 ha in 2009 (potential heroin manufacture:  
1 ton). In 2009, Colombian authorities eradicated 
illicitly cultivated opium poppy covering a total area of 
546 ha. The heroin manufactured in Colombia is sold 
on the illicit market in that country or smuggled into 
other countries in the Americas, in particular the 
United States.  
492. In Peru, in 2009 the authorities eradicated 31.5 ha 
of opium poppy and seized 75 kg of opium latex. In 
2008, Peru reported the destruction of one clandestine 
laboratory for processing opiates.  
493. In 2009, the South American country reporting 
the largest total amount of heroin seized was Colombia 
(over 735 kg), followed by Ecuador (178 kg) and the 
Bolivarian Republic of Venezuela (80 kg).  
 
  Psychotropic substances 
 
494. According to the World Customs Organization, 
the total amount of MDMA (“ecstasy”) seized by 
customs authorities worldwide decreased from  
5,929 kg in 2007 to only 218 kg in 2009, and such a 
sharp decline in the amount of “ecstasy” seized 
worldwide could be attributed to an increase in the 
manufacture of that substance in countries in which it 
is sold on illicit markets and a decrease in the 
smuggling of that substance across national borders. 
Argentina, Brazil, Chile and Colombia reported 
seizures of “ecstasy” by either customs or police 
authorities in 2009. In the period 2008-2009, the 
manufacture of “ecstasy” was reported in Argentina 
and Brazil. 
495. The Colombian authorities warned about attempts 
to barter cocaine from South America for MDMA 
(“ecstasy”) tablets from Europe. In addition, those 
authorities conducted a survey whose findings 
confirmed that many of the tablets sold as “ecstasy” on 
illicit markets in that country actually contained a 
mixture of psychoactive substances, including 
analgesics, benzodiazepines, cocaine, heroin and 
methaqualone. The unpredictable composition of those 
tablets and the unknown quantity of active ingredients 
they contained made them especially harmful to 
“ecstasy” abusers. In July 2010, the Peruvian 
authorities reported that 251,000 “ecstasy” tablets and 
over 100 kg of cocaine had been seized in Lima.  
496. In 2009, the Chilean authorities reported the 
seizure of a small-scale laboratory for illicitly 
manufacturing mescaline, a psychotropic substance in 
Table I of the 1971 Convention. It was the first time 
that such a clandestine laboratory had been identified 
in Chile.  
 
  Precursors 
 
497. Potassium permanganate remains the key 
oxidizing agent used to manufacture cocaine. 
According to DNE of Colombia, the availability of 
potassium permanganate for use in the illicit 
manufacture of cocaine has increased in recent years 
despite the seizure of large amounts of the substance 
and the implementation of the necessary control 
measures in the country. In 2009, 22.8 tons of 
potassium permanganate were seized in Colombia. 
Although that was the smallest total quantity of 
potassium permanganate seized in the country in the 
period 2000-2009, it was the largest total quantity of 
the substance seized in a single country in 2009 
accounting for 90 per cent of the total amount of 
potassium permanganate seized worldwide. In 2009, 
the seizure of potassium permanganate in quantities 
larger than 100 kg was also reported in Peru (1,770 kg) 
and Ecuador (480 kg). 
498. A portion of the potassium permanganate  
seized in Colombia had been illicitly manufactured  
in clandestine laboratories. From 2004 to 2008,  
58 clandestine laboratories manufacturing potassium 
permanganate were seized in the country. Although 
traffickers’ capacity to manufacture their own 
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potassium permanganate still remains difficult to 
assess, the Colombian authorities indicate that 
potassium permanganate may be illicitly manufactured 
in sufficient quantities to cover most of the traffickers’ 
needs for the substance. In 2009, two laboratories 
illicitly manufacturing potassium permanganate were 
destroyed in the country.  
499. In the past three years, Argentina, Chile, 
Colombia and Peru have strengthened controls over the 
licit trade in ephedrine and pseudoephedrine, including 
in the form of pharmaceutical preparations. The 
measures taken included restricting or banning the 
import and use of those substances. Nonetheless, 
ephedrine and pseudoephedrine have continued to be 
smuggled. In 2009, a total of over 1.5 tons of raw 
ephedrine were seized by Chilean, Colombian and 
Venezuelan authorities. In addition, Argentina, Brazil 
and Colombia reported seizures of ephedrine and 
pseudoephedrine in the form of pharmaceutical 
preparations. In July 2010, the Colombian law 
enforcement authorities seized 2 million tablets 
containing pseudoephedrine in a shipment bound for 
Honduras. The Board encourages Governments to use 
the “Guidelines for a voluntary code of practice for the 
chemical industry”, developed by the Board, to further 
strengthen control over the precursor chemical trade in 
their countries, in cooperation with the private sector. 
 
  Substances not under international control 
 
500. The Governments of countries in South America 
continue to pay attention to the use of psychoactive 
substances that are not currently under international 
control. In January 2010, the National Anti-Drugs 
Council (CONAD) of Brazil adopted a resolution on 
the use of ayahuasca for religious purposes. In 
March 2010, the Government of Argentina approved 
decree 299/2010, pursuant to which ketamine was 
included on the list of substances subject to national 
control. 
501. The health and drug regulatory authorities of 
several countries in the Americas have recently focused 
on herbal mixtures marketed under the brand name 
Spice. As small amounts of synthetic cannabinoids 
have been identified in such mixtures, there is concern 
that the use of Spice products may have negative 
effects on health. The CICAD group of experts on 
chemical substances has recently prepared for all 
CICAD member States factsheets on scopolamine 
(hyoscine) and Spice products.  
 
 5. Abuse and treatment 
 
502. The latest estimates on drug abuse indicate that 
cannabis continues to be the most abused drug in South 
America, where about 7.5 million persons aged 15-64 
used that drug during the past year, three times the 
number of persons who used cocaine during the past 
year.  
503. The Board notes that recently, a number of 
countries in South America have used common 
methodologies in conducting surveys on drug abuse in 
the region. For example, Argentina, Bolivia 
(Plurinational State of), Chile, Ecuador, Peru and 
Uruguay conducted the second comparative analysis of 
drug use among students in secondary schools. 
According to the results of the analysis, cannabis herb 
is the drug most commonly abused among students 
aged 13-17. On average, almost 11 per cent of the 
students in those six countries had used the substance 
at least once in their lifetime; the percentages in the 
individual countries ranged from 4 per cent in Peru to 
almost 23 per cent in Chile. The Board wishes to 
encourage the Governments of the countries in South 
America to periodically carry out, in cooperation with 
CICAD and UNODC, standardized drug abuse surveys 
to enable the magnitude of the drug abuse problem to 
be assessed and compared in countries throughout the 
region. 
504. The results of the first national survey on the use 
of alcohol, tobacco and other drugs among university 
students in 27 Brazilian state capitals, announced by 
the Government of Brazil in June 2010, indicate that  
8 per cent of the university students in the survey were 
at risk of becoming dependent on cannabis. The 
Brazilian study also revealed that almost half of the 
surveyed students had used a psychoactive substance at 
least once in their lifetime and that there had been an 
increase in the abuse of synthetic drugs (amphetamines 
and MDMA (“ecstasy”)). The drug most often abused 
among university students was cannabis (13.8 per cent), 
followed by amphetamines (10.5 per cent).  
505. Past-year prevalence of cocaine abuse among the 
general population in South America (0.9-1.0 per cent) 
is far lower than in North America (2.0 per cent) but 
higher than in Central America (0.5-0.6 per cent). 
According to UNODC, in South America cases 
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involving treatment for cocaine abuse accounted for  
65 per cent of all cases involving treatment for 
substance abuse in 1998, and that figure decreased, in 
relative terms, to 49 per cent in 2008. For the past  
10 years, cocaine has been the primary drug of abuse 
among persons treated for drug problems in the region. 
506. Demand for “crack” cocaine appears to be 
emerging in some countries in South America. In 2008, 
seizures of “crack” cocaine were reported in Argentina, 
Brazil, Chile, Paraguay and Venezuela (Bolivarian 
Republic of). In the Bolivarian Republic of Venezuela, 
lifetime prevalence of the abuse of “crack” cocaine 
among the population aged 15-70 is 11.9 per cent. In 
that country, about a quarter of the persons who 
received treatment for drug addiction were addicted to 
“crack” cocaine. In 2010, the Government of Brazil 
launched its integrated plan to combat “crack” cocaine 
and other drugs.  
507. In South America, the countries with the highest 
prevalence of abuse of prescription opioids among 
persons aged 15-64 are Brazil and Chile (0.5 per cent 
in 2008). In both countries, the abuse of prescription 
opioids is the main problem, while the abuse of heroin 
is still low. In Chile, the estimate of 0.5 per cent for 
2008 represents an increase compared with the figure 
for 2006 (0.3 per cent). In other countries in the region, 
the prevalence of abuse of opiates is low, ranging  
from 0.1 per cent in Ecuador to 0.3 per cent in the 
Plurinational State of Bolivia. In most countries in 
South America, the abuse of synthetic opioids is more 
common than the abuse of heroin.  
508. According to an epidemiological study of the 
consumption of synthetic drugs among the university 
population in the Andean subregion, the highest 
lifetime prevalence of the abuse of MDMA (“ecstasy”) 
among students was in Colombia (about 3.5 per cent), 
followed by Ecuador, Peru and the Plurinational State 
of Bolivia. 
509. According to the second comparative analysis of 
drug consumption among students in secondary 
schools in the region, the countries with the highest 
past-year prevalence of cocaine abuse among persons 
aged 15-16 were Uruguay (3.7 per cent), Chile  
(3.21 per cent), Argentina (3.16 per cent), the 
Plurinational State of Bolivia (2.12 per cent), Ecuador 
(1.52 per cent) and Peru (0.95 per cent).  
510. According to the 2009 AIDS Epidemic Update, 
published by the Joint United Nations Programme on 
HIV/AIDS and WHO, an estimated 29 per cent of the 
more than 2 million Latin Americans who abuse drugs 
by injection are infected with HIV. HIV epidemics 
among such drug abusers in the region tend to be 
concentrated in the Southern Cone. It is estimated that 
in Argentina alone, almost half of the persons who 
abuse drugs by injection are infected with HIV.  
 
 
 C. Asia  
 
 
  East and South-East Asia 
 
 
 1. Major developments 
 
511. In East and South-East Asia, progress in reducing 
opium production is under threat, owing to an upswing 
in opium poppy cultivation during the 2009 growing 
season. Successes in reducing opium poppy cultivation 
in the region have been built on decades of successful 
alternative development work in rural communities; 
however, the information available for the last  
three years has been less encouraging. Several factors 
have contributed to the increase in illicit opium poppy 
cultivation in the area known as the Golden Triangle. It 
should be noted that despite some increases in illicit 
opium poppy cultivation since 2008 in South-East 
Asia, that subregion accounts for less than 5 per cent of 
global opium poppy production. Myanmar remains the 
main opium-producing country in the subregion, 
accounting for approximately 95 per cent of total 
opium production in South-East Asia; it is followed by 
the Lao People’s Democratic Republic and Thailand. A 
significant increase in the total area under illicit opium 
poppy cultivation has been reported in Myanmar; the 
total area under such cultivation in that country in 2009 
was 31,700 ha, an increase of 11 per cent over the 
figure for 2008 (28,500 ha). Opium poppy cultivation 
and potential opium production increased in the  
Lao People’s Democratic Republic in 2009; the total 
area under illicit opium poppy cultivation, in that 
country amounted to 1,900 ha in 2009, an increase of  
19 per cent over 2008. According to UNODC, potential 
production of opium in Thailand was negligible in 
2009 — about 3 tons.  
512. An issue of paramount concern to East and 
South-East Asia has been the increasing trafficking in, 
illicit manufacture of and abuse of synthetic drugs in 
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recent years, in particular amphetamine-type 
stimulants, which, because of their low costs of 
manufacture, ease of availability and considerable 
addictive potential, represent a major challenge to 
national health authorities. Since 2008, Cambodia, 
Indonesia, Malaysia, Myanmar and the Philippines 
have reported the dismantling of several laboratories 
that were illicitly manufacturing amphetamine-type 
stimulants. The number of seizures of amphetamine-
type stimulants, including methamphetamine tablets 
and crystalline methamphetamine, has been increasing 
in the region. China reported large seizures of 
methamphetamine in 2009. Methamphetamine 
trafficking was reported to have increased in Japan in 
2009; methamphetamine was being smuggled into that 
country out of Latin America, West Asia and Africa.  
In the Lao People’s Democratic Republic,  
increased seizures of tablets containing different 
types of amphetamine-type stimulants, mostly 
methamphetamine, were also reported.  
513. Amphetamine-type stimulants (primarily 
methamphetamine) and opioids and cannabis continue 
to be widely abused in East and South-East Asia. Cases 
involving opioids and methamphetamine make up the 
bulk of treatment episodes for drug abuse. Persons who 
abuse drugs by injection account for an alarmingly 
high percentage of the drug abusers in the region: it is 
estimated that approximately 25 per cent of all 
injecting drug abusers in the world live in East and 
South-East Asia. The risk of an HIV epidemic among 
the drug-injecting population in the region is therefore 
high. 
 
 2. Regional cooperation 
 
514. The Thirty-fourth Meeting of Heads of National 
Drug Law Enforcement Agencies, Asia and the Pacific, 
was held in Bangkok from 30 November to  
3 December 2010. The main goal of the meeting was to 
promote and coordinate capacity-building for law 
enforcement in the region. The issues discussed 
included major regional drug trafficking trends and 
countermeasures, including international cooperation, 
specific law enforcement measures, such as controlled 
delivery, and approaches to strengthen regional 
cooperation with regard to the dismantling of 
clandestine drug laboratories.  
515. In 2009, border liaison offices assisted the 
Governments of Cambodia, China, the Lao People’s 
Democratic Republic, Myanmar, Thailand and  
Viet Nam in conducting numerous joint operations that 
led to several seizures of drugs and precursors and to 
the dismantling of clandestine laboratories. A cross-
border cooperation meeting between Cambodia and the 
Lao People’s Democratic Republic was held in  
Preah Vihear, Cambodia, and Ban Meuang Sene,  
Lao People’s Democratic Republic, from 19 to 23 July 
2010 to bring together law enforcement officers from 
the border liaison offices of both countries and build a 
network for information-sharing. 
516. Ministers for foreign affairs of member States of 
the European Union and the Association of Southeast 
Asian Nations (ASEAN), as well as the Secretary-
General of ASEAN, at the eighteenth ASEAN-
European Union Ministerial Meeting, on the theme 
“Partners in regional integration”, held in Madrid on 
26 May 2010, reaffirmed their commitment to 
promoting cooperation to combat drug trafficking. The 
foreign ministers also reaffirmed the unique character 
of the partnership between ASEAN and the European 
Union, underlining the potential strategic importance 
of the partnership, bearing in mind that there were 
approximately 1.25 billion people living in the member 
States of ASEAN and the European Union. 
517. A Senior Officials Committee meeting among the 
signatories to the 1993 memorandum of understanding 
on drugs in the Greater Mekong subregion was hosted 
by the Government of Viet Nam in Da Nang from 11 to 
14 May 2010 to review and assess the implementation 
of the memorandum’s subregional action plan and 
related projects.  
518. The twenty-third ASEAN-Australia Forum was 
held in Singapore on 19 March 2010, with the 
participation of representatives from Australia, ASEAN 
member States and the ASEAN secretariat, to tackle, 
among other issues, cooperative mechanisms for 
combating transnational organized crime, including 
drug trafficking.  
519. The first ASEAN-United States Leaders’ 
Meeting, on the theme “Enhanced partnership for 
enduring peace and prosperity”, was held in Singapore 
on 15 November 2009. Leaders from around the world, 
including Heads of State or Government of the member 
States of ASEAN and the United States, gathered to 
enhance regional partnership and issued a joint 
statement on strengthening efforts to prevent and 
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combat transnational organized crime, including drug 
trafficking. 
520. The fifteenth Asia-Pacific Operational Drug 
Enforcement Conference was held in Tokyo in 
February 2010. The meeting promoted information 
exchange and cooperation in investigations and the 
sharing of knowledge and experiences acquired in 
international drug control.  
 
 3. National legislation, policy and action 
 
521. The Board notes that the Governments of Japan 
and Thailand have taken proactive measures to prevent 
drug abuse through successful cooperation among 
related ministries and agencies, such as the Drug Abuse 
Prevention Center of Japan, as well as their private 
sectors. In Thailand, the “To be number one” 
campaign, a joint initiative of the Ministry of Health 
and the Ministry of Education, has been launched with 
the theme “You can only be the best you can be by not 
using drugs”. Actions under the campaign included the 
promotion of nationwide drug abuse awareness and 
prevention in schools and communities.  
522. Several countries in East and South-East Asia 
have adopted or enacted new laws or regulations for 
drug control. Indonesia reported enacting its law on 
narcotics in 2009, which brings internationally 
controlled substances, including precursors, under 
national control and defines the competencies of 
authorities at the national and provincial levels. In the 
Lao People’s Democratic Republic, a new drug law 
was promulgated in January 2009. Also in 2009, the 
Prime Minister’s decree on the implementation of the 
law on drugs was enacted. In Mongolia, a new law was 
implemented in 2009, providing for the monitoring of 
narcotic drugs and envisaging psychological assistance 
for addicts. Following the adoption of a new customs 
law in 2008, the Mongolian Customs General 
Administration began to reform its risk-assessment 
techniques related to drug control.  
523. In Myanmar, safrole oil was recently listed as a 
controlled precursor chemical. It is now subject to the 
same control measures as substances in Table I of the 
1988 Convention. In April 2009 the Philippines 
enacted the regulation on controlled precursors and 
essential chemicals and in November 2009 the 
regulation on psychotropic substances, which included 
N-benzylpiperazine in the list of dangerous drugs. In 
July 2009 the Republic of Korea enacted the 
enforcement decree of the act on the control of 
narcotics, through which additional substances and 
precursor chemicals were placed under national 
control. In addition, in October 2009 the Republic of 
Korea enacted the enforcement rule of the act on the 
control of narcotics, which stipulated the provisions for 
travellers entering the country carrying controlled 
substances. 
524. Singapore introduced, with effect from July 2009, 
a new law for the control of the export of cough 
preparations containing codeine. Viet Nam adopted an 
amendment and supplement to the drug control law, 
which came into effect in January 2009, redefining the 
responsibilities of national authorities in preventing 
drug abuse and controlling the licit drug supply, 
including the roles of law enforcement agencies such 
as the police, maritime police, border protection forces 
and customs service. In addition, the amendment and 
supplement to the penal code adopted in June 2009 
came into effect in January 2010. According to the new 
law, the abuse of narcotic drugs is no longer a criminal 
offence in Viet Nam. 
525. Thailand has enacted new ministerial regulations 
on rules and procedures for issuing licences to 
manufacture, import, sell or possess with intent to sell 
drugs in Schedule II or preparations in Schedule III of 
the 1961 Convention. The regulations came into effect 
in September 2009, redefining the responsibilities of 
national authorities in controlling the illicit drug 
supply and availability.  
 
 4. Cultivation, production, manufacture and 
trafficking 
 
  Narcotic drugs 
 
526. Illicit cultivation of cannabis plant continues to 
be a problem in East and South-East Asia. In the  
Lao People’s Democratic Republic, illicit cannabis 
plant cultivation has taken place mainly in the central 
provinces for export to neighbouring countries, 
particularly in areas near the Mekong. Some 2,800 kg 
of cannabis were seized in April 2010 in Khamouan 
Province, on the Lao-Thai border. In Japan, cannabis 
plants were illicitly cultivated indoors for domestic 
use, and arrests and seizures relating to such 
cultivation increased in 2009. In Mongolia, illicit 
cannabis production, trafficking and abuse were on the 
rise, although still considered small in scale. The level 
of cultivation was estimated to be low in that country, 
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as the most common local source of cannabis was 
naturally growing cannabis plants in the northern 
provinces.  
527. Significant amounts of cannabis continue to be 
seized in East and South-East Asia. In 2009, Chinese 
authorities seized a total of 8.7 tons of cannabis — the 
largest total amount of seized cannabis ever reported 
by China. In the Lao People’s Democratic Republic, 
where cannabis seizures totalled 978 kg in 2009, 
almost 3 tons of cannabis were seized in the first half 
of 2010. Viet Nam also reported significant problems 
with cannabis trafficking: 1.6 tons of cannabis were 
seized in 2009. Indonesia and Thailand reported having 
seized large amounts of cannabis over the past two 
years. 
528. Illicit opium poppy cultivation increased in East 
and South-East Asia from 2008 to 2009. In 2009, the 
total area under illicit opium poppy cultivation was 
33,811 ha, representing an increase of 11 per cent over 
the figure for 2008 (30,388 ha). In Myanmar, illicit 
opium poppy cultivation increased from 27,700 ha in 
2007 to 28,500 ha in 2008 and reached a total of 
31,700 ha in 2009. Opium poppy cultivation in the  
Lao People’s Democratic Republic increased in 2009 
to an estimated 1,900 ha, up from 1,600 ha in 2008 and 
1,500 ha in 2007. Small-scale opium poppy cultivation 
continued in Thailand, where approximately 211 ha of 
opium poppy were cultivated in scattered areas. The 
Government of Myanmar continued its efforts to 
eliminate illicit opium poppy cultivation, dispatching 
eradication teams to opium poppy fields in remote and 
mountainous areas of the country. As a result, 
Myanmar reported the eradication in 2009 of  
illicitly cultivated opium poppy covering 4,087 ha. In  
Viet Nam, the total area under opium poppy cultivation 
continued to decrease, amounting to 31 ha in the 
growing period 2009/10.  
529. In South-East Asia, there has been a significant 
reduction in illicit opium production over the past  
two decades as a result of a combination of law 
enforcement and alternative development initiatives. 
Because of lower yield per hectare, illicit production of 
raw opium in the Lao People’s Democratic Republic, 
Myanmar and Thailand totalled 345 tons in 2009, a 
decrease over the figure for 2008 (424 tons). In 
Myanmar, potential production of opium declined from 
410 tons in 2008 to 330 tons in 2009, a decrease of  
20 per cent. Nevertheless, Myanmar has remained the 
main opium-producing country in the region, 
accounting for approximately 95 per cent of total 
opium production in South-East Asia. Potential opium 
production in the Lao People’s Democratic Republic  
in 2009 was estimated at 11.4 tons, increasing from  
9.6 tons in 2008. There was a risk of opium poppy 
cultivation increasing in the country because of the 
high price for opium and the absence of alternative 
development initiatives.  
530. Seizures of opium continued to be reported. 
China reported seizures of opium totalling 1.3 tons in 
2009. Increasing seizures of opium were reported by 
the Lao People’s Democratic Republic. In contrast, 
there was a significant decline in the amount of opium 
seized in Viet Nam.  
531. According to INTERPOL, illicit heroin 
manufacture in South-East Asia has declined 
substantially in the past five years, as a result of 
several years of unfavourable growing conditions and 
new Government policies of forced eradication. 
However, preliminary figures for 2009 indicate an 
increased number of seizures of opiates (mainly 
heroin). In some countries in the region, heroin has 
been trafficked by international drug trafficking 
organizations, including some originating in Africa. 
The drug trafficking organizations, operating in 
Cambodia, China (including Hong Kong), Indonesia, 
Malaysia, the Philippines and Thailand, have close  
ties with their supply sources in West Asia. 
Furthermore, cases involving non-Chinese drug 
traffickers have increased significantly in China. The 
increasing involvement of Iranian nationals and 
organized criminal organizations in drug trafficking 
was reported as a new development in the region in 
2009 and 2010. 
532. China reported seizures of heroin totalling  
5.8 tons in 2009, compared with 4.3 tons in 2008. 
China, Malaysia, Thailand and Viet Nam accounted for 
the majority of the heroin seizures in East and South-
East Asia. In Hong Kong, China, 59 kg of heroin was 
seized in 2009, compared with 46 kg in 2008. In  
Viet Nam, where 213 kg of heroin was seized in 2009, 
trafficking in opiates continued, as the country is used 
by drug traffickers as a major transit area for shipments 
to China and Australia. In Viet Nam, more than 11 kg 
of heroin was seized in May 2010 through the 
cooperation of Lao and Vietnamese forces, culminating 
in the arrest of West and Southern African and 
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Vietnamese drug traffickers. The amount of heroin 
trafficked into Viet Nam increased by 27 per cent from 
2008 to 2009. Trafficking in opiates continued to be a 
serious problem in the Lao People’s Democratic 
Republic, which reported increasing seizures of heroin.  
533. Seizures of cocaine in East and South-East Asia 
appear to be declining, although Hong Kong, China, 
and the Philippines reported increasing cocaine 
seizures in 2009. China was not only a country of 
destination, but also a transit country for cocaine 
shipments originating in South America. The amount 
of cocaine seized in China decreased from 558 kg  
in 2008 to only 41 kg in 2009. The Lao People’s 
Democratic Republic also reported declining cocaine 
seizures.  
 
  Psychotropic substances 
 
534. Illicit manufacture of and trafficking in 
amphetamine-type stimulants have remained a serious 
concern in East and South-East Asia. The illicit 
manufacture of amphetamine-type stimulants has taken 
place virtually wherever there is easy access to  
the required precursor chemicals. The number of 
clandestine laboratories dismantled in China increased 
from 244 in 2008 to 391 in 2009. Although illicit 
manufacture of methamphetamine on a large scale did 
not take place in Hong Kong, China, several small-
scale “kitchen labs” were dismantled in 2009. Over the 
past two years, Cambodia, Indonesia, Malaysia, 
Myanmar and the Philippines reported the dismantling 
of several clandestine laboratories manufacturing 
amphetamine-type stimulants.  
535. The smuggling of amphetamine-type stimulants 
from the so-called Golden Triangle into China 
continued to increase in 2009, the most common 
substance smuggled being methamphetamine. In 2009, 
6.6 tons of methamphetamine was seized in China.  
The quantity of amphetamine-type stimulants seized 
surpassed that of heroin in 22 Chinese provinces in 
2009. According to INTERPOL, significant quantities 
of methamphetamine were smuggled out of the Islamic 
Republic of Iran via neighbouring countries into East 
and South-East Asia. In Indonesia, thousands of 
kilograms of methamphetamine were seized in 2009. In 
Hong Kong, China, a number of successful operations 
resulting in the interception of methamphetamine 
consignments in 2009 were reported; the consignments 
had been destined for illicit markets in Australia and 
Japan. In recent years, methamphetamine has been 
smuggled into Japan not only from neighbouring 
countries but also from Latin America, West Asia and 
Africa. In 2009, the number of cases of 
methamphetamine trafficking in Japan more than 
doubled the number recorded in the previous years.  
536. The Lao People’s Democratic Republic has been 
used as a transit country for amphetamine-type 
stimulants since the late 1990s. The use of the  
Lao People’s Democratic Republic as a transit area  
for shipments of methamphetamine originating in 
Myanmar and destined for Thailand increased after 
Thai law enforcement efforts were strengthened along 
the northern Thai-Myanmar border. The number of 
seizures of tablets containing various types of 
amphetamine-type stimulants in the Lao People’s 
Democratic Republic almost doubled between 2008 
and 2009; more than 80 per cent of those seizures 
involved methamphetamine tablets. More than 
2,330,000 methamphetamine tablets were seized in the 
country in 2009. A shipment of some 21.8 million 
tablets containing amphetamine-type stimulants, 
weighing 2.18 tons, was seized in February 2010. 
Drug-related crime and violence were also reported to 
have increased in the Lao People’s Democratic 
Republic. Viet Nam reported having seized over 
500,000 methamphetamine tablets in 2009. 
537. In 2009, nearly 1.1 million MDMA (“ecstasy”) 
tablets were seized in China. In Indonesia, seizures of 
“ecstasy” were more common than seizures of 
methamphetamine; millions of “ecstasy” tablets were 
seized in 2009. In Japan, where “ecstasy” from Canada 
and Western European countries, in particular Belgium, 
has been trafficked, the number of seized “ecstasy” 
tablets decreased substantially, from 217,172 in 2008 
to 61,280 in 2009. In Hong Kong, China, in 2009 and 
2010, there was a continuing trend in which “ecstasy” 
tablets were increasingly containing substances other 
than MDMA, such as a mixture of methamphetamine 
and ketamine. The “ecstasy” seized nowadays in  
Hong Kong, China, has been reported to originate in 
Asia, not Europe. While Europe is still cited as a 
source of MDMA, the importance of that region as a 
source has decreased as more countries outside of 
Europe have reported the manufacture of the substance 
on their territory. For example, the sources of MDMA 
seized in Indonesia were reported to be illicit 
manufacture of the substance in that country, as well as 
China and the Netherlands. 
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538. One notable development in recent years is the 
growing presence of nimetazepam, a benzodiazepine in 
Schedule IV of the 1971 Convention, on the illicit 
markets of some East and South-East Asian countries. 
Large seizures of the substance have been made in 
Indonesia and Malaysia in recent years, and a rise in 
the abuse of nimetazepam was reported in Brunei 
Darussalam, Hong Kong, China, Indonesia, Malaysia 
and Thailand.  
539. In China, GHB was reported to be mixed with 
MDMA (“ecstasy”) and ketamine in drugs of abuse.  
540. In Singapore, where diversion and abuse of 
buprenorphine had been a problem, a significant 
decline in such illicit activities became evident in 
2009, owing to new legislation enforced in 2009 and 
stricter penalties imposed by the Government for illicit 
activities involving that substance. 
 
  Precursors 
 
541. Most diversions of precursors take place because 
of the ability of criminal groups to exploit gaps in 
national regulatory frameworks for monitoring trade in 
precursors and identifying suspicious transactions. 
International and regional efforts have been undertaken 
to prevent the diversion in East and South-East Asia of 
precursors.  
542. Despite efforts made by the Government of China 
in precursor control, a number of countries reported 
seizures of precursors originating in China that had 
been intended for use in the illicit manufacture of 
methamphetamine.  
543. Myanmar has exchanged information on a regular 
basis with the neighbouring countries of China, India, 
the Lao People’s Democratic Republic and Thailand in 
order to prevent the diversion of precursor chemicals.  
544. There have been indications that transnational 
organized criminal groups are increasingly smuggling 
precursor chemicals through the Lao People’s 
Democratic Republic. In 2009, there were several 
instances of extraction of ephedrine and 
pseudoephedrine from pharmaceutical products in East 
and South-East Asia, which reflects a global trend.  
 
  Substances not under international control 
 
545. Ketamine continued to be seized in several 
countries in East and South-East Asia. In 2008, figures 
for ketamine seizures were higher than those for annual 
heroin seizures in the region: 6.3 tons of ketamine was 
seized, compared with 5.2 tons of heroin. The countries 
reporting seizures or abuse of ketamine included 
Brunei Darussalam, China (including Hong Kong), 
Malaysia, Singapore, Thailand and Viet Nam. Forensic 
data suggest that many of the so-called “ecstasy” 
tablets seized in the region actually contain substances 
other than MDMA, such as ketamine.  
546. In China, ketamine was ranked fifth among all 
drugs of abuse. Prevalence of the abuse of ketamine 
has increased. The abuse of ketamine accounts for 
more than a third of all drug abuse cases registered as 
involving “new-type drugs”. China reported having 
seized over 5,323 kg of ketamine in 2009. Recent 
reports pointed out that rather than diverting ketamine 
licitly manufactured as an anaesthetic, drug trafficking 
organizations have recently been attempting to procure 
the precursor hydroxylamine hydrochloride and use it 
to illicitly manufacture ketamine in clandestine 
laboratories.  
 
 5. Abuse and treatment 
 
547. Cannabis continues to be the primary drug of 
abuse in Indonesia. Thailand has indicated that 
cannabis is the second most common drug of abuse in 
the country. In Japan, cannabis abuse accounted for the 
second-largest number of drug-related arrests. Other 
countries in East and South-East Asia reporting 
cannabis abuse included Brunei Darussalam, 
Cambodia, China, Indonesia, Japan, the Lao People’s 
Democratic Republic, Malaysia, Myanmar, the 
Philippines, the Republic of Korea, Singapore, 
Thailand and Viet Nam.  
548. Heroin continued to be the primary drug of  
abuse in China, Malaysia, Myanmar, Singapore and 
Viet Nam. Most countries in East and South-East Asia 
reported stable or decreasing trends in heroin abuse; 
the exceptions were the Lao People’s Democratic 
Republic, Singapore, Thailand and Viet Nam. In  
Viet Nam, heroin abusers accounted for 83.1 per cent 
of the total drug-abusing population. In Singapore, 
similar to the situation in 2008, heroin abusers 
accounted for 58 per cent of the drug abusers arrested 
in 2009. In China, which has the largest illicit market 
for opioids in the region, opioid abuse is estimated to 
involve between 1.8 million and 2.9 million persons 
and heroin abuse is the primary reason for seeking 
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treatment for drug abuse. In 2009, 97,000 new heroin 
abusers were registered in China, bringing the total  
to 978,226. 
549. As in some other countries in East and South-East 
Asia, drug abuse by injection has been widespread  
in Viet Nam and remains a major means of HIV 
transmission. It is estimated that in Viet Nam  
persons who abuse drugs by injection account for  
over 80 per cent of the drug-abusing population. In 
Malaysia, the National Strategic Plan on HIV/AIDS  
for 2006-2010 included needle and syringe exchange 
programmes to reduce HIV transmission. In 2009, the 
design and implementation of the HIV/AIDS Asia 
Regional Programme, funded by the Australian Agency 
for International Development, continued to be carried 
out in the Lao People’s Democratic Republic and 
Myanmar with the goal of reducing over a period of 
five years the prevalence of HIV infection transmitted 
through drug abuse by injection. 
550. In Myanmar, two new programmes for methadone 
maintenance therapy were launched in early 2010, one 
at the general hospital in Muse, where persons who 
abuse drugs by injection were offered treatment with 
the assistance of a psychiatrist, and the other at the 
general hospital of Tachilek, where a physician was 
assigned to handle methadone treatment authorized by 
the Department of Health. The Board notes that other 
countries in East and South-East Asia, in particular 
China, Indonesia, Malaysia and Viet Nam, have 
recently initiated or scaled up methadone maintenance 
programmes or expanded the coverage of such 
programmes to include additional segments of the 
population.  
551. The Lao authorities estimated that there were 
between 12,000 and 15,000 opium addicts, mostly in 
the northern provinces, although more precise data on 
the number of drug addicts in the country were not 
available. In Mongolia, many patients hospitalized for 
trauma or other painful conditions became addicted to 
morphine when excessive doses of the narcotic 
analgesic were prescribed. 
552. The abuse of amphetamine-type stimulants, 
especially among young people, was on the rise in 
many countries. All countries in East and South-East 
Asia reported the abuse of methamphetamine, with 
nine countries reporting it as the most common or 
second most common drug of abuse, depending on its 
form. Increasing abuse of methamphetamine has been 
reported in Cambodia, China, Indonesia, the Lao 
People’s Democratic Republic, Malaysia, Myanmar, 
Singapore, Thailand and Viet Nam. According to 
UNODC, methamphetamine was the main drug of 
abuse in the Lao People’s Democratic Republic and 
Thailand and the second most commonly abused drug 
in Cambodia and China. Crystalline methamphetamine 
was reported to be the primary drug of abuse in  
Brunei Darussalam, Japan and the Republic of Korea. 
In Brunei Darussalam in 2009, methamphetamine  
was the drug of choice for 97 per cent of drug abusers. 
In China, the number of registered abusers of 
amphetamine-type stimulants reached 360,000, of 
whom 97,000 were newly registered. In the  
Lao People’s Democratic Republic, the number of 
people addicted to amphetamine-type stimulants was 
estimated at 35,000-40,000. Malaysia is at risk of 
becoming a major illicit market for amphetamine-type 
stimulants, as large amounts of those stimulants have 
been smuggled into the country. 
553. MDMA (“ecstasy”) was not reported as the most 
common drug of abuse in any country in East and 
South-East Asia; however, it was the second most 
common drug of abuse in Indonesia and the third most 
common in many countries in the region, including 
China, where it ranked after heroin and 
methamphetamine. In Viet Nam, “ecstasy” has been 
identified as a new drug of abuse. 
554. Recent surveys in the Lao People’s Democratic 
Republic and Thailand have drawn attention to the 
widespread abuse of volatile substances such as glue, 
primarily by children and teenagers. The abuse of 
inhalants is also a problem in other countries in East 
and South-East Asia, such as Mongolia.  
555. In accordance with the international drug control 
conventions, physical and mental health problems 
related to drug abuse should be evaluated and treated, 
and support for social integration and employment 
provided to those in need. Research has indicated that 
effective treatment for drug dependence responds to 
individual needs and reaches those who are not 
motivated to attend treatment facilities. Unfortunately, 
those principles often were not or could not be 
followed by Governments in East and South-East Asia. 
The practice of making treatment at centres 
compulsory for drug abusers seems to be increasing in 
the region.  
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556. The Board wishes to highlight the importance of 
providing assistance in response to drug abuse and HIV 
prevention, treatment, support and care among persons 
who abuse drugs by injection and among prison 
inmates in East and South-East Asia. In 2009, capacity-
building for the treatment of drug dependence was 
carried out in Cambodia, Myanmar and Viet Nam, and 
counselling clinics and community counselling teams 
for drug abusers were established.  
 
 
  South Asia 
 
 
 1. Major developments 
 
557. South Asia has become one of the main regions 
used by drug traffickers to obtain ephedrine and 
pseudoephedrine for the illicit manufacture of 
methamphetamine. Indian law enforcement authorities 
continue to report significant seizures of these 
precursor chemicals. In addition to being diverted from 
the licit manufacturing industry in India, those 
precursor chemicals are manufactured illicitly, as 
indicated by the discovery of a clandestine ephedrine 
laboratory in 2009. To circumvent measures in place in 
India to control domestic and international trade in 
bulk ephedrine and pseudoephedrine, criminal 
networks have resorted to smuggling pharmaceutical 
preparations containing those chemicals. In addition, 
drug traffickers have begun using Bangladesh to obtain 
large quantities of such preparations. 
558. Law enforcement agencies in India continue to 
uncover clandestine facilities where methamphetamine 
is illicitly manufactured. This indicates that India is 
being used by criminal networks for the illicit 
manufacture of amphetamine-type stimulants. There 
are reports that most of the methamphetamine 
manufactured in clandestine laboratories in India is 
destined for illicit markets in other countries. The 
prevalence of abuse of amphetamine-type stimulants in 
India is not known. 
559. The diversion into illicit channels of 
pharmaceutical preparations containing substances 
under international control, as well as the smuggling of 
such preparations, continues to pose problems in  
South Asia. Law enforcement agencies of Bhutan, 
India and Nepal often seize pharmaceutical 
preparations containing codeine. Seizures of 
pharmaceutical preparations containing buprenorphine 
have increased in recent years in Bangladesh. 
Furthermore, many drug abusers in South Asia  
inject pharmaceutical preparations containing 
dextropropoxyphene or buprenorphine. Concerted 
efforts at the national and regional levels are needed to 
deal with that situation. 
560. High rates of HIV infection are reported among 
people who abuse drugs by injection in some cities, 
such as Dhaka, and in the north-eastern states of India. 
One response to this problem has been the introduction 
and expansion of opioid substitution treatment 
programmes in several countries in the region in recent 
years. Pilot studies on the use of methadone in such 
programmes have been initiated in Bangladesh and 
Maldives and officially approved in India. The opening 
of additional facilities that provide opioid substitution 
treatment using methadone is planned in Nepal. In 
India, measures are being implemented to harmonize 
the quality and improve the efficacy of opioid 
substitution treatment programmes that use 
buprenorphine.  
561. Ketamine, a substance not under international 
control that is increasingly being abused in East and 
South-East Asia, was previously reported to originate 
in China and other countries in that region. In recent 
years, however, ketamine of Indian origin has been 
smuggled into countries in East and South-East Asia. 
In India, the number of large seizures of ketamine has 
increased. In addition, there has been an increasing 
number of shipments of ketamine originating in India 
and illegally imported into other countries. 
 
 2. Regional cooperation 
 
562. The tenth in a series of talks at the level of Home 
Secretary between Bangladesh and India was held in 
New Delhi in November 2009. Draft bilateral 
agreements on mutual legal assistance in criminal 
matters and on combating international terrorism, 
organized crime and drug trafficking were finalized 
during those talks.  
563. In December 2009, the ministers for foreign 
affairs of Bangladesh, Bhutan, India and Sri Lanka 
participated in the twelfth ministerial meeting among 
States involved in the Bay of Bengal Initiative for 
Multi-Sectoral Technical and Economic Cooperation 
(BIMSTEC). The ministers signed the BIMSTEC 
Convention on Combating International Terrorism, 
Transnational Organized Crime and Illicit Drug 
Report of the International Narcotics Control Board  
 
88  
 
Trafficking, aimed at strengthening mutual assistance in 
investigating and suppressing transnational organized 
crime and prosecuting offenders in cases involving 
such crime.  
564. Also in December 2009, Bhutan and India signed 
a memorandum of understanding on drug demand 
reduction and the prevention of trafficking in  
narcotic drugs, psychotropic substances and precursor 
chemicals and related matters. The first meeting of a 
coordination committee composed of drug control 
officials from the two countries was held in Thimphu 
in June 2010 to discuss the implementation of the 
memorandum.  
565. In January 2010, the prime ministers of 
Bangladesh and India signed the Agreement on 
Combating International Terrorism, Organized Crime 
and Illicit Drug Trafficking. Pursuant to the agreement, 
a coordination committee composed of representatives 
of law enforcement and intelligence agencies of the 
two countries was established to extend cooperation in 
the prevention and investigation and trial of criminal 
offences such as drug smuggling. 
566. The secretaries of the interior of India  
and Myanmar held a meeting in Nay Pyi Taw in 
January 2010 and a meeting in Tawang, India, in  
June 2010, focusing on cooperation to prevent 
transnational organized crime and on measures to 
prevent the smuggling of narcotic drugs and arms 
across the border between India and Myanmar.  
567. At the third meeting of ministers of the interior of 
States members of the South Asian Association for 
Regional Cooperation (SAARC), held in Islamabad in 
June 2010, participants discussed possible measures to 
strengthen regional cooperation to combat terrorism, 
trafficking in persons and drug smuggling, including 
the formation of a regional police agency. Also in June, 
and in preparation for the SAARC meeting, the 
SAARC Drug Offences Monitoring Desk held a 
meeting at which participants emphasized the need for 
a border control management system in the region to 
be used to counter the smuggling of narcotic drugs and 
weapons. 
 
 3. National legislation, policy and action 
 
568. National seminars on the abuse of pharmaceutical 
preparations containing controlled substances were 
organized by UNODC in each of the six South Asian 
countries between May and December 2009. The 
seminars, which brought together medical practitioners 
and representatives from drug law enforcement 
agencies and the pharmaceutical industry, provided a 
forum for participants to discuss aspects of the legal, 
regulatory and law enforcement systems that should be 
strengthened in order to stem the widespread abuse of 
pharmaceutical preparations in the region. The Board 
encourages States in the region to implement the 
measures necessary to curb the abuse of and trafficking 
in pharmaceutical preparations containing controlled 
substances. 
569. The National Consultative Committee on  
De-addiction and Rehabilitation Services of India is 
formulating a national policy for the prevention of 
alcoholism and substance abuse and the rehabilitation 
of victims of such abuse. The National Consultative 
Committee, which operates under the chairmanship of 
the Minister of Social Justice and Empowerment, was 
constituted in 2008 to advise the Government of India 
on matters related to the reduction of the illicit demand 
for drugs. 
570. In August 2009, the drug control regulations of 
the State of Andhra Pradesh, India, were amended to 
facilitate access to morphine for medical purposes. The 
elaborate system of licensing in place in many states of 
India can make it difficult for health facilities to  
obtain morphine for medical purposes. In 1998, the 
Government of India issued simplified regulations for 
the provision of morphine and requested states to adopt 
them. Of the 28 states of India, Andhra Pradesh is the 
fourteenth to have complied with that request. The 
Board encourages the Government of India to continue 
to promote the adoption and implementation by states 
of the simplified regulations so as to improve the 
availability of morphine in the country.  
571. In March 2010, new administrative arrangements 
were established for allocating quotas for the 
manufacture of narcotic drugs in India with the aim of 
promoting the submission of accurate statistics and 
estimates to the Board. Previously, quotas were 
allocated to states by the central drug controller and 
were then distributed to individual manufacturers by 
the state drug controllers. The decentralized system 
made it cumbersome to collect from manufacturers 
data on narcotic drugs that must be submitted to the 
International Narcotics Control Board. Under the new 
arrangements, the authority to allocate quotas to 
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manufacturers and to collect the requisite data has been 
transferred to the Narcotics Commissioner of India.  
572. In June 2010, the Ministry of Social Justice and 
Empowerment of India launched a new module on drug 
abuse prevention for out-of-school children aimed at 
providing guidance to non-governmental organizations 
working in that area. The module was prepared by the 
Ministry in collaboration with UNODC as part of a 
project to develop national programmes for preventing 
and raising awareness about drug abuse. 
573. To devise a comprehensive action plan for 
combating the drug-related problems, the Government 
of Maldives organized a conference entitled “Maldives: 
Towards a Future without Drugs”. The conference, 
which was held in Male from 15 to 17 August 2009, 
brought together stakeholders from all segments of 
society, including legal experts, service providers, law 
enforcement officers, policymakers, recovering drug 
abusers and representatives from the private sector and 
international organizations. 
574. In January 2010, the Government of Maldives 
signed a memorandum of understanding with UNODC 
on technical cooperation to implement a programme on 
strengthening the national response to combat drug 
abuse. The programme, supported financially by the 
European Union and UNODC, aims to enhance 
capacity for drug abuse prevention and treatment in 
Maldives. The Board notes with satisfaction the 
continued efforts of the Government of Maldives to 
address the growing problem of drug abuse. 
575. In April 2010, a workshop on the development of 
comprehensive drug abuse prevention programmes in 
schools was organized in Male in the framework of the 
Drug Advisory Programme of the Colombo Plan for 
Cooperative Economic and Social Development in 
Asia and the Pacific. Teachers attending the workshop 
received training on integrating drug abuse prevention 
and life-skills education into school curricula. 
576. Act 1 of 2008 of the Convention against Illicit 
Traffic in Narcotic Drugs and Psychotropic Substances 
of Sri Lanka came into force in June 2009. The act 
translates into national law the provisions of the  
1988 Convention, to which Sri Lanka became a party 
in 1991. 
577. In June 2010, a campaign to raise young people’s 
awareness about the dangers of drug abuse was 
organized in Colombo by the National Dangerous 
Drugs Control Board of Sri Lanka in collaboration 
with the Secretariat of the Colombo Plan. The 
campaign included a ceremony during which each of 
the participants pledged to live a life free of drug 
abuse. 
 
 4. Cultivation, production, manufacture and 
trafficking  
 
  Narcotic drugs 
 
578. Cannabis plants are illicitly cultivated on a large 
scale throughout South Asia, contributing to the 
trafficking in cannabis herb and cannabis resin.  
In 2009, law enforcement authorities in Bangladesh 
seized 2.1 tons of cannabis herb. In June 2009, the 
Government of Bhutan organized an eradication 
campaign that resulted in the destruction of about  
2.5 ha of illicitly cultivated cannabis plants. In the 
same year, law enforcement authorities of India 
eradicated 4,883 ha of illicitly cultivated cannabis 
plants, about three times more than in 2008. In 
addition, 171 tons of cannabis herb and 3.5 tons of 
cannabis resin were seized in that country in 2009. In 
Nepal, the authorities eradicated at least 62 ha of 
illicitly cultivated cannabis plants and seized 16 tons of 
cannabis in 2009. The Government of Sri Lanka 
reported that in 2009 the total area under illicit 
cannabis plant cultivation was about 500 ha and that 
about 8.6 tons of cannabis had been seized in the 
country. 
579. Opium poppy is illicitly cultivated in Bangladesh, 
India and Nepal. Opium poppy eradication campaigns 
are frequently carried out by the drug law enforcement 
authorities of those countries. In 2009, such campaigns 
resulted in the eradication of 2,448 ha of illicitly 
cultivated opium poppy in India and 35 ha in Nepal. In 
addition, the seizure of about 1.45 million opium 
poppy plants was reported by Bangladesh.  
580. Trafficking in heroin, morphine and opium 
continues to pose problems in India, where, in 2009, a 
total of 1,045 kg of heroin, 42 kg of morphine and 
1,732 kg of opium were seized. Furthermore, drug law 
enforcement authorities reported seizures of more than 
4.5 tons of poppy straw. Locally produced low-grade 
heroin base known as “brown sugar” is abused in India 
and is also smuggled into other countries in South 
Asia; higher-grade heroin is smuggled through the 
region from Afghanistan and Myanmar. Courier and 
postal services continue to be widely used to smuggle 
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heroin from India. In 2009, about 21 kg of heroin were 
seized in Bangladesh, more than 14 kg were seized in 
Nepal and 34 kg were seized in Sri Lanka. 
581. Pharmaceutical preparations containing narcotic 
drugs and psychotropic substances are widely abused 
in South Asian countries. India, a country with a large 
pharmaceutical industry, is the main manufacturer of 
such preparations, which are smuggled through the 
porous borders that India shares with neighbouring 
countries. In Bhutan, authorities continue to make 
frequent seizures of pharmaceutical preparations 
containing dextropropoxyphene and codeine 
originating in India. In 2009, law enforcement 
authorities in Bangladesh seized 58,875 bottles 
containing 174 litres of codeine-based syrup, 
92 ampoules containing pethidine and morphine and 
1,617 tablets containing codeine. In Nepal, seizures of 
tablets containing codeine have increased in recent 
years. Factors contributing to the diversion of and 
trafficking in pharmaceutical preparations in the region 
include inadequate regulation of manufacturers, lax 
prescription and dispensing practices, an insufficient 
number of trained pharmacists, the presence of an 
unregulated market in some countries and weak border 
controls. 
 
  Psychotropic substances 
 
582. Seizures of pharmaceutical preparations 
containing buprenorphine have increased significantly 
in recent years in Bangladesh. In 2009, law 
enforcement authorities reported the seizure of  
18,600 ampoules containing buprenorphine, equivalent 
to more than 10 times the total quantity seized in 2006 
and about 4 times the quantity seized in 2007. The 
seizure of 4,051 tablets known as “yaba”, containing 
caffeine and methamphetamine, was also reported  
in 2009. 
583. India is one of the main sources of psychotropic 
substances sold through illegally operating Internet 
pharmacies. In 2009, the drug law enforcement 
authorities of India reported having seized more than  
1 kg of alprazolam and about 31,000 tablets of 
diazepam, phentermine and zolpidem. The tablets were 
found inside a parcel that was about to be dispatched 
through courier services. In addition, 5 kg of diazepam 
destined for London were seized in March 2010 and  
2 kg of alprazolam were seized in May 2010.  
584. In recent years, law enforcement agencies in 
India have uncovered several laboratories illicitly 
manufacturing methamphetamine. In June 2009, the 
seizure of 28 kg of methamphetamine led to the 
discovery of facilities used for the illicit manufacture 
of that substance in the State of Punjab. In  
January 2010, a methamphetamine laboratory was 
dismantled in the State of Himachal Pradesh and 18 kg 
of methamphetamine were seized on the premises. In 
August 2010, law enforcement agencies discovered 
two clandestine methamphetamine laboratories in 
Mumbai, India, and seized large quantities of 
methamphetamine and its precursors ephedrine and 
pseudoephedrine on the premises.  
585. The total amount of amphetamine seized by law 
enforcement authorities in India more than doubled 
between 2008 and 2009, reaching 41 kg in 2009. 
 
  Precursor chemicals 
 
586. Seizures of acetic anhydride continue to be made 
in India. In 2009, about 1,038 litres of that chemical 
were seized, representing about one third of the amount 
seized in the previous year.  
587. In India, ephedrine and pseudoephedrine, which 
are used in the illicit manufacture of amphetamine-type 
stimulants, are either diverted from the licit 
manufacturing industry or produced illicitly. In 
November 2009, Indian law enforcement agencies 
dismantled a laboratory where ephedrine had been 
illicitly manufactured, seizing 82.5 kg of ephedrine on 
the premises. In the course of 2009, a total of 1.2 tons 
of ephedrine were seized in India. In 2009, there were 
reports of large shipments of ephedrine and 
pseudoephedrine tablets originating in India that were 
seized while being smuggled through countries in 
Central America and South America and that had been 
destined for Mexico, where methamphetamine is 
illicitly manufactured on a large scale. 
588. Criminal networks are increasingly targeting 
Bangladesh as a source of pharmaceutical preparations 
containing pseudoephedrine. Pseudoephedrine from 
India is formed into tablets in Bangladesh before being 
sent to countries in Central America and the Caribbean. 
Examples of large seizures of pseudoephedrine tablets 
originating in Bangladesh in 2009 include the seizure 
of more than 2 million tablets in Honduras and the 
seizure of about 400,000 tablets in the Dominican 
Republic. 
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  Substances not under international control 
 
589. India has become one of the main sources of 
ketamine that is smuggled into East and South-East 
Asia, where there is high demand for the substance 
among drug abusers. In 2009, more than 1 ton of 
ketamine was seized in India. Ketamine shipments 
have been uncovered at several major airports in India, 
in sea containers and in parcels sent through courier or 
postal services. The number and size of the ketamine 
seizures made in India and of the seized shipments of 
ketamine originating in India have increased 
significantly in recent years. Two large seizures of 
ketamine, weighing 300 and 440 kg, were made  
in India during the last two months of 2009. In 
December 2009, 147 kg of ketamine were seized at 
Port Klang, Malaysia, in a sea container originating in 
India. In January 2010, a shipment of 254 kg of 
ketamine destined for Taiwan Province of China was 
seized in Bangalore, India. The Board urges the 
Government of India to strengthen measures to prevent 
the smuggling of ketamine from its territory. 
 
 5. Abuse and treatment  
 
590. In Bangladesh, treatment services for drug 
abusers are provided by the Government in four 
treatment centres and at three institutions operating 
within the prison system. Buprenorphine, cannabis  
and heroin are the substances most commonly  
reported as the main drug of abuse among patients  
registered in governmental treatment facilities. In 
2009, 3,793 patients, only four of whom were women, 
were treated for drug abuse by the Government. 
591. The first national baseline survey of drug abuse 
in Bhutan was conducted in 2009 by the Bhutan 
Narcotic Control Agency in collaboration with the 
Ministry of Health and UNODC. The survey was based 
on interviews with 991 drug abusers from 14 districts 
and on questionnaires completed by 20,757 students in 
60 schools throughout the country. Among the drug 
abusers interviewed outside the school setting, the 
lifetime prevalence rates were 96 per cent for cannabis 
abuse and 14 per cent for heroin abuse. The lifetime 
prevalence rates for the abuse of pharmaceutical 
preparations containing codeine, nitrazepam and 
dextropropoxyphene were 47 per cent, 34 per cent and 
61 per cent, respectively. Of the drug abusers,  
11 per cent reported having abused by injection either 
heroin or heroin in combination with buprenorphine 
and dextropropoxyphene. Among students, lifetime 
prevalence of abuse of cannabis was 9.7 per cent, 
whereas the prevalence rates for daily abuse of 
cannabis and pharmaceutical preparations were  
0.6 per cent and 0.3 per cent, respectively.  
592. In Bhutan, drug abusers can receive 
detoxification treatment in the psychiatric ward of a 
major hospital in Thimphu. The Government also 
operates four drop-in centres for drug and alcohol 
abusers that provide information about drug abuse, as 
well as peer-led counselling and referrals to medical 
facilities. In August 2009, the Government opened a 
treatment and rehabilitation centre for drug and alcohol 
dependents in Thimphu, the first of its kind in the 
country. In addition, guidelines on the operation of 
treatment and rehabilitation centres and drop-in centres 
were published by the Government. The Board notes 
with satisfaction the progress made in providing 
treatment services for drug abusers in Bhutan. 
593. The latest national household survey in India was 
conducted during 2000 and 2001; more recent 
information on national prevalence of drug abuse is not 
available. In 2008, the National Sample Survey Office 
of India was tasked with undertaking a national survey 
on drug abuse. The office produced a report on 
methodology for the national survey in 2009 and 
initiated pilot surveys in selected states at the 
beginning of 2010. The Board notes with satisfaction 
the steps taken by the Government of India towards 
obtaining up-to-date information about the national 
prevalence of drug abuse. 
594. In India, treatment and rehabilitation services for 
drug abuse are mainly provided by non-governmental 
organizations, which operate 376 treatment and 
rehabilitation centres and 68 counselling and 
awareness-raising centres nationwide. In 2008 and 
2009, about US$ 5 million were allocated by the 
Government to support those organizations under the 
Scheme of Assistance for Prevention of Alcoholism 
and Substance (Drug) Abuse and for Social Defence 
Services. In 2009, the Government also published a 
manual of minimum standards for programmes to 
provide guidance to organizations funded through the 
Scheme.  
595. In Sri Lanka, cannabis, heroin and opium are the 
most frequently abused drugs. In 2009, 2,975 patients 
were admitted for drug abuse treatment: 80 per cent of 
the patients received treatment at one of four treatment 
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centres operated by the Government of Sri Lanka,  
18 per cent were admitted to treatment programmes 
operating within the prison system and 2 per cent 
received treatment through rehabilitation programmes 
operated by a number of non-governmental 
organizations.  
596. In India, opioid substitution treatment using 
buprenorphine is currently available to 4,800 drug 
abusers in 52 centres operated by non-governmental 
organizations. To increase and harmonize the quality of 
services provided to drug abusers, the Government has 
developed guidelines on standard operating procedures 
for substitution treatment using buprenorphine and an 
accreditation procedure for facilities providing such 
treatment to drug abusers. A curriculum for training 
health professionals in opioid substitution treatment is 
being developed in cooperation with UNODC. 
597. Several countries in South Asia are planning to 
initiate or expand programmes to provide opioid 
substitution treatment using methadone. In Bangladesh, 
a one-year pilot study with 300 patients, conducted in 
collaboration with UNODC, was initiated in July 2010. 
In 2009, the Government of India approved a pilot 
programme to study the efficacy of substitution 
treatment using methadone that will be implemented in 
five health facilities across the country in collaboration 
with UNODC. In Nepal, substitution treatment using 
methadone is provided by the Government to about 
250 drug abusers, and two new centres serving  
300 new patients will open in 2010. 
 
 
  West Asia 
 
 
 1. Major developments 
 
598. In West Asia, the total area under illicit opium 
poppy cultivation, after decreasing in 2008 and 2009, 
remained stable in 2010 at 123,000 ha, but illicit opium 
production declined to almost half the quantity 
reported for 2009. That sharp decline was due to lower 
yields per hectare, a consequence of a fungus affecting 
opium poppy plants, frost and drought. The number of 
Afghan provinces free of opium poppy remained 
unchanged in 2010. However, as opium prices are 
rising sharply, there is a risk that Afghan farmers may 
choose to grow more opium poppy in 2011.  
599. In 2010, the Government of Afghanistan, with the 
support of UNODC, completed a survey of drug use in 
Afghanistan and a survey on cannabis production. The 
2009 Afghanistan drug use survey found that illicit 
drug use has increased across the country, with 
dramatic increases in the abuse of opium, heroin and 
other opiates. There are nearly 1 million drug abusers 
among the population of Afghanistan aged 15-64. 
Compared with the findings of a survey conducted in 
2005, opium use increased by 53 per cent, while heroin 
use increased by 140 per cent. According to the first-
ever survey of cannabis in Afghanistan,39 conducted by 
UNODC in 2009, Afghanistan could be the world’s 
largest producer of cannabis resin (“hashish”). Up to 
630,000 adults in Afghanistan, mostly men, use 
cannabis on a regular basis.  
600. The southern Caucasus is increasingly being used 
as a transit area for consignments of opiates from 
Afghanistan, and as a result, drug abuse is on the rise 
in the subregion. Given the long borders that countries 
of that subregion share with Iran (Islamic Republic of), 
the Russian Federation and Turkey and their access to 
the Black Sea and the Caspian Sea, the Board remains 
concerned that the situation with regard to drug 
trafficking and abuse in Armenia, Azerbaijan and 
Georgia may continue to deteriorate unless increased 
attention is given to information-sharing, more 
efficient border control, drug demand reduction and 
regional and national coordination of drug control 
activities. 
601. Various sources indicate that cannabis plants 
continue to be illicitly cultivated in Iraq and the Bekaa 
valley of Lebanon, although recent eradication efforts, 
coupled with campaigns to discourage new cultivation 
of cannabis plants, have led to positive results in 
Lebanon. Various reports show an increase in drug 
abuse and drug-related cases and arrests, mainly 
involving cannabis, heroin and so-called Captagon 
tablets, in countries in that area. 
602. Although information on trends is limited owing 
to a lack of appropriate systems for monitoring drug 
abuse, the drug abuse situation in the Middle East is 
undoubtedly worsening, and abuse of all kinds of drugs 
has become a growing problem, as shown by indirect 
indicators such as HIV and hepatitis C infection rates, 
which are increasing in the region, particularly among 
__________________ 
 39  United Nations Office on Drugs and Crime, Afghanistan 
Cannabis Survey 2009 (April 2010). 
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persons who abuse drugs by injection and the prison 
population. 
603. In the Islamic Republic of Iran, the illicit traffic 
in methamphetamine appears to have reversed 
direction. In the period 2007-2008, methamphetamine 
was smuggled into the Islamic Republic of Iran  
from China and Malaysia; in 2008, methamphetamine 
was smuggled out of the country to countries such  
as Indonesia, Japan, Malaysia, New Zealand and 
Thailand. 
604. Non-medical use of prescription drugs, in 
particular tranquillizers and sleeping tablets, is 
increasing in some countries in the Middle East. 
Substances often reported to have been  
obtained without the required medical prescription 
include preparations containing methylphenidate, 
pseudoephedrine, tramadol and benzodiazepines such 
as diazepam. 
605. According to the World Custom Organization, 
large seizures of khat have been reported in the 
subregion, in particular in Qatar, where the biggest 
seizure, amounting to 3 tons, was detected in a road 
freight consignment arriving from Kuwait.  
 
 2. Regional cooperation 
 
606. The main outcome of the London Conference on 
Afghanistan, held on 28 January 2010, with the 
participation of more than 70 countries and 
international organizations, was the call for Afghan 
ownership and leadership in implementing the strategy 
in the areas of security, economic development, 
governance and counter-narcotics. Participants in the 
conference emphasized, among other things, the links 
existing between trafficking in narcotic drugs, the 
insurgency and other criminal activities, including 
corruption and trafficking in persons. In that 
connection, participants welcomed the updating of the 
National Drug Control Strategy by the Government of 
Afghanistan, the continuation of the “Paris-Moscow” 
process in countering the illicit production and 
consumption of and trafficking in narcotic drugs and 
the elimination of opium poppy crops and illicit drug 
laboratories and storage facilities, and welcomed the 
“whole-of-government” approach taken by the 
Government of Afghanistan in fighting corruption. 
607. The special conference on Afghanistan held in 
Moscow on 27 March 2010, under the auspices of the 
Shanghai Cooperation Organization, focused on the 
impact that the situation in Afghanistan has on 
neighbouring countries and on identifying ways to 
jointly confront regional threats such as terrorism,  
drug trafficking and organized crime. Conference 
participants included ministers of the States members 
of the Shanghai Cooperation Organization and 
representatives of States members of the Group of 
Eight, Iran (Islamic Republic of), Turkey and 
Turkmenistan, the United Nations, the Collective 
Security Treaty Organization (CSTO), the Organization 
for Security and Cooperation in Europe (OSCE), the 
European Union and the North Atlantic Treaty 
Organization (NATO). Participants in the conference 
recognized that, as a direct result of the inability of the 
Government of Afghanistan to control its borders, Iran 
(Islamic Republic of), Pakistan and countries of 
Central Asia, through which Afghan opiates are 
predominantly smuggled, face a wide range of 
problems related to large-scale drug trafficking, such 
as organized crime, corruption and the highest rates of 
abuse of opiates in the world. 
608. An international forum entitled “Drug Production 
in Afghanistan: A Challenge to the International 
Community” was held in Moscow on 9 and 10 June 
2010. The President of the Russian Federation opened 
the forum, which was attended by heads of national 
drug control and law enforcement agencies, national 
experts and representatives from international 
organizations, CSTO, NATO and the Shanghai 
Cooperation Organization. The forum focused on 
stepping up the fight against trafficking in drugs from 
Afghanistan. The President of the Board and the 
Executive Director of UNODC addressed the forum.  
609. The international Kabul Conference held on  
20 July 2010 brought together representatives of more 
than 60 States, including 40 ministers for foreign 
affairs, and 11 regional and international organizations 
to discuss Afghanistan’s development, governance and 
stability, deliberate and endorse 15 national priority 
programmes for socio-economic development and 
increasingly transfer greater responsibility for the 
management of funds to the Afghan Administration. 
The Kabul Conference was the first international 
meeting on Afghanistan held in the country. 
Subsequent to the Conference, the Ministry of Counter-
Narcotics of Afghanistan is updating the National Drug 
Control Strategy. The Board supports this Afghanistan-
led process, which is aimed at accelerating Afghan 
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leadership and ownership, strengthening international 
partnerships and regional cooperation, improving 
governance in Afghanistan.  
610. The Governments of Afghanistan, Iran (Islamic 
Republic of) and Pakistan are intensifying their 
regional cooperation through the Triangular Initiative, 
aimed at joint implementation of the strategic  
policy outline, developed by UNODC, through projects 
for joint border cooperation. On 4 August 2010, 
representatives of the competent authorities of 
Afghanistan, Iran (Islamic Republic of) and Pakistan 
met in Tehran for the fourth meeting of senior  
officials. The topics of discussion included joint and 
simultaneous operations of the Joint Planning Cell, 
establishment of border liaison offices and lessons 
learned from the pilot border liaison offices in 
Afghanistan, Iran (Islamic Republic of) and Pakistan. 
Meeting participants examined the current status of 
cross-border communications, including the results of 
the fourth cross-border communications expert 
meeting, held in Tehran on 25 and 26 May 2010.  
611. At a meeting in Doha in February 2010, the heads 
of the drug law enforcement agencies of Iran (Islamic 
Republic of) and Qatar emphasized the expansion of 
mutual cooperation in fighting drug trafficking. Both 
sides expressed their readiness to continue and deepen 
cooperation between the two countries at the expert 
level and to exchange intelligence. 
612. In November 2009, the Governments of 
Afghanistan and Pakistan met in Kabul to review 
progress made under the Dubai Process, an initiative 
facilitated by the Government of Canada and aimed at 
increasing cooperation between Afghanistan and 
Pakistan in key areas including counter-narcotics. The 
discussion focused mainly on activities related to 
border liaison offices, precursor chemicals, treatment 
for drug abuse, community engagement, joint 
operations and equipment and training. In April 2010, 
at a follow-up session of the Dubai Process, the 
Governments of Afghanistan and Pakistan reviewed the 
status of the modernization of key border crossing 
points as part of the development of a comprehensive 
border management strategy. 
613. Governments of countries in Central Asia are 
increasing their bilateral and multilateral cooperation 
in areas such as the reduction of illicit drug supply and 
demand, precursor control, border management, 
countering the spread of HIV/AIDS and fighting 
organized crime and money-laundering. They have also 
been participating in various regional projects and 
international operations under the auspices of the 
Commonwealth of Independent States, CSTO, the 
Shanghai Cooperation Organization and the States 
signatories of the 1996 Memorandum of Understanding 
on Subregional Drug Control Cooperation (Azerbaijan, 
Kazakhstan, Kyrgyzstan, the Russian Federation, 
Tajikistan, Turkmenistan and Uzbekistan). Similarly, 
an increasing number of joint programmes are being 
implemented and supported by the United Nations, the 
European Union, OSCE, the World Bank, the World 
Customs Organization, INTERPOL, the Paris Pact 
Policy Consultative Group, the NATO-Russia Council, 
mini-Dublin groups and individual Governments. 
614. Following the entry into force of the framework 
agreement on the establishment of the Central Asian 
Regional Information and Coordination Centre 
(CARICC), in 2010, Azerbaijan, Kazakhstan, 
Kyrgyzstan, the Russian Federation, Tajikistan, 
Turkmenistan and Uzbekistan continued their 
cooperation in countering trafficking in narcotic drugs, 
psychotropic substances and precursors. The Board 
encourages the Governments involved to further 
enhance their joint activities and to include other 
countries in West Asia and the Caucasus, in order to 
ensure greater cooperation in collecting, exchanging 
and analysing drug-related intelligence, organizing and 
coordinating joint operations, promoting training and 
carrying out other efforts to reduce illicit drug supply 
in West Asia. 
615. A meeting organized within the framework of the 
second phase of the UNODC operation called Targeted 
Anti-trafficking Regional Communication, Expertise 
and Training (Operation TARCET) was held in Almaty, 
Kazakhstan, on 30 and 31 March 2010. The meeting 
was hosted by CARICC. The main objectives of the 
second phase of the operation (TARCET II) were to 
reveal and dismantle channels for the smuggling of 
precursors to Afghanistan. During the operation, the 
competent authorities of Afghanistan, Kazakhstan, 
Kyrgyzstan and Pakistan and the International Security 
Assistance Force in Afghanistan seized more than  
440 tons of precursors under international control. 
616. The exchange of operational information is 
essential for the successful apprehension of members 
of drug trafficking organizations, and joint measures 
taken by the Governments of countries in West Asia to 
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combat drug trafficking have continued to produce 
good results. In 2009, there were numerous meetings 
and joint operations with Turkey and other countries  
in the region such as Iran (Islamic Republic of) and the 
Syrian Arab Republic, as well as with European 
countries such as Bulgaria, Germany and the 
Netherlands. 
617. The Governments of 18 Arab countries are 
working with UNODC on the development and 
implementation of a regional programme framework to 
address problems related to drugs and crime for the 
period 2011-2015. The programme was reviewed at a 
regional expert group meeting held in Egypt in  
April 2010, organized jointly with the League of Arab 
States and the Government of Egypt. The main 
objectives of the programme are countering trafficking, 
organized crime and terrorism; promoting integrity and 
strengthening justice systems; and drug abuse 
prevention and health. The regional programme will be 
presented to the Ministerial Council of the League of 
Arab States at the end of 2010 for adoption. 
618. A regional forum for 16 countries of the Middle 
East and North Africa, hosted by the United Arab 
Emirates, was held in Dubai in June 2010. The main 
objective of the forum was to enhance cooperation 
among law enforcement agencies and treatment centres 
in the region. At the meeting, participants adopted a set 
of recommendations, shared with the Council of Arab 
Ministers of the Interior, and highlighted the 
importance of the establishment and implementation of 
shared training programmes for law enforcement 
officers, in the areas of border control, sharing of 
intelligence and controlled deliveries.  
619. Enhanced cooperation in the form of meetings 
and the exchange of information and involving 
countries such as Jordan, Saudi Arabia, the Syrian Arab 
Republic and Turkey has proved effective, resulting in 
significant drug seizures in 2009. Joint operations 
involving Iran (Islamic Republic of) and Turkey have 
led to important seizures of heroin. In a similar 
fashion, cooperation between the Syrian Arab Republic 
and Turkey has proved effective in countering 
trafficking in cannabis originating in the Syrian Arab 
Republic. Controlled deliveries involving Jordanian 
authorities and their counterparts in Saudi Arabia and 
the Syrian Arab Republic have resulted in significant 
drug seizures. 
620. At its twenty-seventh session, held in Tunisia in 
March 2010, the Council of Arab Ministers of the 
Interior approved phased plans for the implementation 
of joint strategies to fight illicit drug use, terrorism, 
corruption, money-laundering, cybercrime and 
transnational organized crime. The Council recognized 
the threat posed to the region by drug trafficking and 
organized crime and reaffirmed the necessity of 
unifying their efforts and the need to develop security 
techniques and enhance regional and international 
cooperation. 
621. The Board notes with appreciation the 
establishment in Doha by the Cooperation Council for 
the Arab States of the Gulf of a criminal information 
centre for combating drug-related problems. The 
centre, which will be opened by the end of 2010, is to 
reinforce the concerted efforts of member States of the 
Cooperation Council to support work in areas such as 
preventing the spread of drug abuse. 
 
 3. National legislation, policy and action 
 
622. The Government of Pakistan has approved a new 
drug control policy for 2010 in an effort to re-energize 
existing drug law enforcement institutions. The new 
policy seeks to promote international cooperation and 
regional partnership in tackling drug-related problems 
and emphasizes the need to control the problem at the 
source, in countries where opium poppy is grown. The 
strategy states that socio-economic factors should be 
taken into consideration and be addressed through 
rapid industrialization and the establishment of 
alternative development projects in areas where opium 
poppy is grown. The new policy aims to strengthen law 
enforcement agencies and streamline their activities 
and, at the same time, to enhance drug demand 
reduction and prevention efforts through education and 
community mobilization campaigns. The new policy 
also envisages the development of systems to provide 
effective and accessible treatment and rehabilitation for 
drug abusers and the conduct of a survey to determine 
the prevalence of drug abuse in the country. 
623. In 2009, the Government of Jordan enacted a new 
regulation on prescriptions and records for narcotic 
drugs, psychotropic substances and preparations 
containing controlled substances that are used in 
hospitals and specialized clinics. Similar administrative 
measures were taken in Bahrain. The authorities of 
Bahrain established drug control offices in various 
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parts of the country, enhanced collaboration with drug 
law enforcement agencies of Arab countries through 
joint training sessions held within national structures. 
At the national level, the authorities organized various 
exhibitions and lectures in order to raise public 
awareness of the danger of drug abuse. 
624. In Iraq, the Ministry of Health has established a 
national drug control committee, headed by the 
Minister of Health, which will act as a coordinating 
body for drug control activities carried out by the 
ministries of the interior, education, justice and labour. 
A database will be established for collection of 
information from health institutions. Drug control 
legislation prepared by the Ministry of Health is in the 
process of adoption by the Parliament. The Board 
welcomes those positive developments in drug control 
in Iraq and encourages the Government to take further 
steps to ensure that a national drug control strategy is 
developed and implemented as soon as possible.  
625. Ten years ago, the Board, having determined that 
Afghanistan had become by far the world’s largest 
illicit producer of opium and that that situation 
seriously endangered the aims of the 1961 Convention, 
invoked article 14 of that Convention with respect to 
Afghanistan, calling the attention of the States parties 
to the 1961 Convention, the Economic and Social 
Council and the Commission on Narcotic Drugs to the 
grave situation in Afghanistan. The Board stresses that 
limited progress has been made in the past decade in 
eliminating the impact of Afghan opium. Effective 
action to counter the threat posed by Afghan opium and 
to support the Government of Afghanistan requires 
close regional cooperation and a coalition of all forces 
at the national, regional and international levels. The 
Board recognizes that addressing the serious situation 
in Afghanistan should not be the burden of the 
Government of Afghanistan alone: it should be a 
shared responsibility, and it requires the full support 
and cooperative action of the international community. 
 4. Cultivation, production, manufacture and 
trafficking 
 
  Narcotic drugs 
 
626. According to the Afghanistan Opium Survey 
2010: Summary Findings, published by UNODC in 
September 2010, the illicit cultivation of opium poppy 
in Afghanistan in 2010 remained at the same level as  
in 2009. However, in 2010, the spread of a disease that 
affected opium poppy plants in the main growing 
provinces resulted in the yield per hectare declining 
sharply, by 48 per cent compared with 2009, and illicit 
opium production decreasing to 3,600 tons, slightly 
more than half the quantity reported for 2009. 
627. Almost all of the illicit opium poppy cultivation 
in Afghanistan remained concentrated in the southern 
and western parts of the country. Helmand remained 
the province with the largest area under illicit opium 
poppy cultivation in 2010, accounting for 53 per cent 
of the total area under such cultivation; it was followed 
by Kandahar (21 per cent). The number of provinces 
free of opium poppy in 2010 was the same as in 2009 
(20 provinces), and the northern region maintained the 
poppy-free status it had achieved in 2009.  
628. As of March 2010, there was an increase in prices 
of fresh and dry opium, both at the farm-gate level  
and at the trader level in Afghanistan. According to 
UNODC, the national average price for dry opium in 
Afghanistan at the farm-gate level in September 2010 
reached US$ 207 per kilogram. That represents a 
marked increase compared with the price in  
September 2009 (US$ 78 per kilogram) and the highest 
price since December 2004.  
629. UNODC estimated that at the end of 2009, opium 
stockpiles in Afghanistan and neighbouring countries 
totalled some 12,000 tons, equivalent to 2.5 years of 
global illicit demand for opiates. The fact that illicit 
opium production decreased significantly in 2010 does 
not mean that illicit heroin manufacture will also fall 
by any significant amount, as there are sufficient 
stocks of opium available. 
630. There remains a strong link between security 
conditions and illicit opium poppy cultivation in the 
southern provinces of Afghanistan. Information 
collected by UNODC indicates that the overwhelming 
majority of villages with poor security are involved in 
such cultivation. Drug traffickers and other criminal 
groups encourage villagers to grow opium poppy, 
ensuring the protection of their opium poppy fields 
and, in some cases, using threats and intimidation to 
force the villagers to engage in illicit opium poppy 
cultivation.  
631. Information released by UNODC in August 2010 
indicates that 2,316 ha of illicitly cultivated opium 
poppy were eradicated in Afghanistan through the 
Governor-led opium poppy eradication campaign, an 
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area 57 per cent less than the area eradicated in 2009 
(5,351 ha) and 88 per cent less than the peak reached in 
2007 (19,510 ha). Although the greatest area of illicitly 
cultivated opium poppy eradicated in 2010 was that 
reported for Helmand (1,602 ha, or 69 per cent of the 
total area), that amount is miniscule compared with the 
total area under illicit opium poppy cultivation in that 
province (65,045 ha). 
632. Afghanistan has emerged as one of the main 
countries in which cannabis plants are illicitly 
cultivated, as evidenced by the outcome of the first 
ever cannabis survey in Afghanistan. Illicit cultivation 
of cannabis plant takes place on a large scale in 17 of 
the 34 provinces in Afghanistan, and the area under 
such cultivation is estimated at 10,000-24,000 ha, 
indicating a production capacity of between 1,500 and 
3,500 tons of cannabis resin per year. The extremely 
high yield of cannabis resin in Afghanistan (about  
145 kg per hectare) is more than three times the yield 
in Morocco (40 kg per hectare). In 2009, 67 per cent of 
farmers growing cannabis plants also grew opium 
poppy.  
633. The campaign against drug trafficking in 
Afghanistan was much more successful than the illicit 
crop eradication campaigns in the country. From  
April 2009 to March 2010, the law enforcement 
authorities of Afghanistan reported 397 cases of drug 
trafficking and seized 2.5 tons of heroin, over 7.5 tons 
of morphine, more than 59 tons of opium, more than  
23 tons of cannabis resin, more than 417.5 tons of solid 
precursor chemicals and almost 40,000 litres of liquid 
precursor chemicals. 
634. The Board once again urges the Government of 
Afghanistan, as well as the international community, to 
take effective measures to eradicate illicit opium poppy 
cultivation and ensure that opium poppy growers  
are provided with legitimate livelihoods that are 
sustainable. The Board wishes to emphasize that 
eradication of illicit opium poppy cultivation in 
Afghanistan will require a sustained effort. 
635. Afghan opiates are smuggled predominantly 
through Iran (Islamic Republic of), Pakistan and 
countries in Central Asia. Those countries are faced 
with a wide range of problems related to large-scale 
drug trafficking, such as organized crime, corruption 
and relatively high illicit demand for opiates.  
636. In the Islamic Republic of Iran, there is no 
significant illicit cultivation of opium poppy. However, 
as the route through the Islamic Republic of Iran is one 
of the shortest routes for smuggling Afghan opiates 
into European countries, it remains the main route used 
by drug traffickers; an estimated 140 tons of Afghan 
heroin is smuggled through the country each year. 
Accordingly the Islamic Republic of Iran continues to 
be the country in which more opiates are seized than in 
any other country in the world. In 2009, the seizures of 
opium (579 tons), heroin (23.4 tons) and morphine 
(16.1 tons) represented increases of 300 per cent, 
113 per cent and 60 per cent compared with 2008. 
637. Pakistan continues to be used by drug traffickers 
as a major transit area for shipments of Afghan opiates. 
According to UNODC estimates, up to 40 per cent  
of the opium produced in Afghanistan transits or is 
abused in Pakistan. From 2007 to 2009, that amounted 
to roughly 8,800 tons of opium or its equivalent when 
refined into morphine and heroin.  
638. In Pakistan, Government data for 2009 show  
a decrease in the amount of opium seized (from 28 to 
25 tons) and the amount of morphine seized (from  
7 to 2 tons), compared with the data for 2008. The 
amount of seized heroin increased marginally, from  
1.9 to 2 tons, whereas the amount of seized cannabis 
increased sharply by 52 per cent, from 134.6 tons in 
2008 to 204.5 tons in 2009.  
639. Illicit cultivation of opium poppy continues to 
take place on a small scale in several countries in 
Central Asia and the southern Caucasus. The illicitly 
produced opium is mostly used locally, though a 
relatively small portion of it is smuggled into the 
Russian Federation.  
640. Trafficking in narcotic drugs along the northern 
route, through Central Asia, persists: it is estimated 
that up to 25 per cent of Afghan opiates passed through 
Central Asia in 2009. However, drug seizures in the 
subregion have followed a significant downward trend. 
In 2009, the total amount of drugs seized in the  
Central Asian countries of Kazakhstan, Kyrgyzstan  
and Tajikistan and in Azerbaijan decreased by  
13.4 per cent, from 49.9 tons in 2008 to 43.2 tons in 
2009. In particular, the amount of seized heroin 
decreased by 34.4 per cent, from 3.7 tons in 2008 to 
2.4 tons in 2009. 
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641. This downward trend appears to have continued 
in 2010. In the first three months of 2010, the total 
amount of heroin seized in Central Asia decreased by 
26 per cent compared with the same period in 2009 
(from 897 to 662.5 kg). The amount of seized heroin 
decreased in Kazakhstan by 60 per cent, in Kyrgyzstan 
by 64 per cent and in Uzbekistan by 60 per cent. Only 
Tajikistan reported an increase in seizures of heroin, of 
33 per cent, from 266 kg to 353 kg. 
642. Compared with 2008, there was a decrease of  
54 per cent in the amount of heroin seized in 
Kazakhstan (from 1.6 tons to 731 kg) and 31 per cent 
decrease in Tajikistan (from 1.6 tons to 1.1 tons), 
although those two countries still accounted for  
76 per cent of the total amount of heroin seized in 
Central Asia. The amount of heroin seized in 
Kyrgyzstan increased by 14 per cent (from 299 kg to 
341 kg) and Azerbaijan by 63 per cent (from 144 kg to 
235 kg). 
643. The total amount of opiates seized in Central Asia 
and Azerbaijan decreased by 27 per cent, from almost  
6 tons in 2008 to 4.4 tons in 2009. 
644. According to official reports, the law 
enforcement authorities of Tajikistan seized 2 tons of 
drugs in the first six months of 2010, nearly a third less 
than the amount seized in the same period of 2009. 
Heroin accounted for more than a quarter of the drugs 
seized (540 kg). Damage to the opium poppy crop 
caused by a fungus was one of the main reasons for the 
decline. 
645. The unstable political situation, mountainous 
landscape and weak border controls, exacerbated by 
conflicts that exist in some parts of the southern 
Caucasus, contribute to the spread of all kinds of 
criminal activities, such as illegal immigration, illicit 
drug crop cultivation, trafficking and money-
laundering. 
646. A total of 811 drug-related crime cases linked to 
the illicit distribution of narcotic drugs, psychotropic 
substances and precursors were registered in Armenia 
in the first half of 2010, a 50-per-cent increase over the 
same period in 2009. 
647. The Middle East, including the Arabian 
Peninsula, is mainly used as a transit area for 
smuggling heroin from Afghanistan into Arab 
countries. Cocaine originating in South America 
reaches the subregion through Europe.  
648. Cannabis remains the most widely abused drug in 
the Middle East, including the Arabian Peninsula, 
where the cannabis plant is illicitly cultivated in many 
countries, such as Iran (Islamic Republic of), Iraq, 
Lebanon, the Syrian Arab Republic and Turkey. In 
Turkey, 25 per cent more cannabis was seized in 2009 
than in 2008, and some of that cannabis may have 
originated in rural areas of the country. 
649. The illicit drug most seized in Jordan, by amount, 
is cannabis, followed by heroin and Captagon tablets. 
There has recently been an increase in the number of 
cocaine shipments seized in Jordan after having 
transited Europe; the shipments had been destined for 
Israel and Lebanon.  
650. According to the World Customs Organization, a 
total of 3 tons of cannabis resin were seized in the 
Middle East in 2009. In Yemen, the largest single 
seizure of cannabis resin amounted to 2.4 kg and was 
concealed in a seafreight shipment from Pakistan. 
Cannabis resin seized in Kuwait originated in Iraq. The 
Lebanese customs authorities uncovered at a seaport  
85 kg of cannabis resin that had been destined for the 
Netherlands. 
651. Although the number of heroin seizures remained 
stable in the Middle East, there was an increase in the 
quantity seized. The two largest seizures of heroin in 
the subregion in 2009 were reported in Jordan (70 kg) 
and Bahrain (34 kg). The heroin shipment seized in 
Jordan had arrived from the Syrian Arab Republic by 
road and had been destined for Saudi Arabia. The 
heroin shipment seized in Bahrain had departed from 
the United Arab Emirates and had transited Saudi 
Arabia.  
652. Heroin from Afghanistan continues to be 
smuggled into European countries via the Balkan, 
northern Black Sea and Eastern European routes. 
Seizures of opiates originating in Afghanistan have 
been reported by the law enforcement agencies of 
Turkey. In Turkey, nearly 98 per cent of the opium 
seizures take place in provinces bordering the Islamic 
Republic of Iran or in the city of Istanbul. The amount 
of heroin seized in Turkey increased to 15.4 tons  
in 2008.  
 
  Psychotropic substances 
 
653. In the Islamic Republic of Iran, the abuse of 
amphetamine-type stimulants has grown dramatically 
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and has led to some major drug trafficking. The 
amount of seized amphetamine-type stimulants reached 
2.4 tons in 2009, an increase of 60 per cent over the 
previous year.  
654. Trafficking in and abuse of amphetamine-type 
stimulants in the Middle East continue to  
increase. Reports indicate that laboratories illicitly 
manufacturing Captagon tablets have continued to be 
dismantled in the subregion, in particular in Saudi 
Arabia and the Syrian Arab Republic. The Middle East 
is the subregion in which the largest amount of 
amphetamine-type stimulants is seized. 
655. Reports of amphetamine seizures in countries in 
the Middle East continue to refer predominantly to 
tablets sold as Captagon. Although it is not always 
clear which psychoactive ingredients are contained in 
such tablets, reports suggest that the main component 
is amphetamine smuggled from South-Eastern Europe 
and that such tablets frequently contain caffeine. 
Analysis of Captagon tablets seized in Iraq confirmed 
that they contained between 7 and 20 milligrams of 
amphetamine and other ingredients such as caffeine 
and theophylline and not fenetylline. 
656. In addition to opiates, cannabis and cocaine, 
synthetic drugs, including pharmaceutical preparations, 
in particular tablets containing amphetamine sold as 
Captagon, are reported to be readily available in  
Iraq. Synthetic drugs are illegally exported to the 
country by mixing them among consignments of licit 
pharmaceutical products. 
657. Captagon tablets containing amphetamine that are 
illicitly manufactured in laboratories in the Syrian Arab 
Republic and Turkey are smuggled into Saudi Arabia, 
the largest illicit market for Captagon, and Iraq. In 
2009, a laboratory illicitly producing Captagon tablets 
from amphetamine was discovered in Istanbul, Turkey. 
In the operation, more than 2 million Captagon tablets 
and the tabletting press were seized, as reported by 
Government sources.  
658. Saudi Arabian customs authorities detected more 
than 13 tons of amphetamine in 2009; the largest 
seizure (2.5 tons) took place at the border with Jordan. 
Most of the amphetamine seized in Saudi Arabia had 
been sent from Jordan; the Syrian Arab Republic and 
Egypt, in descending order, were also important source 
countries. 
659. According to INTERPOL, in 2009, there was a 
significant increase in seizures of methamphetamine 
(in crystalline and liquid form) with links to the 
Islamic Republic of Iran. In 12 cases, the seized 
methamphetamine had originated in the Islamic 
Republic of Iran; however, some countries in the 
region, such as Qatar, Turkey and the United Arab 
Emirates, were frequently used as countries of 
departure or transit countries. Indonesia, Japan, 
Malaysia, New Zealand and Thailand were identified 
as countries of destination. 
660. The non-medical use of prescription drugs, as 
well as psychoactive substances not under international 
control, in particular tranquillizers and sleeping tablets, 
is increasing in some countries in the Middle East. In 
Israel, according to the 2009 national survey on illegal 
use of drugs and alcohol, substances obtained without 
medical prescription include preparations containing 
diazepam, methylphenidate and pseudoephedrine. 
There is also increased abuse of cathinone (“hagigat”) 
tablets, in particular among students. In Kuwait, abuse 
of preparations containing tramadol is increasing.  
 
  Precursors 
 
661. The smuggling of acetic anhydride through  
West Asia continued in 2009 and 2010. During 2010, 
authorities in China and Spain suspended suspicious 
shipments of large quantities of acetic anhydride 
destined for Iraq. In addition, between September 2009 
and May 2010, authorities in the Islamic Republic of 
Iran seized three shipments with a total of 380 litres  
of acetic anhydride originating in northern Iraq. 
Furthermore, countries in West Asia, such as Pakistan 
and the United Arab Emirates, have been used as 
transit areas for shipments of acetic anhydride 
originating in China and the Republic of Korea and  
en route to Afghanistan. 
662. Shipments of ephedrine and pseudoephedrine 
destined for countries in West Asia were seized or 
stopped during the period 2009-2010. The authorities 
of Canada and India stopped large shipments of 
ephedrine and pseudoephedrine, both in the form of 
raw materials and pharmaceutical preparations, 
destined for Iraq, Jordan and the United Arab Emirates. 
In addition, in 2009, there was an increase in seizures 
of methamphetamine with links to the Islamic Republic 
of Iran. In view of the high annual licit requirements  
for pseudoephedrine (55,000 kg) reported by the 
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authorities of the Islamic Republic of Iran, the Board 
urges the Government to remain vigilant and apply 
adequate controls to prevent the diversion of ephedrine 
and pseudoephedrine, precursors used in the illicit 
manufacture of methamphetamine, from licit channels.  
663. Another concern of the Board is the legitimacy of 
large shipments of P-2-P into Jordan and the Syrian 
Arab Republic. Some of those shipments were claimed 
to be re-exported to Iraq. P-2-P, a precursor of 
amphetamine, might have been used in the illicit 
manufacture of amphetamine-type stimulants.  
664. In September 2009, the Turkish police seized 
three clandestine drug laboratories and a storage 
facility containing several tons of precursor chemicals 
and drugs, including 400 kg of amphetamine  
and 600 kg of P-2-P, as well as 5 tons of  
alpha-phenylacetoacetonitrile, a precursor of P-2-P. 
According to police authorities, the material found 
could have been used to manufacture more than  
200 million amphetamine-type-stimulant tablets, which 
were probably intended for countries in the Middle 
East, the main illicit market for such tablets.  
 
 5. Abuse and treatment 
 
665. According to Drug Use in Afghanistan: 2009 
Survey; Executive Summary, prepared by UNODC, 
there are nearly 1 million problem drug users in 
Afghanistan aged 15-64. Compared to the findings of a 
previous survey conducted in 2005, opium use 
increased by 53 per cent, while heroin use increased by 
a staggering 140 per cent. Reportedly, no more than  
11 per cent of drug abusers awaiting treatment  
(86,000 individuals) had received any form of 
treatment or intervention, as there remains an 
enormous treatment gap, with a capacity of only 
10,500 treatment places per year for the 780,000 drug 
abusers awaiting treatment. Drug addiction is harming 
health and welfare among the population of 
Afghanistan, and much greater resources are thus 
required for the prevention and treatment of drug abuse 
as part of mainstream health-care and development 
programmes. 
666. Drug dependency in Afghanistan, notably 
dependency on opiates such as heroin and opioid 
analgesics, continues to increase. Easy access to cheap 
drugs and limited access to drug abuse treatment, 
combined with the effects of three decades of war-
related trauma, have resulted in problematic drug use 
among almost 1 million Afghans, roughly 8 per cent of 
the population aged 15-64 years. The effects of that 
high rate of abuse — twice the global average — are 
debilitating, not only for those affected but also for 
their families, communities and the country as a whole. 
667. The abuse of opiates continues to pose a major 
problem in countries neighbouring Afghanistan and 
even in countries near Afghanistan. Nearly all those 
countries have high rates of drug abuse. The Islamic 
Republic of Iran, for example, has the world’s highest 
rate for abuse of opiates: an estimated 2.8 per cent of 
the population aged 15-64 in 2007. Pakistan also has a 
high abuse rate for opiates: the estimated rate of drug 
abuse among the population aged 15-64 in 2009 was  
0.7 per cent. Many countries in Central Asia have 
similar levels of drug abuse, with heroin having 
replaced cannabis and opium as the main drug of 
abuse. In Central Asia, the incidence of heroin 
dependence among registered drug abusers ranges from 
50 to 80 per cent, the highest rates being recorded in 
Tajikistan and Uzbekistan. 
668. As of April 2010, the number of officially 
registered drug addicts in Kazakhstan stood at  
50,506 persons, which represents the highest 
prevalence rate in Central Asia — 323 per  
100,000 individuals (or 0.5 per cent of the adult 
population). A total of 9,730 persons in Kyrgyzstan (or 
0.3 per cent of the adult population) were officially 
registered as drug abusers in 2010. The number of 
persons abusing drugs is increasing in Tajikistan as 
well; according to official statistics, in 2009, there 
were 8,018 registered drug abusers in the country 
(or 0.2 per cent of the adult population), of which 
81 per cent were abusing heroin. In Uzbekistan, 
20,832 persons (or 0.1 per cent of the adult population) 
were officially registered as drug addicts in 2009; 
however, according to a UNODC assessment study, 
80,000 persons in the country abuse heroin by 
injection.  
669. There are no estimates of the prevalence of drug 
abuse in countries in the Middle East and in the Gulf 
States owing to the lack of proper monitoring systems. 
Lack of adequate resources makes information on the 
extent and patterns of and trends in drug abuse in the 
region very limited, which hampers the tailoring of the 
response to the drug problem. The Board encourages 
the Governments of those countries to conduct 
comprehensive surveys and rapid assessments of the 
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drug abuse situation and to take effective measures in 
the area of demand reduction. 
670. According to the 2009 in-depth survey of new 
referrals (male) to the addiction unit of the 
psychological medicine hospital in Kuwait in 2009, the 
number of new referrals to the unit was greater than in 
2008. The proportion of new cases of polydrug users is 
high (74 per cent). Abuse of amphetamines remains 
high, while cocaine abuse is very low. Substance abuse 
such as tramadol has increased.  
671. For patients treated at the national centre for 
rehabilitation in Amman, the primary substance of 
abuse was alcohol, followed by benzodiazepines, 
opioids and cannabis. Abuse of Captagon and other 
stimulants is increasing.  
672. Lebanese authorities reported that in 2009,  
70 per cent of drug abusers injected drugs. According 
to national estimates, the majority of drug abusers are 
polydrug abusers. Among the 1,022 people in treatment 
(detoxification and rehabilitation), 10 per cent are 
female, and the most prevalent drugs of abuse 
continued to be, in descending order, cannabis, heroin, 
cocaine, benzodiazepines and amphetamine, according 
to Government sources.  
673. With the support of UNODC and other 
international agencies, the Ministry of Health of 
Lebanon is launching an opioid substitution therapy 
programme.  
674. According to a 2008 national survey, among  
10 provinces in Iraq, a total of 1,462 drug addicts 
received treatment (52 females and 1,410 males), with 
the largest proportion in Baghdad (468 individuals).  
675. Drug abuse by injection is increasing in many 
countries in West Asia, contributing to a growing HIV 
problem. Drug abuse by injection is one of the main 
driving forces behind the spread of HIV in Kazakhstan 
and Uzbekistan, the two countries in the region in 
which the virus has spread the fastest. Up to  
54 per cent of all HIV cases in Tajikistan are related to 
drug abuse. The same phenomenon has been noted in 
Pakistan and countries in the southern Caucasus. 
676. In 2010, with the support of the Joint United 
Nations Programme on HIV/AIDS (UNAIDS), 
UNODC and WHO, the Government of Afghanistan 
scaled up its HIV-prevention efforts, which include the 
provision of methadone maintenance therapy, training 
on health and social services for drug abusers in Kabul.  
 
 
 D. Europe 
 
 
 1. Major developments 
 
677. According to EMCDDA and UNODC, the level 
of cannabis abuse in Europe is moving into a period of 
stabilization and even, in some cases, decline. Austria, 
Bosnia and Herzegovina, Finland, France, Italy, 
Romania, Spain and Sweden have all reported a 
decrease in the prevalence of cannabis abuse; the 
United Kingdom, too, has reported a significant decline 
over the past few years. Surveys of students conducted 
in 2008 in Belgium, Italy, Spain, Sweden and the 
United Kingdom indicate that lifetime prevalence of 
cannabis abuse was either comparable to or lower than 
that reported in 2007.  
678. Trafficking in cannabis herb remains at a 
significant level in Europe. Cannabis herb is produced 
in considerable amounts in the Netherlands and in a 
number of other Western European countries. Most of 
the cannabis herb abused in Central Europe and 
Eastern Europe is produced in Albania, Bulgaria, 
Montenegro, the Republic of Moldova, Serbia, the 
former Yugoslav Republic of Macedonia and Ukraine. 
The cannabis resin abused in Europe originates, in 
great part, in Morocco. Cannabis resin produced in 
Morocco is smuggled, mainly by boat, into the Iberian 
peninsula, and from there it is transported by freight or 
passenger vehicle to other countries in Western Europe. 
A particularly noteworthy development is the increase 
in illicit cultivation of cannabis plant in Europe, 
especially indoors and on a large scale. 
679. Cocaine is smuggled into Europe by air and by 
sea. Multi-ton shipments of cocaine are transported by 
sea from Argentina, Brazil, Chile, Colombia, Ecuador, 
Suriname and Venezuela (Bolivarian Republic of) and 
dropped off mainly near the coasts of Portugal, Spain 
and other countries. Although most consignments of 
cocaine are bound for Western Europe, in recent years 
authorities have made substantial seizures of cocaine, 
usually concealed in containers, at major seaports in 
the Balkans.  
680. The abuse of cocaine is spreading from Western 
Europe to other parts of Europe. In some countries, the 
abuse of cocaine may be replacing the abuse of 
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amphetamine and MDMA (“ecstasy”); for instance, in 
Denmark, Spain and the United Kingdom, increases in 
the level of cocaine abuse co-occurred with decreases 
in the level of amphetamine abuse. It is estimated that 
the number of cocaine abusers in Western Europe and 
Central Europe doubled from 2 million in 1998 to  
4.1 million in 2008, with the combined cocaine 
consumption of those two subregions accounting for a 
quarter of global cocaine consumption.  
681. The illicit market for opiates in Europe is the 
largest in the world. The abuse of opiates has 
reportedly been increasing in several Eastern European 
countries, particularly in Albania, Belarus, Croatia, the 
Republic of Moldova and countries along the Balkan 
route. The Russian Federation remains the European 
country with the highest number of people who abuse 
opioids. According to UNODC, there are between  
1.6 million and 1.8 million opioid abusers in the 
Russian Federation, which is equivalent to 1.6 per cent 
of the overall population aged 15-64. 
682. Almost all the heroin available on illicit drug 
markets in Europe originates in Afghanistan. Heroin 
originating in Afghanistan arrives mostly via the 
Balkan route, which runs from Turkey to either 
Bulgaria or Greece and from there to Albania or 
Serbia. In addition, heroin continues to be trafficked 
along the so-called “silk route”, through Central Asia 
into the Russian Federation, to be sold on the illicit 
market in that country or, to a lesser extent, smuggled 
into Western European countries.  
683. Europe has seen an increase in the variety of 
drugs being abused, which include a growing range of 
substances not under international control. The use of 
the Internet to market drugs and the capacity of the 
illicit drug market to adapt swiftly to changes in the 
legal status of psychoactive substances have played a 
major role in the region. Also of significance is the 
increase in the use of the Internet to sell seeds of 
cannabis plants with a high THC level, in particular 
seeds to be used to illicitly cultivate cannabis plants 
indoors.  
 
 2. Regional cooperation 
 
684. In 2009, the European Union and China signed a 
new agreement to enhance precursor control and 
coordination, and China announced tighter controls on 
the manufacture of 3,4-MDP-2-P, the precursor 
chemical most commonly used in Europe in the illicit 
manufacture of MDMA. 
685. Also in 2009, two phases of the operation 
Channel 2009 were conducted by CSTO and the 
Federal Drug Control Service of the Russian 
Federation, with the participation of Armenia, Belarus, 
Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan. 
Several European Union member States also 
participated in the operation, including Bulgaria, 
Estonia, Germany, Latvia, Lithuania, Poland, Romania 
and Spain. In September 2009, representatives of law 
enforcement agencies of Turkey and Venezuela 
(Bolivarian Republic of) took part, for the first time, in 
the operation (first phase).  
686. The goal of the operation was to build a system 
of enhanced collective security to prevent trafficking in 
drugs from Afghanistan and the entry of precursor 
chemicals into Central Asian countries and 
Afghanistan. More than 139,000 officers from various 
drug control agencies of CSTO member States were 
involved in the operation. The joint operation resulted 
in the seizure of over 28 tons of drugs, including more 
than 790 kg of heroin, 799 kg of cocaine, 14 tons of 
cannabis herb and 4.5 tons of cannabis resin. In 
addition, over 12 tons of other opiates of Afghan origin 
were seized; that amount exceeded the quantity seized 
in previous years. 
687. In September 2009, the European Commission 
conference on bridging the research gap in the field of 
illicit drugs in the European Union recommended that 
European Union member States and the scientific 
community work towards the common goals of 
enhancing drug-related research and sharing research 
findings.  
688. The European Union and Governments of the 
region took part in various initiatives addressing the 
problem of opium originating in Afghanistan. For 
example, at the London Conference on Afghanistan 
held in January 2010, the parties agreed to support 
increased regional cooperation to combat the illicit 
trade in drugs in and from Afghanistan. In addition, an 
international forum on the theme “Drug production in 
Afghanistan: A challenge to the international 
community” was held in Moscow in June 2010, 
emphasizing the importance of the role played by the 
Russian Federation in tackling that problem in the 
region. 
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689. At the twelfth High-Level Meeting of the 
Coordination and Cooperation Mechanism on Drugs 
between the European Union, Latin America and the 
Caribbean, held in Madrid in April 2010, participants 
adopted a political declaration that recognized the 
importance of coordinating common political positions 
in the context of international forums such as the 
Commission on Narcotic Drugs, biregional cooperation 
in demand and supply reduction efforts, control of 
precursors and laundering of funds derived from drug 
trafficking.  
690. On the occasion of the sixth summit between 
Latin America, the Caribbean and the European Union, 
held in Madrid in May 2010, the Andean Community 
member States and the European Union confirmed 
their commitment to give greater political impetus to 
biregional dialogue to tackle the global issue of drugs 
as identified and developed in the framework of the 
Coordination and Cooperation Mechanism on Drugs, in 
accordance with the principle of shared responsibility. 
In particular, a commitment was made to strengthen the 
European Union-Andean Community High-Level 
Specialized Dialogue on Drugs. The Madrid Action 
Plan 2010-2012 reflects the priorities established at the 
summit and includes as a key area the world drug 
problem. The Board urges the European Union to 
continue strengthening cooperation with the Andean 
countries within a framework of shared responsibility.  
691. In May 2010, the Mexico-European Union 
Strategic Partnership announced its Joint Executive 
Plan. Under the Plan and within the framework of the 
European Union Regional Strategy for Latin America 
2007-2013, the European Union and Mexico intend to 
explore innovative mechanisms for cooperation that 
build upon the Cooperation Programme between Latin 
America and the European Union on Anti-Drugs 
Policies (COPOLAD) initiative. 
692. The second World Forum against Drugs, 
organized by the World Federation against Drugs, was 
held in Stockholm in May 2010. The main themes of 
the Forum were new research on cannabis abuse,  
the influence of illicit drugs on development and 
democracy in sub-Saharan Africa, and drug abuse 
among adults and its influence on children.  
693. A European pact to combat international drug 
trafficking, focusing on cocaine and heroin, was 
adopted in June 2010 by the Council of the European 
Union. The pact seeks to disrupt cocaine trafficking 
routes by utilizing regional information exchange 
centres set up in West Africa, together with coordinated 
action by the European States and institutions along the 
Atlantic and Mediterranean coasts, as well as by 
streamlining the provision of technical assistance to 
source and transit countries. 
694. In June 2010, the European Medicines Agency 
and EMCDDA signed a new working arrangement 
facilitating the exchange of information on new 
psychoactive substances and misused medicines.  
695. The XVIII International AIDS Conference was 
held in Vienna in July 2010. Under the slogan “Rights 
here, right now”, the Conference participants 
emphasized the necessity of protecting the human and 
civil rights of those living with or most vulnerable to 
HIV. 
696. In September 2010, the seventeenth European 
Cities against Drugs (ECAD) Mayors’ Conference on 
Drugs was held in Malta. The Conference discussed 
ways to strengthen, through international cooperation 
and exchanges, local, national and international efforts 
to combat the abuse of illicit drugs. 
 
 3. National legislation, policy and action 
 
697. In 2009, the Government of Slovakia amended its 
law governing narcotic drugs and psychotropic 
substances. The amendments include a list of the 
entities allowed to possess narcotic drugs and 
psychotropic substances, provide for action against 
unauthorized cultivation of cannabis plant or opium 
poppy and specify the conditions for temporary 
suspension of a licence in cases where a licence holder 
is accused of a criminal offence. 
698. In December 2009, the Government of Croatia 
amended its legislation on combating drug abuse. The 
amendment introduced new requirements in the areas 
of precursor control and the monitoring of chemical 
substances, and it shortened the mandatory period for 
holding seized drugs before they can be destroyed.  
699. Also in December 2009, the Government of the 
Czech Republic stipulated quantity-based limits for the 
illegal possession of controlled drugs without intent to 
sell. The limits were introduced as part of a revision of 
the penal code with effect from 1 January 2010. Under 
the new law, illegal possession of controlled drugs in 
quantities less than the defined amount is classified as 
an administrative offence. 
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700. Hungary’s first national drug control strategy was 
evaluated in 2009, and a new strategy — the National 
Strategy for Tackling the Drugs Problem 2010-2018 — 
was adopted in December of that year. The Strategy is 
built around the following three pillars: prevention and 
community interventions; treatment and care; and 
supply reduction. 
701. In December 2009, the Government of Latvia 
amended its law on the prevention of laundering of the 
proceeds from crime and the financing of terrorism. 
The amendment specifies the operations in the area of 
laundering of proceeds from criminal activities that fall 
under the investigative competence of the State Control 
Service. 
702. In December 2009 and May 2010, the Russian 
Federation considered amendments to its Criminal 
Code aimed at wider use of non-custodial measures for 
non-serious crimes, including drug-related crimes. 
Under the amended Russian Criminal Code, an amount 
of heroin in excess of 2.5 grams is considered an 
extremely large amount and, in case of possession 
without intent to sell, such possession is punishable by 
mandatory imprisonment of 3-10 years.  
703. The Government of Lithuania has approved 
amendments to its Penal Code lengthening prison 
sentences for the illegal production, acquisition, 
storage, transportation, sending, selling or any other 
act involving first-category drugs or precursors of 
psychoactive substances. A prison sentence of  
2-10 years is the punishment foreseen for the illegal 
production, acquisition, storage, transportation, 
sending or selling of large quantities of such 
substances. In 2010, the Lithuanian Psychiatrists 
Association disseminated a methodology for using 
methadone to treat opioid dependency, with the aim of 
assisting psychiatrists in providing evidence-based and 
quality treatment for opioid-dependent individuals. 
704. In 2010, the Government of Luxembourg 
launched its Strategy and Plan of Action on Drugs and 
Drug Addiction for 2010-2014. The Plan of Action 
addresses demand and supply reduction; reduction of 
risk, harm and nuisance; research; and international 
coordination. 
705. In Germany, following the adoption in 2009 of a 
law allowing diamorphine-based substitution treatment 
for addicts meeting strict eligibility requirements, a 
joint national board issued guidelines in March 2010 
for diamorphine-supported substitution treatment.  
706. In May 2010, the Pharmaceutical Society of 
Ireland issued guidance for pharmacists on the  
safe supply of non-prescription medicinal products 
containing codeine. The guidance aims at assisting 
pharmacists in fulfilling professional and legal 
responsibilities in the supply of such products and in 
complying with the Pharmacy Act 2007. Further, the 
Government of Ireland agreed to fund a network of 
drug- and alcohol-free cafes providing counselling and 
health services for young people.  
707. As part of its efforts to prevent the abuse of 
substances to experience “legal highs”, the Government 
of Ireland in May 2010 placed under control a number 
of substances not under international control, including 
N-benzylpiperazine (BZP), mephedrone, synthetic 
cannabinoids, methylone methedrone, butylone, 
flephedrone, methylenedioxypyrovalerone, GBL and 
1,4-butanediol. An additional measure in this direction 
— the Criminal Justice (Psychoactive Substances)  
Bill 2010 — will, once enacted, criminalize the sale or 
supply for human consumption of substances that 
although not specifically proscribed under the Misuse 
of Drugs Act have psychoactive effects.  
708. In June 2010, the Government of the Russian 
Federation adopted the State Antidrug Policy Strategy 
of the Russian Federation for the period 2010-2020. It 
is the first comprehensive document consolidating the 
Government’s efforts to prevent the spread of drug 
abuse in the country. The Strategy aims at suppression 
of the illicit production of and trafficking in drugs, 
reduction of drug demand by improving the system  
of prevention and rehabilitation activities and 
development and strengthening of international 
cooperation in the area of drug control. 
709. Demand for treatment related to cannabis  
abuse continues to increase in the Netherlands. In 
September 2010, the Government decided to regulate 
the so-called “coffee shops”, where the sale, possession 
and consumption of cannabis is tolerated, and to 
introduce harsher penalties for importing and exporting 
drugs, as well as for illicit crop cultivation and drug 
trafficking. However, the Board wishes to reiterate that 
the so-called “coffee shops” contravene the 
international drug control treaties.  
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710. In October 2010, Belgium introduced random 
saliva testing of drivers to detect illicit drug use. A 
driver who tests positive for illicit drug use can be 
fined or banned from driving or, in the case of 
reoffenders, sentenced to prison.  
 
 4. Cultivation, production, manufacture and 
trafficking 
 
  Narcotic drugs 
 
711. Illicit cultivation of cannabis plant is on the rise 
in Europe. In the United Kingdom, the number of 
detected illicit cultivation sites of commercial size 
jumped from 3,032 in the growing period 2007/08 to 
6,866 in the growing period 2009/10. In Germany, the 
increased detection in the growing period 2008/09  
of illicit cultivation sites with capacity for at  
least 1,000 plants pointed to the increasing 
professionalization of this activity. Austria, too, 
reported an increase in recent years of illicit cultivation 
of cannabis plant.  
712. In Iceland, seizures of cannabis plants increased 
dramatically, from 893 plants in 2008 to 11,713 in 
2009. Over 1 million cannabis plants illicitly cultivated 
indoors were eradicated in the Netherlands in 2008, 
and over 200,000 were eradicated in Belgium in 2009. 
In November 2009, the Government of Slovakia 
carried out a special law enforcement operation that 
resulted in the detection of a site used for illicitly 
cultivating cannabis plants indoors; a total of  
318 plants having a combined weight of over 91 kg 
were seized in the operation. 
713. According to the World Customs Organization, 
68 per cent of global cannabis resin seizures by 
customs authorities in 2009 occurred in Western 
Europe. In 2009, Spanish customs authorities seized 
over 27 tons of cannabis resin at sea and on beaches; 
an estimated 93 per cent of the cannabis resin seized in 
Spain in 2009 originated in Morocco.  
714. As reported by the World Customs Organization, 
most of the imported cannabis herb seized by customs 
authorities in Western Europe in 2009 came from 
Ghana; South Africa was the second largest source. It 
has been reported that traffickers may be using the East 
African route to smuggle cannabis from Afghanistan 
into Italy. The United Kingdom and the Netherlands 
were the main destination countries for cannabis herb 
in Western Europe, representing 83 per cent of the 
amount seized in the subregion. 
715. In the former Yugoslav Republic of Macedonia, 
illicit cultivation of cannabis plant appears to be on the 
increase. A major seizure of about 700 kg of locally 
produced cannabis herb suggests that the illicit 
cultivation of cannabis plants in that country was 
significantly higher in 2009 than in previous years, 
when it was reported that cannabis plants were  
illicitly cultivated on small plots only. The country is 
increasingly being used by traffickers as a transit area 
for cannabis shipments. The amount of cannabis seized 
in shipments having as their final destination the 
former Yugoslav Republic of Macedonia increased 
significantly in 2009, to 404 kg, compared with 157 kg 
in 2008.  
716. The flow of cocaine shipments entering Europe 
through West Africa declined between 2007 and 2009. 
According to the World Customs Organization, the 
amount of cocaine seized in Western Europe after 
having arrived from or transited through West Africa 
dropped from 2.4 tons in 2007 to 0.2 tons in 2009. In 
Western Europe, the amount of cocaine seized by 
customs authorities fell from 54.9 tons in 2007 to  
34.9 tons in 2009. UNODC reported that law 
enforcement authorities in Europe seized a total of  
62.7 tons of cocaine in 2008. Seizures made by the 
customs authorities in Spain decreased from over  
36 tons in 2007 to almost 18 tons in 2009. There was 
also a significant drop in cocaine seizures in the 
Netherlands. Between 2008 and 2009, however, 
cocaine seizures increased both in Germany (by a 
factor of 1.6) and in Greece (by a factor of about 9).  
717. Cocaine seized in Europe originates mainly in 
Colombia, although Peru and the Plurinational State  
of Bolivia are increasing in significance as source 
countries. Cocaine is smuggled into Europe by sea 
from the Bolivarian Republic of Venezuela, Ecuador 
and Panama, although Brazil and Suriname are 
increasingly being used as transit countries. In 
addition, Europol has identified the “northern route”, 
leading from the Caribbean via the Azores to the coasts 
of Portugal and Spain, and the “central route”, leading 
from South America via Cape Verde or Madeira and 
the Canary Islands to Europe.  
718. The main European points of entry for cocaine 
are Belgium, the Netherlands, Portugal and Spain: 
together they accounted for about 70 per cent of all 
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cocaine seized in Europe in 2008, although they 
accounted for only 25 per cent of the cocaine 
consumption in the region. That being said, cocaine 
trafficking routes are expanding eastward, in particular 
into the Balkan area. The United Kingdom has also 
been identified as one of the countries through which 
cocaine enters the European Union.  
719. According to the World Customs Organization, 
seizures of “crack” cocaine in Western Europe in 2009 
were reported mainly in the Netherlands; Suriname 
was the source country in most of the cases and 
shipment was mainly by express courier service. The 
amount of “crack” cocaine seized in Germany 
decreased from 8.2 kg in 2008 to 4.6 kg in 2009  
(44 per cent). In France, 12 kg of “crack” cocaine were 
seized in 2009.  
720. In 2009, the Russian Federation reported to the 
World Customs Organization 10 seizures of cocaine 
totalling 101 kg; that was the lowest annual quantity 
seized during the three-year period ending in 2009. In 
five of those seizures (totalling 90 kg), which were 
detected in Saint Petersburg and Novorossiysk, the 
cocaine had been concealed in sea freight shipments 
originating in Ecuador. Consignments of cocaine from 
Ecuador are increasingly being sent to the Russian 
Federation. 
721. According to Europol, the number of nationals of 
Balkan countries involved in cocaine trafficking has 
grown in recent years. Albania, in addition to having a 
historical role in heroin trafficking along the Balkan 
route, has reportedly been used as a storage area for 
consignments of cocaine. The greater involvement of 
organized criminal groups may indicate that the 
infrastructure established in the Balkan area for 
smuggling cannabis and opiates (particularly heroin) is 
now being used for smuggling increasingly larger 
quantities of cocaine. 
722. Seizures of cocaine at seaports in the Balkan area 
showed an increase in 2009. At the Black Sea port of 
Constanţa, Romania, authorities seized 1.2 tons of 
cocaine that had been concealed in a shipment of wood 
loaded at Paranaguá, Brazil. Law enforcement 
authorities in Varna, Bulgaria, seized 1,020 bottles 
containing a mixture of cocaine and wine shipped from 
Santa Cruz de la Sierra, Plurinational State of Bolivia; 
the pure cocaine content was estimated at 100 kg. In 
Greece, 450 kg of cocaine concealed in a shipment of 
scrap metal were seized at Piraeus.  
723. An EMCDDA/Europol analysis of the cocaine 
market, released in April 2010, identified innovative 
techniques being used to smuggle cocaine, such as 
incorporating cocaine base or hydrochloride into other 
materials (e.g. beeswax, plastic and clothing) and then 
extracting it at special laboratories set up inside 
European Union borders. According to the analysis, 
some 40 laboratories for the “secondary extraction” of 
cocaine were identified and dismantled in European 
Union member States in 2008. Similar laboratories 
have been reported in Albania and the Republic of 
Moldova.  
724. Most of the heroin smuggled into Western Europe 
is transported along the Balkan route from Afghanistan 
and Pakistan through the Islamic Republic of Iran, 
Turkey and countries in South-Eastern Europe. The 
Government of Italy has reported that traffickers may 
be using the East African route also to smuggle heroin 
from Afghanistan. The main mode of transport used in 
smuggling heroin into Western Europe was overland by 
road or rail, although the World Customs Organization 
has highlighted the growing significance of air traffic 
routes in this activity. According to the World Customs 
Organization, South Africa was the main source of 
heroin seized in 2009 along air traffic routes in 
Western Europe.  
725. UNODC estimates that about 25 per cent of all 
the heroin manufactured in Afghanistan is smuggled 
each year along the northern route, i.e. through Central 
Asia (Tajikistan, Turkmenistan or Uzbekistan), with a 
final destination of the Russian Federation. Based on 
seizures made at border crossings, most of the heroin is 
transported through Tajikistan and Kyrgyzstan and 
from there through Kazakhstan into the Russian 
Federation. The heroin is smuggled mostly overland by 
road and often in small quantities. 
726. According to the World Customs Organization, 
customs authorities in Eastern European and Central 
European countries seized a total of 3.5 tons of heroin 
in 2009, compared with 4.9 tons in 2008. Europol and 
EMCDDA report that European law enforcement 
authorities seize between 8 and 15 tons of heroin each 
year. The main country of destination for the heroin 
shipments was Germany, followed by Bulgaria, the 
former Yugoslav Republic of Macedonia, Romania, the 
Netherlands and Greece. Heroin continues to be 
smuggled almost exclusively overland in vehicles. 
Although most of the seized shipments of Afghan 
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heroin originate in Turkey, in 2009 — for the first time 
— Iraq and the Syrian Arab Republic were reported to 
be the countries of departure for such shipments  
(27 kg and 11 kg respectively). 
727. The customs authorities of the Russian Federation 
seized a total of 510 kg of heroin in 2009, according to 
the World Customs Organization. The largest single 
seizure of heroin involved 196 kg and was made at the 
Yarag-Kazmalyar border crossing. The consignment, 
which was being transported from Azerbaijan on a 
truck, had originated in the Islamic Republic of Iran 
and was bound for Belarus.  
728. Western Europe saw a slight decrease in seizures 
of heroin by customs authorities in the period 2008-
2009; an estimated 1.9 tons of heroin were seized in 
2009. The largest seizures in 2009 were made in 
France, Germany, Italy and the United Kingdom. While 
Sweden reported a decrease in seizures of heroin, 
increases were reported in Austria, Germany, Greece 
and Norway. 
729. Illicit cultivation of opium poppy occurs to a 
limited extent in some Eastern European countries. In 
Ukraine, the Republic of Moldova and the Russian 
Federation, opium poppy is illicitly produced to supply 
local markets with poppy straw derivatives. 
730. Almost 100 kg of opium were seized in Western 
Europe in 2009. The main country of departure of the 
seized opium was the Islamic Republic of Iran, while 
Germany and Sweden were the main countries of 
destination. 
 
  Psychotropic substances 
 
731. In 2008, Europe accounted for about one third 
(8.4 tons) of global seizures of amphetamine; that 
amount was only slightly below the amount seized in 
2007 (8.7 tons). Seizures of amphetamines by customs 
authorities in Western Europe increased from 2.7 tons 
in 2007 to 3.0 tons in 2009, the main country of 
departure being the Netherlands. The main countries of 
destination of amphetamines seized in Western Europe 
were Denmark, Finland, Germany, Mozambique, 
Norway, Sweden and the United Kingdom. Increases in 
amphetamine seizures were reported in Germany and 
the United Kingdom, while in the Netherlands seizures 
declined. In 2009, the Estonian authorities reported as 
an emerging trend the smuggling of amphetamine from 
the Russian Federation.  
732. The number of methamphetamine seizures 
reported in Europe continued to decrease. In 2009, 
Sweden and Ukraine reported the largest single 
seizures of methamphetamine (13 kg each); the 
shipments were concealed in cars entering from Latvia 
and Lithuania respectively. In Sweden, 154.3 kg of 
methamphetamine were seized in 2009, and there was a 
significant rise in the proportion of seizures identified 
as originating in Lithuania; it was noted that the drugs 
that were seized had been manufactured from P-2-P 
rather than from ephedrine.  
733. According to EMCDDA, MDMA (“ecstasy”) is 
illicitly manufactured mainly in European countries, 
above all in the Netherlands and Belgium and,  
to a lesser extent, Germany, Poland and the  
United Kingdom. UNODC reported in 2009 that  
the Netherlands was mentioned most frequently  
(38.5 per cent) as the source country of seized 
“ecstasy”; it was followed by Belgium (9.5 per cent). 
For “ecstasy” shipments, the main countries of 
destination in Western Europe in 2009 were Germany, 
Malta and Norway. In 2008, Western Europe and 
Central Europe accounted for 20 per cent of global 
seizures of “ecstasy”, whereas South-Eastern Europe 
accounted for only 4 per cent and Eastern Europe for 
1.5 per cent. The amount of “ecstasy” seized in 
Western Europe decreased from 1.1 tons in 2007 to  
0.1 tons in 2009. That development was reflected in the 
amount of “ecstasy” seized in Europe as a whole, 
which fell from 3 tons in 2007 to 1 ton in 2008.  
734. UNODC reported that the availability of MDMA 
(“ecstasy”) tablets in Europe had declined since 2007, 
although tablets sold as “ecstasy” increasingly 
contained greater amounts of substitute psychoactive 
substances not under international control,  
including BZP, 1-(3-chlorophenyl)piperazine (mCPP) 
and 1-(3-trifluoromethylphenyl)piperazine. In the 
European Union, 50 per cent of tablets sold as 
“ecstasy” in 2008 contained mCPP, compared with  
10 per cent in 2006. In the United Kingdom, an 
analysis of “ecstasy” tablets over the period 2006-2009 
showed a decrease in MDMA content and an increase 
in piperazine content.  
 
  Precursors 
 
735. In the past few years, European Union member 
States have become targeted by traffickers in search of 
acetic anhydride. From 2007 to 2009, seizures of acetic 
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anhydride in European Union member States totalled 
159 tons, accounting for almost 60 per cent of global 
seizures of the substance. Most of the acetic anhydride 
seized in those member States had been diverted from 
licit trade within the European Union. While the 
European Commission and member States of the 
European Union seek ways to strengthen control over 
acetic anhydride, the substance continues to be 
diverted in the region. 
736. Suspicious shipments of ephedrine and 
pseudoephedrine from South Asia and South-East Asia 
and destined for Belize, Guatemala and Mexico 
continue to be trans-shipped in European countries, in 
particular Germany, the Netherlands, Spain and the 
United Kingdom. Authorities in European countries 
have also stopped suspicious shipments of those two 
substances to Africa.  
737. There have been no seizures of 3,4-MDP-2-P in 
Europe since 2007. The agreement signed by the 
European Union and China, which has traditionally 
been a source of 3,4-MDP-2-P, may have contributed 
to that. An increase in seizures of safrole-rich oil has 
been reported in Europe and there is concern that that 
substance could be increasingly used in the illicit 
manufacture of MDMA (“ecstasy”).  
 
  Substances not under international control 
 
738. Mephedrone was recently placed under national 
control in Austria, Croatia, Denmark, Estonia, France, 
Germany, Ireland, Romania, the Russian Federation, 
Sweden and the United Kingdom. In May 2010, the 
Council of the European Union called for an 
assessment of the risks arising from the illicit 
manufacture of, trafficking in and use of mephedrone. 
According to a joint Europol/EMCDDA report, 
mephedrone is legally sold in the region, both in bulk 
and small quantities, through the Internet and at shops 
specializing in the sale of psychoactive substances 
(“smart shops”). The number of websites selling 
mephedrone is thought to have doubled between 
December 2009 and March 2010.  
739. Eleven European Union member States have 
reported to Europol having seized mephedrone in 
quantities ranging from 2 g in Italy to 320 g (including 
a single seizure of 4,400 tablets) in Germany. Over the 
past two years, seizures of mephedrone in Sweden and 
the United Kingdom have increased. In the 
Netherlands, over 130 kg of mephedrone were seized 
in 2009 when two tabletting sites and four storage 
locations were raided.  
740. Pursuant to a 2008 Council of Europe decision to 
ban BZP, that substance was recently placed under 
national control in Austria, Cyprus, Ireland, the 
Netherlands, Portugal, Spain and the United Kingdom.  
741. During 2009, a total of 24 new psychoactive 
substances, all of them synthetic, were identified 
through the European early warning system.  
The substances included 9 synthetic cannabinoids,  
5 phenethylamines, 2 tryptamines, 4 synthetic 
cathinones and 2 substances with medicinal properties. 
742. According to the World Customs Organization, 
43.4 tons of khat were seized in Western Europe in 
2009; that was 6 tons less than in 2008. The 
Netherlands and the United Kingdom are the hubs for 
almost all smuggling of khat, which is cultivated and 
produced primarily in East Africa. Khat shipped to the 
United Kingdom is generally transported on to Finland 
and Norway in air passenger baggage or by air  
mail, while khat shipped to the Netherlands is 
generally transported by vehicle to Germany and  
the Scandinavian countries. The main countries of 
destination for the khat shipments seized in 2009 were 
Denmark, Finland, Norway and Sweden.  
743. In the United Kingdom, naphyrone and its related 
compounds became class B drugs in July 2010 
pursuant to the Misuse of Drugs Act 1971. In Ireland, 
there was an increase in 2010 in reports of a new drug 
known as “whack” being sold at drug paraphernalia 
shops; the drug is reported to contain new cocaine-type 
substances and is thought to cause psychotic reactions. 
 
 5. Abuse and treatment 
 
744. Although cannabis resin remains the most 
commonly abused drug in Europe, recent years have 
seen an increase in the abuse of cannabis herb. 
According to EMCDDA, the average annual 
prevalence of cannabis abuse stands at 6.8 per cent (or 
more than 22 million individuals) of the population 
aged 15-64 living in the European Union. National 
figures vary, ranging from 0.4 to 14.6 per cent; the 
European countries with the lowest prevalence rates 
are Bulgaria, Greece, Malta and Romania, and those 
with the highest are the Czech Republic, France, Italy 
and Spain. On average, 22.1 per cent — or more than 
74 million European adults — have reported lifetime 
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prevalence of cannabis abuse, with national estimates 
situated between 1.5 and 38.6 per cent. The Board 
notes with concern that 2.0-2.5 per cent of Europeans 
aged 15-34 abuse cannabis on a daily or near-daily 
basis and that over 1 per cent of adults in Europe abuse 
cannabis daily or almost daily. 
745. Cocaine remains (after cannabis) the second 
most-abused illicit drug in Europe, although levels 
vary greatly between countries. According to 
EMCDDA, the average annual prevalence of cocaine 
abuse in the European Union countries stands at  
1.2 per cent, or an estimated 4 million people  
aged 15-64. The European countries with the lowest 
annual prevalence rates are Romania (0.0), Greece 
(0.1) and the Czech Republic, Hungary and Poland  
(0.2 each), while those with the highest rates are Spain 
(3.1), the United Kingdom (2.4), Italy (2.2) and Ireland 
(1.7). The annual prevalence of cocaine abuse has 
increased in recent years in Albania, Cyprus, the Czech 
Republic, Denmark and Norway. In Italy and Spain, 
the rate has stabilized in recent years, while in the 
United Kingdom the prevalence of cocaine abuse 
among adults decreased over the past year.  
746. Western Europe comprises the world’s largest 
illicit market for heroin, with approximately  
60 per cent of the total illicit supply of heroin in 
Europe being accounted for by four countries  
(United Kingdom, Italy, France and Germany). 
European countries, including the Russian Federation, 
account for almost half of the heroin abused 
worldwide. The annual prevalence of opiate abuse in 
Europe was about 0.5 per cent in 2008, a level similar 
to that of previous years. The Russian Federation  
has the highest level of opiate abuse in Europe  
(1.6 per cent in 2007). Estonia and the United 
Kingdom (Scotland only) are reported to have  
the highest annual prevalence of opiate abuse  
(1.5 per cent) in Western Europe and Central Europe. 
While heroin abuse in Western Europe is reported to be 
decreasing, the number of opioid-related deaths 
increased in more than half of the countries in the 
subregion between 2006 and 2007. Heroin abuse was 
reported to have increased in recent years in the 
Russian Federation, although a decline was reported 
for 2009. According to UNODC, the number of heroin 
abusers in that country is estimated at 1.5 million.  
747. Some countries of the region have shown a trend 
towards stabilization or even a decline in the abuse of 
amphetamines and MDMA (“ecstasy”). In the United 
Kingdom, the annual prevalence of amphetamine abuse 
among young adults in England and Wales declined 
from 6.2 per cent in 2000 to 2.4 per cent in 2010. 
Amphetamine is abused more commonly than 
methamphetamine in Europe. Recent population 
surveys indicate that annual prevalence of 
amphetamine abuse in Europe ranges from 0 to  
1.3 per cent. According to EMCDDA, the average 
annual prevalence of amphetamine abuse among the 
European Union countries stands at 0.5 per cent of the 
population aged 15-64, or about 2 million people. The 
European countries with the highest annual 
prevalences of amphetamine abuse are Estonia (1.3), 
Denmark (1.2) and the United Kingdom (1.0). The 
largest number of amphetamine abusers is found in the 
age group 15-34, with an estimated 7 million people. 
The abuse of methamphetamine in the region appears 
to be limited to the Czech Republic and Slovakia.  
748. According to EMCDDA, about 2.5 million 
European adults, or 0.8 per cent of the population  
aged 15-64, abused MDMA (“ecstasy”) in the past 
year. “Ecstasy” abuse is common among young adults:  
2 million persons, or 1.6 per cent of the persons in the 
age group 15-34. With an average age of 24 years, 
abusers of “ecstasy” are among the youngest groups of 
drug abusers undergoing treatment and often report 
polydrug abuse involving “ecstasy” in combination 
with cannabis, cocaine or amphetamines.  
749. In the Netherlands and the United Kingdom, there 
is increasing abuse of GBL, a solvent that is converted 
in the body to GHB, a substance in Schedule IV of the 
1971 Convention that is associated with drug-
facilitated sexual assault. To counteract that problem, 
GBL was placed under national control in the United 
Kingdom in 2009. 
750. In an EMCDDA report released in June 2010, it 
was found that drug abuse by injection has stabilized 
or is declining in most European countries. EMCDDA 
estimated that the average prevalence of drug abuse by 
injection in the European Union is about 2.5 cases  
per 1,000 adults. The prevalence of drug abuse by 
injection is particularly high in Eastern Europe  
(1.5 per cent). 
751. According to the Government of Ukraine, more 
than 4,000 patients received treatment in 2009 through 
the substitution therapy programmes in that country. 
The primary goal of those programmes is to expand 
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access to antiretroviral therapy treatment among 
injecting drug abusers who are HIV-positive. 
752. The number of people undergoing treatment for 
drug abuse and reporting heroin to be the primary drug 
of abuse increased in 19 European countries between 
2002 and 2007. The primary drug of abuse identified 
by people undergoing such treatment was opioids, 
mainly heroin (48 per cent), followed by cannabis  
(21 per cent) and cocaine (17 per cent). In Europe, 
demand for treatment relating to the abuse of opiates 
decreased slightly over the past decade, contrasting 
with an increase in demand for treatment relating to the 
abuse of cannabis and cocaine. The proportion of 
Europeans undergoing treatment for cocaine abuse 
increased from 3 per cent in the period 1997-1998 to 
10 per cent in the period 2007-2008. In a report by 
EMCDDA, it was indicated that in 16 European 
countries opioid substitution treatment was available to 
at least half of opioid abusers, while in 10 countries 
such treatment was available only to a minority of 
opioid abusers. 
753. Drug-related deaths accounted for 4 per cent of 
all deaths of people aged 15-39 in Europe, with opioids 
involved in about three quarters of those cases. The 
number of drug-related deaths in Italy fell from 1,002 
in 1999 to 484 in 2009. In Germany, 1,331 deaths 
related to the abuse of illegal drugs were reported in 
2009, representing a decrease of 8 per cent compared 
with the previous year. In the United Kingdom,  
2,182 drug-related deaths were reported in 2009, an 
increase of 11.8 per cent compared with 2008. In 
Ireland, the number of drug-poisoning deaths rose from 
178 to 274 during the period 1998-2007, with more 
than half of those deaths involving heroin or other 
opiates. In the same period, the percentage of drug-
poisoning deaths in which cocaine was involved 
increased significantly in that country, from 3 to  
23 per cent. Benzodiazepines accounted for more 
deaths by poisoning in Ireland than any other substance 
during that period.  
754. In the Netherlands, over 2,500 medical cases 
relating to drug abuse were reported in 2009; nearly 
one third of those cases occurred at large dance events. 
Cannabis, MDMA (“ecstasy”), GHB and cocaine were 
the drugs most frequently abused, with GHB 
accounting for 20 per cent of the total number of cases 
and heroin and “crack” cocaine accounting for  
8 per cent. Thirty-nine per cent of the cases involved 
young adults between 18 and 24 years of age, many of 
them having abused “ecstasy” or hallucinogenic 
mushrooms (containing psilocybin). 
755. An independent study in the United Kingdom 
found that there was a substantial decrease in the 
number of young adults entering treatment for the 
abuse of heroin and “crack” cocaine — from 12,320 in 
the period 2005-2006 to 7,427 in the period 2009-
2010. However, the study also found that there was an 
increase in the number of persons — in particular 
young adults — entering treatment for cannabis abuse: 
in the period 2009-2010, 4,400 of those persons under 
the age of 25 listed cannabis as the main drug of abuse, 
compared with 3,300 in the period 2005-2006.  
756. Eastern Europe is one of the few areas of the 
world where HIV prevalence is on the rise, with severe 
and spreading epidemics reported in the Russian 
Federation and Ukraine. The prevalence of HIV 
infection among adults in Ukraine is the highest in 
Europe: over 1.6 per cent. The use of contaminated 
equipment for drug injection was reported as the 
source of infection in over 50 per cent of the newly 
diagnosed HIV cases in Eastern Europe. In Eastern 
Europe, the number of persons who abuse drugs by 
injection is currently estimated at 3.7 million, roughly 
25 per cent of whom are believed to be infected with 
HIV. In Ukraine, prevalence of HIV infection among 
persons who abuse drugs by injection is estimated at 
38.5-50.3 per cent. According to the Ministry of Health 
and Social Development of the Russian Federation, of 
the 555,272 drug abusers registered in 2009, 
386,279 abused drugs by injection; and 50,994  
(or 13.2 per cent) of those who abused drugs by 
injection were HIV-positive. The Board highlights the 
importance of providing assistance in drug abuse and 
HIV prevention, treatment and support among people 
who abuse drugs by injection and in prison settings in 
the region.  
757. Polydrug abuse has been identified as a central 
element of the European drug problem and it is of 
particular concern given the unpredictable effects of 
combinations of drugs. The Government of Italy has 
reported a growing tendency towards polydrug abuse, 
often in association with alcohol consumption. In the 
Netherlands, 15 per cent of drug-related medical cases 
involved combinations of drugs; and in Ireland,  
70 per cent of cases involving treatment for drug abuse 
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in 2008 were reported to involve more than one 
substance.  
 
 
 E. Oceania 
 
 
 1. Major developments 
 
758. In Australia, traffickers are increasingly using the 
Internet to obtain not only precursor chemicals but also 
equipment used for the illicit manufacture of drugs. 
Recently, the Australian customs authorities launched 
an operation to monitor importation from Internet 
pharmacies based overseas. The operation dismantled 
an organized criminal group that ordered 
pharmaceutical products containing pseudoephedrine 
from overseas-based Internet pharmacies, with the 
intention of reselling them to illicit drug 
manufacturers.  
759. The Government of New Zealand has given high 
priority to the fight against the illicit manufacture and 
abuse of methamphetamine. The national action plan  
to tackle illicit manufacture and abuse of 
methamphetamine, launched in October 2009, has led 
to the identification of new trafficking trends, the 
seizure of precursor chemicals and the dismantling  
of clandestine methamphetamine laboratories in  
New Zealand. While most of the clandestine 
laboratories were small, they posed a significant risk to 
communities. In New Zealand, organized criminal 
groups were increasingly utilizing women and 
teenagers to smuggle methamphetamine and its 
precursors into the country.  
760. Recent seizures in Oceania led to increasing 
concern over the use of some countries of the region as 
trans-shipment areas for smuggling drugs and 
precursors. The Oceania Customs Organisation 
highlighted the geographical risk factors leading to the 
use of those countries as transit areas for illicit drug 
shipments. In addition, the lack of comprehensive 
legislation and effective border control, as well as the 
fact that many States of the region are not yet parties to 
international drug control treaties, make these 
countries more vulnerable to drug trafficking. In  
July 2010, the Board held bilateral consultations with 
the Government of Papua New Guinea. The Board 
urged the Government to immediately take the steps 
necessary for Papua New Guinea to become a party to 
the 1988 Convention. The Board urges all States 
concerned, such as Cook Islands, Kiribati, the Marshall 
Islands, Nauru, Palau, Papua New Guinea, Samoa, the 
Solomon Islands, Tuvalu and Vanuatu, to accede to the 
international drug control treaties without further delay 
and to strengthen national legislation and border 
control. 
 
 2. Regional cooperation 
 
761. Regional meetings in Oceania continued to play 
an important role in bringing countries together to 
address drug control issues. At the twenty-eighth 
annual meeting of the Pacific Islands Law Officers’ 
Network, held in Samoa in December 2009, 
participants highlighted the need for States in the 
region that were not yet parties to the international 
drug control treaties to ratify those instruments. The 
annual meeting of the Regional Security Committee of 
the Pacific Islands Forum was held in Fiji in  
June 2010. The issue of transnational crime, including 
trafficking in drugs and precursors, remained high on 
the agenda. There was consensus among participants 
that the region remained vulnerable to threats posed by 
transnational crime and that countries in the region 
must respond collectively and promptly. Recommended 
actions included enhancing national legislation, 
strengthening law enforcement capacity and improving 
regional cooperation in drug control.  
762. Lack of structures for monitoring and reporting 
on drug-related issues is a long-standing problem for 
many countries in Oceania. The Pacific Drug and 
Alcohol Research Network brings countries in Oceania 
together to share information and expertise on drug-
related issues. At the fifth Meeting of the Network, 
held in Vanuatu in July 2010, representatives of  
11 States of the region and international organizations, 
including UNODC, reviewed the latest developments 
and trends in drug and alcohol abuse at the national 
and regional levels and reiterated the need for 
strengthened and coordinated efforts to collect, analyse 
and report drug-related data. They also identified the 
urgent need to develop and implement effective 
legislation. The Board acknowledges the efforts of the 
Network in promoting drug-related research and 
information-sharing in the region and encourages 
participating countries to continue their monitoring and 
reporting with respect to drug-related issues in the 
framework of the Network. 
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763. In 2010, a joint initiative of the Asian 
Development Bank and the Government of Australia 
provided funding and training programmes to improve 
customs legislation and strengthen border control in 
Solomon Islands. Also in 2010, Australia launched the 
Framework for Law and Justice Engagement with the 
Pacific, aimed at strengthening legal and law 
enforcement cooperation throughout the region. Under 
the Framework, the Government of Australia is 
committed to supporting regional collaboration for 
combating transnational crime, including drug 
trafficking, with a focus on ensuring an appropriate 
legislative framework, the exchange of information, 
capacity-building, financial assistance and access to 
technical expertise.  
764. Law enforcement agencies in Australia and  
New Zealand continued to provide support for 
capacity-building initiatives in Oceania. In June 2010, 
the Australian Federal Police and the Government of 
Papua New Guinea organized a workshop on drug 
trafficking and legislative reform in Papua New 
Guinea. Participants at the workshop shared the latest 
information on the situation with regard to trafficking 
in and illicit manufacture of drugs in Papua New 
Guinea and discussed possible legislative reforms to 
improve responses to emerging issues. With the 
assistance of the Australian Federal Police, the Pacific 
Transnational Crime Coordination Centre, established 
in 2004 and based in Samoa, continued to expand its 
network in the region. As of 2009, the network 
included seven transnational crime units, established in 
Fiji, Micronesia (Federated States of), Papua New 
Guinea, Samoa, Solomon Islands, Tonga and Vanuatu. 
The Coordination Centre analyses criminal intelligence 
data and will enhance the sharing of law enforcement 
intelligence in the region. In addition, Australia and 
New Zealand have provided assistance to the Tuvalu 
Police Force in establishing a database to manage 
crime statistics, which will enhance law enforcement 
capacity in Tuvalu.  
765. The Board recognizes the efforts of countries in 
Oceania in combating drug-related crime with the 
support of bilateral assistance. The Board notes the 
lack of adequate resources and capacities in some 
countries to effectively tackle those problems. The 
Board encourages countries in the region, especially 
those that are not yet parties to the international drug 
control treaties, to continue their drug control efforts 
involving regional cooperation and capacity-building 
in order to be well equipped to ratify and implement 
the international drug control treaties. 
 
 3. National legislation, policy and action 
 
766. Drug abuse among young people was the focus of 
the National Drugs Campaign in Australia launched in 
February 2010. The second stage of the campaign is 
aimed at reducing abuse of MDMA (“ecstasy”), 
methamphetamine and cannabis among young people 
by helping them understand the harm caused by drug 
abuse and directing them to counselling and treatment 
services. The Australian Customs (Prohibited Imports) 
Amendment Regulations 2009 (No. 6), which came 
into effect in March 2010, makes it illegal to import 
tablet presses without prior authorization. 
767. In line with the national campaign targeting drug 
abuse among young people, in July 2010, the 
Government of Australia launched the National Youth 
Policing Model. The initiative identified six major 
strategies to tackle youth crime, including one to 
strengthen the police response to drug abuse among 
young people. Australian states and territories will 
adopt initiatives that help prevent young people from 
committing crime or becoming victims of crime. The 
Model also provides the police, communities and all 
levels of government with examples of effective local 
solutions to youth crime. 
768. In October 2009, the Government of New 
Zealand launched a three-year national action plan  
to tackle the increasing problem of abuse of 
methamphetamine in the country. The comprehensive 
action plan contains relevant measures to be 
implemented by all the government agencies 
concerned. Under the action plan, New Zealand will 
restrict the availability of precursors used in the illicit 
manufacture of methamphetamine, improve treatment 
services for methamphetamine abusers and enhance 
school education and community programmes to 
reduce the illicit demand for methamphetamine. The 
Government has developed the new drug education 
guidelines for schools and will continue to support the 
Community Action on Youth and Drugs, with a focus 
on problems associated with methamphetamine abuse.  
769. Under the New Zealand national action plan on 
methamphetamine, a number of legislative instruments 
have been implemented or are currently under review 
by the Government. The New Zealand Crimes 
Amendment Act 2009 strengthened the ability of the 
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police to target gangs and organized criminal groups, 
which are responsible for a significant proportion of 
the activities involving illicit drug manufacture, 
trafficking and supply. The maximum penalty for 
participation in an organized criminal group has  
been extended from 5 to 10 years of imprisonment. 
Furthermore, with respect to treatment for drug 
abusers, the New Zealand Law Commission is 
reviewing the Alcoholism and Drug Addiction  
Act 1966 to include a new system for compulsory 
treatment for people with severe drug dependence. 
770. In February 2010, the New Zealand Law 
Commission published an issues paper on the review of 
the Misuse of Drugs Act 1975. The paper included 
preliminary proposals to amend national drug laws to 
enable a better response to emerging issues related  
to drug control. For instance, the Law Commission 
proposed establishing a new control mechanism for 
substances not under international control and 
imposing strict control measures to prevent the abuse 
of prescription drugs. Moreover, on the issues of 
possession of drugs in small quantities and personal 
use of drugs, the paper proposed to place more 
emphasis on the delivery of effective treatment and 
less emphasis on conviction and punishment. The 
Board trusts that the Government will ensure that  
New Zealand fully complies with its obligations under 
the international drug control treaties when considering 
amendments to the national drug legislation. 
771. In October 2009, the Government of Samoa 
adopted the Narcotics Amendment Act 2009, amending 
the Narcotics Act 1967. The Act established the penalty 
of life imprisonment for offences related to drugs such 
as cocaine, amphetamine and methamphetamine and 
included provisions on the control of substances listed 
in the Tables of the 1988 Convention. To prevent 
Samoa from becoming a transit area used by traffickers 
for shipping precursors used in the illicit manufacture 
of drugs, the Narcotic Amendment Act established 
severe penalties for all illegal activities associated with 
trafficking in and the diversion of precursor chemicals. 
The Board encourages Samoa to further strengthen 
drug control in line with its obligations under the 
international drug control conventions. 
772. In 2009, the Government of the Cook Islands 
adopted the Narcotics and Misuse of Drugs 
Amendment Act 2009, amending the Narcotics and 
Misuse of Drugs Act 2004. Also in 2009, Papua New 
Guinea passed the Dangerous Drugs Act 2009 to better 
respond to emerging challenges in drug control in the 
country. In December 2009, the Government of the 
Marshall Islands established a substance abuse 
prevention advisory council to lead national activities 
related to drug abuse prevention. The Government also 
endorsed the prevention strategies for the period 2010-
2014 for strengthening the role of communities in 
preventing drug abuse. In addition, a number of 
countries in Oceania, including Fiji and Vanuatu, are 
currently reviewing or reforming existing national drug 
control legislation.  
773. Despite the progress in legislative reform in a few 
countries in Oceania, drug control legislation in many 
other countries in the region appears to be outdated and 
insufficient to respond to new issues such as the illicit 
manufacture of and trafficking in amphetamine-type 
stimulants. The Board urges the countries concerned to 
strengthen national drug control legislation to enable a 
better response to emerging issues.  
 
 4. Cultivation, production, manufacture and 
trafficking  
 
  Narcotics 
 
774. Cannabis continues to be the drug seized most 
often in Oceania. As there is extensive illicit 
cultivation of cannabis plants in Oceania, smuggling of 
cannabis into the region remains at a low level. In the 
period 2008-2009, the number of domestic cannabis 
seizures in Australia reached the highest levels in  
10 years — an increase of 12.5 per cent over the 
number of seizures in the period 2007-2008. However, 
the total amount of seized cannabis decreased from 
8,900 kg in the period 2007-2008 to 5,600 kg in the 
period 2008-2009, a year-on-year decrease reflecting 
the large amount of cannabis seized (total: 3,500 kg) in 
the state of Queensland in the period 2007-2008. 
Regarding seizures of cannabis at the Australian 
border, most were of amounts less than 100 grams; 
over 50 per cent of the total amount seized had been 
smuggled in air cargo. In terms of the number of 
seizures of cannabis shipments at the Australian 
border, the Netherlands was the country most often 
identified as the country of departure, whereas over 
half of the total amount of cannabis seized at the 
Australian border involved shipments that had departed 
from the United States. The majority of the cannabis-
related seizures at the Australian border involved 
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seeds, which were believed to be for use in the illicit 
cultivation of cannabis plants on Australian territory. 
775. In 2009, New Zealand reported having seized 
approximately 640 kg of cannabis, an amount similar 
to the amount seized in 2008. The New Zealand 
National Cannabis Crime Operation achieved 
significant results in the period 2008-2009:  
141,000 cannabis plants were destroyed, and  
190 firearms were seized by the police. In April 2010, 
in Operation Lime, which targeted the sale of 
equipment and materials used for illicitly cultivating 
cannabis plants, New Zealand Police detected about 
150 sites used for illicitly cultivating cannabis plants 
indoors, and seized about 65 kg of drugs, including 
cannabis, methamphetamine and MDMA (“ecstasy”). 
Operation Lime also resulted in the seizure of a large 
number of weapons, which were believed to be closely 
linked with organized criminal groups. 
776. The illicit cultivation of cannabis plants and the 
seizure of cannabis are increasingly being reported in 
Fiji, Papua New Guinea and Tonga. In Fiji, cannabis-
related offences decreased significantly, by 42 per cent, 
from 2008 to 2009 (253 cases in 2008 compared with 
148 cases in 2009). However, it appears that the illicit 
cultivation of cannabis has persisted in Fiji, despite the 
cannabis eradication campaigns conducted by the Fiji 
Police in the period 2009-2010 and the nationwide 
awareness-raising programmes carried out in recent 
years. In addition, cannabis plants have been illicitly 
cultivated in some remote areas where eradication is 
difficult. The Board urges the Governments concerned 
to take measures to address the problems of illicit 
cannabis plant cultivation and illicit cannabis 
production and trafficking in countries in Oceania. 
777. The increasing illicit demand for cocaine in 
Australia is reflected in the fact that the amount of 
cocaine seized has remained relatively high since the 
period 2002-2003. During the period 2008-2009, the 
total amount of cocaine seized in Australia was about 
1,100 kg, of which 506 kg were seized at the border. 
Colombia continues to be the main source of cocaine 
seized at the Australian border. Mexicans and South 
Americans with strong links to illicit cocaine 
manufacturers in South America were involved in the 
smuggling of most of the cocaine seized at the 
Australian border. During an 18-month operation  
in the period 2008-2009, the Australian authorities 
dismantled an international drug syndicate that had 
used airport staff to smuggle cocaine into the country. 
In June 2010, the Australian authorities seized 240 kg 
of cocaine concealed in stone pavers from Mexico; that 
was the fifth largest cocaine seizure in Australian 
history.  
778. Customs authorities of Fiji and Papua New 
Guinea reported seizures of cocaine from South 
America and Central America that had been smuggled 
in air cargo and by air passengers. Although the total 
amount of cocaine seized was small, it indicated that 
those countries were being considered as possible new 
markets for the drug.  
779. The total amount of heroin seized in Oceania 
remains low compared with seizure totals in other 
regions. However, the quantity of the heroin seized has 
increased since 2005. In Australia, the total amount of 
heroin seized in the period 2008-2009 (300 kg) was 
almost double the amount seized in the period 2007-
2008 (170 kg). While South-West Asia and South-East 
Asia continue to be major sources of the heroin 
smuggled into Australia, the number of countries from 
which heroin shipments depart for Australia increased 
significantly in the period 2008-2009, indicating that 
new smuggling routes are being used to smuggle the 
drug into the country. About 80 per cent of the heroin 
seized at the Australian border was smuggled in air 
cargo or by air passengers. South Africa was the 
country of departure for the largest shipment of heroin 
seized at the Australian border in the period 2008-
2009: about 18 kg that had been concealed in air cargo.  
780. At the Australian border, the number of seizures 
of pharmaceutical preparations containing opioids 
increased from 12 in the period 2007-2008 to 20 in the 
period 2008-2009. Half of the seizures involved 
morphine, while most of the remaining seizures were 
of pharmaceutical preparations containing oxycodone 
or hydrocodone. Most of the pharmaceutical 
preparations were purchased on the Internet, a trend 
that the Australian authorities expect will continue. 
Most of the shipments seized in the period 2008-2009 
had been concealed in mail originating in countries 
including France, India, South Africa, Thailand, the 
United Kingdom and the United States.  
 
  Psychotropic substances 
 
781. The illicit manufacture of and trafficking in 
amphetamine-type stimulants continue to pose a great 
challenge for countries in Oceania. In Australia, the 
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total amount of amphetamine-type stimulants 
(excluding MDMA (“ecstasy”)) seized at the border in 
the period 2008-2009 increased by 58 per cent 
compared with the period 2007-2008. Ninety per cent 
of the shipments of amphetamine-type stimulants 
seized had been sent in the mail. Most of the 
amphetamine-type stimulants seized at the Australian 
border were found in shipments that had departed from 
Hong Kong, China (50 per cent), followed by mainland 
China, Zambia, Canada and South Africa. Zambia was 
the country of departure of a seized shipment of 68 kg 
of amphetamine. Seizures of amphetamine-type 
stimulants continued to be reported in 2010. Most of 
the crystalline methamphetamine seized at the 
Australian border was found in shipments that had 
departed from, in descending order, Canada, Myanmar, 
the Lao People’s Democratic Republic, Cambodia, 
Indonesia and China. In January 2010, Australian law 
enforcement authorities seized 50 kg of crystalline 
methamphetamine that had been concealed in a 
shipment of car parts sent from China to Australia.  
782. In New Zealand, seizures of methamphetamine 
continued to be reported in the period 2009-2010. 
Sources of the seized drug included, in descending 
order, the United States, China (including Hong Kong 
and Taiwan Province), and the United Kingdom.  
In 2010, law enforcement authorities in New Zealand 
seized methamphetamine smuggled by air passengers 
arriving from China (Hong Kong and Taiwan  
Province) and continued to dismantle clandestine 
methamphetamine laboratories in the country. An 
increasing number of women were involved in 
methamphetamine-related offences such as trafficking 
and illegal possession. As a result, since the  
period 2003-2004, the number of women serving 
prison sentences in New Zealand has almost doubled, 
and methamphetamine-related offences account for a 
significant proportion of the increase.  
783. Increasing numbers of seizures of 
methamphetamine have been reported in other parts of 
Oceania. In 2009, authorities of French Polynesia 
reported the seizure of 340 grams of crystalline 
methamphetamine. The drug had been concealed in 
liquid sent by mail from Mexico and had subsequently 
been transformed into high-purity crystalline form in a 
local laboratory. Smuggling of methamphetamine  
into French Polynesia was first reported in 2004  
and continued in 2005 and 2006. In Tonga, 
methamphetamine was seized in 2009 and 2010. The 
seizures raise concerns about Tonga becoming a trans-
shipment area used by drug traffickers.  
784. Most of the amphetamine-type stimulants found 
on the illicit market in Oceania have been clandestinely 
manufactured within the region, as evidenced by the 
detection of an increasing number of clandestine 
laboratories. Although most of those clandestine 
laboratories are small, they pose a serious risk to 
communities, as many are located in residential areas. 
In Australia, detections of clandestine laboratories 
manufacturing amphetamine-type stimulants (including 
MDMA (“ecstasy”)) increased by 17 per cent, from 
271 in the period 2007-2008 to 316 in the period 2008-
2009. Twenty-four clandestine laboratories seized in 
the period 2008-2009 were each found to have been 
illicitly manufacturing more than one type of drug, for 
instance, methamphetamine and “ecstasy” had been 
illicitly manufactured in the same laboratory. In New 
Zealand, clandestine laboratories are the predominant 
source of amphetamine-type stimulants. Approximately 
137 such clandestine laboratories were dismantled in 
2009. In 2010, seizures of clandestine laboratories 
manufacturing amphetamine-type stimulants continued 
to be reported. Organized crime syndicates were found 
to be illicitly manufacturing the drug and distributing it 
locally.  
785. While the quantity of precursors of MDMA 
(“ecstasy”) seized at the Australian border in the  
period 2008-2009 was small, the illicit manufacture 
and supply of “ecstasy” in Australia appears to have 
continued. Seizures of clandestine laboratories for 
manufacturing “ecstasy” increased significantly in 
Australia, from 11 in the period 2007-2008 to 19 in the 
period 2008-2009. In January 2010, for the first time, 
the Australian authorities dismantled a clandestine 
laboratory that had been used to extract and process 
sassafras oil, a substance used in the illicit manufacture 
of “ecstasy”. New Zealand authorities seized about 
14,000 “ecstasy” tablets in 2009.  
 
  Precursors 
 
786. The total amount of precursors of amphetamine-
type stimulants seized in Oceania has increased 
significantly in recent years. Pseudoephedrine 
contained in pharmaceutical preparations became the 
precursor most commonly seized in the region. In 
Australia, 2,014 kg of ephedrine and pseudoephedrine 
were seized at the border in the period 2008-2009, 
Report of the International Narcotics Control Board  
 
116  
 
nearly double the total amount of all precursors seized 
in the period 2007-2008. Nearly 80 per cent of the 
seizures were of pseudoephedrine. Most of the 
pseudoephedrine seized had been shipped from China 
(including Hong Kong and Taiwan Province),  
New Zealand, Thailand and Viet Nam. In addition to 
being smuggled into Australia, a large amount of 
pseudoephedrine, including in the form of over-the-
counter pharmaceutical preparations is diverted from 
domestic distribution channels in that country. In 
addition to ephedrine and pseudoephedrine, Australia 
reported seizures of 40 litres of sassafras oil in the 
period 2008-2009, destined for the illicit manufacture 
of MDMA (“ecstasy”) in the country. In 2009, 
Australian authorities seized a shipment of safrole that 
had departed from Papua New Guinea, indicating that 
traffickers are looking for new trafficking routes.  
787. In New Zealand, the illicit importation  
of pharmaceutical preparations containing 
pseudoephedrine continues to pose a significant 
challenge for law enforcement authorities. Seizures of 
the substance reached a record high in 2009 (over  
1 ton of cold medication containing pseudoephedrine 
was seized). China continues to be the main  
source of pharmaceutical preparations containing 
pseudoephedrine seized at the New Zealand border. 
Some of those preparations had been smuggled out of 
New Zealand into Australia. Many of the shipments 
seized were found to have been organized by criminal 
groups using teenagers. Furthermore, over-the-counter 
medicines containing pseudoephedrine continue to be 
diverted in New Zealand.  
788. The Board is concerned about the use of countries 
in Oceania as trans-shipment areas for precursor 
chemicals destined for use in illicit drug manufacture 
in Australia and New Zealand. Evidence shows that 
traffickers have attempted to smuggle pharmaceutical 
preparations containing pseudoephedrine from several 
countries, including Fiji, Papua New Guinea and 
Tonga, into New Zealand. Some of those preparations 
appear to have been diverted from licit distribution 
channels in those countries. In order to prevent the 
diversion of over-the-counter medicines containing 
pseudoephedrine, the Fiji authorities have strengthened 
regulations to require registration of sales of such 
medicines and restrict the quantity of each transaction.  
 
  Substances not under international control 
 
789. In Australia, illicit drug manufacturers continue 
to look for precursors not under international control 
that can be used for the illicit manufacture of 
amphetamine-type stimulants. While the extraction of 
ephedrine and pseudoephedrine from medicine used for 
treating colds continues to be a common method of 
obtaining those two precursors of amphetamine-type 
stimulants, restrictions on the sale of pharmaceutical 
preparations containing ephedrine and pseudoephedrine 
have forced illicit drug manufacturers to look for 
alternative precursors not under international or 
national control. For instance, in 2008, the Australian 
authorities dismantled a clandestine laboratory that 
produced l-phenylacetylcarbinol, a precursor of 
ephedrine and pseudoephedrine. Furthermore, in 2009, 
about 28 kg of ephedra, a plant containing ephedrine, 
were seized at the Australian border. In view of the 
increasing trend of using precursors not under 
international control for the illicit manufacture of 
drugs, the Board urges countries in Oceania to apply 
appropriate control to those substances and to provide 
the Board with any information available on precursors 
not under international control and new methods used 
for the illicit manufacture of drugs. 
790. In recent years, the New Zealand customs 
authorities have seen increasing illicit importation  
of mephedrone into the country. Mephedrone is  
an analogue of methcathinone (also known as  
4-methylmethcathinone, or 4-MMC and “meow”) and 
is reported to have effects similar to those of cocaine 
and MDMA (“ecstasy”). While the substance is not 
under international control, it is subject to national 
control in a number of countries, including Australia 
and New Zealand. The first seizure of mephedrone  
by the New Zealand authorities was made in  
November 2009. As at January 2010, a total of  
15 seizures of mephedrone were made in New Zealand, 
mostly of shipments sent in the mail from China or the 
United Kingdom.  
 
 5. Abuse and treatment 
 
791. According to the results of the 2007/08 New 
Zealand Alcohol and Drug Use Survey, one in  
six adults aged 16-64 years (16.6 per cent) had used 
illicit drugs in the past year. Among them, young 
people aged 16-34 years were more likely than other 
age groups to have used illicit drugs. Among the 
Chapter III. Analysis of the world situation
 
 117 
 
past-year drug abusers, only about 3 per cent had 
received assistance in the past year. The Board 
encourages the Government of New Zealand to provide 
better assistance and treatment services for people with 
drug-related problems.  
792. Cannabis continues to be the most widely abused 
drug in Oceania. In New Zealand, the annual 
prevalence rate of cannabis abuse among individuals 
aged 14-64 years was 14.6 per cent in 2008. Although 
the rate decreased slightly from 2003, it was among the 
highest in the world. About 13.4 per cent of past-year 
cannabis abusers had used cannabis daily; about  
54 per cent had used cannabis at least once per month 
in the past year. Cannabis abuse among young people 
is an increasing concern in New Zealand. The 
population aged 18-24 years had the highest prevalence 
rate of past-year cannabis abuse of all age groups. 
Among individuals who had ever used cannabis,  
16.2 per cent had first tried cannabis when they were 
14 years or younger, and 80 per cent had first tried 
cannabis between the ages of 14 and 20 years.  
793. Cannabis abuse among young people was also 
widespread in countries in Oceania other than New 
Zealand. Lifetime prevalence of cannabis abuse in Fiji 
and Papua New Guinea was about 47 per cent and  
55 per cent, respectively, with an average age of first 
use of about 18 years. In Fiji, the abuse of cannabis 
among students in primary and secondary schools 
increased steadily from 1999 to 2005. In Palau, annual 
prevalence of abuse was about 24 per cent among 
people aged 16-64 years. According to the 2009 Palau 
Youth Risk Behaviour Survey, lifetime prevalence of 
cannabis abuse among students in secondary schools 
was about 60 per cent, a significant increase from the 
49 per cent recorded in 2005. Among them, 29 per cent 
of males and 10 per cent of females first tried cannabis 
before the age of 13 years. In addition, Solomon 
Islands and Vanuatu reported that about 50 per cent of 
persons aged 15-24 years had tried cannabis. 
Micronesia (Federated States of) and Tonga also 
reported increased cannabis abuse in recent years. 
794. Although annual prevalence of abuse of 
amphetamines (excluding MDMA (“ecstasy”)) has 
been decreasing over the years in Oceania, it remains 
high compared with other regions. In 2008, Australia 
reported decreased abuse of methamphetamine among 
persons who regularly abused drugs by injection.  
The 2007/08 New Zealand Alcohol and Drug Use 
Survey shows that annual prevalence of abuse of 
amphetamines in the country decreased from about  
3 per cent in 2003 to 2.1 per cent in 2008. Young males 
aged 18-24 years had the highest annual prevalence of 
abuse of amphetamines among all population 
segments.  
795. Abuse of other types of amphetamines is very 
limited in most countries in Oceania except Australia 
and New Zealand. Nevertheless, increased availability 
and abuse of amphetamines (including MDMA 
(“ecstasy”)) in Fiji was reported by the Fiji Police 
Force in 2009. In Palau, annual prevalence of abuse of 
amphetamines in 2007 was about 1.6 per cent. Lifetime 
prevalence of abuse of amphetamines in Palau is about 
7 per cent, which is among the highest rates in the 
region. 
796. Annual prevalence of abuse of MDMA 
(“ecstasy”) in Oceania has been increasing steadily in 
recent years, Australia having the highest annual 
prevalence of such abuse worldwide. In Australia and 
New Zealand, “ecstasy” has replaced amphetamines as 
the second most abused drug. In Australia, annual 
prevalence of abuse of amphetamines increased from 
0.9 per cent in 1995 to 3.5 per cent in 2007. Similarly, 
in New Zealand, annual prevalence of such abuse 
among the population aged 16-64 years increased from 
2.3 per cent in 2003 to 3.3 per cent in 2008. The 
increasing abuse of “ecstasy” may lead to increased 
demand for the substance in the region.  
797. Drug abuse by injection continues to be reported 
in Australia and New Zealand. In Australia, the average 
age of first-time abuse of drugs by injection is about  
19 years. A 2009 Australian national survey revealed 
that the drug most commonly abused by injection was 
heroin (37 per cent), followed by methamphetamine 
(26 per cent). In 2009, New Zealand reported that 
approximately 30,000 people in the country had abused 
drugs by injection during their lifetime.  
798. The Government of Australia has conducted 
surveys of drug abuse among criminal offenders in 
recent years. Although drug abuse among police 
detainees has declined, the issue of drug abuse in 
prison is an increasing concern for the Australian 
authorities. It is estimated that 71 per cent of prisoners 
have abused drugs in the past 12 months. Female 
inmates reported a higher level of drug abuse, 
including by injection, than did male inmates. The 
inmate population segment with the highest proportion 
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of drug abuse in the past 12 months was that of 
prisoners aged 25-34 years (77 per cent) and the lowest 
rate of abuse was that of prisoners aged 45 years  
or older (43 per cent). The drug most frequently  
abused by prisoners in the past year was cannabis  
(52 per cent), followed by amphetamines (30 per cent), 
heroin (19 per cent) and MDMA (“ecstasy”)  
(18 per cent). About 55 per cent of prisoners had at 
some point in their life abused drugs by injection. Of 
those who had abused drugs by injection, 15 per cent 
had shared injection equipment with others. The needle 
exchange programme and opioid substitution treatment 
were available in prisons. 
799. In Australia, substitution therapy is one treatment 
option for people dependent on opioids. According to 
an annual survey by the Government of Australia, as at 
30 June 2009, a total of 43,445 persons were receiving 
pharmacotherapy treatment, a number that had slowly 
increased since 1998. Of that total, 70 per cent 
received methadone, and the remainder received 
buprenorphine or buprenorphine/naloxone, a trend  
that has remained stable since 2006. A total of  
1,350 prescribers were authorized to prescribe 
pharmacotherapy treatment in the country, each 
prescriber having on average 32 patients. In 2009, 
there were approximately 2,150 dosing points in 
Australia, most of which (85 per cent) were located in 
pharmacies.  
800. The drug treatment units located in the prisons of 
New Zealand continue to contribute to reducing drug 
abuse among prisoners. Under the Department of 
Correction’s drug and alcohol strategy for the  
period 2009-2014, three new drug treatment units will 
be established, and annual participation is expected to 
increase from 500 to 1,000 prisoners. In addition to a 
six-month treatment programme offered to prisoners 
serving more than 12 months, the drug treatment units 
offer an intensive three-month programme for people 
serving less than 12 months. Methadone maintenance 
treatment for opioid-dependent prisoners is part of the 
programme. 
801. Even though Australia and New Zealand have 
comprehensive drug treatment response programmes, 
they are still facing the problem of insufficient 
treatment capacity, which may limit the effective 
delivery of treatment service. In Australia, there is a 
shortage of qualified general practitioners who can 
prescribe pharmacotherapy treatment. In New Zealand, 
only about 24,000 people are treated each year for 
alcohol and drug dependence through the publicly 
funded health system. Currently, there are about  
630 alcohol and drug treatment residential beds, 100 of 
which are suitable for moderate or severe abusers. 
Measures are being taken by the Governments of 
Australia and New Zealand to address this issue. 
Australia will provide funding to train more qualified 
doctors. In New Zealand, funding will be provided for 
80 additional treatment beds by 2012, so that an 
additional 3,100 drug addicts can receive treatment.  
802. In Fiji and Papua New Guinea, treatment for drug 
abuse is mostly provided by general and psychiatric 
hospitals. Cannabis abuse was the most common 
problem for which drug abusers sought treatment. In 
Fiji’s hospitals, in 2008, a total of 178 patients were 
treated for substance abuse problems; 60 per cent of 
those patients were treated for cannabis abuse. Papua 
New Guinea reported a lack of financial and other 
resources for treatment of drug abuse. In view of the 
increasing abuse of drugs in those countries, the Board 
encourages Australia and New Zealand to share 
expertise and provide assistance to improve treatment 
services for drug abusers in other countries in Oceania. 
803. During the period 2009-2010, awareness-raising 
and education programmes aimed at reducing drug 
abuse were launched in Fiji, Papua New Guinea and 
Tonga. In response to the increasing abuse of cannabis 
in primary and secondary schools throughout the 
country, the Ministry of Health of Fiji launched the 
drug-free school concept in 2010, on the International 
Day against Drug Abuse and Illicit Trafficking. In  
736 primary schools and 174 secondary schools in Fiji, 
many activities focusing on the harm caused by drug 
abuse were organized with a view to reducing drug 
abuse among students. In addition, the Fiji National 
Substance Abuse Advisory Council conducted training 
programmes related to drug abuse and the prevention 
of HIV/AIDS for community leaders, teachers and staff 
of government agencies and non-governmental 
organizations. Moreover, training workshops for 
inmates and prison officers took place in Fiji’s prisons. 
In 2009, the authorities of Papua New Guinea provided 
training workshops for health-care professionals and 
medical students. In Tonga, the Tonga Alcohol and 
Drug Awareness Centre organized weekly training 
programmes in schools and drug and alcohol abuse 
awareness-raising workshops in prisons and provided 
training for staff of non-governmental organizations. 
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IV. Recommendations to Governments, the United Nations and other relevant 
international and regional organizations 
 
804. The Board monitors the implementation by 
Governments of the international drug control 
conventions and examines the functioning of the 
international drug control system at the national and 
international levels. Based on its analysis, the Board 
makes recommendations to Governments, international 
organizations and regional organizations to support 
implementation of the conventions. 
805. In this chapter, the Board highlights the key 
recommendations contained in chapters II and III of 
the present report. The recommendations contained in 
chapter I are not included in chapter IV. In 2010, the 
Board decided to issue a supplement to the present 
report on the availability of internationally controlled 
drugs,40 which will include several additional 
recommendations. Additional recommendations on the 
control of precursors are contained in the 2010 report 
of the Board on the implementation of article 12  
of the 1988 Convention.41 The Board encourages 
Governments and relevant international and regional 
organizations to examine all the recommendations 
made by the Board and to implement them, as 
appropriate. The Board calls upon those concerned to 
keep the Board informed of their action in response to 
the recommendations.  
806. In 2008, the Board decided to evaluate the 
implementation of the recommendations published in 
its reports for 2005, 2006 and 2007 by Governments 
and relevant international organizations. Information 
on the implementation of the recommendations made 
by the Board to relevant international organizations is 
contained in chapter II of this report; the information 
on the implementation of the Board’s recommendations 
by Governments will be published by the Board in due 
course. 
 
__________________ 
 40  Report of the International Narcotics Control Board on 
the Availability of Internationally Controlled Drugs: 
Ensuring Adequate Access for Medical and  
Scientific Purposes (United Nations publication,  
Sales No. E.11.XI.7). 
 41  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2010 … 
 A. Recommendations to Governments 
 
 
807. The recommendations to Governments are 
grouped according to the following subject areas: 
treaty accession; treaty implementation and control 
measures; prevention of illicit drug production, 
manufacture, trafficking and abuse; prevention of 
diversion of precursors into the illicit traffic; and 
availability and rational use of narcotic drugs and 
psychotropic substances for medical purposes.  
 
 1. Treaty accession 
 
808. The 1961 Convention as amended by the  
1972 Protocol, the 1971 Convention and the  
1988 Convention represent the basis of the international 
drug control system. The accession of all States and the 
universal implementation of the provisions of the 
conventions are a fundamental prerequisite for efficient 
drug control worldwide. 
Recommendation 1: There remain 16 States, 10 of 
which are in Oceania, that are not yet parties to one or 
more of the international drug control treaties.42 In 
addition, Afghanistan and Chad continue to be parties 
to the 1961 Convention in its unamended form only. 
The failure by a State to accede to any of the treaties 
may weaken the collective efforts of the international 
community to prevent and combat illicit drug use and 
drug trafficking. The Board requests those States 
__________________ 
 42  The following States are not parties to the international 
drug control treaties and/or the 1972 Protocol amending 
the 1961 Convention: 
   (a) States not parties to the 1961 Convention as 
amended by the 1972 Protocol or to the 1961 Convention 
in its unamended form: Cook Islands, Equatorial Guinea, 
Kiribati, Nauru, Samoa, Timor-Leste, Tuvalu and 
Vanuatu; 
   (b) States not parties to the 1972 Protocol 
amending the 1961 Convention: Afghanistan and Chad; 
   (c) States not parties to the Convention of 
1971: Cook Islands, Equatorial Guinea, Haiti, Kiribati, 
Liberia, Nauru, Samoa, Solomon Islands, Timor-Leste, 
Tuvalu and Vanuatu; 
   (d) States not parties to the 1988 Convention: 
Equatorial Guinea, Holy See, Kiribati, Marshall Islands, 
Nauru, Palau, Papua New Guinea, Solomon Islands, 
Somalia, Timor-Leste and Tuvalu. 
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which are not yet parties to one or more of the 
international drug control treaties to accede to the 
treaties without further delay. 
 
 2. Treaty implementation and control measures 
 
809. Universal accession to the three international 
drug control treaties will not be sufficient to address 
drug-related problems; that will require, in addition, 
universal implementation of all the provisions of the 
treaties and the effective application of the necessary 
control measures by all Governments. 
Recommendation 2: Parties to the international drug 
control treaties have an obligation to furnish to the 
Board statistical reports on narcotic drugs, 
psychotropic substances and precursors, in accordance 
with the relevant provisions of those treaties. Some 
Governments are, however, not regularly complying 
with that obligation. The Board requests 
Governments to furnish, in a timely manner, 
accurate information in all statistical reports on 
narcotic drugs, psychotropic substances and 
precursors, as required under the conventions. 
Governments are encouraged to seek from the 
Board any information that will assist them in 
complying with their reporting obligations. 
Recommendation 3: In some countries, the deficiencies 
in the submission of statistical reports to the Board are 
the result of the Governments providing insufficient 
resources to the authorities responsible for the control 
of licit activities involving narcotic drugs, psychotropic 
substances or precursors. The Board calls upon the 
Governments concerned to provide adequate 
resources to ensure the compliance of those 
authorities with all reporting obligations under the 
international drug control treaties. 
 
  Narcotic drugs and psychotropic substances 
 
Recommendation 4: Some Governments did not submit 
their estimates of requirements for narcotic drugs for 
2011; therefore the estimates for those countries and 
their territories were established by the Board and will 
remain in force until the estimates established by the 
Governments concerned are received and confirmed by 
the Board. The Board calls upon the Governments 
concerned to examine their national requirements 
for narcotic drugs for 2011 and provide their own 
estimates to the Board for confirmation as soon as 
possible, in order to prevent any possible difficulties 
in importing the quantities of narcotic drugs 
required for medical and scientific purposes. 
Recommendation 5: Pursuant to Economic and  
Social Council resolutions 1981/7 and 1991/44, 
Governments are requested to provide to the Board 
assessments of their annual domestic medical and 
scientific requirements for psychotropic substances in 
Schedules II, III and IV of the 1971 Convention. Some 
Governments have not submitted an update of their 
legitimate requirements for psychotropic substances in 
over three years. The Board calls upon all 
Governments to ensure adequacy of assessments of 
their annual medical and scientific requirements for 
psychotropic substances and when necessary inform 
the Board of modifications to their assessments. The 
Board recommends that Governments review and 
update the assessments at least every three years. 
Recommendation 6: The 1971 Convention allows 
Governments to exempt from some control measures 
foreseen under that Convention certain preparations 
that contain psychotropic substances and that present a 
negligible risk of abuse. Some Governments exempted 
preparations containing psychotropic substances from 
certain control measures but failed to notify the 
Secretary-General of those exemptions, as required by 
article 3 of the 1971 Convention. Such notifications are 
necessary to inform other Governments of those 
exemptions with a view to ensuring that reducing 
controls in one country does not result in diversion and 
abuse of those preparations in other countries. The 
Board requests all Governments that are exempting 
certain preparations at the national level from some 
control measures foreseen in the 1971 Convention 
and that have not yet notified the Secretary-General 
of those exemptions, to do so without delay.  
Recommendation 7: Most Governments have 
introduced the import and export authorization system 
for all psychotropic substances in Schedules III and IV 
of the 1971 Convention. That system has proved 
particularly effective in preventing diversion of those 
substances from international trade. Traffickers may 
target countries in which controls are less strict than in 
other countries. The Board urges the Governments 
of countries in which national legislation does not 
yet require import and export authorizations for all 
psychotropic substances in Schedules III and IV of 
the 1971 Convention to extend such controls to all 
Chapter IV. Recommendations to Governments, the United Nations and other relevant international and regional organizations
 
 121 
 
substances in those schedules as soon as possible 
and to inform the Board accordingly.  
 
  Precursors 
 
Recommendation 8: In seeking to implement key 
provisions of article 12 of the 1988 Convention, States 
have increasingly adopted legal and regulatory control 
measures aimed at stemming the diversion of 
substances in Tables I and II. Those measures have 
limited the diversion of internationally controlled 
precursors into illicit channels and have forced 
traffickers to resort to new means of circumventing 
control measures. The trends noted include the illicit 
manufacture of controlled precursors, in particular 
precursors of amphetamine-type stimulants, using 
substances not under international control. The Board 
calls upon Governments to use form D to report to 
the Board incidents involving the diversion or 
seizure of non-controlled substances used in the 
illicit manufacture of precursors, in order to 
facilitate the evaluation of those substances by  
the Board, with a view to possibly including them 
on the limited international special surveillance list 
of non-scheduled substances or recommending their 
inclusion in Table I or II of the 1988 Convention. 
Recommendation 9: Approximately 40 per cent of 
Governments have not yet provided estimates of their 
annual requirements for certain precursors of 
amphetamine-type stimulants. Moreover, many 
Governments that provided estimates in the past have 
not ensured that the information on record is up to 
date, despite the fact that their legitimate requirements 
for certain precursors may have changed. The Board 
calls upon Governments to comply with the request 
contained in Commission on Narcotic Drugs 
resolution 49/3 and ensure the timely submission 
and continued accuracy of their estimates for 
certain precursors. That is necessary to ensure that 
the estimates can continue to be used to identify 
suspicious transactions involving those particular 
precursors. 
Recommendation 10: PEN Online, the automated 
online system for the exchange of pre-export 
notifications, has continued to be a key tool in global 
efforts to prevent the diversion of precursors from 
international trade. Governments of countries in Africa 
account for half of the Governments that have not yet 
registered for the system. The Board requests all 
Governments that have not yet done so to register 
for the PEN Online system. The Board calls upon all 
Governments registered for PEN Online to use the 
system on a regular basis to enable them to respond 
in a timely manner to requests from exporting 
countries regarding the legitimacy of shipments of 
precursors. 
 
 3. Prevention of illicit drug production, 
manufacture, trafficking and abuse 
 
810. Parties to the international drug control treaties 
have an obligation to limit to legitimate purposes the 
production, manufacture, export, import and 
distribution of, trade in and use of internationally 
controlled substances and to prevent their diversion 
and abuse.  
Recommendation 11: Prevention of the illicit 
cultivation, production, manufacture and abuse of 
narcotic drugs in Afghanistan continues to be of the 
utmost importance to the Government of Afghanistan 
and the international community. The Government  
of Afghanistan is in the process of updating its  
National Drug Control Strategy. The Board urges the 
Government of Afghanistan to vigorously pursue its 
drug control efforts and to ensure that the updated 
National Drug Control Strategy includes effective 
measures to eliminate the cultivation of opium 
poppy and cannabis plant and the manufacture of 
heroin. The Board calls upon the international 
community to continue to assist, in a coordinated 
manner, the Government of Afghanistan in those 
areas.  
Recommendation 12: The Board notes with concern an 
upswing in illicit opium poppy cultivation in countries 
in South-East Asia, in particular in the Lao People’s 
Democratic Republic and Myanmar, during the 2009 
growing season. The Board urges the Governments 
concerned to strengthen their efforts to prevent a 
resurgence of illicit opium poppy cultivation.  
Recommendation 13: The region of Central America 
and the Caribbean continues to be used as a major 
transit area for illicit drug shipments. Given the lack of 
institutional capacity and the limited resources 
available, countries in that region continue to 
experience difficulties in strengthening and enforcing 
drug control measures. Weak law enforcement in the 
region has led to a marked increase in violent crime 
and corruption and, in many countries, has severely 
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undermined economic and political stability. The 
Board calls upon Governments of countries in 
Central America and the Caribbean to ensure the 
enforcement of their drug control measures and to 
coordinate their efforts through initiatives for 
regional cooperation. 
Recommendation 14: The surveys conducted by 
Governments and UNODC indicate that the total area 
under illicit coca bush cultivation in South America 
decreased in 2009. That decrease can, in particular, be 
attributed to a significant reduction in the area under 
illicit coca bush cultivation in Colombia, which 
counterbalanced increases in the area under such 
cultivation in Bolivia (Plurinational State of) and Peru. 
The Board encourages the Government of Colombia 
to continue its efforts to eliminate illicit coca bush 
cultivation on its territory and to ensure the 
sustainability of the positive results achieved so far. 
Recommendation 15: In 2009, the total area under 
illicit coca bush cultivation in the Plurinational State  
of Bolivia increased for the fourth consecutive year — 
an increase of 22 per cent over the figure for 2005.  
The Board calls upon the Government of the 
Plurinational State of Bolivia to adopt effective 
policies and strengthen its efforts to eliminate illicit 
coca bush cultivation on its territory, as well as to 
address in a decisive manner the illicit manufacture 
of and trafficking in cocaine. 
Recommendation 16: The key objectives of the 
Peruvian national drug control plan for the  
period 2007-2011 include significantly reducing the 
total area under illicit coca bush cultivation in the 
country and preventing illicit coca bush cultivation 
from being introduced in areas of the country not 
affected by such cultivation so far. The Board notes 
with concern that despite the Government’s efforts to 
eliminate the illicit cultivation of coca bush, the 
objectives of the current national drug control plan are 
not being met, as evidenced by the fact that the total 
area under illicit coca bush cultivation in the country 
has been increasing since 2005. The Board urges the 
Government of Peru to strengthen its illicit crop 
eradication efforts in order to eliminate illicit coca 
bush cultivation in the country. Furthermore, the 
Board encourages the Government of Peru to adopt 
further measures to strengthen the interdiction 
capacity of its national drug control agencies.  
Recommendation 17: In spite of the general acceptance 
of the principle that all Governments share 
responsibility for tackling drug-related problems, some 
countries in which drugs are illicitly produced, in 
particular low-income countries, lack adequate 
financial resources to address illicit drug production in 
a decisive manner. The Board calls upon the 
international community, including the 
Governments of developed countries, to provide 
further financial support and technical assistance to 
assist the Governments concerned in intensifying 
their efforts to counter illicit drug production.  
Recommendation 18: The system of estimates of 
annual legitimate requirements is an important control 
measure to prevent diversion of narcotic drugs and 
psychotropic substances from international trade. The 
Board calls upon Governments to respect the system 
of estimates and assessments pursuant to the  
1961 Convention and relevant Economic and  
Social Council resolutions by ensuring that their 
estimates and assessments are in line with their 
actual legitimate requirements and that no imports 
of narcotic drugs and psychotropic substances 
exceeding those requirements are authorized. The 
Board also calls upon the Governments of exporting 
countries to regularly check the estimates and 
assessments of importing countries and not to 
authorize exports of narcotic drugs and 
psychotropic substances that are not in line with 
legitimate requirements.  
Recommendation 19: Investigations in South Africa 
revealed that large amounts of cathine, a stimulant in 
Schedule III of the 1971 Convention, were licitly 
imported into that country and then purchased by 
criminal organizations for use in clandestine 
laboratories illicitly manufacturing amphetamine-type 
stimulants. The Board calls upon all Governments to 
monitor shipments of cathine, in particular when 
they are destined for Africa, in order to prevent the 
illicit use of that substance in countries in the region 
where national control measures may not be 
adequate and to consult the Board in cases where 
there are doubts about the legitimacy of those 
transactions. 
Recommendation 20: The diversion of pharmaceutical 
preparations containing narcotic drugs or psychotropic 
substances from domestic distribution channels and 
their abuse continue to pose problems in many 
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countries. Such diversions often indicate loopholes in 
national drug control legislation or insufficient 
monitoring of compliance with existing legislation or 
regulations. The Board requests Governments that 
are faced with problems involving the diversion of, 
trafficking in or abuse of pharmaceutical 
preparations containing narcotic drugs or 
psychotropic substances to identify the source of the 
diverted preparations and take measures to prevent 
such activity.  
Recommendation 21: Cases involving the diversion of 
pharmaceutical preparations containing substances 
used in substitution treatment, such as buprenorphine, 
methadone and morphine, continue to be reported. The 
Board requests the Governments of all countries 
that have substitution treatment programmes and 
that are faced with problems involving the diversion 
and abuse of preparations used in such treatment to 
examine the control measures applied with a view to 
closing any loopholes and prevent their diversion 
and abuse while making them available for use in 
medical treatment.  
Recommendation 22: The Board publishes on a secure 
area of its website, which is accessible to specifically 
authorized Government officials only, a summary of 
the national requirements in place in individual 
countries for authorizing the import and export of 
ketamine, in compliance with Commission on Narcotic 
Drugs resolution 49/6, entitled “Listing of ketamine as 
a controlled substance”. The Board calls upon 
Governments to review that information on the 
website of the Board in order to inform themselves 
about any restrictions to international trade in 
ketamine that may be in place in other countries 
and to respect those restrictions. 
Recommendation 23: The abuse of 4-methyl-
methcathinone (a “designer drug” also known as 
“mephedrone” or 4-MMC) and other “designer drugs” 
used as stimulants, has been reported in a growing 
number of countries and regions. The Board 
recommends that all Governments should closely 
monitor trends in substance abuse on their 
territory, with a view to identifying new substances 
of abuse, such as “designer drug” stimulants. 
Governments are urged to share with the Board  
and WHO any new trends in substance abuse. If 
necessary, Governments that have not yet done so 
should take immediate action to place mephedrone 
and other “designer drug” stimulants under 
national control. To that end, Governments might 
consider generic scheduling, where it is allowed by 
national legislation. Governments might also 
consider notifying the Secretary-General of 
problems involving the abuse of mephedrone on 
their territory, with a view to adding the substance 
to Schedules I, II, III or IV of the 1971 Convention.  
Recommendation 24: The Governments of some 
countries, in particular in South America, have 
experienced problems with regard to the abuse by 
inhalation of volatile organic compounds containing 
various alkyl nitrites, which are commonly referred  
to as “poppers”. The Board recommends that 
Governments share with WHO information on 
health issues related to the abuse of “poppers”.  
Recommendation 25: Synthetic cannabinoid receptor 
agonists have emerged as a new class of substances of 
abuse. These substances are added to herbal mixtures, 
marketed under brand names such as Spice, which are 
sold through the Internet and in specialized shops. The 
Board recommends to Governments to continue 
monitoring the abuse of synthetic cannabinoid 
receptor agonists and to adopt measures to prevent 
their trafficking and abuse. All Governments are 
encouraged to continue to provide the Board with 
information regarding the extent of abuse of and 
trafficking in products containing those substances 
and measures that have been adopted to counter 
such abuse. 
Recommendation 26: Many Governments have, pursuant 
to Commission on Narcotic Drugs resolution 53/7, 
introduced measures to tackle the problem of covert 
administration of psychoactive substances to facilitate 
the commission of sexual assault or other criminal acts. 
The Board welcomes initiatives launched by some 
Governments, in cooperation with industry, to prevent 
the diversion and use of medicines for the commission 
of drug-facilitated crime. The Board calls upon all 
Governments that have not yet done so and that are 
affected by such problems, to consider taking 
appropriate measures to prevent the covert 
administration of psychoactive substances to 
commit sexual assault or other types of crime. 
Recommendation 27: The wide availability of cannabis 
seeds, which are not controlled under the international 
drug control treaties, contributes to the illicit 
cultivation of cannabis plants. The Board is 
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particularly concerned about the widespread sale over 
the Internet of cannabis seeds that are used for illicit 
purposes. The Board encourages all Governments to 
continue identifying good practices in addressing 
the use of cannabis seeds for illicit purposes and to 
consider appropriate measures at the national level 
to effectively prevent that activity. Those measures 
may include, for instance, trade restrictions on 
cannabis seeds capable of germination or on seeds 
of cannabis plant varieties with a THC content 
exceeding a certain threshold. The Board calls upon 
Governments to increasingly monitor cases 
involving the use of the Internet to sell cannabis 
seeds to be used for illicit purposes and to 
strengthen efforts to stop such activity. In that 
connection, the Board also calls upon Governments 
to apply article 3, paragraph 1 (c) (iii), of the  
1988 Convention, which requires States parties to 
establish as a criminal offence public incitement or 
inducement of others to engage in, inter alia, the 
illicit cultivation of cannabis plants and the illicit 
use of cannabis. 
Recommendation 28: The Guidelines for Governments 
on Preventing the Illegal Sale of Internationally 
Controlled Substances through the Internet43 were 
launched by the Board in March 2009. The Board sent 
out a questionnaire in 2010 to all Governments to 
assess the progress achieved in implementing the 
Guidelines. The Board calls upon Governments  
that have not yet done so to furnish to the Board 
their responses to the questionnaire on the 
implementation of the Guidelines. The Board 
requests all Governments to implement the 
Guidelines. 
 
 4. Prevention of diversion of precursors into the 
illicit traffic 
 
811. Parties to the 1988 Convention have an obligation 
to prevent the diversion of precursors for subsequent 
use in the illicit manufacture of narcotic drugs or 
psychotropic substances. 
Recommendation 29: The Board prepares each  
year a report on the implementation of article 12  
of the 1988 Convention and that report contains 
recommendations to Governments on the control of 
precursors. The Board calls upon Governments to 
__________________ 
 43  United Nations publication, Sales No. E.09.XI.6. 
implement the additional recommendations 
contained in the 2010 report of the Board  
on the implementation of article 12 of the 
1988 Convention.44  
Recommendation 30: As access to ephedrine and 
pseudoephedrine has become subject to a growing 
array of control measures, traffickers have sought to 
adapt their manufacturing techniques by using as a 
source for those precursors pharmaceutical 
preparations and natural products containing the 
precursors, which may be beyond the scope of existing 
national drug control measures. The Board calls upon 
all Governments to enact effective measures to 
control ephedrine and pseudoephedrine in the form 
of pharmaceutical preparations and natural 
products in the same manner as they control the 
substances themselves. 
Recommendation 31: The Board has noted that there 
continue to be cases involving the diversion of  
acetic anhydride from domestic distribution channels 
(especially in Europe and East Asia) and its subsequent 
smuggling into regions in which heroin is illicitly 
manufactured. The Board calls upon all Governments 
to evaluate the efficiency of their control measures 
applied to domestic trade in acetic anhydride and to 
adopt further measures as deemed necessary to 
prevent such diversions. 
Recommendation 32: The Board is concerned about the 
legitimacy of large shipments of P-2-P to countries in 
West Asia, in particular Jordan and the Syrian Arab 
Republic; Iraq has been the final destination of some of 
those shipments. P-2-P, a precursor of amphetamine, 
might have been used in the illicit manufacture of 
amphetamine-type stimulants in the region. The Board 
requests the Governments of all countries in West 
Asia to ensure that adequate controls over P-2-P are 
in place and to revise their annual requirements for 
that substance.  
 
__________________ 
 44  Precursors and Chemicals Frequently Used in the Illicit 
Manufacture of Narcotic Drugs and Psychotropic 
Substances: Report of the International Narcotics 
Control Board for 2010 … 
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 5. Availability and rational use of narcotic drugs 
and psychotropic substances for medical 
purposes 
 
812. One of the key objectives of the international 
drug control treaties is to ensure the availability of 
narcotic drugs and psychotropic substances for medical 
and scientific purposes and to promote access to and 
rational use of narcotic drugs and psychotropic 
substances. 
Recommendation 33: In Commission on Narcotic 
Drugs resolution 53/4, entitled “Promoting adequate 
availability of internationally controlled licit drugs for 
medical and scientific purposes while preventing their 
diversion and abuse”, the Commission invited the 
Board to include in its report for 2010 information on 
the consumption of narcotic drugs and psychotropic 
substances used for medical and scientific purposes 
worldwide, including an analysis of impediments to 
their adequate availability and actions to be taken to 
overcome those impediments and, when available, 
specific information about the status of progress made 
by countries. In response to that request, the Board 
decided to issue, as a supplement to the present report, 
a report on the availability of internationally controlled 
drugs. The Board calls upon Governments to 
implement recommendations contained in its report 
on the availability of internationally controlled 
drugs.45 
Recommendation 34: Under the 1971 Convention, 
Governments have no obligation to furnish to the 
Board information on the consumption of psychotropic 
substances. However, reliable data on the consumption 
of psychotropic substances are necessary to enable the 
Board to analyse current consumption and promote the 
adequate availability of psychotropic substances for 
medical and scientific purposes while preventing their 
diversion and abuse, as required under Commission on 
Narcotic Drugs resolution 53/4. The Board 
encourages Governments to consider providing the 
Board with information on the consumption of 
psychotropic substances in the same manner as for 
narcotic drugs.  
Recommendation 35: Large parts of the world remain 
seriously undersupplied with medications that are 
necessary to alleviate patients’ pain and suffering. The 
__________________ 
 45  United Nations publication, Sales No. E.11.XI.7. 
Board urges the Governments of the countries 
concerned, in particular the Governments of 
countries with consumption of opioids below  
100 defined daily doses for statistical purposes  
(S-DDD)46 per million inhabitants per day, to take 
appropriate action to ensure that their populations 
have adequate access to opioid-based medications, 
in line with the international drug control 
conventions.  
Recommendation 36: In a number of countries, high 
prescription levels for certain narcotic drugs and 
psychotropic substances have led to the diversion and 
abuse of those substances. The Board encourages 
Governments to remain vigilant and identify 
consumption levels that are inappropriate and/or 
not required for sound medical practice.  
Recommendation 37: The accurate estimation of 
requirements for internationally controlled substances 
is an essential step in ensuring their adequate supply 
for medical and scientific purposes. While poor 
estimation of requirements can contribute to problems 
in the use of controlled substances, notably shortages 
or irrational prescribing, it can also lead to surpluses, 
wastage and an increased risk of diversion. The Board 
urges Governments to properly apply the systems of 
estimates for narcotic drugs and assessments for 
psychotropic substances as an important tool in 
ensuring adequate availability of internationally 
controlled substances for legitimate purposes.  
Recommendation 38: Emergency situations in the wake 
of natural and man-made disasters may create a  
sudden and acute need for medicines containing 
controlled substances. To address that issue, WHO,  
in consultation with the Board, prepared the  
Model Guidelines for the International Provision of 
Controlled Medicines for Emergency Medical Care.47 
The Board calls upon Governments to ensure that 
competent authorities are aware of and prepared 
for the simplified procedures contained in the 
Guidelines so as to expedite the supply of controlled 
__________________ 
 46  The concept of defined daily doses for statistical 
purposes is explained in the Report of the International 
Narcotics Control Board on the Availability of 
Internationally Controlled Drugs: Ensuring Adequate 
Access for Medical and Scientific Purposes. 
 47  World Health Organization, Model Guidelines for the 
International Provision of Controlled Medicines for 
Emergency Medical Care, document WHO/PSA/96.17. 
Report of the International Narcotics Control Board  
 
126  
 
medicines as soon as the need arises. Governments 
and humanitarian relief agencies are encouraged to 
bring to the attention of the Board any problems 
encountered in the working of emergency deliveries 
of controlled medicines. Governments may also wish 
to include in their special stocks of narcotic drugs 
and psychotropic substances quantities that are 
necessary to meet the need for such substances in 
the event of an emergency situation. 
 
 
 B. Recommendations to the United 
Nations Office on Drugs and Crime 
and to the World Health Organization 
 
 
813. UNODC is the primary United Nations entity 
responsible for providing technical assistance in drug 
control matters, as well as coordination of such 
assistance provided by Governments and other 
organizations. The treaty-based function of WHO is to 
provide recommendations, based on medical and 
scientific assessments, regarding changes in the scope of 
control of narcotic drugs under the 1961 Convention and 
psychotropic substances under the 1971 Convention. 
WHO plays also a key role in supporting the access to 
and the rational use of substances under international 
control.  
Recommendation 39: A large proportion of 
Governments have not been submitting to the Board on 
a regular basis their mandatory statistical reports on 
narcotic drugs, psychotropic substances or precursors. 
That is particularly the case for Governments of 
countries in Africa, the Caribbean and Oceania. The 
difficulties encountered by the Governments of several 
countries in those regions in submitting statistical 
reports indicate major deficiencies in their national 
regulatory mechanisms for controlled substances. The 
Board requests UNODC to support the secretariat 
of the Board in assisting the Governments of the 
countries concerned in Africa, the Caribbean and 
Oceania in strengthening their capacity to ensure 
adequate oversight and regulatory control with 
regard to licit activities involving narcotic drugs 
and psychotropic substances and to prevent the 
diversion of precursors. 
Recommendation 40: The region of Central America 
and the Caribbean continues to be used as a major 
transit area for illicit drug shipments. Given the lack of 
institutional capacity and the limited resources 
available, States in Central America and the Caribbean 
continue to experience difficulties in strengthening  
and enforcing drug control measures. Weak law 
enforcement in the region has led to a marked increase 
in violent crime and corruption and in many States 
severely undermined economic and political stability. 
The Board appreciates the recent opening in Panama 
City of the UNODC Regional Programme Office for 
Central America, Cuba and the Dominican Republic, as 
well as the establishment of four centres of excellence 
in the region. The Board encourages UNODC to 
continue to assist Governments in the region 
through capacity-building initiatives. 
Recommendation 41: The Board appreciates the 
various initiatives implemented by UNODC to provide 
technical assistance to countries in Africa in fighting 
the illicit drug traffic, particularly in West Africa, such 
as the West Africa Coast Initiative, AIRCOP and the 
Container Control Programme, which are implemented 
by UNODC in cooperation with other agencies such as 
the Department of Peacekeeping Operations of the 
Secretariat, INTERPOL and the World Customs 
Organization. The Board calls upon UNODC as well 
as other bilateral and multilateral partners to 
continue to assist Governments in the region 
through capacity-building measures for law 
enforcement as well as judicial capacity-building. 
Recommendation 42: The abuse of “designer drug” 
stimulants, such as mephedrone, which has been a 
problem in many countries and regions, cannot be 
tackled by national countermeasures alone, as trends in 
drug abuse spread quickly within and among regions. 
The Board encourages UNODC, through its 
Laboratory and Scientific Section, and WHO to 
develop effective measures to deal with the problem 
of “designer drugs”. 
Recommendation 43: WHO has, for some time, not 
been able to convene its Expert Committee on Drug 
Dependence to assess substances for possible 
scheduling under the 1961 Convention and the  
1971 Convention, a situation that has serious 
repercussions for the international drug control system. 
The Board calls upon WHO to resume, as soon as 
possible, its activities regarding review of 
psychoactive substances for international control, in 
accordance with the responsibilities by WHO under 
the 1961 Convention and the 1971 Convention. 
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Recommendation 44: The Commission on Narcotic 
Drugs, in its resolution 53/7, urged WHO, UNODC and 
the Board to counter the covert administration of 
psychoactive substances related to sexual assault and 
other criminal acts. The Board calls upon WHO to 
cooperate with UNODC and the Board to 
implement resolution 53/7 as soon as possible. 
 
 
 C. Recommendations to other relevant 
international organizations 
 
 
814. International organizations such as INTERPOL 
and the World Customs Organization play an important 
role in international drug control. In cases where States 
require additional operational support in specific areas 
such as drug law enforcement, the Board addresses 
relevant recommendations pertaining to the specific 
spheres of competence of the relevant international and 
regional organizations, including INTERPOL and the 
World Customs Organization. 
Recommendation 45: A large proportion of 
Governments have not been submitting to the Board on 
a regular basis their mandatory statistical reports on 
narcotic drugs, psychotropic substances or precursors. 
That is particularly the case for Governments of 
countries in Africa, the Caribbean and Oceania. The 
difficulties encountered by the Governments of several 
countries in those regions in submitting statistical 
reports indicate major deficiencies in their national 
regulatory mechanisms for controlled substances. The 
Board requests relevant regional organizations to 
provide support to the Governments of the 
countries concerned in Africa, the Caribbean and 
Oceania in strengthening their capacity to control 
licit activities involving narcotic drugs and 
psychotropic substances and to prevent the 
diversion of precursors. 
Recommendation 46: The region of Central America 
and the Caribbean continues to be used as a major 
transit area for illicit drug shipments. Given the lack of 
institutional capacity and the limited resources 
available, States in Central America and the Caribbean 
continue to experience difficulties in strengthening  
and enforcing drug control measures. Weak law 
enforcement in the region has led to a marked increase 
in violent crime and corruption and in many States 
severely undermined economic and political stability. 
The Board invites CICAD to assist Governments in 
the region through capacity-building programmes. 
Recommendation 47: In many countries, law 
enforcement officers’ awareness of the diversion of and 
trafficking in precursors continues to be insufficient. 
The Board calls upon INTERPOL and the World 
Customs Organization to support training for law 
enforcement officers in preventing trafficking in 
precursors.  
(Signed) 
Hamid Ghodse 
President 
(Signed) 
Raymond Yans 
Rapporteur 
(Signed) 
Jonathan Lucas 
Secretary 
Vienna, 12 November 2010 
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Annex I 
 
 
  Regional groupings used in the report of the International 
Narcotics Control Board for 2010 
 
 
 The regional groupings used in the report of the International Narcotics 
Control Board for 2010, together with the States in each of those groupings, are 
listed below. 
 
Africa 
 
Algeria 
Angola 
Benin 
Botswana 
Burkina Faso 
Burundi 
Cameroon 
Cape Verde 
Central African Republic 
Chad 
Comoros 
Congo 
Côte d’Ivoire 
Democratic Republic of the Congo 
Djibouti 
Egypt 
Equatorial Guinea 
Eritrea 
Ethiopia 
Gabon 
Gambia 
Ghana 
Guinea 
Guinea-Bissau 
Kenya 
Lesotho 
Liberia 
 
Libyan Arab Jamahiriya 
Madagascar 
Malawi 
Mali 
Mauritania 
Mauritius 
Morocco 
Mozambique 
Namibia 
Niger 
Nigeria 
Rwanda 
Sao Tome and Principe 
Senegal 
Seychelles 
Sierra Leone 
Somalia 
South Africa 
Sudan 
Swaziland 
Togo 
Tunisia 
Uganda 
United Republic of Tanzania 
Zambia 
Zimbabwe 
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Central America and the Caribbean
 
Antigua and Barbuda 
Bahamas 
Barbados 
Belize 
Costa Rica 
Cuba 
Dominica 
Dominican Republic 
El Salvador 
Grenada 
 
Guatemala 
Haiti 
Honduras 
Jamaica 
Nicaragua 
Panama 
Saint Kitts and Nevis 
Saint Lucia 
Saint Vincent and the Grenadines 
Trinidad and Tobago 
 
 
North America
 
Canada 
Mexico 
 
United States of America 
 
 
 
South America
 
Argentina 
Bolivia (Plurinational State of) 
Brazil 
Chile 
Colombia 
Ecuador 
 
Guyana 
Paraguay 
Peru 
Suriname 
Uruguay 
Venezuela (Bolivarian Republic of) 
 
 
East and South-East Asia
 
Brunei Darussalam 
Cambodia 
China 
Democratic People’s Republic of  
    Korea 
Indonesia 
Japan 
Lao People’s Democratic Republic 
Malaysia 
 
Mongolia 
Myanmar 
Philippines 
Republic of Korea 
Singapore 
Thailand 
Timor-Leste 
Viet Nam 
 
 
South Asia
 
Bangladesh 
Bhutan 
India 
Maldives 
Nepal 
Sri Lanka 
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West Asia 
 
Afghanistan 
Armenia 
Azerbaijan 
Bahrain 
Georgia 
Iran (Islamic Republic of) 
Iraq 
Israel 
Jordan 
Kazakhstan 
Kuwait 
Kyrgyzstan 
 
Lebanon 
Oman 
Pakistan 
Qatar 
Saudi Arabia 
Syrian Arab Republic 
Tajikistan 
Turkey 
Turkmenistan 
United Arab Emirates 
Uzbekistan 
Yemen 
 
Europe
 
Albania 
Andorra 
Austria 
Belarus 
Belgium 
Bosnia and Herzegovina 
Bulgaria 
Croatia 
Cyprus 
Czech Republic 
Denmark 
Estonia 
Finland 
France 
Germany 
Greece 
Holy See 
Hungary 
Iceland 
Ireland 
Italy 
Latvia 
Liechtenstein 
 
Lithuania 
Luxembourg 
Malta 
Monaco 
Montenegro 
Netherlands 
Norway 
Poland 
Portugal 
Republic of Moldova 
Romania 
Russian Federation 
San Marino 
Serbia  
Slovakia 
Slovenia 
Spain 
Sweden 
Switzerland 
The former Yugoslav Republic of 
    Macedonia 
Ukraine 
United Kingdom of Great Britain 
    and Northern Ireland 
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Oceania
 
Australia 
Cook Islands 
Fiji 
Kiribati 
Marshall Islands 
Micronesia (Federated States of) 
Nauru 
New Zealand 
 
Niue 
Palau 
Papua New Guinea 
Samoa 
Solomon Islands 
Tonga 
Tuvalu 
Vanuatu 
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Annex II 
 
 
  Current membership of the International Narcotics Control 
Board 
 
 
  Hamid Ghodse 
 
 
 Born in 1938. National of the Islamic Republic of 
Iran. Professor of Psychiatry and of International Drug 
Policy, University of London (since 1987). Director, 
International Centre for Drug Policy, St. George’s 
University of London (since 2003); President, 
European Collaborating Centres for Addiction Studies 
(since 1992); Non-Executive Director, National Patient 
Safety Agency, United Kingdom (since 2001); 
Chairman, Higher Degrees in Psychiatry, University of 
London (since 2003); Chairman, Honours Committee, 
Royal College of Psychiatrists, United Kingdom  
(since 2006). 
 Recipient of the following degrees, qualifications 
and awards: Doctor of Medicine (M.D.), Islamic 
Republic of Iran (1965); Diploma Psychological 
Medicine (D.P.M.), United Kingdom (1974); Doctor of 
Philosophy (Ph.D.), University of London (1976); and 
Doctor of Science (D.Sc.), University of London 
(2002). Fellow of the Royal College of Psychiatrists 
(F.R.C.Psych.), United Kingdom (1985); Fellow of the 
Royal College of Physicians (F.R.C.P.), London 
(1992); Fellow of the Royal College of Physicians of 
Edinburgh (F.R.C.P.E.), Edinburgh (1997); Fellow of 
the Faculty of Public Health Medicine (F.F.P.H.), 
United Kingdom (1997); Fellow of the Higher 
Education Academy (F.H.E.A.), United Kingdom 
(2005); International Fellow, American Psychiatric 
Association (APA) (2009). Honorary Fellow, Royal 
College of Psychiatrists (R.C.Psych.) (2006); Honorary 
Fellow, World Psychiatric Association (2008). Member 
of the World Health Organization (WHO) Expert 
Advisory Panel on Alcohol and Drug Dependence 
(since 1979); Adviser, Joint Formulary Committee, 
British National Formulary (since 1984); Honorary 
Consultant Psychiatrist, St. George’s and Springfield 
University Hospitals, London (since 1978); Honorary 
Consultant Public Health, Wandsworth Primary Care 
Trust, London (since 1997). Consultant Psychiatrist,  
St. Thomas’s Teaching Hospital and Medical School, 
London (1978-1987); member, rapporteur, chairman 
and convener of various WHO and European 
Community expert committees, review groups and 
other working groups on drug and alcohol dependence; 
M. S. McLeod Visiting Professor, Southern Australia 
(1990); Honorary Professor, Peking University  
(since 1997). Author or editor of over 300 scientific 
books and papers on drug-related issues and 
addictions, including the following books: The Misuse 
of Psychotropic Drugs, London (1981); Psychoactive 
Drugs and Health Problems, Helsinki (1987); 
Psychoactive Drugs: Improving Prescribing Practices, 
Geneva (1988); Substance Abuse and Dependence, 
Guildford (1990); Drug Misuse and Dependence: The 
British and Dutch Response, Lancashire, United 
Kingdom (1990); Misuse of Drugs (3rd ed.), London 
(1997); Young People and Substance Misuse, London 
(2004); Addiction at Workplace, Aldershot (2005); 
International Drug Control into the 21st Century, 
Aldershot (2008). Ghodse’s Drugs and Addictive 
Behaviour: A Guide to Treatment (4th ed.), Cambridge 
(2010); Editor-in-Chief, International Psychiatry; 
Honorary Editor-in-Chief Chinese Journal of Drug 
Dependence; member of the Editorial Board, 
International Journal of Social Psychiatry; member of 
the Editorial Board, Asian Journal of Psychiatry. 
Convener of WHO expert groups on medical  
education (1986), pharmacy education (1987), nurse 
education (1989) and rational prescribing of 
psychoactive drugs. Chairman, Association of 
Professors of Psychiatry of the British Isles  
(since 1991); Chairman, Association of European 
Professors of Psychiatry; Director, National 
Programme on Substance Abuse Deaths (since 1997); 
member of the International Association of 
Epidemiology (since 1998).  
 Member of the International Narcotics Control 
Board (since 1992). Member of the Standing 
Committee on Estimates (1992). President of the Board 
(1993, 1994, 1997, 1998, 2000, 2001, 2004, 2005, 
2008 and 2010). 
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  Galina Korchagina 
 
 
 Born in 1953. National of the Russian Federation. 
Deputy Director of Research at the National Centre for 
Research on Drug Addiction, Ministry of Health and 
Social Development, Russian Federation (since 2010). 
 Leningrad Paediatrics Institute, Russian 
Federation (1976); doctor of medicine (2001). Doctor, 
boarding school, Gatchina, Leningrad region  
(1976-1979). Head of the Organizational and Policy 
Division, Leningrad Regional Drug Clinic  
(1981-1989); Lecturer, Leningrad Regional Medical 
Academy (1981-1989); Head Doctor, City Drug Clinic, 
St. Petersburg (1989-1994); Assistant Lecturer (1991-
1996) and Professor (2000-2001), Department of 
Social Technologies, State Institute for Services and 
Economics; Assistant Lecturer (1994-2000), Associate 
Professor (2001-2002) and Professor (2002-2008), 
Department for Research on Drug Addiction,  
St. Petersburg Medical Academy of Postgraduate 
Studies; Chief Professor and Head of the Department 
for Medical Research and Healthy Lifestyles, Herzen 
State Pedagogical University of Russia (2000-2008); 
Professor, Department for Conflict Studies, Faculty of 
Philosophy, St. Petersburg State University (2004-
2008); Member of numerous associations and societies, 
including: Association of Psychiatrists and Drug 
Addiction Specialists of Russia and St. Petersburg; 
Kettil Bruun Society for Social and Epidemiological 
Research on Alcohol; International Council on Alcohol 
and Addictions; International Society of Addiction 
Medicine: head of the sociology of science aspects of 
medical and biological research section of the Research 
Council on the Sociology of Science and the 
Organization of Scientific Research, St. Petersburg 
Scientific Centre of the Russian Academy of Sciences 
(2002-2008). Author of more than 100 publications, 
including more than 70 works published in the Russian 
Federation, chapters in monographs and several 
practical guides. Award for excellence in health 
protection, awarded by the Ministry of Health of the 
Union of Soviet Socialist Republics (1987). 
Consultant, Global Business Coalition on HIV/AIDS, 
Tuberculosis and Malaria (since 2006); co-trainer, 
WHO programme “Skills for change” (since 1995); 
participant in meetings of the Commission on Narcotic 
Drugs (2002-2008); expert on the epidemiology of 
drug addiction, Pompidou Group of the Council of 
Europe (1994-2003); temporary representative, WHO 
(1992-2008). 
 Member of the International Narcotics Control 
Board (2010). 
 
 
  Carola Lander 
 
 
 Born in 1941. National of Germany. 
 Pharmacist, doctoral degree in natural science; 
Certified Specialist in Public Health (Chamber of 
Pharmacists). Research assistant and assistant 
professor, University of Berlin (1970-1979); person in 
charge of pharmaceutical quality control of herbal 
drugs, Federal Institute for Drugs and Medical 
Devices, Berlin (1979-1990); head of the division for 
the control of manufacturers of narcotic drugs, Federal 
Opium Agency of Germany (1990-1992). Head of the 
Federal Opium Agency, the German authority with 
competence under article 17 of the Single Convention 
on Narcotic Drugs of 1961 and article 6 of the 
Convention on Psychotropic Substances of 1971, and 
Chairperson of the federal expert group for narcotic 
drugs (1992-2006). Member of the German delegation 
to the Commission on Narcotic Drugs (1990-2006). 
Lecturer on drug regulatory affairs, University of Bonn 
(2003-2005). Recipient of a certificate of appreciation 
for outstanding contributions in the field of drug law 
enforcement awarded by the Drug Enforcement 
Administration of the United States and recipient of a 
certificate of appreciation awarded by the former 
Yugoslav Republic of Macedonia. 
 Member of the International Narcotics Control 
Board (since 2007). Member (2007), Vice-Chairperson 
(2008) and Chairperson (2009) of the Standing 
Committee on Estimates. Second Vice-President of the 
Board (2009). First Vice-President of the Board (2010). 
 
 
  Melvyn Levitsky 
 
 
 Born in 1938. National of the United States. 
Retired Ambassador in the United States Foreign 
Service. Professor of International Policy and Practice 
and Senior Fellow, International Policy Center,  
Gerald R. Ford School of Public Policy, University of 
Michigan (since 2006). Faculty Associate, Center for 
Russian and East European Studies, Faculty  
Advisor, Weiser Center for Emerging Democracies,  
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University of Michigan. Member of the Operating 
Committee, Substance Abuse Research Center, 
University of Michigan.  
 United States diplomat for 35 years, serving as, 
inter alia, Ambassador of the United States to Brazil 
(1994-1998); Assistant Secretary of State for 
International Narcotics Matters (1989-1993); Executive 
Secretary and Special Assistant to the Secretary of the 
United States Department of State (1987-1989); 
Ambassador of the United States to Bulgaria  
(1984-1987); Deputy Director, Voice of America 
(1983-1984); Deputy Assistant Secretary of State for 
Human Rights and Humanitarian Affairs (1982-1983); 
Director, Office of United Nations Political Affairs, 
Bureau of International Relations (1980-1982); 
Officer-in-Charge for Bilateral Relations, Office of 
Soviet Union Affairs (1975-1978); Political Officer, 
United States Embassy in Moscow (1973-1975); 
Consul, United States consulates in Frankfurt, 
Germany (1963-1965), and Belem, Brazil (1965-1967). 
Professor of International Relations and Public 
Administration, Maxwell School of Citizenship and 
Public Affairs, Syracuse University (1998-2006). 
Recipient of several United States Department of State 
Meritorious and Superior Honor Awards, Presidential 
Meritorious Service Awards and the United States 
Secretary of State’s Distinguished Service Award. 
Member of the Washington Institute of Foreign Affairs, 
the American Academy of Diplomacy and the 
American Foreign Service Association. Member of the 
Advisory Board, Drug Free America Foundation. 
Member of the Institute on Global Drug Policy. 
Member of the Board, Global Panel of the Prague 
Society. Member of the Public-Private Working Group 
on Sale of Controlled Substances via the Internet 
(Harvard University Law School). Distinguished 
Fellow, Daniel Patrick Moynihan Institute of Global 
Affairs, Maxwell School of Citizenship and Public 
Affairs, Syracuse University. Member of the University 
of Michigan Substance Abuse Research Center. Listed 
in Who’s Who in American Politics, Who’s Who in 
American Government and Who’s Who in American 
Education. 
 Member of the International Narcotics Control 
Board (since 2003). Chairman of the Committee on 
Finance and Administration (2004). Chairman of the 
Working Group on Strategy and Priorities (2005). 
 
 
  Marc Moinard 
 
 
 Born in 1942. National of France. Retired law 
officer. School of Political Sciences, Paris; Paris Law 
Faculty; Faculty of Arts, Poitiers. Public Prosecutor, 
Beuvais (1982-1983); Public Prosecutor, Pontoise 
(1990); Public Prosecutor, Lyon (1990-1991); Public 
Prosecutor, Bobigny (1992-1995); Public Prosecutor in 
the Court of Appeal, Bordeaux (1999-2005), 
introducing major reforms into the legal system 
involving: the creation of centres for legal advice and 
mediation; the provision of legal advice in deprived 
areas; the establishment of a new system of 
cooperation between the courts and the police services 
allowing for the immediate handling of criminal 
offences; and the creation of a new category of judicial 
personnel — assistant prosecutors. 
 Senior administrative posts in the Ministry of 
Justice: Director of Record Offices (1983-1986); 
President of the teaching board, National School of 
Clerks to the Court; Director of Legal Services; 
member of the Board of Directors, French National 
School for the Judiciary; Representative of the 
Minister of Justice in the Supreme Council of Justice 
(1995-1996); Director, Criminal Matters and Pardons 
(1996-1998); President, French Monitoring Centre for 
Drugs and Drug Addiction; Secretary-General, 
Ministry of Justice (2005-2008); President, Law and 
Justice Mission, responsible for the reform of the 
judicial map; President, Commission on Information 
Technology and Communication; Head of the 
International Affairs Service, Ministry of Justice. 
Lecturer, Paris Institute of Criminology (1995-2005); 
President, Fondation d’Aguesseau, a welfare body. 
Recipient of the following awards: Commander of the 
National Order of Merit; Commander of the Legion of 
Honour.  
 Member of the International Narcotics Control 
Board (2010). 
 
 
  Jorge Montaño 
 
 
 Born in 1948. National of Mexico. Professor of 
International Organizations and Mexican Foreign 
Policy, Instituto Tecnológico Autónomo de México, 
private consultant on the enforcement of the North 
American Free Trade Agreement (NAFTA). 
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 Law and Political Science, Universidad Nacional 
Autónoma de México; Master of Arts and Doctor of 
Philosophy in International Affairs, London School of 
Economics. Director General de Educación Superior — 
Secretaría de Educación Pública (1976-1979); Member 
of the Mexican Foreign Service (1979-2008); Director 
of International Agencies (1979-1982); Assistant 
Secretary of Multilateral Affairs (1982-1988); 
Permanent Representative of Mexico to the United 
Nations organizations (1989-1992); Chairman of the 
Group of Experts to enhance the efficiency of the 
United Nations structure for drug abuse control (1990); 
Ambassador of Mexico to the United States  
(1993-1995); member of the Multilateral Evaluation 
Mechanism on drugs (2001-2003) of the Inter-
American Drug Abuse Control Commission (CICAD). 
Author of the following publications: Partidos y 
política en América Latina; Implicaciones legales de la 
presencia de Estados Unidos en Viet Nam; Análisis del 
Sistema de Naciones Unidas; ACNUR en América 
Latina; Negociaciones del Tratado de Libre Comercio 
de America del Norte; Cooperación México-Estados 
Unidos en materia de narcotráfico; Debilidades de la 
certificación del Congreso de Estados Unidos; Retos 
de la frontera norte de México; Tráfico de armas en las 
fronteras mexicanas. Author of 50 articles published in 
specialized journals. Weekly contributor to the editorial 
pages of La Jornada, Reforma and El Universal. 
President and founding member of Foreign Affairs 
Latinoamérica (formerly Foreign Affairs en Español). 
Founding President, Asesoría y Análisis, S.C., Mexican 
Council on Foreign Relations (COMEXI). Recipient of 
awards from the Governments of Chile, El Salvador, 
Greece and Guatemala. Participant in many meetings 
of organizations in the United Nations system, the 
Organization of American States and the Movement of 
Non-Aligned Countries. 
 Member of the International Narcotics Control 
Board (2009). Member of the Committee on Finance 
and Administration (2010). 
 
 
  Lochan Naidoo 
 
 
 Born in 1961. National of South Africa. Family 
Practitioner, Durban, South Africa (since 1985).  
 Bachelor of Medicine and Bachelor of Surgery 
(MBChB), University of Natal, South Africa (1983). 
Professional in Residence Programme: Hanley 
Hazelden (1995); Member of the South African 
Medical Association (since 1995); Member and Vice-
Chairman of the Bayport Independent Practitioners 
Association (1995-2000). Certified Chemical 
Dependency Counsellor, National Board of Addiction 
Examiners (NBAE) (1996); Member of the American 
Society of Addiction Medicine (1996-1999). Diploma 
in Business Management, South African Institute of 
Management (1997). Founding member, International 
Society of Addiction Medicine (1999); Programme 
Designer and Principal Addictions Therapist of the 
Jullo Programme, a multi-disciplinary treatment model 
for primary, secondary and tertiary prevention of 
addiction disorders and dual diagnoses (since 1994); 
Clinical Director, Serenity Addiction Treatment Unit, 
Merebank, Durban, South Africa (since 1995). Member 
of the KwaZulu-Natal Managed Care Coalition  
(since 1995); Member of the Durban South  
Doctors’ Guild (since 2000); Honorary Lecturer,  
Nelson R. Mandela School of Medicine, University of 
KwaZulu-Natal, South Africa (since 2005). Curriculum 
Committee undergraduate Lifestyle Medicine, 
University of KwaZulu-Natal (since 2005).  
Drafter of the National Detoxification Policy and 
Procedure for the Department of Health of South 
Africa (2006); designer of the Roots connect software 
program, an Internet-driven emotional and addiction 
psychoeducation delivery system (2007); Member of 
the Opiate Advisory Board of South Africa  
(2006-2008); Member of the Board, Central Drug 
Authority of South Africa (2006-2010); Member of the 
Governance Committee, Central Drug Authority of 
South Africa (2006-2010). Member of the Expert 
Committee on Opiate Treatment (2007-2008); Central 
Drug Authority representative to the Western Cape 
Province, South Africa (2007-2010); established 
“Roots HelpPoints” for early intervention and primary 
prevention among high-risk individuals (2008). 
Co-author of “Guidelines for opiate treatment in South 
Africa”, South African Medical Journal (2008). 
Member of the Suboxone Advisory Board (2009). 
Co-author of “Suboxone update”, South African 
Medical Journal (2010); Designer of “RehabFlow” 
cloud computing software for addiction and 
co-morbidity management (2010); Management 
Committee Member of eThekweni District Mental 
Heath and Substance Abuse Forum (2010). 
Rehabilitation and addictions trainer for health-care 
practitioners. Medical educator for undergraduate and 
postgraduate medical practitioners (since 1995); Patron 
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of Andra Maha Sabha of South Africa; founder, 
Merebank West Community Coalition (1995). Trustee, 
Merebank Community Trust (2000-2005).  
 Member of the International Narcotics Control 
Board (since 2010). 
 
 
  Rajat Ray 
 
 
 Born in 1948. National of India. Professor and 
Head of the Department of Psychiatry and Chief, 
National Drug Dependence Treatment Centre 
(NDDTC), All India Institute of Medical Sciences 
(AIIMS), New Delhi. 
 Graduate of Medicine (MBBS), Medical College 
in Calcutta (1971). M.D. (Psychiatry), AIIMS (1977). 
Member of the faculty, Department of Psychiatry, 
National Institute of Mental Health and Neuro Sciences 
in Bangalore (1979-1988). Author of several technical 
reports and articles in peer reviewed national and 
international journals. Assistant Editor, Addiction 
Biology. Member of the International Advisory Board, 
Mental Health and Substance Use: Dual Diagnosis. 
Recipient of research support from various bodies at 
the national level (such as the Ministry of Health and 
Family Welfare and the Indian Council of Medical 
Research) and the international level (such as the 
United Nations Office on Drugs and Crime (UNODC) 
and WHO). Member of a study on HIV/AIDS, a 
collaborative project of NDDTC, AIIMS and the 
Center for Interdisciplinary Research in Immunology 
and Disease, University of California, Los Angeles 
(UCLA), United States of America. Member of the 
WHO Expert Advisory Panel on Drug Dependence and 
Alcohol Problems. Member of the expert group to 
discuss mental health and substance use disorder at the 
primary care level, an activity of the WHO Regional 
Office for South-East Asia. Member of the WHO 
expert group on regional technical consultation to 
reduce harmful use of alcohol. Coordinator of various 
activities in India on substance use disorder, sponsored 
by WHO (since 2004). Member of the National Drug 
Abuse Control Programme, India, and the Technical 
Guidelines Development Group on Pharmacotherapy 
of Opioid Dependence, a joint project of UNODC and 
WHO. Member and Chairperson of the Technical 
Resource Group on Injecting Drug Use, a project of the 
National AIDS Control Organization. Member of the 
project advisory committee on the prevention of 
transmission of HIV among drug users in South Asian 
Association for Regional Cooperation (SAARC) 
member States, a project of the UNODC Regional 
Office for South Asia. Member of the Subcommittee on 
Postgraduate Medical Education, Medical Council of 
India.  
 Member of the International Narcotics Control 
Board (2010). Member of the Standing Committee on 
Estimates (2010). 
 
 
  Viroj Sumyai 
 
 
 Born in 1953. National of Thailand. Retired 
Assistant Secretary-General of the Food and Drug 
Administration, Ministry of Public Health of  
Thailand, and clinical pharmacologist specializing in  
drug epidemiology. Professor, Mahidol University  
(since 2001). 
 Bachelor of Science degree in Chemistry (1976), 
Chiang Mai University. Bachelor’s degree in Pharmacy 
(1979), Manila Central University. Master’s degree in 
Clinical Pharmacology (1983), Chulalongkorn 
University. He then took apprenticeship in narcotic 
drugs epidemiology at St. George’s University of 
London in England in 1989. Doctor of Philosophy, 
Health Policy and Administration (2009), National 
Institute of Administration. Member of the 
Pharmaceutical Association of Thailand. Member of 
the Pharmacological and Therapeutic Society of 
Thailand. Member of the Thai Society of Toxicology. 
Author of nine books in the field of drug prevention 
and control, including Drugging Drinks: Handbook for 
Predatory Drugs Prevention and Déjà vu: A Complete 
Handbook for Clandestine Chemistry, Pharmacology 
and Epidemiology of LSD. Columnist, Food and Drug 
Administration Journal. Recipient of the Prime 
Minister Award for Drug Education and Prevention 
(2005).  
 Member of the International Narcotics Control 
Board (2010). Member of the Standing Committee on 
Estimates (2010). 
 
 
  Sri Suryawati 
 
 
 Born in 1955. National of Indonesia. Coordinator, 
Master Degree Program for Medicine Policy and 
Management, Gadjah Mada University. Senior Lecturer 
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in Pharmacology/Clinical Pharmacology (since 1980); 
supervisor for more than 120 master’s and  
doctoral theses on medicine policy, the rational  
use of medicines, clinical pharmacokinetics 
pharmacoeconomics, and pharmaceutical management. 
 Pharmacist (1979). Specialist in pharmacology 
(1985); doctoral degree in clinical pharmacokinetics 
(1994). Former Director of the Centre for Clinical 
Pharmacology and Medicine Policy Studies, Gadjah 
Mada University (2002-2010). Former Head of Clinical 
Pharmacology, Faculty of Medicine, Gadjah Mada 
University, Indonesia (1999-2006 and 2008-2009). 
Member of the WHO Expert Advisory Panel for 
Medicine Policy and Management. Member of the 
Executive Board of the International Network for the 
Rational Use of Drugs (INRUD). Member of the WHO 
Expert Committee on the Selection and Use of 
Essential Medicines (2002, 2003, 2005 and 2007). 
Member of the WHO Expert Committee on Drug 
Dependence (2002 and 2006). Member of the United 
Nations Millennium Project Task Force on HIV/AIDS, 
Malaria and Tuberculosis and Access to Essential 
Medicines (Task Force 5) (2001-2005). Consultant in 
essential medicine programmes and promoting rational 
use of medicines in Bangladesh (2006-2007), 
Cambodia (2001-2008), China (2006-2008), Fiji 
(2009), the Lao People’s Democratic Republic  
(2001-2003), Mongolia (2006-2008) and the 
Philippines (2006-2007). Consultant in medicine 
policy and drug evaluation in Cambodia (2003, 2005 
and 2007), China (2003), Indonesia (2005-2006) and 
Viet Nam (2003). Facilitator in various international 
training courses in medicine policy and promoting the 
rational use of medicines, including WHO and INRUD 
courses on promoting the rational use of medicines 
(1994-2007), training courses on hospital drugs and 
therapeutics committees (2001-2007) and international 
courses on drug policy in developing countries  
(2002-2003). 
 Member of the International Narcotics Control 
Board (since 2007). Member (2008), Vice-Chair (2009) 
and Chair (2010) of the Standing Committee on 
Estimates. Second Vice-President of the Board (2010). 
 
 
  Camilo Uribe Granja 
 
 
 Born in 1963. National of Colombia. Medical 
Director, Maldonado Editorial Foundation, ILADIBA, 
Bogota; Director Toxicology Unit, Clínica de Marly, 
Bogota (since 1990); Toxicologist, Clínica Palermo, 
Bogota (since 1994); Scientific Director, Unidad de 
Toxicología Integral (UNITOX), Hospital Infantil 
Universitario de San José (since 2008); Chief 
Coordinator, Clinic Toxicology, Hospital Infantil 
Universitario de San José, Bogota. 
 Medical doctor, Surgery, Faculty of Medicine, 
University of Our Lady of the Rosary (1989); 
specialization in clinical toxicology, Faculty of 
Medicine, University of Buenos Aires (1990); 
specialization in occupational toxicology (1997), 
University Teacher’s Certificate (1998), diplomas in 
hospital management (1998) and high-level social 
security administration (1999), High-Level Public 
Administration School (ESAP). Diploma in 
toxicological emergencies, University of Our Lady of 
the Rosary, FUNDASALUD (1998); diploma in higher 
education tuition, University of Our Lady of the 
Rosary. Forensic medical doctor, toxicologist, technical 
coordinator and manager in several hospitals and 
institutions. Medical Director, Hospital of San Martín, 
Meta, Colombia (1988); Head of Medical Attention, 
Caja de Previsión Social de Comunicaciones 
(CAPRECOM), Meta and national territories  
(until 1990); Regional Director, CAPRECOM, Bogota 
(until Dec. 1992); Scientific Director, Toxicology 
Clinic, toxicology advisory centre, “Guillermo Uribe 
Cualla” (1991-2005); Director, Clinical Toxicology, 
Clínica Fray Bartolomé de las Casas (until Jan. 1991); 
Toxicology Doctor, Clínica San Pedro Claver  
(1990-1991); President, Tropical Medicine Institute 
Corporation “Luis Patiño Camargo” (until 1992); 
Medical Coordinator and (since 1993) Director, 
National Emergency Network; Director, Toxicology 
Department, Hospital de Occidente Kennedy, Bogota 
(1993-1998); Director, Toxicology, Health Department, 
District of Bogota (1993-1999); Director, Health 
Services Management Programme, ESAP (until 2001); 
Member of the Steering Committee of Drugs and Food 
Control Administration, National Institute of Food and 
Drug Monitoring (INVIMA) (1994-2001); Director-
General, INVIMA (2001-2002); Secretary, Colombian 
Medical Association, Cundinamarca and Bogota 
sections (until 2002); Director-General, Nueva Clínica 
Fray Bartolomé de las Casas, Bogota (2002-2003); 
Adviser to the toxicology office, United States 
Department of State (until 2005); Adviser in 
Toxicology, National Narcotics Directorate (DNE) of 
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Colombia (until 2005). President, Colombian 
Association of Toxicology and Drug Abuse 
(ACOTOFA) (since 1992); Vice-President (1988-1990 
and 1995-1998) and President (2003-2009), Latin 
American Toxicology Association (ALATOX); Vice-
President, International Union of Toxicology (IUTOX) 
(2005-2007 and 2007-2009). Author of numerous 
works, including: the chapter on benzodiazepines in 
Therapeutic Compendium of the Colombian Internal 
Medicine Association (1992); Criminal Intoxication 
with Scopolamine-Like Substances; Handbook on 
Toxicological Emergency Management; and Manual on 
the Treatment of Intoxication by Plaguicides (1995). 
Recipient of numerous awards, including: award for 
academic records and qualifications, Iberoamerican 
Congress of Toxicology (Bicongretox), Spanish 
Association of Toxicolgy (AETOX) (1993); and 
honourable mention for services to Colombian society 
in the field of toxicology, First International Congress 
of Toxicology, University of Antioquia (1996). 
Participant in numerous professional conferences and 
seminars, including: XVIII International Congress of 
Internal Medicine, Bogota (1986); 35th Annual 
Meeting, Society of Toxicology, Anaheim,  
California (1996); Pan-American Congress of 
Neuropsychopharmacology and International Seminar 
on Addictive Diseases, Bogota (1998). National 
Congress on Heroin: A Challenge for Mental and 
Public Health, Medellin (2008); and International 
Congress on Synthetic Drugs (2009). Head of the Law 
Faculty, Pontificia Universidad Javeriana (1990-2006); 
Industrial Toxicology Professor, Colombian Security 
Council (until 1993); Postgraduate Professor, 
Fundación Universitaria Luis Amigó; and Instructor of 
Toxicology, Faculty of Medicine, National University 
of Colombia.  
 Member of the International Narcotics Control 
Board (since 2005). Member (since 2009), Vice-
Chairman (2006 and 2007) and Chairman (2008) of the 
Standing Committee on Estimates; Member (since 
2007) and Chair (2010) of the Committee on Finance 
and Administration.  
 
 
  Raymond Yans 
 
 
 Born in 1948. National of Belgium. Graduate in 
Germanic philology and in philosophy (1972). Belgian 
Foreign Service: Attaché, Jakarta (1978-1981); 
Deputy-Mayor of Liège (1982-1989); Consul, Tokyo 
(1989-1994); Consul, Chargé d’affaires, Luxembourg 
(1999-2003); Head of the Drug Unit, Ministry of 
Foreign Affairs (1995-1999 and 2003-2007); Chairman 
of the Dublin Group (2002-2006); Chairman of the 
European Union Drug Policy Cooperation Working 
Group during the Belgian Presidency of the European 
Union; charged with the national coordination of the 
ratification and implementation process of the 
Convention on Psychotropic Substances of 1971 and 
the United Nations Convention against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances of 1988 
(1995-1998); liaison between the Ministry of Foreign 
Affairs and the National Police for drug liaison officers 
in Belgian embassies (2003-2005); participation in the 
launching by the European Union Joint Action on New 
Synthetic Drugs of an early warning system to alert 
Governments to the appearance of new synthetic drugs 
(1999); active in the creation of the Cooperation 
Mechanism on Drugs between the European Union, 
Latin America and the Caribbean (1997-1999). Author 
of numerous articles and speeches including: “The 
future of the Dublin Group” (2004) and “Is there 
anything such as a European Union Common Drug 
Policy” (2005). Member of the Belgian delegation to 
the Commission on Narcotic Drugs (1995-2007); all 
the preparatory sessions (on amphetamine-type 
stimulants, precursors, judicial cooperation, money-
laundering, drug demand reduction and alternative 
development) for the twentieth special session of the 
General Assembly; European Union Seminar on Best 
Practices in Drug Enforcement by Law Enforcement 
Authorities, Helsinki (1999); Joint European 
Union/Southern African Development Community 
Conferences on Drug Control Cooperation, Mmabatho, 
South Africa (1995) and Gabarone (1998); United 
Nations Office on Drugs and Crime/Paris Pact round 
tables, Brussels (2003), Tehran and Istanbul (2005); 
meetings of the High-level Dialogue on Drugs between 
the Andean Community and the European Union,  
Lima (2005) and Vienna (2006). 
 Member of the International Narcotics Control 
Board (since 2007). Member of the Standing 
Committee on Estimates (2007 and 2010). Member of 
the Committee on Finance and Administration  
(since 2007). Rapporteur (2010). 
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  Yu Xin 
 
 
 Born in 1965. National of China. Clinical 
Professor of Psychiatry, Institute of Mental Health, 
Peking University (since 2004). Licensed Psychiatrist, 
China Medical Association (since 1988). Founding 
President, Chinese Psychiatrist Association  
(2005-2008); Chairperson, Credential Committee for 
Psychiatrists, Ministry of Health of China; President-
elect, Chinese Society of Psychiatry (since 2006); 
Vice-President, Management Association for 
Psychiatric Hospitals (2009); Vice-Chairman, 
Alzheimer’s Disease, China (since 2002). 
 Bachelor of Medicine, Beijing Medical 
University (1988); Fellow in Psychiatry, University of 
Melbourne, Australia (1996-1997); Fellow in 
Substance Abuse, Johns Hopkins University  
(1998-1999); Doctor of Medicine (M.D.), Peking 
University (2000); Senior Fellow in Social Medicine, 
Harvard University (2003). Residency in psychiatry  
(1988-1993) and Psychiatrist (1993-1998), Institute of 
Mental Health, Beijing Medical University; Head, 
Associate Professor of Psychiatry, Geriatric 
Psychiatrist, Department of Geriatric Psychiatry, 
Institute of Mental Health, Peking University  
(1999-2001); Assistant Director (2000-2001) and 
Executive Director (2001-2004), Institute of Mental 
Health, Peking University. Author and co-author of 
numerous works on various topics in psychiatry, such 
as psychopharmacology, early intervention of 
schizophrenia, mental health and HIV/AIDS and drug 
use, mental health outcome of harmful alcohol use, 
neuropsychology of mental disorders, neuroimaging of 
late life depression, late onset psychosis, and 
assessment, treatment and care for dementia. Editor of 
several textbooks, including Geriatric Psychiatry, 
Textbook of Psychiatry for Asia and Psychiatry for 
Medical Students. Recipient of the Outstanding 
Clinician Award, Beijing Medical University, and the 
Innovation and Creation Award, Beijing Medical 
Professional Union (2004). Member of the expert 
group for the section on analgesics and sedatives of the 
State Food and Drug Administration (since 2000). 
Evaluator of the effectiveness of methadone clinics. 
Leader of a project to follow up the neurocognitive and 
mental functioning of patients infected with HIV/AIDS 
as a result of intravenous drug abuse. Chief 
Psychiatrist, National Community Mental Health 
Service Programme. Senior consultant, Chinese 
Association on Tobacco Control. Senior consultant, 
Chronic Pain Treatment Programme.  
 Member of the International Narcotics Control 
Board (since 2007). Chairman of the Committee on 
Finance and Administration (2009). Member (since 
2007) and Vice-Chair (2010) of the Standing 
Committee on Estimates. 
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Annex III 
 
 
 Other international instruments used in efforts to fight 
drug-related crime 
 
 
 The main mechanisms supporting international cooperation among criminal 
justice agencies are mutual legal assistance, extradition, transfer of proceedings in 
criminal matters, freezing and confiscation of the proceeds of crime and a number 
of less formal measures. Those mechanisms are based on bilateral or multilateral 
agreements or arrangements, as well as on national laws. All of them are evolving 
rapidly to keep pace with new technologies. Their strengthening over the past  
10 years or so reflects the determination of Member States to work more closely 
with each other to face the growing threats of organized crime and corruption. 
 In addition to the United Nations Convention against Illicit Traffic in Narcotic 
Drugs and Psychotropic Substances of 1988,a two other conventions are crucial to 
promoting international cooperation in the fight against organized crime and 
corruption: the United Nations Convention against Transnational Organized Crimeb 
and the Protocols thereto;c and the United Nations Convention against Corruption.d 
Having national legislation in place to fully implement those legal instruments is 
therefore of paramount importance, as is the adoption of the administrative 
measures necessary to support the various modalities of international cooperation. 
 
  United Nations Convention against Transnational Organized Crime and the 
Protocols thereto 
 
 The Organized Crime Convention and its Protocols apply to serious offences 
committed by criminal organizations, including participation in the activities of 
those organizations. Drug trafficking and corruption offences are also included. The 
Convention is an important legal instrument for establishing the legislative 
framework needed to address the illicit drug trade and for building mechanisms for 
international cooperation. In the absence of bilateral arrangements, the Organized 
Crime Convention can act as a treaty on mutual legal assistance or an extradition 
treaty between States parties to the Convention. The Convention strengthens most 
existing international cooperation mechanisms, such as extradition, mutual legal 
assistance, law enforcement cooperation, and protection of victims, informants and 
witnesses. 
 
  Making full use of mechanisms for international cooperation 
 
 Some significant progress has already been made towards the universal 
implementation of the Organized Crime Convention, but much remains to be done. 
There is unfortunately still a gap between the rapid ratification of the Convention 
and its implementation. The full potential of the Convention in the area of ensuring 
effective action against the illicit drug trade and other forms of organized crime has 
not yet been realized. That is being progressively addressed by the Conference of 
__________________ 
 a United Nations, Treaty Series, vol. 1582, No. 27627. 
 b Ibid., vol. 2225, No. 39574. 
 c Ibid., vols. 2237, 2241 and 2326, No. 39574. 
 d Ibid., vol. 2349, No. 42146. 
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the Parties to the United Nations Convention against Transnational Organized 
Crime, by supporting and monitoring the implementation of the Convention. 
 
  United Nations Convention against Corruption 
 
 The main purposes of the Convention against Corruption are:e to promote and 
strengthen measures to prevent and combat corruption more efficiently and 
effectively; to promote, facilitate and support international cooperation and 
technical assistance in the prevention of and fight against corruption, including in 
asset recovery; and to promote integrity, accountability and proper management of 
public affairs and public property. 
 States parties to the Convention against Corruption are required to introduce 
effective policies aimed at the prevention of corruption. An entire chapter of the 
Convention is devoted to that issue. A variety of measures concerning both the 
public and the private sector are covered. The measures range from institutional 
arrangements, such as the establishment of a specific anti-corruption body, to codes 
of conduct and policies promoting good governance, the rule of law, transparency 
and accountability.f 
 States parties to the Convention against Corruption are obliged to criminalize a 
wide range of acts of corruption and to fully engage the criminal law and criminal 
justice system in the fight against corruption. Most importantly, the Convention is 
aimed at providing a strong framework for international cooperation in fighting 
corruption, particularly with respect to the tracing, freezing and seizure of assets, as 
well as asset recovery and measures to counter money-laundering. 
 The Convention against Corruption opens the door for a much greater level of 
cooperation between national anti-corruption agencies and other law enforcement 
agencies involved in the fight against organized crime, drug trafficking and 
corruption. That cooperation includes efforts to build the capacity of national law 
enforcement and criminal justice institutions to fight organized crime and 
corruption. Fighting corruption is a particularly important part of effective 
international cooperation. The provision of technical and other assistance in support 
of capacity-building initiatives is one of the aims of the Convention against 
Corruption, as well as the Organized Crime Convention and the 1988 Convention.g 
 
 
__________________ 
 
 e See article 1 of the Convention against Corruption. 
 f Legislative Guide for the Implementation of the United Nations Convention against Corruption 
(United Nations publication, Sales No. E.06.IV.16), para. 5. 
 g See article 10 of the 1988 Convention. 
                                          
  
 
 
  
About the International Narcotics Control Board 
 
 
 The International Narcotics Control Board (INCB) is an independent and quasi-judicial control organ, established by treaty, 
for monitoring the implementation of the international drug control treaties. It had predecessors under the former drug control 
treaties as far back as the time of the League of Nations. 
 
 
Composition 
 
 
 INCB consists of 13 members who are elected by the Economic and Social Council and who serve in their personal capacity, 
not as Government representatives. Three members with medical, pharmacological or pharmaceutical experience are elected from a 
list of persons nominated by the World Health Organization (WHO) and 10 members are elected from a list of persons nominated by 
Governments. Members of the Board are persons who, by their competence, impartiality and disinterestedness, command general 
confidence. The Council, in consultation with INCB, makes all arrangements necessary to ensure the full technical independence of 
the Board in carrying out its functions. INCB has a secretariat that assists it in the exercise of its treaty-related functions. The INCB 
secretariat is an administrative entity of the United Nations Office on Drugs and Crime, but it reports solely to the Board on matters 
of substance. INCB closely collaborates with the Office in the framework of arrangements approved by the Council in its  
resolution 1991/48. INCB also cooperates with other international bodies concerned with drug control, including not only the 
Council and its Commission on Narcotic Drugs, but also the relevant specialized agencies of the United Nations, particularly WHO. 
It also cooperates with bodies outside the United Nations system, especially the International Criminal Police Organization 
(INTERPOL) and the World Customs Organization. 
 
 
Functions 
 
 
 The functions of INCB are laid down in the following treaties: the Single Convention on Narcotic Drugs of 1961 as amended 
by the 1972 Protocol; the Convention on Psychotropic Substances of 1971; and the United Nations Convention against Illicit Traffic 
in Narcotic Drugs and Psychotropic Substances of 1988. Broadly speaking, INCB deals with the following: 
 (a) As regards the licit manufacture of, trade in and use of drugs, INCB endeavours, in cooperation with Governments, to 
ensure that adequate supplies of drugs are available for medical and scientific uses and that the diversion of drugs from licit sources 
to illicit channels does not occur. INCB also monitors Governments’ control over chemicals used in the illicit manufacture of drugs 
and assists them in preventing the diversion of those chemicals into the illicit traffic; 
 (b) As regards the illicit manufacture of, trafficking in and use of drugs, INCB identifies weaknesses in national and 
international control systems and contributes to correcting such situations. INCB is also responsible for assessing chemicals used in 
the illicit manufacture of drugs, in order to determine whether they should be placed under international control. 
 In the discharge of its responsibilities, INCB: 
 (a) Administers a system of estimates for narcotic drugs and a voluntary assessment system for psychotropic substances 
and monitors licit activities involving drugs through a statistical returns system, with a view to assisting Governments in achieving, 
inter alia, a balance between supply and demand; 
 (b)  Monitors and promotes measures taken by Governments to prevent the diversion of substances frequently used in the 
illicit manufacture of narcotic drugs and psychotropic substances and assesses such substances to determine whether there is a need 
for changes in the scope of control of Tables I and II of the 1988 Convention; 
 (c) Analyses information provided by Governments, United Nations bodies, specialized agencies or other competent 
international organizations, with a view to ensuring that the provisions of the international drug control treaties are adequately 
carried out by Governments, and recommends remedial measures; 
 (d) Maintains a permanent dialogue with Governments to assist them in complying with their obligations under the 
international drug control treaties and, to that end, recommends, where appropriate, technical or financial assistance to be provided. 
 INCB is called upon to ask for explanations in the event of apparent violations of the treaties, to propose appropriate remedial 
measures to Governments that are not fully applying the provisions of the treaties or are encountering difficulties in applying them 
and, where necessary, to assist Governments in overcoming such difficulties. If, however, INCB notes that the measures necessary 
to remedy a serious situation have not been taken, it may call the matter to the attention of the parties concerned, the Commission on 
Narcotic Drugs and the Economic and Social Council. As a last resort, the treaties empower INCB to recommend to parties that they 
  
stop importing drugs from a defaulting country, exporting drugs to it or both. In all cases, INCB acts in close cooperation with 
Governments. 
 INCB assists national administrations in meeting their obligations under the conventions. To that end, it proposes and 
participates in regional training seminars and programmes for drug control administrators. 
 
 
Reports 
 
 
 The international drug control treaties require INCB to prepare an annual report on its work. The annual report contains an 
analysis of the drug control situation worldwide so that Governments are kept aware of existing and potential situations that may 
endanger the objectives of the international drug control treaties. INCB draws the attention of Governments to gaps and weaknesses 
in national control and in treaty compliance; it also makes suggestions and recommendations for improvements at both the national 
and international levels. The annual report is based on information provided by Governments to INCB, United Nations entities and 
other organizations. It also uses information provided through other international organizations, such as INTERPOL and the World 
Customs Organization, as well as regional organizations. 
 The annual report of INCB is supplemented by detailed technical reports. They contain data on the licit movement of narcotic 
drugs and psychotropic substances required for medical and scientific purposes, together with an analysis of those data by INCB. 
Those data are required for the proper functioning of the system of control over the licit movement of narcotic drugs and 
psychotropic substances, including preventing their diversion to illicit channels. Moreover, under the provisions of article 12 of the 
1988 Convention, INCB reports annually to the Commission on Narcotic Drugs on the implementation of that article. That report, 
which gives an account of the results of the monitoring of precursors and of the chemicals frequently used in the illicit manufacture 
of narcotic drugs and psychotropic substances, is also published as a supplement to the annual report. 
 Since 1992, the first chapter of the annual report has been devoted to a specific drug control issue on which INCB 
presents its conclusions and recommendations in order to contribute to policy-related discussions and decisions in national, 
regional and international drug control. The following topics were covered in past annual reports: 
 1992:  Legalization of the non-medical use of drugs 
 1993:  The importance of demand reduction 
 1994:  Evaluation of the effectiveness of the international drug control treaties 
 1995:  Giving more priority to combating money-laundering 
 1996:  Drug abuse and the criminal justice system 
 1997:  Preventing drug abuse in an environment of illicit drug promotion 
 1998:  International control of drugs: past, present and future 
 1999:  Freedom from pain and suffering 
 2000:  Overconsumption of internationally controlled drugs 
 2001:  Globalization and new technologies: challenges to drug law enforcement in the twenty-first 
  century 
 2002:  Illicit drugs and economic development 
 2003:  Drugs, crime and violence: the microlevel impact 
 2004:  Integration of supply and demand reduction strategies: moving beyond a balanced approach 
 2005:  Alternative development and legitimate livelihoods 
 2006:  Internationally controlled drugs and the unregulated market 
 2007:  The principle of proportionality and drug-related offences 
 2008:  The international drug control conventions: history, achievements and challenges 
 2009:  Primary prevention of drug abuse 
 Chapter I of the report of the International Narcotics Control Board for 2010 is entitled “Drugs and corruption”. 
 Chapter II presents an analysis of the operation of the international drug control system based primarily on information 
that Governments are required to submit directly to INCB in accordance with the international drug control treaties. Its focus 
is on the worldwide control of all licit activities related to narcotic drugs and psychotropic substances, as well as chemicals 
used in the illicit manufacture of such drugs. 
 Chapter III presents some of the major developments in drug abuse and trafficking and measures by Governments to 
implement the international drug control treaties by addressing those problems. 
 Chapter IV presents the main recommendations addressed by INCB to Governments, the United Nations Office on 
Drugs and Crime, WHO and other relevant international and regional organizations. 
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